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Ithaka 
 
As you set out for Ithaka 
hope your road is a long one, 
full of adventure, full of discovery. 
Laistrygonians, Cyclops, 
angry Poseidon—don’t be afraid of them: 
you’ll never find things like that on your way 
as long as you keep your thoughts raised high, 
as long as a rare excitement 
stirs your spirit and your body. 
Laistrygonians, Cyclops, 
wild Poseidon—you won’t encounter them 
unless you bring them along inside your soul, 
unless your soul sets them up in front of you. 
 
Hope your road is a long one. 
May there be many summer mornings when, 
with what pleasure, what joy, 
you enter harbours you’re seeing for the first 
time; 
may you stop at Phoenician trading stations 
to buy fine things, 
mother of pearl and coral, amber and ebony, 
sensual perfume of every kind— 
as many sensual perfumes as you can; 
and may you visit many Egyptian cities 
to learn and go on learning from their scholars. 
 
Keep Ithaka always in your mind. 
Arriving there is what you’re destined for. 
But don’t hurry the journey at all. 
Better if it lasts for years, 
so you’re old by the time you reach the island, 
wealthy with all you’ve gained on the way, 
not expecting Ithaka to make you rich. 
 
Ithaka gave you the marvelous journey. 
Without her you wouldn't have set out. 
She has nothing left to give you now. 
 
And if you find her poor, Ithaka won’t have 
fooled you. Wise as you will have become, so 
full of experience, you’ll have understood by 
then what these Ithakas mean. 
 
C. P. Cavafy, "The City" (1984) from C.P. 
Cavafy: Collected Poems. 
Ἰθάκη 
 
Σὰ βγεῖς στὸν πηγαιμὸ γιὰ τὴν Ἰθάκη,  
νὰ εὔχεσαι νἆναι μακρὺς ὁ δρόμος,  
γεμάτος περιπέτειες, γεμάτος γνώσεις. 
Τοὺς Λαιστρυγόνας καὶ τοὺς Κύκλωπας,  
τὸν θυμωμένο Ποσειδῶνα μὴ φοβᾶσαι,  
τέτοια στὸν δρόμο σου ποτέ σου δὲν θὰ 
βρεῖς, ἂν μέν᾿ ἡ σκέψις σου ὑψηλή, ἂν 
ἐκλεκτὴ συγκίνησις τὸ πνεῦμα καὶ τὸ 
σῶμα σου ἀγγίζει. 
Τοὺς Λαιστρυγόνας καὶ τοὺς Κύκλωπας,  
τὸν ἄγριο Ποσειδώνα δὲν θὰ 
συναντήσεις, ἂν δὲν τοὺς κουβανεῖς μὲς 
στὴν ψυχή σου, ἂν ἡ ψυχή σου δὲν τοὺς 
στήνει ἐμπρός σου. 
Νὰ εὔχεσαι νά ῾ναι μακρὺς ὁ δρόμος.  
Πολλὰ τὰ καλοκαιρινὰ πρωϊὰ νὰ εἶναι  
ποὺ μὲ τί εὐχαρίστηση, μὲ τί χαρὰ  
θὰ μπαίνεις σὲ λιμένας 
πρωτοειδωμένους·νὰ σταματήσεις σ᾿ 
ἐμπορεῖα Φοινικικά,  
καὶ τὲς καλὲς πραγμάτειες ν᾿ἀποκτήσεις,  
σεντέφια καὶ κοράλλια, κεχριμπάρια κ᾿ 
ἔβενους, καὶ ἡδονικὰ μυρωδικὰ κάθε 
λογῆς, ὅσο μπορεῖς πιὸ ἄφθονα ἡδονικὰ 
μυρωδικά. Σὲ πόλεις Αἰγυπτιακὲς πολλὲς 
νὰ πᾷς, νὰ μάθεις καὶ νὰ μάθεις ἀπ᾿ τοὺς 
σπουδασμένους.  
Πάντα στὸ νοῦ σου νἄχῃς τὴν Ἰθάκη.  
Τὸ φθάσιμον ἐκεῖ εἶν᾿ ὁ προορισμός 
σου.Ἀλλὰ μὴ βιάζῃς τὸ ταξείδι διόλου.  
Καλλίτερα χρόνια πολλὰ νὰ διαρκέσει.  
Καὶ γέρος πιὰ ν᾿ ἀράξῃς στὸ νησί,  
πλούσιος μὲ ὅσα κέρδισες στὸν δρόμο,  
μὴ προσδοκώντας πλούτη νὰ σὲ δώσῃ ἡ 
Ἰθάκη. 
Ἡ Ἰθάκη σ᾿ ἔδωσε τ᾿ ὡραῖο ταξίδι.  
Χωρὶς αὐτὴν δὲν θἄβγαινες στὸν δρόμο.  
Ἄλλα δὲν ἔχει νὰ σὲ δώσει πιά. 
Κι ἂν πτωχικὴ τὴν βρῇς, ἡ Ἰθάκη δὲν σὲ 
γέλασε.  
Ἔτσι σοφὸς ποὺ ἔγινες, μὲ τόση πείρα,  
ἤδη θὰ τὸ κατάλαβες ᾑ Ἰθάκες τί 
σημαίνουν. 
 
Κ.Π. Καβαφης. Από τα Ποιήματα 1897-
1933, Ίκαρος 1984)  
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Abstract 
Colorectal cancer (CRC) is the second most common cause of cancer 
death in the UK. Since the introduction of the NHS Bowel Cancer Screening 
Programme CRC incidence and mortality rates have reduced, however, 
screening uptake in the overall population remains suboptimal and is 
disproportionately low among populations with low socioeconomic status (SES) 
and Black and Minority Ethnic populations. This thesis aimed to critically assess 
the available evidence of public health interventions to improve CRC screening 
and to examine the possible mechanisms of socioeconomic inequalities in CRC 
screening uptake within a UK setting.  
A systematic review and meta-analysis (Study 1) of randomised 
controlled trials (RCTs) to increase CRC screening uptake was conducted. Data 
from 102 RCTs including 1.94 million participants were analysed and 
intervention effectiveness was examined by level of SES. Interventions 
significantly improved screening uptake, especially among low SES populations, 
and helped reduce - but not eliminate - SES disparities. Specific intervention 
strategies were highlighted as effective among low SES groups.  
Study 2 used qualitative interviews (N = 27) to explore the views of 
different socioeconomic and sociodemographic population subgroups and 
identify the barriers and facilitators to CRC screening. Results highlighted both 
practical and emotional factors that influenced screening decisions and 
revealed both similarities and differences in the views of different subgroups. 
Study 3 used cross-sectional, observational, survey data (N = 206) to explore 
key sociodemographic and psychosocial variables as potential moderators and 
mediators of screening intention. Results indicated that psychosocial variables 
mediated the effects of past behaviour on screening intention and identified 
some differences by educational attainment and area-level deprivation.  
This thesis argues the importance of considering both sociodemographic 
and psychosocial factors in relation to improving CRC screening uptake and 
reducing inequalities. Results highlighted key determinants of CRC screening 
participation and identified specific pathways via which sociodemographic and 
psychosocial variables interact to affect screening intention. This thesis 
 v 
provides an evidentiary basis that can be used to inform future public health 
initiatives and/or interventions that aim to reduce the CRC inequality gap. 
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 CHAPTER 1 
Introduction: Background and Context, Thesis Aims and Objectives 
1.1 Chapter summary 
This chapter sets out the context of the present thesis firstly, by 
presenting a summary of the information regarding the global burden of 
colorectal cancer (CRC), also known as bowel, colon or rectal cancer, as well 
as its etiology and risk factors. Secondly, this chapter provides a brief outline of 
the socioeconomic inequalities observed in health overall, but provides a more 
detailed description of the evidence of inequalities that are specific to CRC. 
Thirdly, this introductory chapter describes the UK’s current cancer strategy 
implementation plan and the aspects that specifically relate to cancer control 
through population-based screening, which have been implemented to achieve 
earlier diagnosis of CRC. Finally, this chapter will conclude by providing the 
rationale for the three PhD studies included in the thesis and by outlining the 
thesis aims and objectives.  
1.2. Colorectal Cancer: Prevalence and Consequences 
Globally, CRC is among the leading causes of mortality and morbidity 
and represents the third most commonly diagnosed malignancy (following lung 
and breast cancer) and the fourth leading cause of cancer death worldwide 
(Torre et al., 2015). CRC accounts for over 9% of all cancer incidence with 
approximately 1.4 million new cases and near 700,000 deaths occurring in 2012 
(Ferlay et al., 2015). The global distribution of CRC burden is not uniform, with 
almost 60% of new cases occurring in countries with high Human Development 
Index (HDI) with a Western culture (Janout & Kollárová, 2001).The difference in 
CRC incidence between countries with the highest and lowest CRC rates can 
vary up to 10-fold; countries with the highest CRC incidence rates include North 
America, New Zealand, Australia and several European countries, whereas 
lower incidence rates are observed in Africa, Central America and South-Central 
Asia (Boyle & Langman, 2000; Ferlay et al., 2015).  
In the UK, CRC is the fourth most commonly diagnosed cancer 
(following, lung, breast and prostate cancer), with approximately 41,200 people 
being diagnosed with CRC and 16,000 people dying from CRC annually. Most 
new cases of CRC occur among older adults with the risk for CRC rising sharply 
over the age of 55 (Brenner et al., 2007). Approximately 90% of new cases 
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occur in individuals above the age of 50 and nearly 60% of new cases are 
diagnosed in people aged 70 or older. Contrary to common belief, nearly 75% 
of CRC diagnoses occur among average-risk individuals – that is, individuals 
without a family history or a genetic predisposition to CRC – whereas, 
approximately 20%-25% of people develop CRC directly as a result from 
familial history of CRC or adenomatous polyps (Haggar & Boushey, 2009; Valle, 
2014). 
Several risk factors are associated with CRC incidence. Non-modifiable 
risk factors of CRC include age, gender and hereditary factors (e.g., family 
history, genetic predisposition). With regards to hereditary conditions, 
approximately 5% to 10% of CRC cases result from commonly inherited 
conditions, that include familial adenomatous polyposis (FAP) and hereditary 
non-polyposis colorectal cancer (HNPCC), also known as Lynch syndrome 
(Jackson‐Thompson, Ahmed, German, Lai, & Friedman, 2006). Additionally, 
having a predisposing gastrointestinal illness, such as inflammatory bowel 
disease (IBD) – a term used to define both ulcerative colitis and Crohn’s 
disease – is also an important risk factor and patients with these conditions 
present with a 4- to 20-fold increased relative risk for developing CRC (Janout 
et al., 2001). However, numerous lifestyle and environmental factors play an 
important role in the development of CRC; for instance, it has been reported 
that at least 10% of colon cancers in the UK are obesity-related, with visceral, 
abdominal fat accumulation being highlighted as an important risk factor directly 
linked to colon carcinogenesis (Ning, Wang, & Giovannucci, 2010; 
Organization, 2007; Riondino et al., 2014). Other lifestyle factors are also 
associated with significant increases in the risk for developing CRC, including 
physical inactivity, high intake of fatty and processed foods, consumption of red 
and processed meat, high alcohol intake and smoking (Aune et al., 2011; 
Grosso et al., 2017; WCRF/AICR, 2007). Indeed, CRC is largely considered to 
be an environmental disease due to its direct link with socio-environmental 
factors (Brenner, Kloor, & Pox, 2014; Haggar et al., 2009). Some factors have 
been identified as having a protective effect in that they are associated with a 
reduced risk for developing CRC; such factors include increased intake of total 
dietary fibre – indeed, a recent meta-analysis reported an approximately 10% 
reduced risk of colorectal adenoma (CRA) per 10g/day increase in fibre (Ben et 
al., 2014) – as well as, chronic use of non-steroidal, anti-inflammatory drugs 
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(NSAIDs; e.g., aspirin), which appear to reduce CRC risk by preventing 
inflammation in anatomic subsites within the colorectum. Recent evidence 
suggests that low-dose daily aspirin use is an effective CRC prevention strategy 
among individuals with a first-degree relative with a history of CRC (Friis, Riis, 
Erichsen, Baron, & Sørensen, 2015; Ruder et al., 2011).   
The aetiology of CRC remains largely unclear, however, it is widely 
accepted that there is no single gene that causes CRC, rather the formation of 
adenomatous polyps is a multistep process, which involves tumour-suppressor 
and DNA-repair genes being inactivated whilst, concurrently, certain oncogenes 
(i.e., genes that cause cancer) are being activated, through a series of genetic 
and epigenetic alterations, referred to as the ‘adenoma-carcinoma sequence’ 
(Arnold, Goel, Blum, & Richard Boland, 2005; Leggett & Whitehall, 2010). CRC 
is characterised by a step-wise progression where normal, healthy cells develop 
into malignant growths over a time-period estimated to last from five to 15 years 
(Bogaert & Prenen, 2014; Feng et al., 2015). Depending on the severity of the 
cancer (i.e., size of cancerous growths, whether the cancer has invaded 
regional lymph nodes or metastasised), there are four key stages in CRC 
development; a process also referred to as ‘CRC staging’. These stages are: 
Dukes’ A, where the tumour(s) has invaded into the inner lining of the bowel but 
has not grown through the muscle layer of the bowel; Dukes’ B, where the 
tumour(s) has grown through the muscle layer of the bowel; Dukes’ C, where 
the tumour(s) has spread to at least one lymph node close to the bowel; and 
lastly, Dukes’ D, where the cancer has metastasised to other organs of the body 
(Akkoca et al., 2014).   
The degree of cancer symptomatology experienced by patients – for 
instance, blood in stool, abdominal pain, and constipation - is also directly 
indicative of the stage of cancer. Patients who are diagnosed with CRC after 
having experienced subjective symptoms are usually considered to have 
advanced colorectal tumours compared to asymptomatic CRC patients. 
Symptomatic CRC patients have more unfavourable intraoperative and short-
term, postoperative outcomes, with a recent study reporting less need for 
Intensive Care Unit (ICU) stay and significantly fewer days of hospitalisation 
among asymptomatic CRC patients compared to symptomatic CRC patients 
(Inada et al., 2017). Moreover, the invasiveness and intensity of CRC treatment 
is largely dictated by the stage of diagnosis; asymptomatic CRC patients 
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presenting with early-stage CRC have greater chance of undergoing minimally 
invasive surgery (e.g., polypectomy) compared to patients with advanced 
CRCs, which require more invasive treatment procedures, including open-
surgery/laparoscopic colectomy – a surgical procedure that removes all or part 
of the colon - which is required to treat the majority of patients presenting with 
Duke’s Stage B and Stage C CRC and is usually combined with chemotherapy 
to lower the risk of cancer recurrence (Miller et al., 2016)- , and partial 
hepatectomy, which is usually required in Duke’s stage D, which has 
metastasised to the liver and is performed in combination with chemotherapy 
and radiotherapy (Butte et al., 2015).  
CRC and its treatment are known to have a negative impact on patients’ 
general wellbeing, with a large proportion of patients diagnosed with advanced 
CRC reporting higher levels of symptoms of depression and anxiety, greater 
physical functioning impairment, reduced cognitive, emotional and social 
functioning over time and overall lower ratings of both global and health-related 
quality of life (HRQOL) that last many years post-diagnosis (Denlinger & 
Barsevick, 2009; Frazzetto et al., 2012; Mols, Schoormans, de Hingh, 
Oerlemans, & Husson, 2018; Ramsey, Berry, Moinpour, Giedzinska, & 
Andersen, 2002; Siegel, Miller, Fedewa, et al., 2017). Apart from the increased 
burden of disease that patients themselves experience with later-stage CRC 
diagnosis, treating CRC at a later stage also has implications with regards to 
medical costs, with evidence suggesting that medical costs are significantly 
reduced the earlier the stage of diagnosis due to treatment being either less 
invasive or less intensive than treatment for more advanced CRC (Inada et al., 
2017; Lansdorp-Vogelaar, Van Ballegooijen, Zauber, Habbema, & Kuipers, 
2009).  
Indeed, evidence from health economic evaluations conducted in several 
countries suggests that the staggering financial impact of CRC is another 
indicator of the heavy burden of this disease on the health of the population. 
Apart from the above-mentioned direct costs associated with medical care (e.g., 
hospitalisation, surgery), CRC and its treatment result in the loss of economic 
resources as a result of indirect costs as well, which refer to the financial losses 
associated with the time spent receiving medical care. Indirect costs incorporate 
morbidity costs – that is, time lost from work and/or loss of ability to participate 
in other usual activities, including leisure - as well as mortality costs, which 
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refers to lost productivity due to premature death  (Jonas, Russell, Sandler, 
Chou, & Pignone, 2008; Max et al., 2003; Yabroff, Lund, Kepka, & Mariotto, 
2011). These costs are not only incurred by patients themselves, but also their 
carers and families due to costs associated with the time spent in providing care 
and/or assistance (Hayman et al., 2001; Van Houtven, Ramsey, Hornbrook, 
Atienza, & van Ryn, 2010; Yabroff & Kim, 2009) and also employers, due to 
costs associated with employee disability and increased absenteeism among 
cancer survivors (Chang et al., 2004).  
Moreover, considerable economic costs are associated with long term 
cancer survivorship, which extends beyond the initial period following a cancer 
diagnosis or the end of life, and these costs relate to later or lasting effects of 
treatment or cancer recurrences. For instance, recent evidence suggests that 
cancer survivors, on average, report greater levels of financial hardship (e.g., 
medical dept, bankruptcy) as well as increased health-related unemployment 
and underemployment compared to similar individuals without cancer, even 
many years post-diagnosis (Banegas et al., 2016; Guy Jr et al., 2013; Yabroff et 
al., 2016). Currently, the national annual cost for CRC in the USA is estimated 
between $4.5 billion to $9.6 billion (Yabroff et al., 2009), in Australia $1 billion 
(Ananda et al., 2016) and in the UK, recent evidence suggests that 
approximately £542 million are spent annually on CRC-related, hospital care 
alone (Laudicella, Walsh, Burns, & Smith, 2016). Projections of the costs of 
future CRC care - based on data for incidence, patterns of care, survival and 
inflation - suggest that the economic burden of cancer is expected to increase 
significantly, with these increases being primarily attributed to an aging and 
growing population, and secondarily to increases in the costs of medical care 
(Lang et al., 2009; Mariotto, Robin Yabroff, Shao, Feuer, & Brown, 2011). Taken 
together these findings strongly indicate that CRC is a significant social and 
public health issue and therefore initiatives that aim to reduce CRC incidence 
and mortality should be prioritised. 
1.3. Inequalities in Health  
Within the UK and internationally, there is a clear association between 
socioeconomic status (SES) and overall health, which shows a consistent 
pattern of poorer health-related outcomes – including all-cause mortality, 
reduced life expectancy, disability and higher prevalence of diseases – among 
people with poorer socioeconomic circumstances (Mackenbach et al., 2008; 
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Marmot, 2005; Pickett & Wilkinson, 2015; Wilkinson & Marmot, 2003). An 
improvement in health outcomes has been directly associated with increases in 
SES – in what is commonly referred to as the socioeconomic gradient in health 
– with a clear gradient being observed both between and across countries. For 
instance, the relationship between income inequality and health has been 
observed in a variety of settings, including rich, developed market economies, 
such as the UK, USA, Japan, Singapore and Australia (Wilkinson & Pickett, 
2007, 2009), as well as developing countries (Babones, 2008). In addition, 
socioeconomic gradients in health have been reported across states/regions 
within nations, including Argentina (De Maio, Linetzky, Ferrante, & Fleischer, 
2012), China (Pei & Rodriguez, 2006), India (Rajan, Kennedy, & King, 2013), 
Italy (De Vogli, Mistry, Gnesotto, & Cornia, 2005), Greece (Charonis et al., 
2017) and Brazil (Rasella, Aquino, Santos, Paes-Sousa, & Barreto, 2013).   
The evidence suggests that the socioeconomic gradient in health is not 
invariant over time and is influenced by two key processes. Firstly, by social 
causation – that is, the causal mechanisms of health inequalities resulting from 
differences in resources, knowledge, support and other factors that are socially 
stratified. Secondly, by heath selection – that is, the notion that people with 
good health tend to move upward in the social hierarchy whereas people with 
less good health tend to move downward -, and the current evidence suggests 
that both of these processes contribute to socioeconomic disparities in health 
and their continuation over time (Goldman, 1994; Hoffmann, Kröger, & Geyer, 
2018; Kaplan & Keil, 1993; Kröger, Pakpahan, & Hoffmann, 2015; Williams, 
1990; Williams, Mohammed, Leavell, & Collins, 2010). For instance, in line with 
the social causation interpretation, a longitudinal study examining 
socioeconomic health inequalities over a period of 10 years, found that the 
proportion of participants reporting worse health-related outcomes increased 
the most among those with greater socioeconomic disadvantage (Elstad & 
Krokstad, 2003). Similarly, another study reported an inverse association 
between employment grade and worsening of perceived health over a three-
year period (Hemingway, Stafford, Stansfeld, Shipley, & Marmot, 1997). Other 
studies, have focused predominantly on examining the impact of health 
selection on socioeconomic health inequalities and have shown that ill health 
has a direct influence on productivity; for instance, unexpected illness 
necessitates fewer working hours and therefore lower pay, movement to a lower 
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paying job or even stopping work completely, but at the same time illness may 
lead to increased levels of absenteeism within the workplace, which in turn can 
lead to employers favouring employees who are healthy compared to those 
who are less healthy, both of which can reduce capacity for social mobility and 
for pursuing opportunities that would provide better and more stable income 
(Haahr, Frost, & Andersen, 2007; Kröger, 2017).  
The fact that the social gradient of health is not fixed - in fact, it varies 
between countries as well as within regions of the same country and can 
change over time through processes such as social causation and health 
selection - implies that there is not a set standard or an absolute metric of 
socioeconomic inequality that is consistent over time and locality. This in turn 
suggests that population welfare can fluctuate in response to a range of 
structural determinants, including age, income, education, occupation, gender, 
race, ethnicity and place of residence and their interactions with psychosocial 
determinants of health, including, social support and access to social networks, 
knowledge, attitudes and beliefs, perceptions of autonomy and control over 
health (Egan, Tannahill, Petticrew, & Thomas, 2008). The variation of the social 
gradient in health implies that, in principle, the process by which the magnitude 
and the steepness of the gradient changes is dynamic rather than static in 
nature, thereby offering opportunities for the development of interventions and 
policies that can target key determinants that are amenable to change, reduce 
the slope of the gradient and therefore reduce the scale of inequalities.  
In recent decades, significant resources have been devoted to 
uncovering the etiology of socioeconomic disparities in health, however the 
understanding of these disparities is further complicated due to the confounding 
of SES and race/ethnicity (Dressler, Oths, & Gravlee, 2005; LaVeist, 2005; 
Williams et al., 2010). Early approaches to health inequalities research were 
often limited by conceptualising SES as a binary concept, whereby individuals 
were either rich – and as a result had better overall health - or poor - and had 
worse overall health - and failed to consider SES and health on a continuum 
(Ostrove, Adler, Kuppermann, & Washington, 2001). Moreover, the impact of 
SES on health was predominantly examined in isolation and the mechanisms 
by which SES affected health or how the effects of SES might be moderated by 
a combination of factors, such as education or occupational status, had been 
largely unexplored. There was also relatively little research on the relationship 
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between race/ethnicity and SES, with many studies of this earlier era of health 
inequalities research focusing either on SES or race/ethnicity independently 
(Adler & Stewart, 2010). However, in recent years the health inequalities 
literature has evolved and renewed attention has been placed on understanding 
the possible causal mechanisms, mediators and confounders between 
socioeconomic inequality and health, with a large proportion of the literature 
predominantly focusing on understanding the complex interrelationship between 
SES, race/ethnicity and health (Chen, Martin, & Matthews, 2006; Do, Frank, & 
Finch, 2012; Kawachi, Daniels, & Robinson, 2005; Subramanian, Chen, 
Rehkopf, Waterman, & Krieger, 2005; Williams et al., 2010). 
Racial and ethnic disparities in health have been well-documented, and it 
is now widely accepted that SES is a key driver of this relationship (El-Sayed, 
Finkton Jr, Paczkowski, Keyes, & Galea, 2015; Karlsen & Nazroo, 2002; 
Navarro, 1990; Schroeder, 2016; Sheldon & Parker, 1992; Smith et al., 1998). 
In the USA, research findings consistently show that race and SES are 
correlated (e.g., African Americans are overrepresented among lower SES 
groups) and national data suggests that there has been relatively little change 
over time (Williams et al., 2010). An examination of the levels of overall poverty 
by race from 1980 to 2006 showed that Black and Hispanic ethnic groups had 
two to three times higher overall poverty compared to White ethnic groups 
(DeNavas-Walt, 2010). Similarly, in the UK ethnic inequalities in health among 
Black and Asian Minority Ethnic (BAME) populations have shown to reflect, in 
part, inequalities in socioeconomic position and social class, health service 
access and use and racial discrimination (Nazroo, 1997, 2003). For example, 
national UK data suggests that unemployment rates among BAME populations 
are higher than White British populations, and particularly high among 
Black/Black British ethnic groups (Department of Work and Pensions, 2016) 
and the proportion of low-income BAME households is higher compared to low-
income White British households (Kenway & Palmer, 2007). UK data also 
suggest that socioeconomic inequalities are fundamental cause of ethnic 
inequalities in health and there are direct associations between ethnic minority 
status and ill health on the one hand and socioeconomic disadvantage on the 
other (Bartley, Sacker, & Clarke, 2004; Emerson & Hatton, 2007).  
Nonetheless, several studies (Crimmins, Kim, Alley, Karlamangla, & 
Seeman, 2007; Franks, Muennig, Lubetkin, & Jia, 2006; Williams et al., 2010) 
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have reported that racial/ethnic disparities between BAME populations and 
White Caucasian populations remain even after adjusting for SES differences. 
For example, a study using USA national data from the Health Interview Study 
linked to the National Death Index found that there were large Black-White 
hazard ratios across all age groups (i.e., from ages 18 to 75 years), and that 
these differences in mortality remained significantly higher among the Black 
Ethnic groups even after adjusting for SES (Franks et al., 2006). Similarly, 
another study examined variation in scores on chronic disease factors – 
including indicators of blood pressure, inflammation and metabolic risk – and 
found that even after adjustment for income, education, gender, age and health 
behaviours (including smoking, poor diet, physical activity, and access to care), 
Black populations maintained a higher risk profile on blood pressure, 
inflammation and total risk compared to White populations (Crimmins et al., 
2007). A similar pattern of findings is evident in the UK as well; for example, 
evidence of the elevated disease risk for ethnic minority populations after SES 
is considered comes from national UK data that compared all-cause mortality 
for selected immigrant populations against the national average over the period 
of 1970 to 1992 and found that mortality ratios for stroke and hypertension were 
significantly higher among Black immigrant populations (Wild & McKeigue, 
1997). 
Evidence for the notion that ethnicity affects health independently from 
SES comes from studies that have examined racial differences in relation to 
health among middle- and high- income groups. For instance, a handful of 
studies have shown that Black women and men in high status jobs are 
significantly more likely to report worse mental and physical health outcomes 
compared to their White counterparts. This has been attributed partly to 
occupational tokenism – which occurs when an individual stands apart because 
of their physical characteristics – as well as discrimination due to minority status 
within competitive majority spaces (Braboy Jackson & Saunders, 2006; James 
et al., 2006; Sellers & Neighbors, 2008). Thomas and colleagues (1997) 
compared a cohort of White physicians from John’s Hopkins University with a 
cohort of Black physicians from Meharry Medical College and found that the 
Black physicians were significantly more likely to have a greater body mass 
index (BMI), higher systolic blood pressure, higher risk for cardiovascular 
disease (CVD), higher incidence of coronary artery disease and higher all-
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cause mortality. A more recent study examined race and ethnic disparities 
among high-income populations (i.e., reported income of $175,000 or above per 
year) and found that Black ethnic groups were the most disadvantaged 
compared to other ethnic groups. Namely, Black populations experienced 
greater risk in terms of diabetes, hypertension and obesity and reported worse 
overall health, reduced physical activity and fewer routine medical visits relative 
to White populations, therefore concluding that the health profiles of Black 
populations were significantly worse despite having an equally high income 
status as White populations and that health disparities exist even among the 
highest income groups (Wilson, Thorpe Jr, & LaVeist, 2017). Collectively, these 
findings suggest that income alone cannot fully explain racial/ethnic inequalities 
in health and that ethnic/racial minority status is an independent predictor of 
health. 
1.4. Inequalities in CRC 
Inequalities in incidence and outcome have been reported for a variety of 
cancer types (Coleman, Babb, Sloggett, Quinn, & De Stavola, 2001; Dalton et 
al., 2008; Weiderpass & Pukkala, 2006). Similar to other cancers and diseases, 
the impact of CRC is not uniform and it is well-documented that the public 
health burden of CRC varies both by level of SES (Faggiano, Partanen, 
Kogevinas, & Boffetta, 1997) and by race/ethnicity (Espey et al., 2007; Trivers, 
Shaw, Sabatino, Shapiro, & Coates, 2008; Wong, Ettner, Boscardin, & Shapiro, 
2009). Greater socioeconomic deprivation is associated with a significantly 
higher CRC incidence rate; for instance, a systematic review examined the 
association between SES and CRC incidence, treatment, survival and mortality 
and found that significantly higher CRC incidence was observed among low 
SES groups compared to high SES groups. Additionally, CRC treatment, 
survival and mortality all showed less favourable results for people with lower 
SES (Aarts, Lemmens, Louwman, Kunst, & Coebergh, 2010). Similarly, a 
recent, prospective study conducted in the US examined whether 
neighbourhood SES and education, which is considered an SES proxy, were 
associated with greater CRC risk among a sample of 1.5 million participants, 
and found CRC incidence to be higher among people with lower educational 
attainment and those who lived in socioeconomically deprived neighbourhoods 
compared to individuals who were more educated and had higher SES. These 
education- CRC incidence and SES-CRC incidence associations were evident 
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even after accounting for non-modifiable risk factors, including age, 
race/ethnicity and familial CRC history, as well as lifestyle factors including 
obesity, physical activity and smoking (Doubeni et al., 2012).  
The factors that might generate the large racial and socioeconomic 
disparities in CRC death are several, including less access to curative 
treatment, greater risk of receiving poorer quality care, diet that may be more 
conducive to CRC development, higher obesity rates, lower physical activity, 
greater tobacco and alcohol use and greater medical mistrust (Albano et al., 
2007; Dalton et al., 2008; Lumpkins et al., 2013; Lyratzopoulos, Sheridan, 
Michie, McElduff, & Hobbiss, 2004; Woods, Rachet, & Coleman, 2005). 
However, one of the main factors contributing to the observed inequalities is 
that CRC screening uptake is disproportionately low among more 
socioeconomically vulnerable and BAME populations. Inequalities in CRC 
screening uptake by income level and race/ethnicity have been shown in 
several countries, including countries with and without universal health care 
(Javanparast et al., 2010; Lo, Halloran, et al., 2014; Wardle, McCaffery, Nadel, 
& Atkin, 2004; Whitaker et al., 2011).  
The mechanisms that sustain CRC screening inequalities are several; 
apart from objective SES factors that undoubtedly influence screening uptake 
(e.g., income, education, employment), there are also health-related and 
psychosocial factors that can impede screening uptake among more deprived 
populations. For instance, empirical evidence suggests that limited health 
literacy, which pertains to an individual’s capacity to obtain, process and 
understand health information and access health services as needed in order to 
make informed decisions about one’s health, is one of the pathways that can 
explain nonparticipation in CRC screening among low SES and BAME 
populations (Gimeno Garcia, 2012; Kobayashi, Wardle, & von Wagner, 2014; 
Power, Miles, Von Wagner, Robb, & Wardle, 2009). Psychosocial and attitudinal 
determinants have also been proposed to underlie the observed screening 
inequalities; studies report that low SES and BAME populations are more likely 
to experience both emotional and practical barriers in relation to screening, 
including negative beliefs towards screening procedures, fatalistic beliefs about 
cancer, lack of recognition with regards to the benefits of screening uptake and 
lower perceived self-efficacy with regards to screening procedures (James et 
al., 2006; Power et al., 2009; Schroy et al., 2008; Von Wagner, Semmler, Good, 
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& Wardle, 2009). More recently, researchers have aimed to develop a 
conceptual framework for investigating inequalities in cancer screening by 
investigating the complex links between SES and associated aspects of life 
experiences (Von Wagner, Baio, et al., 2011). For instance, it is known that 
individuals with lower incomes experience adverse life events more frequently 
than high-income populations, have fewer socioeconomic resources in order to 
cope with stressful events and, as a result, have less time available to engage 
with preventative health behaviours such as screening (Hatch & Dohrenwend, 
2007; Marmot et al., 2008).  
In the UK there have been a number of studies examining stool-based 
CRC screening uptake – using the guaiac Faecal Occult Blood Test (gFOBT) - 
in relation to area-level socioeconomic deprivation; for instance a study by von 
Wagner and colleagues (2009) examined gFOBT uptake rates over the first 30 
months of the national screening programme in London in a sample of over 
400,000 participants. The authors concluded that a strong socio-economic 
gradient exists in gFOBT uptake (49% and 32% uptake in the least and most 
deprived quintile of postcodes respectively). Von Wagner et al (2011) later 
conducted a follow-up analysis to include UK-wide data in order to improve 
generalisability of findings, and analysed data from 2.6 million participants that 
were invited to take part in gFOBT screening between October 2006 and 
January 2009. A similar pattern of findings was observed, where a clear 
socioeconomic gradient in uptake was highlighted again. Moreover, uptake 
rates ranged from 35% to 61% in the most and least deprived areas of England. 
Results further indicated that the most ethnically diverse areas also had lower 
uptake (38%) than other areas (52%-58%), a finding which was independent of 
SES, age, gender and region, suggesting that ethnicity uniquely contributes to 
the observed screening disparities. 
Indeed, a number of international and national studies have highlighted 
ethnic inequalities in CRC screening. Evidence from the US shows that CRC 
screening uptake is substantially lower among African American populations; a 
disparities trend consistently observed in the USA since 1980 (Boring & 
Squires; Breen, Lewis, Gibson, Yu, & Harper, 2017; Weinrich, 1990) as well as 
in immigrant Asian populations including Korean, Chinese, Japanese and 
South-East Asian immigrants  (Kim, Yu, Chen, Kim, & Brintnall, 1998; Lee et al., 
2012; Tang, Solomon, & McCracken, 2001; Wong, Gildengorin, Nguyen, & 
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Mock, 2005). A UK-based study (Szczepura, Price, & Gumber, 2008) analysed 
gFOBT uptake patterns among a sample of 123,367 participants to compare 
uptake rates between South Asian and non-Asian UK populations, as well as 
between five Asian subgroups (including Hindu-Gujarati, Hindu-Other, Muslim, 
Sikh and South Asian Other), and found that uptake rates were significantly 
lower among South Asian populations compared to non-Asian populations 
(32.8% and 61.3% uptake respectively) and that rates were particularly low for 
the Muslim subgroup (26.1% and 21.5% for the first and second screening 
rounds respectively).  
CRC inequalities in uptake also widen inequalities in stage of cancer 
diagnosis and cancer survival (Frederiksen, Osler, Harling, & Jørgensen, 2008; 
Mitry, Rachet, Quinn, Cooper, & Coleman, 2008). In a recent report, Siegel and 
colleagues (2017) analysed the latest US-based data on CRC incidence, 
survival, mortality rates and trends by gender, age group, anatomic subsite, 
race/ethnicity and geographic area. Results indicated that incidence rates in 
non-Hispanic Black populations were approximately 20% higher than the rates 
of non-Hispanic White populations, and the magnitude of the disparity for 
mortality was double that for incidence – that is, mortality rates were 
approximately 40% higher among non-Hispanic Blacks compared to non-
Hispanic Whites. The authors reported that differences in screening uptake 
were estimated to account for 40% of the racial disparity in CRC mortality 
between Black and White ethnic groups.  
This finding is consistent with the results from a microsimulation study 
conducted by Lansdorp-Vogelaar and colleagues (2012), which estimated how 
much of these racial disparities in CRC incidence and mortality could be 
explained by differences in CRC screening uptake. Results indicated that 
screening uptake explained more than 40% of the existing racial disparity in 
CRC incidence and 20% of the disparity in CRC mortality, between Black and 
White ethnic groups. Similarly,  Valeri and colleagues (2016) quantified the 
extent to which survival disparities would be reduced, had Black-White 
disparities in stage of diagnosis been eliminated. Results showed that the 
elimination of disparities in stage of diagnosis would contribute to a reduction of 
approximately 35% in survival disparities. These findings imply that reductions 
in screening disparities could in turn lead to substantially fewer disparities 
observed at stage of diagnosis, which consequently would also reduce racial 
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disparities in survival. The importance of CRC screening in cancer control, an 
overview of the screening modalities currently utilised and a description of the 
UK’s national bowel cancer screening programme are described below.  
1.5. The Importance of Colorectal Cancer Screening  
CRC screening is a well-established component of secondary preventive 
medical care in high-income countries (Altobelli, Lattanzi, Paduano, Varassi, & 
Di Orio, 2014; Burt et al., 2010; Gupta et al., 2013; Schreuders et al., 2015). 
The purpose of screening is to reduce CRC incidence and mortality and 
increase detection of early-stage CRC when cancer is highly treatable. The 
capacity of CRC screening to reduce CRC incidence and mortality has 
prompted the introduction of population-based, mass screening programmes 
over the past decades mostly in developed countries including the USA, 
European countries – including the UK, Netherlands, Denmark, Sweden, 
Finland, Austria, France, Germany, Italy, Spain, Poland and the Czech Republic 
– and non-European countries – including Israel, Japan, Korea, Australia and 
Uruguay (Benson et al., 2008; Gutiérrez-Ibarluzea, Asua, & Latorre, 2008). 
The implementation of such programmes has led to significantly more 
favourable disease prognosis, has improved overall patient outcomes and has 
already had a measurable impact on disease burden on a global scale (Gellad 
& Provenzale, 2010). Results from several randomised controlled trials (RCTs) 
have shown that CRC screening is associated with significant reduction in CRC 
incidence and/or mortality (Atkin et al., 2010; Hardcastle et al., 1996; Kronborg, 
Fenger, Olsen, Jørgensen, & Søndergaard, 1996; Lindholm, Brevinge, & 
Haglind, 2008; Schoen et al., 2012). According to Cancer Research UK 
statistics (2014), stool-based screening – and particularly gFOBT screening - is 
expected to save 2,000 lives each year in the UK by 2025. Reinforcing this 
notion, a systematic review including data from a sample of 320,000 
participants, with follow-up ranging from 8 to 18 years (Hewitson, Ward, 
Heneghan, Halloran, & Mant, 2011), found that gFOBT screening achieved a 
reduction in the relative risk of CRC mortality by 16%. Other CRC screening 
modalities, including screening colonoscopy (SC) and flexible sigmoidoscopy 
(FS), have achieved similar reductions in CRC mortality (Zauber et al., 2008). 
Moreover, early diagnosis combined with early intervention and treatment are 
estimated to achieve population-wide reductions in CRC incidence by as much 
as 33% and CRC mortality by as much as 43% (Atkin et al., 2010).  
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Unlike other cancers, early stages of CRC are identifiable and often 
treatable. According to national statistics, five-year, overall survival rates are 85-
95% when CRC is detected during Duke’s stage A, whereas survival rates 
gradually decline to 60-80%, 30-60% and to <10% for Duke’s stages B, C and 
D respectively (National Cancer Intelligence Network, 2009). Collectively, these 
statistics suggest that CRC is largely treatable when diagnosed at the earliest 
stage possible and in the UK the NHS Five Year Forward View (National Cancer 
Transformation Board, 2016) report has identified earlier diagnosis of cancer 
through screening as a key strategic priority for achieving the best cancer 
outcomes in England by 2020.  
1.6. Overview of Screening Modalities 
1.6.1. Non-endoscopic Screening Modalities: Faecal and Serum Tests 
i) Guaiac Faecal Occult Blood Test (gFOBT) 
The gFOBT is the least invasive CRC screening method and operates by 
detecting the presence or absence of blood in stool. A positive test is noted 
when occult blood is found in the stool sample, which may indicate the 
presence of CRC or polyps in the colon or rectum. Despite its ease of use, 
accurate screening with gFOBT can be difficult and screening results are known 
to be affected by dietary changes. Moreover, the gFOBT requires samples to be 
collected multiple times (two samples from three consecutive bowel 
movements) on multiple occasions (biennially in most countries), with multiple 
sampling increasing the risk of false-positive results and in turn increasing 
medical costs from further diagnostic workup (Dressler et al., 2005; Vilkin et al., 
2005).   
ii) Faecal Immunochemical Stool Tests (FIT) 
The FIT is based on principles similar to those of the gFOBT, however 
the specificity of the FIT is increased due to its ability to detect human 
hemoglobin, hence removing any need for dietary restrictions that apply to 
gFOBT and thus reducing the risk of false-positive results. Currently, there are 
no RCTs evaluating the benefits of the FIT in relation to CRC incidence and 
mortality. However, numerous RCTs have compared the gFOBT to the FIT with 
regards to their diagnostic specificity and sensitivity and have reported, that in 
comparison to the gFOBT, the FIT exhibits greater diagnostic performance, 
improved sensitivity and increased detection rates of advanced cancerous 
neoplasms (Faivre et al., 2012; Levi et al., 2011). Preliminary evidence also 
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suggests that an additional benefit of the FIT is that it has potential to improve 
compliance rates due to greater ease of completion, given that the FIT requires 
a single stool sample to be collected, as well as the lack of dietary restrictions 
(Chambers, Callander, Grangeret, & O’Carroll, 2016; Goede et al., 2017). 
1.6.2. Endoscopic Screening Modalities: Screening Colonoscopy and 
Flexible Sigmoidoscopy  
i) Screening Colonoscopy (SC) 
SC is considered an optical screening procedure, during which the entire 
colon and rectum are visually examined to detect polyps or cancer. The major 
advantage of SC is that it allows for the direct visualisation of the entire colon 
and any polyps discovered during the procedure can be readily removed by 
polypectomy. SC is the only modality that offers a one-step approach to CRC 
screening and patients with abnormal test results from stool-based screening 
modalities are required to undergo a follow-up SC. An important advantage of 
SC is the extended recommended interval between testing which is 10 years, 
which has been associated with improved patient compliance (Lee et al., 2012). 
There are several disadvantages associated with SC including the invasiveness 
of the procedure and the inherent risks that are associated with it, the time and 
discomfort experienced by patients during bowel preparation, and increased 
medical costs. Despite these disadvantages, SC is considered the ‘gold 
standard’ for the detection of CRC and adenomatous polyps and the available 
epidemiological evidence suggests that SC is effective in reducing CRC 
incidence and mortality.  
ii) Flexible Sigmoidoscopy (FS) 
In contrast to SC, FS only inspects the left side of the colon for 
neoplasia. Its usage is usually in a two-stage model, with FS used in 
conjunction with SC for initial FS-positive patients. It is a safe and quick process 
which can be performed without sedation, thereby negating the need for 
hospital admission. FS is associated also with greater patient acceptability due 
to the fewer preparations required in comparison to SC. The main disadvantage 
of FS as a screening tool is that empirical evidence shows that approximately 
50% of colonic neoplasia will be missed. Nevertheless, meta-analyses suggest 
that the efficacy of FS in reducing CRC mortality has been proven in several 
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case-controlled and cohort studies (Elmunzer et al., 2012; Shroff, Thosani, 
Batra, Singh, & Guha, 2014).  
1.7. NHS Bowel Cancer Screening Programme 
The UK is among the many countries that have implemented population-
based, national CRC screening programmes, which aim to look for early signs 
of cancer in people who are not currently experiencing any cancer 
symptomatology (i.e., are asymptomatic). The UK National Health Service 
Bowel Cancer Screening Programme (NHSBCSP) was officially introduced in 
England in 2006, following two pilot programmes. Prior to the introduction of the 
programme, CRC screening had operated on an ad-hoc basis. There are two 
aspects of the NHSBCSP – the programme predominantly uses the gFOBT, 
and more recently, the complementary English Bowel Scope Screening (BSS) 
programme has been introduced, which uses the FS. In the UK, eligible 
individuals are automatically sent self-administered bowel cancer screening kits 
(i.e., home-based gFOBT testing) every two years. To be eligible for gFOBT 
screening, people are required to be registered with a general practitioner (GP) 
and to be aged between 60 and 74 years. gFOBT screening kits are distributed 
nationally via five regional screening hubs across England. The main aim of the 
NHSBCSP is to detect CRC at an early stage when treatment is more likely to 
be effective and survival rates are likely to be higher. In June 2016 Public 
Health England announced the replacement of the gFOBT with the FIT, which is 
anticipated to improve uptake, especially among populations with low SES and 
BAME ethnic groups (Moss, Mathews, Day, Smith, & Halloran, 2015). Based on 
the recent NHS Five Year Forward View the government’s goal at present is to 
achieve 75% uptake of the FIT in all CCGs by 2020.  
The government’s target for 75% uptake of the FIT is particularly 
ambitious, given that CRC screening has been an ongoing public health 
challenge in England. Both pilots of the English Bowel Cancer Screening 
programmes (implemented in 2000 and 2006) found that only 52.1% and 52% 
of those that had been sent a gFOBT screening kit had returned it, for the first 
and second pilot respectively, not managing to meet the government’s target for 
60% gFOBT uptake (UK Colorectal Cancer Screening Pilot Group, 2004; Weller 
et al., 2007a). Particularly challenging has been the engagement of low SES 
and BAME populations with gFOBT screening – as mentioned previously, 
inequalities in CRC screening is a recurrent theme within the literature – with 
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significant reductions in gFOBT uptake being observed with increasing level of 
deprivation (Weller et al., 2007a). In addition, results from the two pilots showed 
that gFOBT uptake was particularly low in men compared to women, and 
screening among both genders further decreased with increasing level of 
deprivation (Weller et al., 2007a). More recently Logan and colleagues (2012) 
analysed data from 2.1 million participants that were invited during the first 
round of the English bowel cancer screening programme (rolled out between 
June 2006 and October 2008) and found that uptake was generally lower in 
areas with greater deprivation. Notably, in certain London areas, gFOBT uptake 
was critically low, marginally reaching 40% uptake rate, with the authors partly 
attributing lower screening rates to the greater ethnic mix and larger immigrant 
population in London compared to the rest of England (Logan et al., 2012). The 
figures for gFOBT screening rates are also substantially lower compared to 
uptake rates achieved by other national, population-based screening 
programmes, with recent UK data showing a 75.1% uptake for breast cancer 
screening and a 73.5% uptake for cervical screening in comparison to 58.2% 
uptake for CRC screening (Public Health England, 2015).  
Similarly low CRC screening uptake rates are observed in the city of 
Leeds, West Yorkshire. Based on regional data, screening adherence in Leeds 
ranges from 52.1% in the Leeds South and East Clinical Commissioning 
Groups (CCG), to 56.08% in Leeds North CCG. Substantial variability in uptake 
exists by postcode ranging from as high as 69.2% in more affluent areas (North 
Leeds) to as low as 25.9% in more deprived, inner-city areas (South and East 
Leeds). Screening uptake is lowest in the South and East CCG. Moreover, the 
South-East Leeds CCG was ranked as the most socioeconomically deprived 
among the three Leeds CCGs according to the Public Health England report on 
Indices of Deprivation at CCG level (Smith et al., 2015). 
1.8. Thesis Aims 
This chapter has showcased the importance of CRC screening and has 
outlined the available evidence, which strongly suggests that earlier diagnosis 
of CRC via screening can be transformative in terms of improving survival, 
reducing mortality and improving quality of life. This chapter also provided an 
overview of the socioeconomic and racial/ethnic inequalities in both CRC 
incidence, mortality and survival, which are partly explained by disparities in 
CRC screening participation. Given that the NHSBCSP in the UK provides the 
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means via which early detection of CRC can be achieved, it is crucial to further 
understand what strategies might be effective in increasing CRC screening 
compliance across the entire population, but also among low SES and BAME 
populations in particular. In doing so, it is anticipated that this will inform and 
extend the current evidence base and will contribute to the development of 
more efficient strategies to firstly, improve overall CRC uptake and secondly, to 
improve the equitable distribution of CRC screening services.  
Therefore the present thesis aimed: 
1. To evaluate the effectiveness of existing interventions to improve CRC 
screening uptake and to examine whether effectiveness varies by level of 
SES (Study 1). 
2. To identify the barriers and facilitators to gFOBT uptake among different 
population subgroups (Study 2). 
3. To explore acceptability of the FIT screening kit (Study 2) 
4. To assess the direct and indirect pathways via which sociodemographic and 
psychosocial factors influence gFOBT screening intention (Study 3).
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CHAPTER 2 
Systematic Review and Meta-Analysis of Interventions to Increase 
Colorectal Cancer Screening (Study 1) 
2.1. Introduction 
Although colorectal cancer (CRC) still figures prominently among the 
most commonly diagnosed cancers in both men and women (as outlined in 
Chapter 1), recent reports suggest that CRC incidence and mortality rates have 
been stabilising or declining for several decades (Arnold et al., 2016). A recent 
analysis on CRC statistics conducted by Siegel and colleagues (2017), reported 
that the rate of CRC death in the US has declined by approximately 2% per 
year during the 1990s and by approximately 3% per year over the last decade. 
In the UK, CRC mortality rates have decreased by 42% since the early 1970s 
and between 2003 and 2014 rates have decreased by approximately 12% 
(Office of National Statistics, November 2015).  The reasons for the recent 
declining trends in incidence are diverse and ill-defined but seem to be driven 
by two main reasons;  firstly, by historical changes in risk factors, including 
lifestyle factors (e.g., decreased smoking, increased use of aspirin), and 
secondly, by the introduction of population-based screening programmes, that 
have facilitated the dissemination of early detection tests. Notably, screening is 
estimated to be the most important driver of the observed decline in CRC 
incidence and mortality over the past decades (Edwards et al., 2010). Together 
changes in risk factors and the implementation of screening programmes, 
improvements in cancer treatment – including perioperative care, chemotherapy 
and radiation therapy – have also contributed to improved overall survival and 
reduced recurrence of cancer (André et al., 2009; Center, Jemal, & Ward, 2009; 
Murphy, Harlan, Lund, Lynch, & Geiger, 2015).  
Despite the effectiveness of screening and the increased accessibility of 
screening since the introduction of stool-based screening tests, uptake rates 
are alarmingly low and patterned by SES and ethnic background, and previous 
studies have demonstrated that a substantial percentage of CRC deaths are 
attributable to nonuse of screening (Altobelli et al., 2014; Dubé, 2012; Meester 
et al., 2015). Therefore, it is important, from a public health perspective, to 
identify which interventions make the greatest contributions for: a) increasing 
CRC screening uptake across the whole of the population, and b) reducing the 
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observed inequalities in CRC screening uptake. A greater understanding of the 
approaches that are effective in maximising screening participation is vital for 
prioritising future interventions. Previous studies and reviews in the CRC 
screening literature has predominantly focused on epidemiological analyses 
that examine the effectiveness of screening programmes in reducing CRC 
incidence and mortality, or the test performance characteristics of the different 
screening tests for detecting CRC – that is, examining metrics relating to the 
accuracy, specificity and sensitivity of screening methods to detect cancer - and 
the potential adverse effects that different screening tests may present with 
(Heresbach, Manfredi, D'halluin, Bretagne, & Branger, 2006; Lin et al., 2016; 
Whitlock, Lin, Liles, Beil, & Fu, 2008). An ample number of reviews and meta-
analyses have also focused on the prevention of colorectal cancer. For 
example, Bjelakovic, Nikolova, Simonetti and Gluud (2004) examined the 
potential preventive effects of antioxidant supplements for the prevention of 
gastrointestinal cancers; Aune and colleagues (2011) examined whether 
increased intake of whole grains and dietary fibre reduced the risk of colorectal 
cancer; and Papaioannou et al (2010) looked at the effect of chemopreventive 
agents, such as aspirin, folic acid and calcium, on colorectal cancer incidence. 
Other meta-analytic reviews have examined the associations between lifestyle 
factors such as excess body weight (Harriss et al., 2009; Renehan, Tyson, 
Egger, Heller, & Zwahlen, 2008) or cigarette smoking (Liang, Chen, & 
Giovannucci, 2009) and the incidence of colorectal cancer.   
Reviews and/or meta-analyses that have examined intervention 
effectiveness in increasing CRC screening uptake are scarce in the existing 
literature. A systematic review by Sabatino and colleagues (2008) presented 
results on the effectiveness, applicability, economic efficiency and barriers to 
implementation of provider-directed interventions, to increase screening uptake 
for breast, cervical and colorectal cancers. The findings indicated that 
interventions that incorporate healthcare provider assessment and feedback 
can increase screening for all three types of cancer. In contrast, Baron et al. 
(2008) conducted a systematic review on the effectiveness of different classes 
of patient-directed interventions – including patient reminders or recall, patient 
incentives, small media, mass media and group education - to increase breast, 
cervical and colorectal cancer screening. The evidence from this review 
suggested that reminders and the use of small media (e.g. videos, written 
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materials) led to important increases in screening uptake for all three cancers. 
Both of these reviews are limited by their narrative approach and by their focus 
on either provider-directed or patient-directed interventions respectively. 
Additionally, an important limitation of these reviews is that they do not provide 
specific, actionable guidance as to which interventions are best-suited for 
increasing screening uptake among populations with traditionally lower uptake 
rates, such as low SES and BAME populations, which compromises their 
capacity to inform public health policy on how to combat such disparities. For 
instance, despite general success of patient reminders in increasing screening 
uptake, this approach might not be as successful among socioeconomically 
deprived and ethnically diverse communities, where more intensive 
interventions (e.g., interventions that incorporate educational and motivational 
components to raise awareness about cancer screening) might be necessary in 
order to promote screening participation among non-screeners or under-users 
of screening services.   
Given the lack of meta-analytic reviews in this area of research, the 
present systematic review and meta-analysis was conducted, in order to: firstly, 
address the limitation of previous reviews, and secondly, provide the most up-
to-date and comprehensive quantitative overview on the effectiveness of 
interventions to increase CRC screening uptake. This review also aimed to 
examine intervention effectiveness by level of SES, which has not been a focus 
in any of the currently available, published reviews. Moreover, the present 
review examined four groups of moderators in order to identify factors 
associated with increased intervention effectiveness. The rationale for 
examining each moderator and a more detailed overview of the aims of the 
systematic review and meta-analysis are outlined in the sections below. 
2.1.1. Intervention Characteristics as Moderator Variables  
2.1.1.1. Intervention delivery mode 
One factor that should be considered for its potential impact on 
intervention effectiveness is the choice of intervention delivery mode. A growing 
body of research has shown that patient receptivity and the acceptability of 
health-related information, partly relies on the way that health messages are 
presented and delivered, and that a common oversight in research is that these 
factors are overlooked in both the planning and implementation phases of 
healthcare interventions, potentially compromising, the ability to sustain long-
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lasting intervention effects (Freimuth & Mettger, 1990; Lambert, Loiselle, & 
Macdonald, 2009; Sekhon, Cartwright, & Francis, 2017). The importance of 
mode of delivery has been examined by previous studies but this has been 
either within the context of physical activity research (Beall, Baskerville, Golfam, 
Saeed, & Little, 2014; Foster, Richards, Thorogood, & Hillsdon, 2013), 
cardiovascular medication adherence (Cutrona et al., 2010), or obesity 
prevention, weight loss and dietary change (Greaves et al., 2011; Kozica et al., 
2015). Authors have also frequently examined specific delivery modes in 
isolation; for instance a number of meta-analyses have focused on evaluating 
which characteristics of internet-based interventions alone best promote health 
behaviour change (Lustria et al., 2013; Maher et al., 2014; van Genugten, 
Dusseldorp, Webb, & van Empelen, 2016; Webb, Joseph, Yardley, & Michie, 
2010), some studies have only examined the effectiveness of computer-
delivered interventions (Portnoy, Scott-Sheldon, Johnson, & Carey, 2008) and 
others have evaluated the impact of mobile phone and text messaging 
interventions (Wei, Hollin, & Kachnowski, 2011). However, within the context of 
cancer screening, there is little evidence available comparing all the available 
modes of delivery with regards to screening uptake, indicating a gap in the 
evidence base.  In order to address this gap, the present meta-analysis sought 
to examine whether intervention effectiveness varied as a function of three 
dimensions relating to mode of delivery; first, it was examined whether 
interventions were delivered remotely or face-to-face, second, whether 
interventions were individual- or group-based and third, what types of materials 
were used to deliver the intervention (e.g., written, electronic, phone).  
With regards to the first dimension, both face-to-face and remote delivery 
modes have their advantages and disadvantages. A commonly mentioned 
advantage for interventions that are delivered face-to-face is that intervention 
providers can better engage participants in open dialogue about their own 
healthcare, which has been associated with greater informed decision-making 
and willingness to take independent actions to manage their health (Alston et 
al., 2012; Carman et al., 2013; Couët et al., 2015; Hibbard & Greene, 2013). 
Several articles have shown that engaging participants in conversation about 
their own medical decisions leads to improved understanding and awareness 
about their healthcare options and more accurate expectations of anticipated 
benefits and harms pertinent to the health behaviour of interest (Drew, 2006; 
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Maynard & Heritage, 2005). Delivering public health interventions face-to-face 
might provide an opportune moment for interventionists to, on the one hand, 
communicate the importance of strategies and messages that are effective in 
raising awareness about CRC screening, and for patients on the other hand, to 
interact with the healthcare system and become engaged in their own health. 
The synergistic action of these two components has been recognised for its 
potential to improve the health of populations and individual patients (Légaré et 
al., 2014; Légaré & Witteman, 2013). Another advantage of face-to-face 
intervention delivery is that the interpersonal interaction between participants 
and interventionists is more likely to generate empathy(Moyers, Miller, & 
Hendrickson, 2005), which may be an element that contributes to increased 
intervention effectiveness through the elicitation of rapport, which is difficult to 
establish with distal delivery modes where the interpersonal interaction is 
lacking. 
Another aspect that may have an impact on the effectiveness and 
acceptability of interventions – and one that has yet to be examined with 
respect to CRC screening uptake - is whether interventions are being delivered 
on a one-to-one or group basis. A systematic review by Baron and colleagues 
(2008) identified only one study that reported using group education and only 
two studies that used one-to-one education to increase screening by gFOBT. 
For both modes of delivery the authors reported that there was insufficient 
evidence to evaluate intervention effectiveness and therefore the general 
applicability of these approaches to CRC screening was not addressed, nor was 
the comparison between the two approaches feasible. It therefore remains 
unclear whether one-to-one education is more effective than group education in 
promoting CRC screening. Comparing individualised and group-based modes 
of delivery within the context of bowel cancer might be particularly important as 
it represents a sensitive, health-related topic and the absence of anonymity 
within a group setting might have an impact on participants’ willingness for 
conversation and self-disclosure with regards to their perceptions, beliefs and 
attitudes on the topic of interest. Studies of emotion are increasingly 
demonstrating that CRC screening methods can stir a number of aversive 
affects, including embarrassment, fear and disgust (both experienced and 
anticipated), which have been characterised as ‘the affective substrates of 
avoidant behaviour in the CRC context’ (Consedine, Reynolds, & Borg, 2017; 
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Reynolds, Consedine, Pizarro, & Bissett, 2012, pg. 2). It might be that such 
emotions are exacerbated if these, traditionally private, topics are discussed 
within a group setting where confidentiality and anonymity cannot be ensured.  
Both qualitative (Holt et al., 2012; Honein-AbouHaidar et al., 2016; 
Tarasenko, Wackerbarth, Love, Joyce, & Haist, 2011) and quantitative (Bynum, 
Davis, Green, & Katz, 2012; Robb, Solarin, Power, Atkin, & Wardle, 2008; Shi, 
Lebrun, Zhu, & Tsai, 2011) research into the public perceptions of bowel cancer 
and screening, suggests that bowel cancer stigma is partly driven by the 
negative perceptions surrounding the CRC screening process. Evidence 
suggests that the collection of faecal samples is generally considered 
unsanitary and frequently described as ‘disgusting’, ‘repulsive’ and ‘dirty’ 
(Javanparast, Ward, Carter, & Wilson, 2012), people often feel apprehensive 
about being subjected to screening procedures that require the insertion of an 
endoscopic instrument into the anus (e.g., for a digital-rectal exam) (Greisinger, 
Hawley, Bettencourt, Perz, & Vernon, 2006), or about undergoing invasive 
treatment, such as colostomy, chemotherapy and/or surgical removal of tumors, 
in the event of a cancer diagnosis. Negative attitudes towards CRC screening, 
paired with the aforementioned aversive emotional barriers, have contributed to 
the stigmatisation of CRC screening, which is one of the driving factors 
negatively influencing people’s engagement with both primary and secondary 
prevention behaviours (Azaiza & Cohen, 2008a, 2008b; Bynum et al., 2012; 
Matthews, Berrios, Darnell, & Calhoun, 2006). Widespread negative beliefs and 
connotations associated with CRC screening might also affect how receptive 
people are to cancer-related health promotion materials, and particularly so if 
these are delivered within the context of group-based health interventions. It 
might be that the acceptability of screening- and cancer-related messages is 
compromised within a group setting due to the stigma associated with CRC. 
Within this context, it has yet to be examined whether intervention effectiveness 
varies as a result of group versus individualised modes of delivery.  Another 
mode of delivery domain that might have an impact on intervention 
effectiveness is the communication channel through which healthcare 
interventions are delivered (e.g., written, electronic, phone, in-person), which is 
another area that remains under-researched with regards to CRC screening.  
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2.1.1.2. Intervention provider 
Despite past research identifying intervention provider as an important 
factor to consider with regards to intervention effectiveness, previous reviews 
and meta-analyses in the CRC screening literature have not examined this as a 
potential moderator of intervention effectiveness. Cutrona and colleagues 
(2010) examined what the optimal modes of delivery were with respect to 
improving cardiovascular medication adherence and found that patient 
receptivity to adherence-related messages varied as a result of the intervention 
provider’s professional training (e.g., lay person, pharmacist, physician). 
Additionally, there is some evidence to suggest that the involvement of health 
workers and lay health advisors might be particularly beneficial in implementing 
interventions within the community and/or interventions that target ethnic and 
racial minorities and socioeconomically deprived populations (Gorin et al., 2006; 
Holmes et al., 2008; Palmer & Schneider, 2005; Shavers, Fagan, & McDonald, 
2007). Low SES and ethnic minority populations might respond better to 
interventions delivered by community health advisors partly because these 
individuals are frequently perceived as liaisons between the healthcare system 
and their local community, and are uniquely positioned to communicate health-
related information to target groups through their existing social networks to 
which they themselves belong to (Kaiser, Thomas, & Bowers, 2017; Verhagen, 
Steunenberg, de Wit, & Ros, 2014). The fact that lay health educators are 
‘rooted’ within the community and hold indigenous knowledge enables them to 
handle intervention delivery with greater cultural sensitivity and to adapt their 
communication style to the cultural context of their local communities.  
2.1.1.3. Intervention setting 
The intervention setting has also been recognised as a factor that can 
have impact on intervention effectiveness. For instance, community-based 
interventions – and especially those that incorporate an intervention 
development phase employing participatory research methods – are considered 
the current ‘gold standard’ for eliminating disparities in clinical and public health 
systems and population status. This might partly be driven by the fact that 
community-based interventions offer participants the opportunity to connect with 
aspects of their social environment, which can enforce collaborative/community 
decision-making and even encourage collective action for behaviour change 
(Anderson, Scrimshaw, Fullilove, & Fielding, 2003; Swan, 2009; Wallerstein & 
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Duran, 2010). Yet it remains unanswered whether community-based 
interventions are more effective than those implemented within a primary care 
setting with regards to CRC screening. Questions about the role that factors, 
such as the mode of delivery, the setting and the provider, have to play have yet 
to be sufficiently examined within this context and the investigation of such 
intervention components can direct attention to questions of what interventions 
to apply, with which target population and under what conditions.  
2.1.1.4. Intervention screening modality 
The screening modality used may also influence intervention 
effectiveness. Participants may be more or less receptive to preventive health 
messages depending on whether the screening procedure is endoscopic or 
non-endoscopic in nature. What might attract patients to endoscopic 
procedures (i.e., colonoscopy, computed tomographic colonography (CTC), 
double-contrast barium enema, flexible sigmoidoscopy) is that they are 
diagnostic in nature and they involve the examination of the entire colon during 
which polyps can be removed. It is also not uncommon to diagnose other 
diseases, not limited to CRC, that were undetected until then, which is seen by 
many as an added benefit of endoscopic tests. However, the two main 
limitations of endoscopic screening procedures is that they are not particularly 
cost effective for countries with universal health systems such as the UK, and 
they are also associated with greater risks of bowel tears and infections, that 
are not present with the noninvasive, stool-based tests. The invasiveness of 
endoscopic screening methods may engender a greater sense of fear, 
discomfort or concern and might elicit unpleasant emotions such as shyness 
and anxiety, which could serve to prevent screening uptake. For instance, a 
study by Adler and colleagues (2014) found that patients that had previously 
refused to undergo a colonoscopy were more likely to accept a noninvasive FIT 
test and approximately five times more likely to accept a blood test as an 
alternative method for CRC screening (i.e., a method based on the detection of 
methylated Septin9 DNA in patient plasma), demonstrating that the level of 
invasiveness associated with each screening method is an important 
determinant of CRC screening uptake. Additional evidence suggests that 
colonoscopy is associated with reduced CRC screening uptake, especially 
among racial and ethnic minorities and that providing the option of a stool-
based test, or being a given a choice between stool-based tests or a 
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colonoscopy, can result in significantly greater screening uptake rates (Inadomi 
et al., 2012). Therefore, the current meta-analysis also sought to examine 
whether intervention effectiveness varied as a result of test modality.  
2.1.1.5. Use of theory 
The use of theory in interventions that aim to increase colorectal cancer 
screening uptake has also not been systematically assessed by previous 
reviews, and therefore, theory application and its impact on behaviour change 
remains unaddressed within the context of cancer screening (Lippke & 
Ziegelmann, 2008; Threlfall et al., 2014; Wallace, Brown, & Hilton, 2014) Given 
that more than half of all CRC deaths that occur each year are attributed to the 
nonuse of screening, and given that screening uptake is, in and of itself, a 
detection behaviour, it can be suggested that the development of theory-driven 
interventions that target modifiable, behavioural factors, could demonstrate 
substantial public health benefits. Only a small number of studies in the cancer 
screening literature have directly used behavioural science theories as a basis 
for developing intervention strategies; for example, Sheeran and Orbell (2000) 
examined whether the formation of implementation intentions increased 
attendance for cervical cancer screening and another study by Champion, 
Foster and Menon (1997) examined the usefulness of theories in tailoring 
health promotion messages to increase health-protecting behaviours. Although 
studies that directly use behavioural science theories in the planning, 
development and implementation phases of interventions seem scarce, it is 
suspected that many of the existing interventions targeting health behaviours 
will often have foundations in behavioural science theory (Jamtvedt, Young, 
Kristoffersen, O’Brien, & Oxman, 2006; Legler et al., 2002), but an important 
limitation is that interventionists themselves might have a moderate or poor 
level of awareness of theory and theoretical constructs that are used in their 
interventions. For instance, Glanz and Bishop (2010) summarise the findings 
from a series of interviews with 59 programme-development coordinators and 
61 recruitment coordinators responsible for developing programmes organised 
by the National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP), in order to assess the extent to which evidence-based cancer 
prevention strategies were used in programmes aiming to increase access to 
breast and cervical cancer-screening services for medically underserved 
women. Interviewees were asked about the theories they used to develop their 
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intervention strategies; responding coordinators often listed a number of 
different theories – the most commonly mentioned theories were adult learning 
theory, social influence theory, diffusion of innovation and stages of change – or 
they responded by simply listing a concept or a term, but not a theory. Others 
indicated that a theory was used to design the intervention but that they could 
not remember what it was called, indicating that practitioners, who are often 
responsible for organising large-scale public health programmes, are largely 
unaware of the role that theory might have in their interventions. It is vital to 
obtain a clear understanding of how current public health practitioners, and 
interventionists in general, are using theory and whether the lack of substantial 
impact often seen in community-based health promotion programmes (Merzel & 
D’Afflitti, 2003; Thompson, Coronado, Snipes, & Puschel, 2003) is due, in part, 
to weaknesses in the application of existing theoretical models. In the context of 
CRC screening, a question is raised relating to whether existing studies, that 
claim the use of behavioural science theory in developing their interventions, 
focus only on changing screening behaviours by facilitating initial compliance, 
or whether they also examine the intervention’s impact on maintaining 
behaviour change. This is particularly relevant for screening programs that use 
stool-based screening tests, whose capacity to decrease CRC mortality heavily 
depends on repeat-screening every two years. The current meta-analysis 
sought to systematically examine the extent to which theory use affected CRC 
screening uptake.  
2.1.2. Participant Characteristics as Moderator Variables  
Another substantial limitation of currently published reviews in this area, 
is that they refrain from identifying differential intervention effectiveness for 
specific populations. Specifically, they offer little insight into the applicability of 
different approaches and interventions among populations that are traditionally 
deemed as hard-to-reach – including socioeconomically deprived, black and 
ethnic minority (BEM) and medically underserved populations.  
Other patient-level attributes also remain insufficiently examined within 
this context. For instance, there is a basis for investigating gender as a 
moderator of health intervention effectiveness to increase CRC screening 
uptake since gender differences in screening uptake, as well as the variation in 
determinants of screening participation by gender, have been documented in 
several studies. For instance, Friedemann-Sanchez and colleagues (2007) 
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examined CRC screening barriers, attitudes and preferences by gender and 
found that, although both men and women reported similar preferences for CRC 
screening modalities, they also reported notable differences relating to modality-
specific barriers and facilitators. For example, both genders reported 
experiencing fear regarding endoscopic screening procedures, but women 
expressed these fears as being predominantly affective while men 
communicated theirs as being primarily physical. Such differences may explain 
part of the gender differences observed in utilisation of different screening 
modalities. Findings across the UK and the US suggest that screening uptake is 
higher among men for more invasive procedures (i.e., endoscopic screening 
modalities) than it is for women (Ananthakrishnan, Schellhase, Sparapani, 
Laud, & Neuner, 2007; McGregor, Hilsden, Li, Bryant, & Murray, 2007; 
Meissner, Breen, Klabunde, & Vernon, 2006; Wardle, Miles, & Atkin, 2005). 
However, the evidence regarding gender differences with regards to gFOBT 
adherence in the US is fairly inconclusive; some results based on National 
Health Interview Surveys report no significant differences in the prevalence of 
gFOBT by gender (Meissner et al., 2006), some report that female gender is 
associated with decreased screening (Wernli et al., 2014), while others 
document rates of 1-4% higher among women compared to men (Clarke, 
McNamara, et al., 2016; Joseph et al., 2012; Steele et al., 2013). In the UK, the 
current evidence base suggests that gFOBT rates have higher uptake in women 
than in men. For instance, in the Nottingham gFOBT trial uptake was 51% for 
men and 55% for women (Hardcastle et al., 1996). Findings from both the first 
and second evaluation reports of the English Pilot of Bowel Cancer Screening 
reported significantly lower gFOBT uptake among men compared to women 
(52.1%, 47.7% for men and 61.4%, 56.2% for women for the first and second 
pilot respectively) (Weller et al., 2007b) and in another study, conducted on 
behalf of the English Bowel Cancer Screening Evaluation Committee, the 
authors examined early outcomes regarding uptake of gFOBT screening after 
the first one million invitations (i.e., sent out between June 2006 and October 
2008) and documented rates of 49.6% for men and 54.4% for women (Logan et 
al., 2012). Similarly, the most recent Key Performance Indicators (KPI) report for 
the Scottish Bowel Cancer Screening Programme, published in August 2017, 
has noted similar findings; gFOBT uptake was higher in women than men with 
rates of 60.1% and 53.8% respectively (Scottish Bowel Screening Programme 
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Statistics, 2017). Whether gender has an impact on intervention effectiveness to 
increase CRC screening uptake – irrespective of the screening modality used - 
has not been examined, and therefore this meta-analysis aimed to assess 
whether intervention effectiveness varied by gender.  
Similarly, the age of participants has not been examined in meta-analysis 
moderator analyses, however, differences in CRC screening uptake by age 
have been observed. The evidence on whether uptake rates are more 
favourable for older or younger participants remains inconsistent (Denberg et 
al., 2005; Klabunde, Meissner, Wooten, Breen, & Singleton, 2007), but 
understanding whether intervention effectiveness varies by age, among other 
sample characteristics, may lead to more personalised care. The literature 
suggests that having a family history of CRC is another factor that should be 
considered as it is known to influence CRC screening uptake. Studies show that 
CRC screening uptake among individuals with a family history is higher 
compared to those without a family history (Janssen, van Osch, de Vries, & 
Lechner, 2011; Kim et al., 2008; Murphy et al., 2015).  
Further studies suggest that having a family history of cancer makes the 
risk of the disease more salient and have found that increased perceived risk 
acts as a strong predictor of cancer screening uptake among individuals with a 
family history (DiLorenzo et al., 2006; Peipins et al., 2015). Greater perceived 
risk and vulnerability are known to motivate medical decisions and health 
behaviours and it is likely that greater CRC risk perceptions might affect one’s 
interpretation of cancer-related risk messages and increase engagement with 
cancer screening recommendations, compared to those with lower perceived 
risk (Han, Moser, & Klein, 2007). Interventions targeting CRC screening uptake 
almost universally provide information about cancer and the risks associated 
with non-participation (also referred to as risk communication interventions) and 
therefore it was considered useful for the present meta-analysis to examine 
whether intervention effectiveness varied as a function of the proportion of 
people within the sample with a family history of CRC.  
Participants’ screening status at time of study was also believed to be a 
potential moderator; psychological research concerned with the antecedents of 
health behaviour change postulates that past behaviour is a central precursor of 
future behaviour (Ouellette & Wood, 1998). Based on this principle, it would be 
logical to presume that intervention effectiveness would increase if more 
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participants within the sample were up-to-date with CRC screening at baseline. 
However, CRC screening is a rather idiosyncratic type of behaviour, in that it 
does not occur regularly enough to be considered habitual. Rather, CRC 
screening occurs occasionally (every two years when using a stool-based test 
or every five years for a colonoscopy). Unlike habitual behaviours, it is not clear 
whether past behaviours that occur occasionally strongly predict future 
screening, hence the need for examining screening uptake at baseline as a 
potential moderator.  
2.1.3. Methodological Characteristics as Moderator Variables  
Furthermore, existing reviews have not considered the methodological 
heterogeneity between studies as a contributing factor to intervention 
effectiveness (or lack of). Interventions in the colorectal cancer screening 
literature are varied in terms of setting, provider, mode of delivery, the extent to 
which theory was used to develop the intervention, screening modality and 
other methodological quality parameters, which are all aspects likely to 
influence intervention effectiveness. Scant evidence exists comparing multiple 
possible interventions in the context of CRC screening, which is problematic for 
identifying which interventions, or which intervention characteristics, will work 
best and for which populations. There is increasing recognition that the way in 
which complex social and public health interventions are organised and 
implemented can impact on their ability to achieve behaviour change (Bambra 
et al., 2009; Beall et al., 2014; Conn, Ruppar, Phillips, & Chase, 2012; Hillier-
Brown et al., 2014).  
2.1.4. Behaviour Change Techniques (BCTs) as Moderator Variables  
Another limitation of currently published reviews is that they exclusively 
examine the use of patient reminders as a behaviour change technique (BCT), 
however they fail to assess the impact of other BCTs on intervention 
effectiveness. Indeed, in recent years a number of taxonomies, identifying 
specific BCTs, have been developed (Abraham & Michie, 2008; Michie et al., 
2011; Michie et al., 2013). These taxonomies are used to specify behavioural 
intervention components, the presence of which might be what determines the 
observed differences in effect between one intervention and another, or 
between the intervention and control groups. The process of breaking down 
complex, multi-component interventions, into active ingredients that can be 
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specified and categorised, aids the making of direct links between which 
aspects are associated with increased intervention effectiveness. 
Understanding what drives the difference in effects holds enormous potential 
and is likely to influence the degree to which future public health interventions 
are going to have successful outcomes.  
Collectively the information presented here suggests that existing 
reviews have considerable methodological shortcomings, which, to a certain 
extent, compromise the quality of evidence and the capacity of these reviews to 
inform health policy. The current meta-analytic review aims to address the 
limitations outlined above in relation to previous reviews and to provide the most 
up to date (including studies published until October, 2016) and comprehensive 
quantitative overview of interventions aiming to increase colorectal cancer 
screening uptake.  
2.1.5. Aims 
The purpose of the present study was to conduct a meta-analytic review 
of randomised controlled trials (RCTs) to identify the overall effectiveness of 
interventions to increase CRC screening uptake and to identify successful 
strategies for behaviour change that can be used to guide intervention 
development. A particular focus of this meta-analysis was to examine whether 
interventions were more effective for socioeconomically deprived versus non-
deprived populations and to ascertain whether specific intervention features and 
BCTs were beneficial in increasing screening uptake, specifically for 
disadvantaged populations in comparison to higher socioeconomic status 
populations. As outlined earlier, several variables were expected to influence 
the impact of health interventions on CRC screening uptake. Therefore, the 
present review examined four groups of moderators in order to identify factors 
associated with increased intervention effectiveness. The first category of 
moderator variables related to participant characteristics and it was examined 
whether intervention effectiveness varied by sample age, gender, family history 
of CRC and participants’ screening status at the time of the study. The second 
category of moderators related to intervention characteristics where it was 
investigated whether factors such as mode of delivery, setting, provider 
characteristics, screening modality and reported use of theory are associated 
with improved screening uptake. The third category of moderator analyses 
related to methodological characteristics of the included studies and specifically: 
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a) whether the outcome variable was measured objectively or through self-
report; and b) whether the study quality was judged as having low, unclear or 
high risk of bias. A fourth category of moderator variables was dedicated to 
assessing the effectiveness of individual BCTs in improving screening uptake, 
the identification of which was based on the taxonomy proposed by Michie et al 
(2013). Each of these variables was considered as having the potential to 
influence intervention effectiveness and the studies reviewed here provided 
data regarding these characteristics.  
2.2. Method 
2.2.1. Protocol Registration 
The protocol for this systematic review and meta-analysis was pre-
registered with the International Prospective Register of Systematic Reviews 
(PROSPERO) database (registration number: CRD42016033782, 14/01/2016). 
Details of the protocol can be viewed in Appendix 2.1.  
2.2.2. Data Sources and Searches  
The electronic databases MEDLINE (1950- ), EMBASE (1947- ), and 
PSYCINFO (1806- ) were searched using Ovid (date of last search: 
24/10/2016). The search strategy was developed on the basis of the PICOS 
framework; a technique used to formulate focused health related research 
questions by setting inclusion criteria relating to participants, interventions, 
comparisons, outcome(s) and study design. The search strategy was also 
informed by two previous systematic literature reviews (Baron et al., 2008; 
Holden, Jonas, Porterfield, Reuland, & Harris, 2010) and identified studies that 
examined the impact of any given intervention, including patient-directed and 
physician-directed interventions, on CRC screening uptake (Ferreira et al., 
2005; Myers et al., 2007). 
The search was performed using the explode (exp) function available 
when using the Ovid interface, combined with Medical Subject Heading (MeSH) 
terms and keywords that related to screening for colorectal cancer (e.g., exp 
colorectal cancer OR colorectal neoplasms) AND (exp intervention study OR 
health promotion OR behaviour change) AND (exp cancer screening OR health 
education OR early diagnosis). This review did not augment the literature 
search by conducting manual searches of reference lists of relevant studies or 
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additional systematic and narrative reviews. The search was restricted to 
English-language studies and articles published in peer-reviewed journals.  
The present meta-analysis only included studies that adopted a RCT 
study design, however, this was not a primary focus at the start of the review 
and therefore the chosen study design is not reflected in the review search 
strategy. Despite initially searching the databases for all study designs, the 
decision to restrict to RCTs only was justified by two main reasons: firstly, it has 
been argued that meta-analyses seeking to examine the effects of interventions 
should be limited to RCTs because the RCT design eliminates the influence of 
confounding variables and minimises the threat of selection bias due to random 
allocation of participants to study condition, which is increased in non-
randomised studies of interventions (NRSIs) (Odgaard‐Jensen et al., 2011). 
Within the context of evaluating healthcare interventions, RCTs are widely 
accepted as the ideal research design (but the critical appraisal of trial quality is 
equally vital) for obtaining unbiased estimates of intervention effects and are 
placed at the top of the evidence hierarchy(Evans, 2003). Secondly, the 
inclusion of NRSIs would have been necessary had there been a lack of 
adequately-sized RCTs identified through the database search that addressed 
the research question of interest.  This pertains to a common criticism against 
the selection of RCTs only for inclusion in meta-analyses, which is that RCTs 
will often have smaller sample sizes - partly due to greater recruitment 
challenges associated with conducting RCTs - compared to NRSIs. Small-sized 
trials are often underpowered, more prone to chance effects and at a greater 
risk for biased reporting (Counsell, Clarke, Slattery, & Sandercock, 1994; Egger, 
Smith, Schneider, & Minder, 1997; Kunz & Oxman, 1998). However, in meta-
analyses the power of individual studies is not thought to influence the precision 
of the findings, since the evidence from all studies is pooled to provide a 
collective estimation of intervention effectiveness. Furthermore, within the 
context of the present meta-analysis, the average number of participants per 
RCT was approximately 19,000 with a cumulative number of participants above 
1.9 million, which was considered large enough to ensure that the 
aforementioned sources of bias do not pose a substantial threat to the reliability 
of the findings discussed here.    
An initial search was conducted in December 2014 and was updated in 
October 2016 to ensure that the search was as current as possible. The same 
  
49 
search strategy was used with all databases applying appropriate alterations 
analogous to each database’s interface where necessary. Studies were 
considered irrespective of type of intervention, which is reflected in the wide 
range of search terms used to identify potentially eligible studies (see Table 
2.1). 
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Table 2.  1. Meta-analysis search strategy 
Embase PsycInfo Medline Notes 
Step 1: Intervention    
Embase PsycInfo Medline Notes 
1. intervention study/ 
2. intervention*.tw. 
3. health promotion/ 
4. patient navigat$.tw. 
5. reminder$.mp. 
6. incentive$.mp. 
7. reduc$ cost.mp. 
8. mass medium/ 
9. attitude to health/ 
10. health behavior/ 
11. health belief/ 
12. health belief model/ 
13. risk reduction/ 
14. behavio?r change/ 
15. Social Cognitive 
Theory/ 
16. persuasive 
communication/ 
17. "theory of planned 
behavior"/ 
18. message fram*.mp. 
19. implementation 
intention$.mp. 
20. protection motivation 
theory.mp. 
21. social cognition 
model$.mp. 
22. self efficacy.mp. 
23. or/ 1-22 
 
1. intervention/ 
2. intervention*.tw. 
3. exp Health 
Promotion/ 
4. patient 
navigat$.tw. 
5. reminder$.mp. 
6. incentive$.mp. 
7. reduc$ cost.mp. 
8. mass media/ 
9. health attitudes/ 
10. health behavior/ 
11. health 
belief*.mp. 
12. health belief 
model.mp. 
13. exp Behavior 
Change/ 
14. social cognitive 
theory.mp. 
15. exp Persuasive 
Communication/ 
16. exp Reasoned 
Action/ 
17. message 
fram*.mp. 
18. implementation 
intention$.mp. 
19. protection 
motivation 
theory.mp. 
20. social cognition 
model$.mp. 
21. exp Self 
Efficacy/ 
22. or/1-21 
1. Intervention 
Studies/ 
2. intervention*.tw. 
3. Health 
Promotion/ 
4. patient 
navigat$.tw. 
5. reminder$.mp. 
6. incentive$.mp. 
7. reduc$ cost.mp. 
8. Mass Media/ 
9. Attitude to 
Health/ 
10. Health 
Behavior/ 
11. health 
belief*.mp. 
12. health belief 
model.mp. 
13. behavio?r 
change.mp. 
14. social cognitive 
theory.mp. 
15. Persuasive 
Communication/ 
16. theory of 
planned 
behavio?r.mp. 
17. message 
fram*.mp. 
18. implementation 
intention$.mp. 
19. protection 
motivation 
theory.mp. 
20. social cognition 
model$.mp. 
21. Self Efficacy/ 
22. or/1-21 
/ = MeSH term 
*/$ = Truncation 
.tw = title, 
abstract 
.mp = title, 
abstract, subject 
heading  
Exp = explode 
search 
? = letter may 
appear or not 
Step 2: Type of Cancer    
COLORECTAL CANCER (including medical terminology and synonyms) 
Embase PsycInfo Medline Notes 
24.  colorectal cancer/ 
25. bowel cancer.mp. 
26. colon cancer/ 
27. rectum cancer/ 
28. (colorectal adj2 
neoplasm$).mp. 
29. or/24-28 
23. colorectal 
cancer.mp. 
24. bowel 
cancer.mp. 
25. colon 
cancer.mp. 
26. rect* 
cancer.mp. 
23. colorectal 
cancer.mp. 
24. bowel 
cancer.mp. 
25. colon 
cancer.mp. 
26. rect* 
cancer.mp. 
/ = MeSH term 
.mp = title, 
abstract, subject 
heading 
Adj = adjacent 
$ = truncation 
  
51 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. The ‘OR’ Boolean function was used in Step 1, Step 2 and Step 3. Then the three separate steps were combined 
using the ‘AND’ Boolean function in order to retrieve papers to be assessed for eligibility 
 
2.2.3. Study Selection  
The first criterion for inclusion in the meta-analysis was that the 
intervention had to directly target CRC screening uptake. Studies were included 
regardless of screening modality and therefore the review contains studies that 
used both non-endoscopic screening procedures, including the gFOBT and FIT, 
as well as endoscopic screening procedures, including FS, SC or barium 
enema. The second criterion for inclusion was that studies adopted a RCT 
study design, where participants were randomly assigned to a treatment group, 
27. (colorectal adj2 
neoplasm$).mp. 
28. or/ 23-27 
27.  colorectal adj2 
neoplasm$).mp. 
28. or/23-27 
Step 3: Outcomes    
Adherence/Compliance to Screening (for all methods of CRC screening) in middle 
aged populations 
Embase PsycInfo Medline Notes 
30. cancer screening/ 
31. self examination/ 
32. cancer prevention/ 
33. health education/ 
34. health literacy/ 
35. health promotion/ 
36. health kowledge.mp. 
37. early diagnosis/ 
38. patient compliance/ 
39. patient 
adherence.mp. 
40. health care access/ 
41. barium enema.mp. 
42. endoscop$.mp. 
43. f?ecal occult 
blood.mp. 
44. occult blood/ 
45. occult blood test/ 
46. occult blood.mp. 
47. or/30-46 
 
29. cancer 
screening/ 
30. "self 
examination 
(medical)"/ 
31. cancer 
prevention.mp. 
32. health 
education/ 
33. health literacy/ 
34. health 
promotion/ 
35. health 
knowledge/ 
36. early 
diagnosis.mp. 
37. treatment 
compliance/ 
38. patient 
adherence.mp. 
39. health care 
services/ 
40. barium 
enema.mp. 
41. endoscop$.mp. 
42. f?ecal occult 
blood.mp. 
43. occult blood 
test.mp. 
44. or/29-43 
 
 
27. cancer 
screen*.mp. 
28. self-
examination.mp. 
29. cancer 
prevention.mp. 
30. Health 
Education/ 
31. Health Literacy/ 
32. Health 
Promotion/ 
33. Health 
Knowledge, 
Attitudes, Practice/ 
34. Early 
Diagnosis/ 
35. treatment 
complicance.mp. 
36. Patient 
Compliance/ 
37. Health Services 
Accessibility/ 
38. barium 
enema.mp. 
39. endoscop$.mp. 
40. f?ecal occult 
blood.mp. 
41. occult blood 
test.mp. 
42. or/ 27-42 
 
/ = MeSH term 
.mp = title, 
abstract, subject 
heading 
*/$ =  truncation  
? = letter may 
appear or not 
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which received an intervention to increase CRC screening uptake, and a 
comparison group, which received either a control intervention or no 
intervention. The third criterion for inclusion was that the intervention outcome 
had to be measured and reported quantitatively to enable the calculation of an 
effect size. The fourth criterion for inclusion was that each study had to report 
original data not reported in another paper in order to avoid inflating effect sizes.  
The fifth criterion for inclusion was that studies had to involve participants aged 
50 years or older. The sixth criterion for inclusion was that studies had to involve 
participants without a prior or current personal history of CRC.  The seventh 
criterion for inclusion was that studies had to be published in English language 
and in peer-reviewed journals. There was no restriction in year of publication. 
Studies were excluded if they were an abstract, a dissertation, a review, a 
protocol, a poster, a think piece or guidelines.  
This systematic review and meta-analysis was conducted and reported in 
accordance with the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) statement (Moher, Liberati, Tetzlaff, Altman, & Group, 
2009). The PRISMA checklist encourages authors to describe eligibility criteria 
using the PICOS framework; a technique used to formulate focused health 
related research questions by setting inclusion criteria relating to participants, 
interventions, comparisons, outcome(s), and study design of the included 
studies. Table 2.2 outlines the inclusion criteria for studies included in the 
present review according to the PICOS framework. 
 
Table 2.  2. Inclusion criteria using the PICOS framework 
Component Inclusion Criterion  
Population(s)/ 
Participants 
Studies were included if they recruited participants that 
were at least 50 years of age and had no personal history 
of bowel cancer (i.e., average risk populations). 
 
Intervention  
Studies were included if they tested the effect of an 
intervention (of any intensity) on increasing CRC screening 
uptake.  
 
Comparison 
Main interventions were compared against an inactive 
control (i.e., no-treatment or wait list control) condition 
and/or an active control and/or comparison intervention 
Outcome CRC screening uptake  
Study Design Randomised controlled trials 
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Titles and abstracts of all citations identified by the literature search were 
examined for relevance to the predefined inclusion criteria. After the removal of 
duplicate publications, the author initially screened titles and abstracts of 
studies retrieved using the search strategy to identify studies that are in 
accordance with the above-mentioned inclusion criteria. Ineligible studies were 
excluded and the reason of rejection was recorded. The full texts of these 
potentially eligible studies were retrieved and assessed for eligibility. The author 
extracted relevant information for the entirety of the studies and a second 
postgraduate student independently assessed 20% of the full text studies for 
inclusion in the review. Discrepancies were resolved through discussion. 
2.2.4. Data Extraction and Quality Assessment  
A standardised, pre-piloted form (See Appendix 2.2.) was used to extract 
data from the included studies for assessment of study quality and evidence 
synthesis. The data extraction form was piloted on 5% of the included studies 
and was modified accordingly to ensure that the form extracted information on 
all the relevant points of interest. To further facilitate subsequent moderator 
analysis, a data extraction Excel spreadsheet containing all the extracted 
information was created. The information employed for moderator analyses, 
included mean age of sample (as reported or as inferred when means were not 
reported1), gender composition (percent males, as reported), ethnic background 
(percent non-white, as reported), sample socioeconomic status/level of 
deprivation (studies were coded either as low SES or non-low SES). Studies 
were deemed as involving low SES populations in respect of: (1) poverty/SES 
status; (2) ethnic minority status; (3) education/literacy level; (4) geographical 
location – that is, areas described as disadvantaged or medically underserved. 
The allocation of studies to the low SES group was decided based on author-
set criteria; the main reason for this was that the majority of studies did not 
report data for objective SES markers such as income, area or individual-level 
deprivation, educational attainment etc. Details of how studies were classified 
as being low SES can be viewed in Appendix 2.3.  
Information was also extracted with regards to sample family history of 
CRC (percentage with family history, as reported), average number of past 
                                                        
1  For studies that reported sample age only as a threshold (e.g., 60 years or older), the 
threshold age was used as the mean age of the sample. For studies that reported sample age 
only as a range (e.g., 60-74) the midpoint of the range was used as the mean age of the 
sample. 
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screening invites (which was reported for only two studies2 and therefore this 
variable was not included in moderator analyses), baseline CRC screening 
rates (percentage screened at baseline, as reported), screening modality, 
intervention intensity (which was based on the number of contacts with the 
intervention and control group3 as well as the total contact time4, length of 
follow-up (as reported, in weeks), latency of screening uptake, coded as the 
average duration from screening invite to screening uptake (reported only for 
two studies 5  and therefore this variable was not included in moderator 
analyses), contact type (e.g., remote, in person or mixed contact), intervention 
format and mode (e.g., individual- or group-based and using paper-based or 
non-paper based materials respectively), intervention provider (e.g., clinically 
trained health professionals versus non-clinically trained health professionals) 
and intervention setting (primary care versus community setting).  
Specifically, interventions were coded depending on whether they were 
delivered: (1) in person or (2) remotely; in the former, the intervention required 
real-time, face-to-face contact with an interventionist, whereas in the latter case, 
the intervention was not delivered face-to-face and was primarily delivered 
through a variety of delivery modes including standard mail, the internet and 
telephone. The intervention delivery format was categorised as being individual-
based, if the intervention involved providing one-to-one health promotion, 
education, advice or counselling, as group-based, if the intervention involved 
group-based health promotion, education, advice or counselling, and as mixed, 
if the intervention included both aspects that were delivered individually and 
aspects that were delivered in a group. Intervention providers were classified 
as: (1) clinically-trained healthcare professionals (e.g., general practitioners, 
physicians, nurses), (2) non-clinically trained healthcare professionals (e.g., 
community health educators, patient navigators, health advisors), (3) research 
staff (academic staff, research assistants, students) and (4) some interventions 
were characterised as being ‘person-independent’ (also known as ‘no contact’ 
interventions) - that is, the intervention was delivered without direct, real-time 
                                                        
2 Baker et al (2014); Cameron et al (2011) 
3 Total number of contacts was unclear and not consistently reported for the majority of the 
studies and therefore this variable was not included in moderator analyses 
4 Total contact time was reported for 14 studies and was unclear, not reported or not relevant 
for the remaining studies (e.g., for paper-based studies) and therefore was not included in 
moderator analyses. 
5 Baker et al (2014); Wardle et al (2016) 
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contact with an interventionist and relied exclusively either on paper-based 
materials, that were sent to participants through the post, or on electronic-based 
materials (e.g., text messages, electronic reminders). Intervention mode was 
classified as: (1) paper-based, if it involved the distribution of printed materials 
including brochures, leaflets, and standard screening invitations, (2) electronic-
based, if it involved mobile applications, texting, the internet (e.g., internet-
based chat room exchanges and use of websites), online educational videos 
and/or DVDs, (3) phone-based, if a telephone was used to facilitate the 
intervention and (4) as interventions that were delivered in person (i.e., material-
independent interventions); this category included studies that did not involve 
any of the aforementioned materials and relied predominantly on interpersonal 
interactions between the intervention provider and the intervention recipient, 
including studies that involved patient navigation services 6 , educational 
workshops or talks and/or any informal community gatherings to raise 
awareness about CRC screening. Intervention setting was classified as being 
either: (1) a community setting, if the intervention was delivered within 
community-based institutions such as churches, schools, voluntary 
organisations, and/or local community health centres or if it required the 
involvement of local communities within a certain neighbourhood, or (2) a 
primary care setting, if the intervention was delivered in a primary or secondary 
care facility such as GP practices, hospitals, primary care clinics and community 
pharmacies, among others. Studies were also coded for the type of screening 
modality they used and were classified as using: (1) endoscopic screening 
procedures (i.e., any procedure that requires viewing the bowel internally e.g., 
colonoscopy, sigmoidoscopy etc.), (2) non-endoscopic screening procedures, if 
they used stool-based screening tests and (3) studies that offered participants a 
choice to undergo either an endoscopic or non-endoscopic screening 
procedure. Information was also extracted on whether interventions 
incorporated reminders or not, and also on whether studies assessed screening 
uptake at follow-up either: (1) objectively, through the use of claims and/or 
administrative data or by accessing patients’ electronic medical records (EMRs) 
or (2) through self-report.  
                                                        
6 Patient navigation is a community-based intervention, which aims to reduce access barriers to 
cancer services for deprived and vulnerable populations (Freeman & Rodriguez, 2011). 
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Studies were also coded on the extent to which theory was used to 
develop the intervention. Specifically, studies were coded for their reported use 
of theory using the Theory Coding Scheme (TCS) proposed by Michie and 
Prestwich (2010), granted that studies mentioned the theory and/or model of 
behaviour in the Introduction or Methods sections of the paper. The TCS 
consists of 19 items that collectively enable the systematic assessment of 
reported theory-use by specifying, whether theory is mentioned (e.g., ‘Is the 
theory/model of behaviour mentioned in the Introduction or Methods section of 
the paper?’), how theory is directly used in intervention design (e.g., ‘Are 
theory/predictors used to select/develop intervention techniques?’), how theory 
indirectly influences interventions via the selection of participants (e.g., ‘Is 
theory/predictors used to tailor intervention techniques to recipients?’), how 
theory explains intervention effects on outcomes (e.g., ‘Are theory-relevant 
predictors and constructs measured?’) and the implications of results for future 
theory development (e.g., ‘Are results discussed in relation to theory?’). The 
extent of reported theory use was included in the moderator analyses by using 
a coding strategy similar to that outlined in a meta-analysis by Prestwich and 
colleagues (2014) that examined whether reported theory use influences the 
effectiveness of health behaviour interventions. The authors in that meta-
analytic review combined certain items from the TCS to reflect the extent of 
reported theory use. Specifically, Prestwich and colleagues (2014) created three 
composite measures reflecting: firstly, the extent to which each BCT reported by 
the authors was linked to a theory-relevant construct (this aspect of theory use 
is reflected by items 7-9 items of the TCS7); secondly, the extent to which the 
constructs within the underlying theory were specifically targeted by the BCTs 
(this aspect of theory use is reflected by items 9-11 of the TCS8) and thirdly, an 
overall theory score on all of the TCS items that relate to the use of theory to 
develop an intervention (reflected by items 3-11 of the TCS9). Studies received 
                                                        
7  Item 7: ‘All intervention techniques are explicitly linked to at least one theory-relevant 
construct; Item 8: ‘At least one, but not all, of the intervention techniques are explicitly linked to 
at least one theory-relevant construct’; Item 9: ‘Group of techniques are linked to a group of 
constructs’  
8  Item 10: ‘All theory-relevant constructs are explicitly linked to at least one intervention 
technique’; Item 11: At least one, but not all, of the theory relevant constructs are explicitly 
linked to at leas one intervention technique.  
9 Item 3: ‘Intervention based on single theory’; Item 4: ‘Theory used to select recipients for the 
intervention; Item 5: ‘Theory used to select/develop intervention techniques’; Item 6: ‘Theory 
used to tailor intervention techniques to recipients’ 
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points depending on the extent of reported theory use for each of these three 
composite measures, ultimately resulting in a scale ranging from 0 (no theory 
use) to +8 (most extensive theory use). The same approach was applied to the 
present meta-analytic review and the intensity of reported use of theory was 
included in the moderator analyses as a categorical variable by being 
segregated into studies demonstrating sparse, moderate and extensive 
reported use of theory (with scores ranging from 0-2, 3-5 and 6-8 respectively; 
see Appendix 2.4. for a detailed assessment of reported theory use for each 
study). Additional items, that did not directly address the objective of examining 
the intensity of theory application in health interventions to increase CRC 
screening uptake, were not considered.  
Risk of bias was assessed using the criteria set forth by the Cochrane 
Collaboration that are specific to the features of the RCT design. These are: (1) 
random sequence generation in order to check for selection bias (biased 
allocation to interventions) due to inadequate generation of a randomised 
sequence; (2) allocation concealment, to check for selection bias (biased 
allocation to interventions) due to inadequate concealment of allocations prior to 
assignment; (3) performance bias, to check for bias due to knowledge of the 
allocated interventions by participants and personnel during the study; (4) 
detection bias, to check for bias due to knowledge of the allocated interventions 
by outcome assessors; (5) attrition bias to check for bias due to amount, nature, 
or handling of incomplete outcome data; (6) selective reporting bias: to check 
for bias due to selective outcome reporting by comparing in-publication 
reporting of the outcomes of interest reported in the methods section to those 
reported in the results section. To further assess the methodological quality of 
studies information was extracted on whether the studies conducted intention-
to-treat (ITT) analysis. The following judgments were used: low risk, unclear risk 
(due to either lack of information or uncertainty over the potential of bias) or 
high risk. A summary assessment of risk of bias across the seven domains was 
decided as follows; when studies provided sufficient detail across all the 
aforementioned domains they were classed as having low risk of bias. If 
insufficient detail was reported in terms of what happened in the trial relating to 
one or more of the key domains then studies were classed as having unclear 
risk of bias. Studies were considered as having high risk of bias if they failed to 
meet the criteria set forth by the Cochrane Risk of Bias tool for one or more of 
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the key domains (Higgins et al., 2011). An overview of all the moderators 
included in the meta-analysis can be found in Appendix 2.5.  
Finally, information was also extracted on the BCTs present in both the 
intervention and control arms10. BCTs were coded based on the Behaviour 
Change Technique Taxonomy Version 1 (BCTTv1) developed by Michie et al., 
2013 (see Appendix 2.6. for an overview of the taxonomy). Only BCTs that were 
present in the intervention and absent in the control condition were included in 
the moderator analysis. This approach was used to ensure that any difference 
in effect could be attributed to the inclusion of specific BCTs in any given 
intervention, as emphasised by Peters, de Bruin and Crutzen (2015), and used 
by MacDonald, Lorimer, Knussen and Flowers (2016) and Samdal, Eide, Barth, 
Williams and Meland (2017). Data on the presence of BCTs in each condition 
were extracted by two researchers. Only BCTs that identified by both 
researchers were coded as present.  
2.2.5. Data Synthesis and Analysis 
All summary effects and associated statistics were computed using 
Comprehensive Meta-Analysis (CMA) (Biostat, Englewood, NJ, USA; 2014). 
Effect size estimates were calculated based on the number of events screened 
per number of participants in a given study arm and pooled under the random 
effects model, with data expressed as odds ratios (ORs) with 95% confidence 
intervals (CIs) and Hedge’s g. Due to the inclusion of a large and 
heterogeneous sample of studies in the meta-analysis, it was assumed a priori 
that the true effect size would differ between studies and therefore a random-
effects meta-analysis was performed (rather than using a fixed-effects model, 
which assumes that all studies have the same true effect size). Where studies 
had more than one experimental groups compared with a single control 
condition, the number of participants in the control condition was evenly divided 
across the experimental conditions to ensure each participant was included only 
once in order to avoid double counting of participants in the meta-analysis.  
Heterogeneity was assessed by formal statistical testing using two 
indicators; firstly, the Q-statistic, which is a measure of weighted squared 
deviations, and secondly, the I2 statistic, which is a descriptive index that 
                                                        
10 BCTs in the intervention arm were only coded if they were not present in the control arm in 
order to capture the differences in techniques used and their impact on intervention 
effectiveness 
  
59 
estimates the proportion of total observed variance attributable to between-
study variation in effect size as opposed to random error.  Assumptions of 
homogeneity were considered invalid when the p-value for the Q-test was p < 
0.05. The more I2 values deviate from zero the greater the justification for 
subsequent moderator analysis to explore the reasons of between-study 
variation. It is proposed that an I2 value of 25%, 50% and 75% represents low, 
moderate and large study-to-study dispersion respectively, and therefore, 
greater heterogeneity (Higgins, Thompson, Deeks, & Altman, 2003). Using 
procedures described by Borenstein, Hedges, Higgins and Rothsetain (2009), 
the impact of categorical moderator variables was assessed using subgroup 
analyses analogous to ANOVAs that partition the total effect size variance into 
variance within and between groups (Borenstein et al., 2009).  Between group 
variance (Qb) was used to test whether effect sizes differed among categories of 
a given moderator. For moderators with more than two levels, an overall Qb was 
calculated, which, if statistically significant, was followed-up by multiple pairwise 
comparisons to further examine between group differences. The influence of 
continuous moderator variables was assessed using weighted regression 
analyses. Publication bias was assessed using two indices; firstly, publication 
bias was examined graphically using a funnel plot of effect sizes versus their 
standard errors to investigate the relationship between study sample size and 
study effect size, and secondly the trim and fill method, proposed by Duval and 
Tweedie (2000a, 2000b; see also Duval, 2005) (Duval, 2005; Duval & Tweedie, 
2000a, 2000b) was used to estimate the number of studies missing from the 
meta-analysis due to the suppression of the most extreme results on one side 
of the funnel plot.  
2.2.6. Additional Analyses  
In order to assess whether any of the moderator variables were 
confounded, Pearson’s correlation coefficient analysis was conducted. 
Specifically, the correlations between moderators were examined in order to 
determine any excessive overlap. Variables were considered to be confounded 
with one another if their shared variance exceeded 25% (i.e., r > .50). 
Categorical moderator variables were converted to dichotomies and entered 
into SPSS using the coding strategy outlined in Table 2.3. 
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Table 2.  3. Coding strategy to identify potential confounding variables. 
 
Moderator 
 
 
Coding in SPSS 
Contact type 1 = In person/mixed contact, 0 = Remote contact 
Intervention Delivery  1 = Individual delivery, 0 = Group/mixed delivery 
Provider 1 = Delivered by a person (includes clinically and non-clinically 
trained health professionals and research staff), 0 = not 
delivered by a person 
Materials 1 = Single technique (e.g., Phone, paper-based media) 0 =  
more than one techniques (e.g., paper-based media plus phone) 
Setting 1 = Community setting, 0 = Primary care setting 
Use of theory 1 = Extensive use of theory, 0 = Sparse/Moderate use of theory 
Screening modality  1 = Non endoscopic screening (i.e., gFOBT/FIT), 0 = endoscopic 
screening (i.e., CS, FS) 
Use of reminders 1 = Yes, 0 = No 
Outcome 
assessment 
1 = Objective, 0 = self-report 
Risk of bias  1 = High/unclear bias, 0 = Low bias 
 
2.3. Results  
2.3.1. Study Selection  
A total of 8,783 relevant articles were identified. After removal of 
duplicates, 6,650 remained and article titles and abstracts were screened 
against the predefined selection (i.e., inclusion/exclusion) criteria. Out of these 
6,390 did not meet the inclusion criteria and therefore were excluded, resulting 
in 260 full-text articles to be assessed for eligibility.  After independent review, 
158 articles were excluded resulting into 102 articles containing 152 studies that 
were obtained for further analysis and coding. The PRISMA template was used 
to produce a flowchart outlining the exclusion and inclusion of studies at each 
stage of the selection process (See Figure 2.1).  
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Figure 2. 1. PRISMA flow chart: schematic overview of the selection process 
for interventions eligible for full review. 
2.3.2. Study Characteristics  
A total of 102 published articles, incorporating 152 study comparisons11, 
met study criteria and were coded accordingly, representing a cumulative N = 
1,941,165 participants (median N per study = 1,220). A total of 919,037 
participants were assigned to intervention and 1,022,128 to control arms. All of 
the studies were published between 2000 and 2016, with a median publication 
                                                        
11 Thirty papers included several treatment arms and a single control arm.  Each 
comparison of a treatment arm to a control arm was referred to here as a ‘study comparison’. 
Records identified through 
database searching  
(n = 8,783) 
Records reviewed  
(n = 6,650) 
Full-text articles reviewed  
(n = 260) 
Studies included in meta-analysis  
(n = 102, k = 152) 
Duplicates excluded  
(n = 2,133) 
Records excluded by title (n = 4,713) 
Records excluded by abstract (n = 
1,677) 
 
Records excluded (n=158) 
Not RCTs (n = 30) 
Did not assess relevant outcome (n = 
26) 
Not an intervention to increase uptake 
(n = 15) 
Reviews, editorials, conference 
abstracts (n = 41) 
Insufficient data (n = 7) 
Secondary publications (n = 4) 
Duplicates (n = 5) 
Involved cancer patients (n = 8) 
Qualitative research (n = 1) 
Requested data w/o response (n = 13) 
Restricted access (n = 8) 
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year of 2012. The number of participants in each study ranged from 21 to over 
250,000 participants, with a mean of 18,488 participants per study. The mean 
age of study participants was 61.3 years and ranged from 50 to 80 years. The 
majority of participants were female (59.1%). All but seven studies included both 
men and women; four studies recruited female participants only (k = 7, 4.6%) 
(Dietrich et al., 2006; Dietrich et al., 2007; Dietrich et al., 2013; Weinberg et al., 
2013) and three studies recruited male participants only (Ferreira et al., 2005; 
Fitzgibbon et al., 2007; Ford et al., 2006). Seventy-six studies (77.5%) involved 
U.S. samples, one study was conducted in France (Barthe et al., 2015), one 
study in Poland (Boguradzka et al., 2014), three in Canada (Clouston et al., 
2014; Ritvo et al., 2015; Tinmouth et al., 2014), three in Australia (Cole et al., 
2007; Cole, Young, Byrne, Guy, & Morcom, 2002; Wilson et al., 2015), two in 
Spain (Gimeno-García, Quintero, Nicolás-Pérez, Parra-Blanco, & Jiménez-
Sosa, 2009; Guiriguet et al., 2016), one in Italy (Rossi et al., 2011), three in 
Israel (Hagoel, Neter, Stein, & Rennert, 2016; Neter, Stein, Barnett-Griness, 
Rennert, & Hagoel, 2014; Vinker, Nakar, Rosenberg, & Kitai, 2002), 12 in the 
UK (Hewitson, Ward, Heneghan, Halloran, & Mant, 2011; Lo et al., 2014; 
McGregor et al., 2016; O’Carroll, Chambers, Brownlee, Libby, & Steele, 2015; 
Raine et al., 2016; Shankleman et al., 2014; Wardle et al., 201612; Wardle et al., 
2003; White et al., 2015), one in Iran , one in the Netherlands (van Roon et al., 
2011) and one in Belgium (Van Roosbroeck, Hoeck, & Van Hal, 2012). For the k 
= 144 studies (94.7%)13 that reported follow-up period this ranged from four 
weeks to three years, with a median follow-up period of 10 months. For the 
majority of studies (k = 119, 78.2%) screening uptake rates post-intervention 
were assessed objectively (e.g., accessing patient’s medical records, health 
data derived from insurance plan claims) with only a small number of studies 
relying on self-report (k = 21, 13.8%). Apart from few studies (k = 10, 6.5%) that 
were restricted to endoscopic screening procedures alone (Boguradzka et al., 
2014; Christie et al., 2008; Denberg et al., 2005; Ford et al., 2006; Jandorf et 
al., 2013; Ling et al., 2009; Wardle et al., 2003) most studies either involved 
non-endoscopic screening procedures (k = 56, 36.8%) or gave patients the 
option to choose between endoscopic and non-endoscopic screening (k = 86, 
                                                        
12 The study by Wardle et al (2016) comprised of four separate cluster-randomised 
controlled trials and therefore these were treated as four separate studies in the meta-analysis. 
13 Six studies did not clearly report follow-up period (Horne et al., 2015; Jandorf et al., 
2013; Krok-Schoen et al., 2015; Levy, Daly, Xu, & Ely, 2012; Lo, Good, et al., 2014; Van 
Roosbroeck et al., 2012). 
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56.5%). See Appendix 2.7 for a detailed overview of the characteristics of each 
study included in the meta-analytic review.  
2.3.3. Risk of Bias  
A composite score from all the studies for all the types reflecting risk of 
bias was calculated and a summary of the risk of bias assessment is shown in 
Figure 2.2.  
 
Figure 2. 2. Breakdown of each type of risk of bias identified in the included 
studies.  
Less than a fifth of trials were graded as having low risk of bias (N = 19, 
18.6%) across all areas assessed (Basch et al., 2006; Clouston et al., 2014; 
Denberg et al., 2005; Dietrich et al., 2006; Fortuna et al., 2014; Green et al., 
2016; Green et al., 2013; Gupta et al., 2013; Hendren et al., 2014; Hewitson et 
al., 2011; Lee et al., 2009; McGregor et al., 2016; Miller, Kimberly, Case, & 
Wofford, 2005; O'Carroll, Chambers, Brownlee, Libby, & Steele, 2015; Phillips, 
Hendren, Humiston, Winters, & Fiscella, 2015; Pignone, Harris, & Kinsinger, 
2000; Raine, Duffy, et al., 2016; Ruffin, Fetters, & Jimbo, 2007; Wardle et al., 
2016). 
Randomisation procedures were judged to place results at risk of 
selection bias in 11 studies (10.7%) (Blumenthal, Smith, Majett, & Alema‐
Mensah, 2010; Fiscella et al., 2011; Fitzgibbon et al., 2007; Ford et al., 2006; 
Ganz et al., 2005; Goldberg et al., 2004; Lewis, Brenner, Griffith, Moore, & 
Pignone, 2012; Menon et al., 2011; Pignone et al., 2011; Potter, Gildengorin, 
Wang, Wu, & Kroon, 2010; Potter et al., 2011), in a further 32 (31.3%) they were 
not described in sufficient detail and were judged as being unclear, and in 59 
studies (57.8%) randomisation procedures were considered adequate and were 
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therefore judged as having low risk of bias. Ten studies (9.8%) were judged to 
be at high risk of bias for allocation concealment (Fiscella et al., 2011; Lewis et 
al., 2012; Menon et al., 2011; Percac-Lima et al., 2009; Potter et al., 2011; 
Salimzadeh, Eftekhar, Majdzadeh, Montazeri, & Delavari, 2014; Vernon et al., 
2011; White et al., 2015; Wilson et al., 2015; Zapka et al., 2004). For nine 
studies (8.8%) blinding of participants and personnel was considered 
inadequate and therefore these studies were judged to be at high risk of 
performance bias (Krok-Schoen et al., 2015; Lewis et al., 2012; Menon et al., 
2011; Potter et al., 2011; Price-Haywood, Harden-Barrios, & Cooper, 2014; 
Salimzadeh et al., 2014; Simon et al., 2010; Vernon et al., 2011; Wilson et al., 
2015). 
Twenty-two studies (21.5%) were judged as being at high risk for 
detection bias because outcome assessors were not considered to be 
adequately blinded (Blumenthal et al., 2010; Boguradzka et al., 2014; Braun et 
al., 2015; Church et al., 2004; Coronado, Golovaty, Longton, Levy, & Jimenez, 
2011; Dignan et al., 2014; Ferreira et al., 2005; Ford et al., 2006; Goldberg et 
al., 2004; Horne et al., 2015; Hwang et al., 2013; Marcus et al., 2005; Maxwell 
et al., 2010; Maxwell, Danao, Cayetano, Crespi, & Bastani, 2016; Ornstein, 
Nemeth, Jenkins, & Nietert, 2010; Potter et al., 2010; Potter et al., 2011; Price-
Haywood et al., 2014; Salimzadeh et al., 2014; Simon et al., 2010; Walsh et al., 
2010; Zapka et al., 2004). Overall, 19 (18.6%) studies were judged to be at high 
risk of attrition bias because of participant drop-outs, (Braun, Fong, Kaanoi, 
Kamaka, & Gotay, 2005; Christie et al., 2008; Church et al., 2004; Cole et al., 
2007; Dignan et al., 2014; Fitzgibbon et al., 2007; Ford et al., 2006; Horne et 
al., 2015; Jandorf et al., 2013; Jean-Jacques et al., 2012; Krok-Schoen et al., 
2015; Levy et al., 2012; Lewis et al., 2012; Ling et al., 2009; Potter et al., 2010; 
Resnicow et al., 2014; Vinker et al., 2002; Walsh, Salazar, Terdiman, 
Gildengorin, & Pérez‐Stable, 2005; White et al., 2015), however, one of these 
studies performed both per protocol and intention-to-treat analysis (Vinker et al., 
2002), suggesting that the effect reported in these studies is not likely to be 
influenced by participant drop-outs during the follow-up. Four studies (3.9%) 
were judged to be at high risk of bias for selective reporting because they did 
not report some outcomes which authors had prespecified  (Gimeno-García et 
al., 2009; Lo, Good, et al., 2014; Vinker et al., 2002; White et al., 2015). Twenty 
studies (19.6%) did not conduct intention-to-treat analysis and these were 
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judged as having high risk of bias (Baker et al., 2014; Boguradzka et al., 2014; 
Cole et al., 2007; Coronado et al., 2011; Dignan et al., 2014; Ford et al., 2006; 
Ganz et al., 2005; Jean-Jacques et al., 2012; Jensen et al., 2014; Lewis et al., 
2012; Lo, Good, et al., 2014; Maxwell et al., 2016; McGregor et al., 2016; 
Menon et al., 2011; Mosen et al., 2010; Price-Haywood et al., 2014; Resnicow 
et al., 2014; Salimzadeh et al., 2014; van Roon et al., 2011; White et al., 2015). 
See Appendix 2.8 for a detailed overview of the risk of bias assessment for 
each study across all domains.  
2.3.4. Syntheses of Results  
2.3.4.1. Overall effect of health interventions on bowel cancer screening 
uptake  
Across 102 articles (k = 152) results revealed that health interventions 
led to significantly higher CRC screening uptake rates than did 
comparison/control conditions, g = .221, OR = 1.493, 95% CI: 1.428, 1.561, p 
< .001 (See Appendix 2.9 for forest plot comparing interventions in the full 
sample, low SES and non-low SES subgroups). This composite effect size 
represents a small, yet statistically significant result, favouring the intervention 
group over the control group. Specifically, participants that had been exposed to 
the intervention had a screening uptake rate that was 1.25% higher compared 
to the control group, which translates into 24,265 more people being screening 
as a direct result of the intervention.     
Given the focus of the present meta-analysis to identify which strategies 
were more effective in increasing screening uptake among deprived 
populations, a subset analysis was conducted by grouping studies by level of 
socioeconomic status (SES). As mentioned earlier, studies were deemed as 
involving low SES populations in respect of: (1) poverty/SES status; (2) ethnic 
minority status; (3) education/literacy level; (4) geographical location – that is, 
areas described as disadvantaged or medically underserved. Studies that did 
not report including any of the aforementioned groups were classified as non-
low SES.   
2.3.4.2. Effect of health interventions on CRC screening uptake by level of 
SES  
Results from the subset analysis indicated that for the group of studies in 
low SES populations, health interventions were significantly more effective 
compared to the non-low SES group of studies; g = .403, OR = 2.080, 95% CI: 
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1.745, 2.478, p < 0.001 (See Appendix 2.10 for forest plot) and g = .174, OR = 
1.372, 95% CI: 1.310, 1.438, p < 0.001 (See Appendix 2.11 for forest plot) 
respectively, and this difference in effect between the two SES groups was 
statistically significant (Qb: 37.896, df = 1, p<.001). Notably, this statistically 
significant effect observed in the low SES studies, translated into a 12.6% 
increase in screening uptake, compared to a 1.00% increase in screening 
uptake for the non-low SES studies, and a 1.25% increase in screening uptake 
in the full sample of studies (see Figure 2.3).  
 
Figure 2. 3. Screening uptake (%) by study condition and SES group. 
Despite the substantial increase observed in the studies involving more 
deprived populations, screening uptake in the intervention condition of the low 
SES group was still lower compared to screening uptake in the control condition 
of the non-low SES group (43.81% versus 50.29% respectively, absolute 
difference: 6.48%). An independent samples t-test was conducted to compare 
screening uptake between the two groups; results indicated that, despite the 
substantial increase in screening uptake, screening rates were significantly lower 
in the low SES intervention group compared to the non-low SES control group (t 
(150)= 2.590, p = .011). The 95% CIs for proportions were also calculated for 
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these two groups to further examine whether these were significantly different 
(See Appendix 2.12 for calculation of 95% CIs). Results indicated that the 
confidence intervals for the non-low SES control group (0.502, 0.503) and the 
low SES intervention group (0.431, 0.444) did not overlap. Therefore, it was 
concluded that there is a statistically significant difference in the two population 
values at the given level of confidence. Specifically, it was concluded that 
screening uptake was significantly higher for people in the non-low SES control 
group compared to people in the low SES intervention group.  
Overall, results indicated that health interventions were substantially 
more beneficial for the more vulnerable populations and as a result there was a 
substantial increase in screening uptake rates. Nonetheless, it is worrying that 
uptake rates remained suboptimal and significantly lower for the low SES groups 
compared to the non-low SES groups.  
2.3.4.3. Moderator analyses 
Subgroup analyses were conducted to determine the influence of all 
categorical moderators on intervention effectiveness. For non-categorical 
variables weighted meta-regression analyses were conducted. In terms of 
contact type (i.e., moderator one in Table 2.4 below), results showed that mixed 
interventions that were delivered to low SES populations yielded the greatest 
increase in screening uptake (g = .744, OR = 3.863, 95% CI: 2.105, 7.008, p 
< .001) and remote interventions delivered to a non-low SES populations 
resulted in the smallest increase in screening uptake (g = .164, OR = 1.347, 
95% CI: 1.280, 1.417, p<.001). The Q-test analogous to the ANOVA test 
revealed that the overall difference among intervention contact types and SES 
populations was significant (Qb (5) = 56.535, p < 0.001). Follow-up pairwise 
comparisons indicated that only two comparisons were statistically significant.  
Interventions that were not delivered in person yielded significantly greater 
screening uptake rates for the low SES group compared to the non-low SES 
group (Qb (1) =32.643, p<0.001); and that mixed interventions – that is, those 
that combined aspects that were delivered both in person and remotely – were 
significantly more effective among the low SES populations compared to 
studies that were delivered remotely among non-low SES populations (Qb (1) = 
4.429, p = .035).  
In terms of intervention delivery (i.e., moderator two in Table 2.4 below) 
results revealed that interventions that were delivered on an individual basis 
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(i.e., one-to-one) among low SES populations yielded the greatest increase in 
screening uptake (g = .414, OR = 2.123, 95% CIs, 1.738, 2.593, p<.001) and 
group and/or mixed interventions delivered to non-low SES populations resulted 
in the smallest  - and non-significant - increase in screening uptake (g = .068, 
OR = 1.131, 95% CI: 0.957, 1.336, p = .149).  The Q-test revealed that the four 
groups significantly differed from one another in terms of overall effect size (Qb 
(3) = 43.505, p < 0.001). Follow-up pairwise comparisons indicated that several 
differences were significant.  In particular, interventions delivered on an 
individual basis to a low SES population were significantly more effective 
compared to similar interventions (Qb (1) = 31.530, p < .001) and group or 
mixed interventions delivered to a non-low SES group (Qb (1) = 17.95, p 
< .001). Interventions delivered within a group were also significantly more 
effective for the low SES group when compared to the equivalent interventions 
delivered to the non-low SES group (Qb (1) = 7.874, p = 0.005) and these were 
also significantly more effective compared to the one-to-one interventions 
delivered to the less deprived group (Qb (1) = 10.32, p = 0.001).   
In terms of intervention provider (i.e., moderator three in Table 2.4 below) 
results indicated that interventions that did not involve an element of interaction 
between providers and participants, yielded the smallest study effect sizes for 
both the low SES and non-low SES groups (g = 0.295, OR = 1.709, 95% CI: 
1.248, 2.339, p = 0.001 and g = 0.130, OR = 1.265, 95% CI: 1.202, 1.332, p 
< .001 respectively), suggesting that the provider’s involvement in the delivery 
of the intervention may be particularly important within the context of CRC 
screening. The largest effect sizes for this moderator were observed among the 
low SES studies and particularly for interventions that were delivered by 
clinically-trained healthcare professionals (g = 0.643, OR = 3.215, 95% CI: 
2.045, 5.054, p < .001) or research staff (g = 0.657, OR = 3.303, 95% CI: 1.892, 
5.766, p < .001). The Q-test revealed that the eight groups significantly differed 
from one another in terms of overall effect size (Qb (7) = 155.78, p < .001). 
Follow-up pairwise comparisons indicated that interventions that were delivered 
by non-clinically trained healthcare providers (e.g. community health educators) 
were significantly more effective in increasing screening uptake compared to 
interventions that were not person dependent, for both the low SES populations 
(Qb (1) = 4.887, p = 0.027) and the non-low SES populations (Qb (1) =20.00, p 
< .001). In agreement to this finding, interventions that were not delivered by a 
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person - rather they solely relied on other modes of delivery, such as 
educational brochures - appeared to be significantly less effective for the non-
low SES populations when compared to interventions delivered to low SES 
populations by both clinically and non-clinically trained health professionals (Qb 
(1) = 6.219, p = 0.013 and Qb (1) =18.34, p < .001, respectively), indicating that 
less deprived populations benefit less from interventions that do not involve an 
interaction between the intervention provider and the intervention recipient. 
When research staff delivered the intervention, the effect size was significantly 
greater compared to interventions that were not delivered by a person for both 
the low SES and non-low SES populations (all pairwise comparisons p < .05).  
In terms of whether certain intervention materials (i.e., moderator four in 
Table 2.4 below) were more useful than others in increasing screening uptake, 
results indicated that this variable modified overall effect size (Qb (11) = 
107.327, p < .001). Follow-up pairwise comparisons indicated that several 
differences were statistically significant. Specifically, interventions delivered to 
non-low SES populations and that involved the use of electronic media, were 
significantly less effective compared to interventions delivered to the same 
group but that used paper-based media (e.g., brochures, leaflets etc.), paper-
based media and/or phone calls, and those that were delivered in person rather 
than involving the use of any of the aforementioned media (p < .05 for all 
pairwise comparisons). Similarly, these interventions were also significantly less 
effective compared to the equivalent interventions that involved electronic 
media, paper-based interventions and phone interventions delivered among low 
SES populations (p < .05 for all pairwise comparisons). These results suggest 
that incorporating electronic media in interventions delivered to less deprived 
groups is not particularly effective in increasing screening uptake for this 
population. Conversely, for the low SES group interventions that did make use 
of electronic media seemed to be significantly more effective compared to those 
delivered in person within the same SES level (Qb (1) = 5.889, p = 0.015) and 
also compared to those that used paper-based media among the non-low SES 
groups (Qb (1) = 10.69, p < .001). It is worth noting however, that few studies 
incorporated electronic media for interventions delivered to low SES 
populations (k = 3), therefore not allowing meaningful inferences to be made 
regarding the value of this approach in increasing screening uptake among 
people within this demographic. Lastly, the use of paper-based media among 
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the non-low SES studies did not seem to be particularly useful in increasing this 
population’s screening uptake rates, as the effect size was significantly smaller 
than similar studies in the low SES group, paper based plus telephone studies 
in both the low and non-low SES groups and studies delivered in person to the 
non-low SES groups (p < .05 for all pairwise comparisons). Notably, studies 
delivered to non-low SES populations that included both paper-based materials 
alongside phone calls were substantially more effective than those that just 
used paper-based materials (g = .442 and g = .150 respectively) and this 
difference in effect was statistically significant (Qb (1) = 7.777, p = 0.005). 
Interestingly, the intervention materials that were associated with the greatest 
effect sizes, for both the non-low SES group and the low SES group14, were 
observed for interventions that incorporated a paper-based element alongside a 
phone call (g = 0.442 and g = 0.474). These findings suggest that incorporating 
a phone call alongside standard, paper-based invitations and brochures might 
be particularly useful for increasing CRC screening uptake irrespective of SES.  
With regard to the setting in which interventions took place (i.e., 
moderator five in Table 2.4 below), results revealed greater effect sizes for 
community settings versus primary care settings for both low and non-low SES 
populations (g = .485 and g = .197 respectively). Results from the Q-test 
indicated that there were significant differences in overall effect size between 
the four groups within this moderator (Qb (3) = 44.497, p < 0.001). Follow-up 
pairwise comparisons revealed that, for the low SES populations, interventions 
delivered in a community setting had a greater effect on screening uptake 
compared to those delivered in both primary care and community settings to 
non-low SES populations (Qb (1) = 16.24, p < .001 and Qb (1) = 6.389, p = 0.011 
respectively). Interventions delivered in primary care were more effective for the 
low SES populations compared to interventions delivered to non-low SES 
populations in a similar setting (Qb (1) = 22.813, p < 0.001).  
The level of reported use of theory (i.e., moderator six in Table 2.4 below) 
was also a significant moderator of overall effect size (Qb (3) = 23.15, p < 
0.001). Specifically, sparse to moderate reported use of theory was more 
effective than extensive use of theory for the non-low SES studies (Qb (1) = 
17.41, p < .001). Extensive use of theory was significantly more effective for low 
                                                        
14 For this group the greatest effect size was observed for electronic media plus paper-based 
media (g=0.779), however, due to the small sample size (k=3) the second greatest effect size 
was considered for this comparison. 
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SES populations compared to similar studies conducted among non-low SES 
populations (Qb (1) = 4.577, p = .032). 
 With regards to the type of screening modality used (i.e. endoscopic, 
non-endoscopic or having the choice of either of these; moderator seven in 
Table 2.4 below), the greatest effect size observed, across the two SES groups 
and screening modalities, was that reported for non-endoscopic screening 
among low SES studies (g =.701, OR = 3.577, 95% CI: 2.415, 5.297, p < .001). 
Contrastingly, the lowest effect size was reported for interventions using 
endoscopic screening procedures among low SES studies (g = .045, OR = 
1.082, 95% CI: 0.584, 2.006, p = .802). Results from the Q-test indicated that 
the type of screening modality was a moderator of overall effect size (Qb (5) = 
114.880, p < .001). Follow-up pairwise comparisons indicated that a number of 
comparisons were significantly different. Among the non-low SES studies, 
interventions that involved endoscopic CRC screening procedures (e.g., 
colonoscopy) resulted in a significantly greater effect size compared to studies 
involving stool-based screening tests (Qb (1) = 4.648, p = .031). Within the 
sample of low SES studies however, a reverse pattern of findings was 
observed; that is - interventions that involved stool-based tests as their selected 
screening modality generated a significantly greater effect size compared to 
those that used endoscopic screening, indicating that the greater level of 
invasiveness that these tests present with, might be a deterring factor from 
screening for more deprived participants (Qb (1) = 24.26, p < .001).  Study effect 
size remained significantly higher for non-endoscopic screening procedures 
among the low SES studies, even when compared to interventions where 
participants had the option of choosing their preferred screening method, and 
this was the case among both low SES populations (Qb (1) = 7.134, p = .008) 
and non-low SES populations (Qb (1) = 14.34, p < .001). Contrastingly, non-
endoscopic screening procedures (i.e., stool-based tests) for the non-low SES 
studies were significantly less effective compared to interventions that gave 
participants the option to choose their preferred screening method, and this was 
observed when compared to both non-low SES (Qb (1) = 30.78, p < .001) and 
low SES groups (Qb (1) = 18.18, p < .001). Comparisons between the two SES 
groups indicated that non endoscopic screening procedures (e.g., FIT, gFOBT) 
were significantly more effective for the low SES groups compared to the non-
low SES groups (Qb (1) = 22.813, p < .001), and that endoscopic screening 
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procedures were significantly more effective in increasing uptake for the non-
low SES studies compared to the low SES studies (Qb (1) = 5.088, p = .024), 
showcasing the exact opposite pattern of findings between the two SES groups.  
The use or reminders (i.e., prompt/cues to obtain screening) was 
included in the moderator analyses separate from other behaviour change 
techniques because of the frequency to which interventions incorporated them 
as an integral aspect of the study (i.e., moderator eight in Table 2.4 below). 
Results indicated that this BCT significantly moderated the overall effect size 
(Qb (3) =, 45.578, p < .001). Overall, the greatest effect size, across the levels of 
this moderator and across SES groups, was observed for studies that used 
reminders and that were targeted at more deprived populations (g = .453, OR = 
2.276, 95% CI: 1.798, 2.882, p < .001), whereas the lowest effect size was 
observed among studies that did not use reminders among non-low SES 
studies (g = .144, OR = 1.298, 95% CI: 1.216, 1.386, p < .001), highlighting the 
overall usefulness of interventions incorporating prompts and cues, irrespective 
of SES level. Follow-up pairwise comparisons indicated that four comparisons 
were statistically significant. Specifically, the use of reminders in studies 
targeting low SES populations resulted in a significantly greater effect size when 
compared to similar studies targeting non-low SES populations (Qb (1) = 
23.801, p < .001). Within the non-low SES studies, interventions that used 
reminders were significantly more effective that those who did not (Qb (1) = 
5.220, p = .022). Interventions that did not use reminders in the non-low SES 
group were significantly less effective compared to both studies that used and 
did not use reminders in the low SES group (Qb (1) = 19.25, p <.001 and Qb (1) 
= 9.301, p = .002).   
 The strategy by which authors assessed screening uptake (i.e., 
moderator nine in Table 2.4 below) was also a significant moderator of the 
overall effect size (Qb (3) = 45.819, p < .001). Follow-up pairwise comparisons 
showed that only two comparisons were significantly different; firstly, results 
indicated a significantly larger effect in uptake for low SES studies when this 
was assessed objectively (e.g., through electronic medical records) compared 
to non-low SES studies which also assessed screening uptake objectively (Qb 
(1) = 22.99, p < .001). Secondly, within the low SES studies a similar finding 
was observed; studies that assessed screening uptake objectively resulted in 
greater effect sizes compared to studies targeting the same demographic but 
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that assessed screening rates through self-report (Qb (1) = 4.638, p = .031). 
These findings are particularly promising as they indicate that the greater effect 
size observed among more deprived populations is not attributed to this 
particular bias in methodology.   
Similarly, the risk of bias (i.e., moderator ten in Table 2.4 below) evident 
within studies was another variable that significantly moderated overall effect 
size (Qb (5) = 96.683, p < .001). Overall, across all levels of the moderator and 
across SES groups, the greatest effect size was observed among studies with 
low risk of bias delivered to low SES populations (g = .551, OR = 2.719, 95% 
CI: 1.864, 3.967, p < .001) and the smallest effect size was reported for studies 
with a high risk of bias delivered to non-low SES populations (g = .115, OR = 
1.232, 95% CI: 1.156, 1.314, p < .001).  Follow-up pairwise comparisons 
showed that studies that had low risk of bias, and that targeted low SES 
populations, were significantly more effective than studies with high bias that 
targeted non-low SES populations (Qb (1) = 12.86, p < .001) and also than 
studies with unclear bias or low bias among non-low SES populations (Qb (1) = 
6.557, p = .010 and Qb (1) = 12.38, p <.001 respectively). Results of the 
subgroup analyses can be found in Table 2.4 below.
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Table 2.  4. Summary of meta-analysis results for non-low SES versus low SESa studies (k =105 and k = 47 respectively). 
   Sample   
  Non-low SES  Low SESa   
Analysis   Random-
effects model 
Sig. Heterogeneity Within 
subgroup 
differences 
  Random-
effects model 
Sig. Heterogeneity Within 
subgroup 
difference
s 
 Overall 
between 
group 
effect 
  k g, OR (95% 
CI) 
p Q, Ph, I2 (%)  (Qb, df, p)  k g, OR (95% 
CI) 
p Q, Ph, I2 (%) (Qb, df, p)  (Qb, df, p) 
Overall effect  105 0·174, 1·372 
(1·310-1·438) 
p<0·001 3179·00 
p<0·001, 
96·7% 
-  47 0·403, 2·080 
(1·745-2·478) 
 p<0·001 508·01, 
p<0·001, 90·9% 
-  37·896b, 1, 
p<0·001 
INTERVENTION CHARACTERISTICS            
Moderator 1: Contact type          56·535, 5, 
p<0·001 
Face-to-face   6 0·216, 1·478 
(1·221-1·790) 
p<0·001 92·48, 
p<0·001, 
94·5% 
4·545, 2, p 
= 0·103  
 11 0·282, 1·669 
(1·144-2·435) 
p = 0·008 49·40, p<0·001, 
79·7% 
5·297, 2, p 
= 0·071 
  
Remote  89 0·164, 1·347 
(1·280-1·417) 
p<0·001 2899·00, 
p<0·001, 
96·9% 
  32 0·401, 2·071 
(1·673-2·562) 
p<0·001 358·2, p<0·001, 
91·3% 
   
Mixed  10 0·261, 1·608 
(1·360-1·900) 
p<0·001 155·8, 
p<0·001, 
94·2% 
  4 0·744, 3·863 
(2·105-7·008) 
p<0·001 56·98, p<0·001, 
94·7% 
   
Moderator 2: Delivery            43·505, 3, 
p<0·001 
Individual (i.e., 
one-to-one) 
 98 0·184, 1·397 
(1·330-1·467) 
p<0·001 3150·00, 
p<0·001, 
5·702, 1, p 
= 0·017 
 39 0·414, 2·123 
(1·738-2·593) 
p<0·001 407·2, p<0·001, 
90·6% 
0·151, 1, p 
= 0·698 
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96·9% 
Group/Mixed  7 0·068, 1·131 
(0·957-1·336) 
p = 0·149 27·00, 
p<0·001, 
77·7% 
  8 0·363, 1·934 
(1·268-2·950) 
p = 0·002 89·35, p<0·001, 
92·1% 
   
Moderator 3: Providerc           155·78, 7, 
p<0·001 
Clinically-
trained health 
professionals  
 3 0·426, 2·172 
(1·551-3·043) 
p<0·001 35·49, 
p<0·001, 
94·3% 
65·773, 3, 
p<0·001 
 4 0·643, 3·215 
(2.045-5.054) 
P<0·001 122·1, p<0.001, 
97·5% 
7.958, 3, p 
= 0.047d 
  
Non-clinically 
trained health 
professionals  
 8 0·469, 2·342 
(2·012-2·727) 
p<0·001 99·88, 
p<0·001, 
92·9% 
  27 0·374, 1·973 
(1·603—
2·427) 
p<0·001 136·3, p<0.001, 
80·9% 
   
Research staff   11 0·229, 1·516 
(1·294-1·776) 
p<0·001 109·2, 
p<0·001, 
90·8% 
  4 0·657, 3·303 
(1·892-5·766) 
p<0·001 923·00, 
p=0·026, 67·4% 
   
Not person 
dependent  
 77 0·130, 1·265 
(1·202-1·332) 
p<0·001 2519·00, 
p<0·001, 
96·9% 
  11 0·295, 1·709 
(1·248-2·339) 
p = 0·001 47·08, p<0·001, 
78·7% 
   
Moderator 4: Materialse          107·327, 
11, 
p<0·001 
Electronic and 
paper-based 
media 
 26 0·082, 1·161 
(1.057-1.273) 
p = 0·002 198·7, 
p<0·001, 
87·4% 
42·392, 5, 
p<0·001 
 3 0·779, 4·138 
(1·891-9·052) 
p<0·001 4·648, p = 
0·098, 56·9% 
6·043, 5, 
p=0·302 
  
Paper-based 
media only 
 50 0·150, 1·312 
(1.237-1.392) 
p<0·001 1857·00, 
p<0·001, 
97·3% 
  11 0·383, 2·006 
(1·351-2·979) 
p<0·001 93·62, p<0·001, 
89·3% 
   
Paper-based 
and phone  
 10 0·442, 2·232 
(1·851-2·691) 
p<0·001 59·40, 
p<0·001, 
84·8% 
  15 0·474, 2·365 
(1·718-3·257) 
p<0·001 195·46, 
p<0·001, 92·8% 
   
Phone  5 0·222, 1·495 
(1·237-1·807) 
P<0·001 147·0, 
p<0·001, 
  7 0·332, 1·830 
(1·116-3·001) 
p = 0·017 20·68, p = 
0·002, 70·9% 
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97·2% 
In-person 
delivery 
 8 0·226, 1·508 
(1·295-1·755) 
p<0·001 112·9, 
p<0·001, 
93·7% 
  5 0·164, 1·345, 
(0.757-2.392) 
p = 0·312 28·99, p<0·001, 
86·2% 
   
Paper-based 
media and in 
person 
delivery 
 3 0·099, 1·197 
(0·894-1·603) 
p = 0·227 7·838, p = 
0·020, 74·4% 
  6 0·386, 2·014 
(1·236-3·282) 
p = 0·005 96·13, p<0·001, 
94·8% 
   
Moderator 5: Settingf          44·497, 3, 
p<0·001 
Community  20 0·197, 1·431 
(1·282-1·597) 
p<0·001 380·9, 
p<0·001, 
95.0% 
0·836, 1, p 
= 0·361 
 22 0·485, 2·416 
(1·844-3·166) 
p<0·001 153·2, p<0·001, 
86·2% 
2·040, 1, p 
= 0·153 
  
Primary care  82 0·167, 1·353 
(1·290-1·418) 
p<0·001 2005·9, 
p<0·001, 
95·9% 
  25 0·341, 1·859 
(1·467-2·356) 
p<0·001 350·1, p<0·001, 
93·1% 
   
Moderator 6: Use of Theory           
Sparse/Moder
ate 
 29 0·132, 1·328 
(1·160-1·521) 
p<0·001 144·9, 
p<0·001, 
80.6% 
17.41, 1, p 
< 0·01 
 5 0.149, 1.311, 
(0.869-1.978) 
p=0.197 24.75, p<0.001, 
83.7% 
0.0150, 1, 
p=0.903 
  
High  4 -0·006, 0·989 
(0·961-1·017) 
P=0·440 1·826, 
p=0·609, 0% 
  6 0.133, 1.273 
(1.012-1.601) 
p=0.039 7.537, p = 0.184, 
33.6% 
   
Moderator 7: Screening modality          114·880, 5, 
p<0·001 
Endoscopic  5 0·475, 2·373 
(1·818-3·098) 
p<0·001 25·73, 
p<0·001, 
84·4% 
50·52, 2, 
p<0·001 
 5 0·045, 1·082 
(0.584-2.006) 
p = 0·802 4·77, p=0·11, 
16·2% 
12·112, 2, 
p = 0·002 
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Non-
endoscopic 
 46 0·097, 1·193 
(1.126-1.264) 
p<0·001 1592·00, 
p<0·001, 
97·1% 
  10 0·701, 3·577 
(2.415-5.297) 
p<0·001 179·6, p<0·001, 
94·9% 
   
Either  54 0·237, 1·538 
(1·442-1·640) 
p<0·001 740·1, 
p<0·001, 
92·8% 
  32 0·359, 1·921 
(1·544-2·388) 
p<0·001 275·9, p<0·001, 
88·7% 
   
Moderator 8: Use of reminders        47·578, 3, 
p<0·001 
Reminders  47 0·217, 1·483 
(1·380-1·594) 
p<0·001 1438·00, 
p<0·001, 
96·8% 
7·231, 1, p 
= 0·007 
 27 0·453, 2·276 
(1.798-2.882) 
p<0·001 328·2, p<0·001, 
92% 
1·255, 1, p 
= 0·263 
  
No reminders  58 0·144, 1·298 
(1·216-1·386) 
p<0·001 1735·00, 
p<0·001, 
96·7% 
  20 0·339, 1·853 
(1·412-2·431) 
p<0·001 165·4, p<0·001, 
88·5% 
   
METHODOLOGICAL CHARACTERISTICS        
Moderator 9: Outcome assessmentg         45·819, 3, 
p<0·001 
Objective   84 0·176, 1·376 
(1.306-1.449) 
p<0·001 3021·00, 
p<0·001, 
97·2% 
3·812, 1, p 
= 0·051 
 35 0·463, 2·319 
(1·894-2·839) 
p<0·001 477·5, p<0·001, 
92·8% 
1·753, 1, p 
= 0·186h 
  
Self-report  12 0·270, 1·633 
(1.386-1.923) 
p<0·001 96·10, 
p<0·001, 
88·5% 
  9 0·289, 1·692 
(1·110-2·579) 
p = 0·015 15·91, p=0·044, 
49·7% 
   
Moderator 10: Risk of bias     96·683, 5, 
p<0·001 
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High bias  42 0·115, 1·232 
(1·156-1·314) 
p<0·001 352·1, 
p<0·001, 
88·3% 
13·904, 2, 
p<0·001 
 27 0·310, 1·755 
(1·409-2·187) 
p<0·001 119·5, p<0·001, 
78·2% 
4·663, 2, p 
= 0·097 
  
Unclear bias  40 0·212, 1·469 
(1.374-1.571) 
p<0·001 954·8, 
p<0·001, 
95·9% 
  12 0·459, 2·301 
(1·718-3·082) 
p<0·001 164·9, p<0·001, 
93·3% 
   
Low bias  23 0·167, 1·354 
(1·253-1·463) 
p<0·001 602·9, 
p<0·001, 
96·3% 
  8 0·551, 2·719 
(1·864-3·967) 
p<0·001 73·14, p<0·001, 
90·4% 
   
Notes. k = number of comparisons, g = Hedge’s g measure of effect size, OR = odds ratio, CI = confidence interval, Ph=p value of Q test for heterogeneity test, Qb = Q value indicating the 
between-group effect. aStudies were determined as having a ‘low SES’ sample in respect of: (1) Poverty/SES status; (2) Ethnic minority status; (3) Education/literacy; (4) Geographical location 
(areas described as disadvantaged/medically underserved) and was categorised into ‘low SES’ or ‘non-low SES’ according to author-set criteria. bQb value reported from subgroup analysis 
conducted across k=152 but the effect sizes reported in the table are taken from individual sensitivity analyses for non-low and low SES studies. cThree papers were not included in the analysis 
(Groups 1 and 2 from Church et al 2004; Groups 1, 2 and 3 from Marcus et al, 2005; Walsh et al, 2005) as it was unclear, or not reported, who delivered the intervention. dOne paper was not 
included in the analysis (Price-Haywood et al., 2014) as it was unclear who delivered the intervention. eThree papers were not included in the analysis (Cameron et al, 2011; Clouston et al 
2014; Group 3 from Green et al, 2013) as they did not meet inclusion criteria for any of the moderator categories. fTwo papers not included in the analysis (Krok-Schoen et al, 2015; Groups 3 
and 4 from White et al, 2015) as they did not meet inclusion criteria for any of the moderator categories. gFive papers not included in the analysis (Barthe et al., 2015; Clouston et al., 2014; 
Groups 1, 2 and 3 from Cole et al., 2002; Groups 1, 2 and 3 from Cole et al., 2007; Guiriguet et al., 2016) as it was either unclear or not reported how screening uptake was assessed. hTwo 
papers not included in the analysis (Ford et al., 2006; Groups 1 and 2 from Jandorf et al., 2013) as it was either unclear or not reported how screening uptake was assessed. 
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The weighted meta-regressions with each continuous moderator as the 
independent variable revealed that for the non-low SES studies, only age 
composition of the sample and screening status at time of study (defined as the 
percentage of participants up-to-date with screening at the start of the research) 
had a moderating influence on effect size (β = -.022, Ζ = -2.64 , p = .008 and β 
= -.012, Ζ = -2.853 , p = .004). Studies with older participants in the sample 
showed a smaller increase in screening uptake rates, as did studies with more 
participants up-to-date with screening at baseline. For the low SES studies 
none of the continuous variables were significant moderators of overall study 
effect size (see Table 2.5.)
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Table 2.  5. Continuous variables meta-regresseda on screening uptake by level of SES. 
  
Non-low SES  
 
 
Low SES 
    95% CI      95% CI   
Predictor k Q-test Beta Lower 
limit 
Upper 
limit 
Z P k Q-test Beta Lowe 
limit 
Upper 
limit 
Z P 
Age (mean) 97 6·994** -0·022** -0·038 -0·005 -2·644 0·008** 43 0·045 0·004 -0·040 0·050 0·213 0·83 
Gender (%males) 93 0·309 -0·001 -0·004 0·002 -0·556 0·57 46 0·699 -0·003 -0·010 -0·004 -0·836 0·40 
Family history (%yes) 20 0·672 0·014 -0·019 0·048 0·820 0·41 20 0·322 0·010 -0·026 0·047 0·568 0·56 
Screening status at time 
of study (%yes) 
36 8·142** -0·012** -0·020 -0·003 -2·853 0·004** 24 0·471 -0·004 -0·016 0·007 -0·686 0·49 
Notes.  k = number of comparisons, CI = confidence interval, BCTs = behaviour change techniques. *p<0·05, **p<0·01. aMeta-regression analysis was applied only if the pooled cohorts 
exceeded k = 10.  
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2.3.4.3.1.1. Moderator analyses: Behaviour Change Techniques (BCTs) 
Overall 39 out of the 93 BCTs in the BCTTc1 taxonomy were identified 
as being employed in the studies reviewed. The median N of BCTs used in 
interventions was N = 3 and the range of BCTs used across the included 
studies was between 1 and 10 techniques. Individual BCTs were included as 
moderators in the analysis if they were coded for at least k = 10 studies. The 
five most commonly reported BCTs were ‘Information about health 
consequences’, ‘Prompts/cues’, ‘Social Support (practical)’, Adding Objects to 
the Environment’15 and ‘Problem Solving’. The five least commonly reported 
BCTs were ‘Imaginary Punishment’, ‘Non-specific Incentive’, ‘Specific 
Incentive’, ‘Social Incentive’ and ‘Information about Social and Environmental 
Consequences’. An overview of the frequencies of the 39 BCTs used in the 
102 studies reviewed, ranked by the most frequently applied techniques, can 
be seen in Figure 2.4. BCTs were also organised in terms of their 16 
overarching groupings and an overview of these groupings alongside the 
frequencies of each BCT within each grouping can be found in Figure 2.5.  
                                                        
15 This BCT was coded only for U.S.-based studies that sent a stool-based screening 
kit for free irrespective of participants’ insurance status. This BCT was not coded for countries 
with universal healthcare. 
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Figure 2. 4. Frequencies of the 39 behaviour change techniques used in the 
102 studies reviewed and ranked by the most frequently applied techniques 
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Figure 2. 5. Behaviour change techniques grouped into their 16 taxonomy 
clusters and ranked by frequency. 
 
Results from the moderator analyses examining whether BCTs 
moderated overall study effect size are summarised below by level of 
participant SES (see Table 2.6 below). For the non-low SES studies, the BCT 
‘Social Support (unspecified)’, defined as advising on or arranging and/or 
providing social support for performance of the behaviour, moderated 
intervention effect size, with studies that incorporated this BCT in their 
intervention resulting in a significantly greater effect size compared to those 
that did not (g = 0.391, p<.001 and g = .148, p<.001 respectively) and this 
difference in effect was statistically significant (Qb (1) = 32.088, p < .001). 
‘Practical Social Support’, defined as the provision of practical help for 
performance of the behaviour, also resulted into significantly greater effect 
sizes compared to studies that did not incorporated this BCT (g = 0.252, 
p<.001 and g = .149, p<.001 respectively) and this difference in effect was 
statistically significant (Qb (1) = 11.61, p = .001). The BCT ‘Instructions on how 
to Perform the Behaviour’, defined as the provision of advice or agreeing with 
the participant how to perform the behaviour, was found to reduce study effect 
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size compared to studies that did not incorporate this BCT (g = .1514, p < .001 
and g = .265, p < .001 respectively) and this difference in effect was 
statistically significant (Qb (1) = 10.983, p = .001). The BCT ‘Adding Objects to 
the Environment’, defined within this context as any intervention that sent a 
free, stool-based screening kit in order to aid screening uptake, significantly 
increased study effect size compared to studies that did not incorporate this 
BCT (g = 0.227, p < .001 and g = .150, p<.001 respectively) and this difference 
in effect was statistically significant (Qb (1) = 7.686, p < .001).  
For the low SES studies, the BCT ‘Problem Solving’, defined as the 
process of analysing and/or prompting the person to analyse factors that 
influence their screening uptake and generate or select strategies that include 
overcoming barriers and/or increasing facilitators, appeared to reduce study 
effectiveness in increasing screening uptake compared to studies that did not 
incorporated this BCT into their intervention (g = .317, p<.001 and g = .505, p 
< .001 respectively) and this difference in effect size was marginally non-
significant (Qb (1) = 3.507, p = .061). Similarly, interventions that incorporated 
the BCT ‘Practical Social Support’ were also less effective compared to 
studies that did not incorporate this BCT (g = .304, p<.001 and g = .498, p 
< .001) and this difference in effect was marginally non-significant (Qb (1) = 
3.767, p = .052). Incorporating ‘Instructions on how to Perform the Behaviour’, 
resulted in a significantly greater effect size compared to studies that did not 
incorporate this BCT (g = .572, p<.001 and g = .315, p < .001 respectively) 
and this difference in effect was statistically significant (Qb (1) = 6.183, p 
= .013). Additionally, ‘Adding Objects to the Environment’ was also a useful 
BCT in increasing study effect size compared to studies that did not 
incorporate this BCT (g = .632, p < .001 and g = .228, p < .001) and this 
difference in effect was statistically significant (Qb (1) = 23.09, p < .001). 
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Table 2.  6. Summary of moderator analysis for behaviour change techniques (BCTs) for non-low SES vs. low SESa studies (k=105 vs. 
k=47 respectively) 
. 
   SAMPLE  
  Non-low SES  Low SES  
Analysis  k Random 
effects 
model 
 Heterogeneity Test for 
subgroup 
differences 
 k Random 
effects model 
 Heterogeneity Test for 
subgroup 
differences 
 
  105 g, OR (95% 
CI) 
P Q, I2 (%), Ph (QBET, df, 
p) 
 47 g, OR (95% 
CI) 
P Q, I2 (%), Ph (QBET, df, 
p) 
 
BCT: Problem solving          
Yes  12 0.194, 1.421 
(1.238-1.630) 
p<0.001 140.8, p<0.001, 
92.1% 
0.271, 1, 
p=0.603 
 24 0.317, 1.778 
(1.394-2.267) 
P<0.001 169.8, p<0.001, 
86.4% 
3.507, 1, 
p=0.061 
 
No  93 0.172, 1.367 
(1.300-1.436) 
p<0.001 2994, p<0.001, 
96.9% 
-  23 0.505, 2.504 
(1.927-3.253) 
P<0.001 319.7, p<0.001, 
93.1% 
-  
BCT: Social support (unspecified)   
Yes  11 0.391, 2.035 
(1.759-2.354) 
p<0.001 234.6, p<0.001, 
95.7% 
32.088, 1, 
p<0.001 
 6 0.365, 1.940 
(1.185-3.177) 
P=0.008 26.66, p<0.001, 
81.2% 
0.091, 1, 
p=0.763 
 
No  94 0.148, 1.308 
(1.250-1.370) 
p<0.001 2267, p<0.001, 
95.8% 
-  41 0.410, 2.105 
(1.740-2.548) 
P<0.001 479.0, p<0.001, 
91.6% 
-  
BCT: Social support (practical)           
Yes  25 0.252, 1.580 
(1.439-1.736) 
p<0.001 489.7, p<0.001, 
95% 
11.61, 1, 
p<0.001 
 22 0.304, 1.736 
(1.345-2.242) 
P<0.001 115.8, p<0.001, 
82.7% 
3.767, 1, 
p=0.052 
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No  80 0.149, 1.310 
(1.242-1.382) 
P<0.001 2568, p<0.001, 
96.9% 
-  25 0.498, 2.473 
(1.930-3.170) 
P<0.001 371.0, p<0.001, 
93.5% 
-  
BCT: Instructions on how to perform the behaviour   
Yes  18 0.265, 1.617 
(1.452-1.801) 
P<0.001 453.2, p<0.001, 
96.2% 
10.983, 1, 
p=0.001 
 17 0.572, 2.827 
(2.097-3.810) 
P<0.001 339.0, p<0.001, 
95.2% 
6.183, 1, 
p=0.013 
 
No  87 0.154, 1.321 
(1.255-1.392) 
P<0.001 2674, p<0.001, 
96.7% 
-  30 0.315, 1.773 
(1.430-2.197) 
P<0.001 122.1, p<0.001, 
76.2% 
-  
BCT: Information about health consequences   
Yes  54 0.176, 1.378 
(1.290-1.471) 
P<0.001 1004, p<0.001, 
94.7% 
0.000, 1, 
p=0.993 
 26 0.473, 2.361 
(1.860-2.997) 
P<0.001 393.3, p<0.001, 
93.6% 
2.399, 1, 
p=0.121 
 
No  51 0.176, 1.377 
(1.284-1.476) 
P<0.001 2085, p<0.001, 
97.6% 
-  21 0.316, 1.777 
(1.358-2.326) 
P<0.001 114.7, p<0.001, 
82.5% 
  
BCT: Demonstration of the behaviour 
Yes  12 0.292, 1.701 
(1.330-2.175) 
P<0.001 295.0, p<0.001, 
96.2%% 
3.667, 1, 
p=0.055 
 10 0.466, 2.330 
(1.577-3.444) 
P<0.001 115.5, p<0.001, 
92.2% 
0.394, 1, 
p=0.530 
 
No  93 0.158, 1.331 
(1.269-1.397) 
P<0.001 2816, p<0.001, 
96.7% 
-  37 0.388, 2.025 
(1.651-2.482) 
P<0.001 382.8, p<0.001, 
90.5% 
-  
BCT: Adding objects to the environment  
Yes  27 0.227, 1.510 
(1.386-1.647) 
P<0.001 785.7, p<0.001, 
96.6% 
7.686, 1, 
p=0.006 
 18 0.632, 3.153 
(2.502-3.974) 
P<0.001 226.2, p<0.001, 
92.4% 
23.09, 1, 
p<0.001 
 
No  78 0.150, 1.312 
(1.248-1.379) 
P<0.001 1769, p<0.001, 
95.6% 
-  29 0.228, 1.512 
(1.249-1.830) 
P<0.001 94.33, p<0.001, 
70.3% 
-  
Notes. BCT = Behaviour Change Technique, k = number of comparisons, g = Hedge’s g, OR = Odds Ratio, CI = Confidence Interval, Ph = p value of Q-test for heterogeneity, Qb = Q 
value indicating the between-group effect. 
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2.3.4.3.1.2. Moderator analyses: Reported theory use 
Moderator analyses for reported theory use included only the studies that 
reported using theory to develop the intervention either in the Introduction or the 
Methods section of the paper (k = 44, 28.9%). Due to the relatively small 
sample of studies reporting use of theory, it was decided to conduct the analysis 
without splitting by level of SES as done in earlier analyses (i.e., main 
moderator analyses seen in Table 2.4 and BCT moderator analyses seen in 
Table 2.6) in order to avoid having modest cell sizes that could compromise our 
ability to draw robust conclusions about the usefulness of theory-driven 
interventions. Nine items (as outlined in section 2.2.4. above) from Michie and 
Prestwich’s TCS were included in the analysis and each of these items was 
evaluated as an independent moderator of overall effect size.  
Out of k = 44 studies, k = 18 (40.9%) reported to be based on a single 
theory, none of the studies reported using theory to recruit study participants, k 
= 37 (84.0%) reported that they used theory to select and/or develop 
intervention techniques, and k = 23 (52.3%) reported using theory to tailor 
intervention techniques to participants. Of these k = 44 studies, k = 16 (36.3%) 
reported that all intervention techniques were explicitly linked to at least one of 
the theory-relevant construct/predictor, while k = 24 (54.5%) reported that at 
least one of the intervention techniques had explicit links to theory-relevant 
constructs/predictors and k = 16 (36.3%) reported that a group of intervention 
techniques were linked to a group of constructs or predictors. Results indicated 
that none of the items were significant moderators of overall effect size. Table 
2.7 below illustrates how theory was used across the k = 44 studies. A summary 
of the theories and/or models of behaviour seen in k = 44 studies included in 
the meta-analytic review can be found in Table 2.8. below. 
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Table 2.  7. Summary of moderator analysisa for Theory Coding Scheme variables for all included studies (k = 44). 
FULL SAMPLE 
Theory item  Random-effects model  Heterogeneity Between group effect  
 k g, OR (95% CI) p Q, Ph, I2 (%) (Qb, df, p) 
1.  Intervention based on single theory      
Yes 18 0.101, 1.202 (1.041-1.387) p = 0.012 69.03, p<0.001, 75.3% 0.470, 1, p = 0.493 
No 26 0.136, 1.281 (1.143-1.436) p<0.001 208.5, p<0.001, 88%  
2. Theory/predictor used to select recipients for the intervention    
Yes 0 - - - - 
No 44 0.119, 1.242 (1.143-1.349) p<0.001 277.6, p<0.001, 84.5% - 
3. Theory/predictor used to select/develop intervention to techniques    
Yes 37 0.100, 1.200 (1.106-1.302) p<0.001 137.9, p<0.001, 73.9% 1.683, 1, p = 0.194 
No 7 0.169, 1.359 (1.147-1.610) p<0.001 58.48, p<0.001, 89.7%  
4. Theory/predictors used to tailor intervention techniques to recipients    
Yes 23 0.094, 1.186 (1.048-1.342) p = 0.007 45.02, p=0.003, 51.1% 1.156, 1, p = 0.282 
No 21 0.146, 1.303 (1.157-1.466) p<0.001 204.9, p<0.001, 90.2%  
5. All intervention techniques explicitly linked to at least one theory-relevant construct/predictor   
Yes 16 0.079, 1.155 (1.032-1.293) p = 0.012 85.32, p<0.001, 82.4% 2.181, 1, p = 0.140 
No 28 0.142, 1.295 (1.171-1.432) p<=0.001 119.5, p<0.001, 77.4%  
6. At least one, but not all, of the intervention techniques are explicitly linked to at least one theory-relevant construct/predictor  
Yes 24 0.137, 1.283 (1.133-1.452) p<0.001 40.14, p=0.015, 42.7% 0.474, 1, p = 0.491 
No 20 0.105, 1.210 (1.084-1.350) p = 0.001 225.5, p<0.001, 91.5%  
7. Group of techniques are linked to a group of constructs/predictors 
Yes 16 0.172, 1.367 (1.165-1.605) p<0.001 28.08, p=0.021, 46.5% 1.918, 1, p = 0.166 
No 28 0.100, 1.198 (1.090-1.318) p<0.001 235.4, p<0.001, 88.5%  
8. All theory-relevant constructs/predictors are explicitly linked to at least one intervention     
Yes 11 0.070, 1.134 (0.994-1.295) p = 0.062 53.22, p<0.001, 81.2% 2.256, 1, p = 0.133 
No 33 0.138, 1.285 (1.170-1.411) p<0.001 160.8, p<0.001, 80%  
9. At least one, but not all, of the theory-relevant constructs/predictors are explicitly linked to at least one intervention technique  
Yes 26 0.132, 1.270 (1.128-1.430) p<0.001 72.94, p<0.001, 65.7% 0.271, 1, p = 0.603 
No 18 0.107, 1.215 (1.082-1.365) p = 0.001 197.9, p<0.001, 91.4% 
 
 
Notes. aModerator analysis included only the studies that reported using theory to develop the intervention either in the introduction or methods sections. k = number of comparisons, g 
= Hedge’s g measure of effect size, OR = Odds Ratio, CI = Confidence Interval, Ph = p value of Q-test for heterogeneity, Qb = q value indicating the between-group effect. 
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Table 2.  8. Summary of theories/models of behaviour used in 28 of the studies (k = 44) included in the meta-analytic review. 
 
Theory 
 
 
Key constructs 
 
Studies of meta-analysis addressing theory 
Health Belief Model (Rosenstock, 
1974)  
 Perceived susceptibility                   
 Perceived severity                             
 Perceived benefits   
 Perceived barriers                         
 Cues to action 
Fitzgibbon et al (2007); Gimeno-Garcia et al (2009); 
Hendren et al (2013); Holt et al (2012); Jensen et al 
(2014); Marcus et al (2005); Maxwell et al (2010); 
Menon et al (2011); Price-Haywood et al (2014); 
Salimzadeh et al (2014); Wardle et al (2003); Basch 
et al (2006); Davis et al (2013); Myers et al (2007); 
Krok-Schoen et al (2015); 
Stages of 
change/Transtheoretical model 
(DiClemente & Prochaska, 1998) 
 Pre contemplation stage                 
 Contemplation stage                     
 Preparation stage                                   
 Action stage                                        
 Maintenance stage 
Marcus et al (2005); Menon et al (2011); Lasser et 
al (2011); Vernon et al (2011); Pignone et al (2000); 
Walsh et al (2010) 
Social Cognitive Theory (Bandura, 
1998) 
 Behavioural capability                     
 Reciprocal determinism                     
 Outcome expectations                          
 Self-efficacy  
 Observational learning  
 Reinforcement 
Braun et al (2005); Hewitson et al (2011); Krok-
Schoen et al (2015); a et al (2004) 
Theory of planned behaviour 
(TPB)   (Ajzen, 1991, 2002b; Ajzen 
& Madden, 1986) 
 Intention  
 Attitudes towards a behaviour  
 Subjective norms 
 Perceived behavioural control (PBC) 
Wardle et al (2003) 
Implementation Intentions 
(Gollwitzer, 1993) 
 Motivational phase: phase of formation intention                                            
 Volitional phase: planning of goal pursuit through 
forming ‘if-then’ plans 
Lo et al (2013); Neter et al (2014) 
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Protection Motivation Theory 
(Rogers, 1983) 
 Threat appraisal (perceived severity + perceived 
susceptibility) 
 Coping appraisal (self-efficacy + response 
efficacy) 
Cameron et al (2011); Katz et al (2012)  
Approach/Avoidance Motivation, 
Message framing (Kahneman & 
Tversky, 1981; Rothman & Salovey, 
1997) 
 Gain frame: Benefits of engaging in behaviour 
made salient 
 Loss frame: costs of failing to engage in 
behaviour made salient 
Hewitson et al (2011); Lipkus et al (2003); Schroy et 
al (2012); Sequist et al (2009); Sequist et al (2011) 
Precaution Adoption Process 
Model (PAPM) (Weinstein, 1988; 
Weinstein, Rothman, & Sutton, 
1998) 
 Stage 1: Unaware of Issue 
 Stage 2: Unengaged by issue 
 Stage 3: Undecided about acting 
 Stage 4: Decided not to act 
 Stage 5: Decided to act 
 Stage 6: Acting 
 Stage 7: Maintenance 
Costanza et al (2007); Ritvo et al (2015); Wilson et 
al (2015) 
Actor-Partner Interdependence 
Model  (APIM) (Cook & Kenny, 
2005) 
The effect of a person’s (e.g. partner’s X variable) on 
the person’s Y variable  - assesses how members of a 
dyad (i.e., couple) influence each other’s behaviours 
simultaneously 
Manne et al (2013)  
Preventive Health Model  Integrates theoretical components from Theory of 
Reasoned Action, Social Learning Theory and Health 
Belief Model  
Myers et al (2007); Salimzadeh et al (2014) 
General Model of Determination 
of Behaviour Change (a synthesis 
of behavioural theories) 
Main determinants of behaviour:  
 Attitudes 
 Perceived norms 
 Self-efficacy 
 Ability to perform the behaviour 
Potter et al (2011) 
Self-Determination Theory (Ryan 
& Deci, 2000) 
Identifies three psychological needs that predict 
behaviour: 
 Autonomy (feeling of being the origin of one’s 
Resnicow et al (2014) 
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own behaviours) 
 Competence (feeling effective) 
 Relatedness (feeling understood and cared for 
by others) 
Anticipated Regret  By anticipating regret – a strong negative affect – 
people may take action to avoid actually experiencing 
this emotion 
Wardle et al (2003); O’Carroll et al (2015) 
Cognitive-Social Information 
Processing Model  (Miller, Brody, 
& Summerton, 1988) 
Supports that people can have 2 distinct attentional 
styles and each style is associated with different 
behavioural reactions 
 High monitoring (information seeking) 
 Low monitoring (information distracting) 
Weinberg et al (2013) 
Question-Behaviour Effect  Supports that questioning people about a future 
behaviour influences the subsequent performance of 
that behaviour 
O’Carroll et al (2015) 
Attitude Accessibility Theory 
(Fazio, Powell, & Williams, 1989) 
Attitude accessibility refers to the ease with which 
attitudes can be retrieved from memory and plays a key 
role in the attitude-behaviour link 
 If attitude is memorable  Immediate impact on 
behaviour 
 If attitude is not memorable  Will only have an 
impact on behaviour when recalled 
Krok-Schoen et al (2015) 
Elaboration Likelihood Model  
(Petty & Cacioppo, 1986) 
Proposes there are two routes to attitude change; (1) 
the central route which leads to enduring attitude 
change that is predictive of behaviour; (2) the peripheral 
route where attitudes may remain unchanged and is 
dependent on the individual’s motivation  
Ruffin et al (2007) 
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2.3.4.4. Publication Bias 
Funnel plot investigation (see Figure 2.6) revealed that studies were not 
distributed symmetrically about the mean effect size, therefore indicating the 
presence of publication bias. Specifically, the plot indicated a suppression of 
studies on the left side of the mean, suggesting that there might be studies missing 
from the left rather than the right. The adjusted funnel plot (see Figure 2.7.) indeed 
indicated that there were eleven imputed studies (indicated in the plot as red 
circles). To further investigate the impact of the observed publication bias on the 
overall effect size, the Duval and Tweedie (2000) iterative trim and fill test was 
conducted. This test was used to demonstrate how the summary effect size would 
shift, if apparent bias was to be removed (i.e., removal of most extreme small 
studies from the sample of studies). The Duval and Tweedie test showed that the 
unadjusted odds ratio corresponded to a value of 1.493 (95% CI: 1.428-1.560) 
whereas the adjusted odds ratio was 1.458 (95% CI: 1.395-1.524), suggesting an 
adjusted estimate that was fairly close to the original. Therefore, the impact of 
publication bias was concluded to be present but unlikely to have substantive 
implications on interpreting the overall effect. 
 
Figure 2. 6. Unadjusted funnel plot of the studies included in the meta-analysis. 
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Figure 2. 7.  Adjusted funnel plot of the studies included in the meta-analysis with 
the nine additional studies estimated by the trim and fill analysis.  
 
2.3.5. Additional Analyses 
As indicated earlier in this chapter, variables were considered to be  
confounded with one another if the shared variance exceeded 25% (i.e., r >.5). 
Results of the correlation analyses revealed the variables contact type (with two 
levels: in person/mixed or remote) and intervention delivery (with two levels: one-
to-one or group/mixed delivery) were confounded. Specifically, results indicated 
that interventions that were delivered in person or those that incorporated both 
aspects that were delivered in person and remotely, were less likely to be delivered 
on a one-to-one basis, therefore indicating that these types of interventions were 
more likely to be delivered in groups (r = -0.501, k = 152, p < .001). The 
confounding of these two moderators has implications on the interpretation of 
effect sizes. The strong association between contact type (i.e., face-to-face, 
remote, or mixed contact type) and delivery format (i.e., individual or group/mixed 
delivery format) makes it difficult to disentangle the relationship between the type 
of intervention and CRC screening uptake rates. It therefore remains unclear which 
moderator is more important for increasing intervention effectiveness - is it contact 
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type or is it delivery format that drives the observed effect sizes?  For results of all 
correlation analyses see Appendix 2.13. 
2.4. Discussion 
The overall aim of this meta-analysis was to quantitatively review the 
evidence of the effectiveness of health interventions to improve CRC screening 
rates. This review also sought to examine the evidence of the effectiveness of 
health interventions on CRC screening rates among populations of higher 
socioeconomic disadvantage. Finally, this review aimed to assess the relative 
effects of contributing factors (i.e., moderators) on CRC screening uptake.   
2.4.1. Summary of Principal Findings 
We identified 102 studies incorporating 152 interventions and a sample 
population of 1.92 million participants. Studies used a wide range of methods to 
increase CRC screening uptake rates. Most interventions were conducted in the 
US, were delivered remotely, relied on the use of paper-based materials and were 
conducted through primary care settings. Approximately one third of interventions 
reported using theory to develop the content of intervention materials. Studies 
predominantly used objective strategies to assess screening uptake and most 
studies were classified as having high or unclear risk of bias. The most frequently 
identified BCT used in interventions was ‘Information about Health Consequences’.  
 The principal finding of this review is that, across all studies, the receipt of a 
health intervention led to a significant increase in CRC screening rates. The meta-
analysis estimated a small, but significant, post-intervention summary effect size (g 
= 0.26, p<.001). This review also provides reasonably strong evidence that health 
interventions significantly improved CRC screening rates among socioeconomically 
vulnerable populations with traditionally low screening participation rates such as 
ethnic minorities, low-income and medically underserved populations. Specifically, 
the pooled effect of the 47 studies delivered to low SES study samples, showed an 
overall effect of 2.1 times higher likelihood for participants in the intervention group 
to be screened for CRC, compared to participants in the comparison/control group. 
When comparing the estimated summary effect sizes between the disadvantaged 
and more privileged populations, results showed a significantly greater effect size 
for interventions delivered to the low SES sample of participants (g = 0.40, p 
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< .001), compared to the effects size calculated for the non-low SES studies (g = 
0.17, p < .001). Although the delivery of health interventions significantly increased 
CRC screening for both disadvantaged and more affluent populations, results 
indicate that underprivileged patients may benefit from health interventions 
substantially more than less disadvantaged populations. The small effect size 
among the non-low SES studies may be, to an extent, the result of a ceiling effect 
caused by potentially greater CRC screening rates among participants of a higher 
socioeconomic status, which could potentially leave a smaller proportion of 
participants in whom effects of the intervention could be observed. However, even 
a small effect size is noteworthy when contemplating the possibility to improve the 
prognosis of the approximately 1,361,000 people who are diagnosed with CRC 
each year (GLOBOCAN 2012; Ferlay et al., 2015).  
In the control condition, screening uptake was 19% higher for the non-low 
SES populations compared to low SES populations, whereas this difference in 
uptake was reduced to 7.5% in the experimental condition, indicating that the gap 
between the highest and lowest levels of socioeconomic deprivation was 
substantially reduced (by 11.5 percentage points) and that the delivery of health 
interventions led to a significant improvement in equitable delivery of CRC 
screening. This is a particularly promising finding since it indicates that the public 
health interventions reviewed here led to a reduction in screening inequalities. It is 
also encouraging that interventions did not widen screening inequalities by 
disproportionately benefitting less disadvantaged populations, which is not a rare 
occurrence in the area of research focusing on health inequalities (Lorenc, 
Petticrew, Welch, & Tugwell, 2013; McGill et al., 2015). Indeed, the findings 
presented here suggest that if vulnerable populations benefit from health 
interventions as strongly as indicated by these results, it can be expected that if 
similar strategies were to be implemented in public health policy, an overall gradual 
reduction of the socioeconomic gradient in CRC screening would follow. The need 
for implementing interventions that reduce CRC screening disparities has been 
widely recognised as a central precursor for reducing disparities in cancer mortality 
(Von Wagner, Baio, et al., 2011).  
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2.4.2. Interpretation  
In order to further understand the mechanisms behind the positive impact of 
health interventions on CRC screening uptake rates, among both less and more 
socioeconomically disadvantaged populations, a range of moderator variables 
were examined. Moderation effects revealed significant variation in screening 
behaviour between the low and non-low SES studies.  
2.4.3. Intervention Characteristics as Moderators 
2.4.3.1. Intervention delivery mode 
Our findings suggest that for low-income subgroups it was more effective to 
implement interventions remotely rather than face-to-face, or administer 
interventions that involved both types of contact. Contrary to this finding, for the 
non-low SES populations the strongest effect size emerged for interventions that 
relied on having face-to-face contact with the interventionist or mixed contact. For 
face-to-face interventions, it is common for interventionists to present statistics and 
numerical risk estimates, use specialist medical terms and might also prompt 
participants to engage in a conversation about their health. Dialogue-based health 
communication, as well as the complexities of the health information to be 
communicated, might represent significant challenges for patients with poor 
literacy, lower educational attainment or individuals for whom English is not their 
first language, thereby potentially decreasing participants’ understanding of and 
attention towards the health promotion messages being delivered. However, it was 
not feasible for this review to investigate the content or the communication style 
used in interventions, and therefore it was not possible to assess whether such 
factors mediated the difference in effect size observed among the two SES groups.  
The finding that effect sizes for individual-based interventions (i.e., one-to-
one) were significantly greater compared to group-based interventions aligns with 
our prediction, that health communication about CRC screening, delivered in a 
group setting, might compromise participants’ acceptability of health promotion 
messages. This finding was consistent across both SES groups. It is unclear 
whether group-based interventions are less effective due to the sensitive nature of 
the discussions surrounding CRC and CRC screening - which could, in turn, make 
participants more hesitant to disclose personal health information - or whether it is 
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that group dynamics influence how health messages are received, and this was 
outside the scope of the present meta-analysis. The literature does however show, 
that cancer and cancer screening constitute taboo matters, especially among 
minority groups (Karbani et al., 2011; Palmer, Thomas, McGregor, von Wagner, & 
Raine, 2015; Raymond et al., 2014; Robb, Solarin, et al., 2008; Thomas, Saleem, 
& Abraham, 2005), and therefore it seems reasonable to suggest that an 
individualised mode of delivery is superior to group-based interventions within the 
context of CRC screening. Nevertheless, only a small number of studies (k = 14) 
were classified as being group-based or mixed – that is, they contained both 
group- and individual-based components - and therefore it was not possible to 
extract conclusive evidence regarding the effectiveness of group-based 
interventions to increase CRC screening. Indeed, there seems to be a significant 
lack of literature comparing the effectiveness of group- and individual-based 
interventions within the wider context of cancer screening. From the patient’s 
perspective, the intervention mode of delivery might have implications for 
acceptability and can affect overall intervention effectiveness (Sekhon et al., 2017). 
A suggestion for further study would be to explore whether the relationship 
between group- and individual-based interventions and intervention effectiveness 
is mediated by the acceptability of health promotion messages to a recipient.  
In terms of intervention materials, delivering CRC screening promotion 
messages by using a combination of electronic media and paper-based media, 
translated into increased CRC screening rates for socioeconomically 
disadvantaged populations, yielding a large effect size (g = 0.78. p<.001). 
However, the evidence available in support of this delivery mode, is very limited as 
only three studies (Aragones, Schwartz, Shah, & Gany, 2010; Katz, Fisher, 
Fleming, & Paskett, 2011; Tu et al., 2006) were classified as using this combination 
of intervention materials. It is worth noting however, that all three of the 
aforementioned studies incorporated a video element, suggesting that there may 
be added value in engaging patients through the use of videos in web-based health 
interventions. This is in agreement with previous research that has shown that 
information presented in video-format is associated with improved recall of health-
related information and improved engagement, when compared to other emerging 
technologies, such as text messages (Koehler, Yadav, Phillips, & Cavazos-Kottke, 
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2005; Yadav et al., 2011). The findings also suggest that paper-based materials – 
including invitation letters and information pamphlets on CRC cancer screening – 
combined with additional telephone reminders, and/or health communication over 
the phone, demonstrated a positive effect on CRC screening rates. For the majority 
of included studies, a phone call either acted as a reminder for screening uptake, 
or as a means to further communicate the importance of CRC screening to 
participants. The critical role of adding a phone call was demonstrated in six trials, 
which compared postal invitation with postal invitation plus telephone outreach and 
reported an advantage for adding a telephone call in the intervention (Church et al., 
2004; Fortuna et al., 2014; Green et al., 2013; Levy, Xu, Daly, & Ely, 2013; Myers 
et al., 2007; Walsh et al., 2010).  These findings highlight that a letter of invitation, 
or a leaflet about the benefits of screening alone, might not be enough to motivate 
participants to take part in screening. In line with the conclusions of previous 
systematic reviews (Baron et al., 2008; Everett et al., 2011; Jepson et al., 2000) the 
evidence presented here suggests that telephone contact is associated with 
increased screening compliance and this finding has been observed across CRC, 
breast and cervical cancer screening programmes. More recently, a few papers 
have highlighted that a phone call component might be particularly beneficial for 
people who have never or have infrequently undergone screening (Ferroni et al., 
2012; Musa et al., 2017). Therefore, the findings presented here suggest that in a 
population of eligible individuals, who are often considered hard-to-reach based on 
greater socioeconomic deprivation, following-up screening invitations with phone 
reminders, and/or offering further information about the benefits of CRC screening 
through the phone, could potentially lead to substantial increases in CRC 
screening rates. Over-the-phone health communication also offers the chance for 
personal contact with someone knowledgeable about CRC screening, which might 
be an effective method of health communication, especially for individuals who 
might feel anxious about the screening process, but simultaneously feel 
apprehensive to discuss directly with their doctor.   
2.4.3.2. Intervention provider 
In terms of the intervention provider, the pattern of evidence observed 
between low-income and more affluent subgroups was substantially different; for 
the low SES studies, the results suggested that clinically trained health 
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professionals (including doctors and nurses) and research staff can deliver more 
effective interventions for increasing CRC screening rates, whereas for the more 
privileged populations, having non-clinically trained health professionals deliver 
health interventions was shown to be most effective. The finding that medical staff 
and researchers result in greater intervention effectiveness for socioeconomically 
disadvantaged populations contests previous evidence, which has extensively 
shown that the involvement of lay health educators and advisors in health 
promotion programmes and interventions has been successful in improving health 
behaviours and outcomes among many socially disadvantaged groups (Bonevski 
et al., 2014; Henderson, Kendall, & See, 2011; Montgomery & Jones Schubart, 
2010; Norris et al., 2006; Spencer et al., 2011; Swider, 2002). The results 
presented here suggest that healthcare providers might have a fundamental role in 
recommending screening, and factors such as the delivery provider’s professional 
training, level of experience with delivering health interventions, the interpersonal 
style involved in the communication and the quality of the participant-provider 
interactions might all have the potential to affect outcomes either directly, or 
indirectly by having an impact on intermediate predictors of outcomes. For 
instance, there might be important differences between medical professionals and 
lay educators with regards to their interpersonal style involved in the 
communication between themselves and patients/participants, which might in turn 
affect personal relatedness (Beall et al., 2014; Silva, Marques, & Teixeira, 2014). 
Whether relatedness is a factor that could affect the successful delivery of 
interventions to increase CRC screening rates is a potential area for future 
research.  
2.4.3.3. Intervention setting 
Wirth regards to whether the setting in which the intervention was delivered 
impacted on intervention effectiveness, results indicated that interventions 
delivered in the community setting resulted in greater effect sizes for both 
disadvantaged and non-disadvantaged populations. More specifically, community-
based interventions were significantly more effective for underprivileged 
populations than they were for more affluent populations. This is in agreement with 
previous evidence, which highlights that community-based interventions might 
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motivate greater behaviour change among socioeconomically deprived and 
marginalised populations, partly because they have the potential to connect study 
participants to aspects of their social environment (Bonevski et al., 2014; Kreuter, 
McQueen, Boyum, & Fu, 2016). Indeed, there is a growing movement of research 
aiming to reduce health inequalities by engaging members of the community in 
public health interventions - for instance, through the use of participatory research 
methods. The current evidence base suggests that the involvement of under-
represented communities can help contextualise an intervention within that specific 
setting, thereby increasing the likelihood of delivering interventions that can help 
eliminate disparities and bridge the gap between scientific research and public 
health policy (Belone et al., 2016; Israel et al., 2010; Trickett & Beehler, 2013; 
Wallerstein & Duran, 2010). In the present review, approximately 50% of 
interventions that were delivered to socioeconomically disadvantaged populations, 
were classed as being community-based, whereas less than a fifth of the studies 
targeting less socioeconomically disadvantaged populations were delivered in a 
community setting; an observation which lends its support to the trend observed in 
the literature, that posits a growing interest of researchers and academics in 
involving underserved communities in public health research, and especially in 
research that is concerned with the reduction of health inequalities. In terms of how 
community engagement in public health interventions was operationalised in the 
present review, community-based interventions took many forms. The majority of 
studies engaged underserved communities by providing information about the 
benefits of screening and offered further consultation with regards to the screening 
process – which is considered minimal engagement based on the five-rung ladder 
of participation proposed by (Wilcox, 1994) – and only a few community-based 
studies incorporated greater levels of involvement, such as joint decision-making 
and acting together (e.g., Christie et al., 2008; Horne et al., 2015; Lasser et al., 
2011; Maxwell et al., 2016; Percac-Lima et al., 2009). The latter levels of 
engagement are thought to lead to greater behaviour change that is more likely to 
be sustained long-term. It is important to note, that researchers face important 
challenges when conducting community-based participatory research – for 
instance the identification, recruitment and engagement of community 
representatives is a considerable barrier – however, from the findings presented 
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here, a heavier reliance upon community-based interventions may be advisable 
and appear to have greater potential to increase CRC screening uptake for 
populations with greater socioeconomic disadvantage and thereby reduce health 
inequalities.   
2.4.3.4. Intervention screening modality 
The variation of study effectiveness by type of screening modality revealed 
significant differences between populations with higher and lower SES. A large and 
statistically significant effect size was observed for interventions using stool-based 
screening procedures among more disadvantaged populations, whereas for more 
privileged populations, endoscopic screening procedures appeared to be more 
effective. One explanation could be, that the greater level of invasiveness of 
endoscopic screening procedures represents an additional barrier, among the 
multiple others, that populations with greater socioeconomic disadvantage usually 
face. It may be also be that individuals with higher SES might be more 
knowledgeable and appreciate the advantages of undergoing an endoscopic 
screening procedure – for instance, the fact that they are diagnostic in nature, the 
greater time interval required between repeat examinations compared to stool-
based screening procedures, as well as the opportunity to instantaneously remove 
polyps during the examination - all of which are considerable advantages of 
endoscopic procedures. The finding that intervention effectiveness varies as a 
result of screening modality – and therefore each method’s level of invasiveness - 
is not directly relevant to the UK health system - which provides universal, 
comprehensive healthcare free at the point of delivery and has implemented the 
provision of free CRC screening via FIT/gFOBT through the NHSBCSP - it might, 
however, offer some insights to the, heavily private, US health system, whereby the 
type of screening modality available is reliant on patients’ health insurance. 
2.4.3.5. Use of theory 
Findings with regards to the extensiveness of reported theory use on intervention 
effectiveness were mixed. For both disadvantaged and more affluent study 
samples, higher levels of reported theory use to guide intervention development 
was not a moderator of health intervention effectiveness. However, 
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sparse/moderate reported use of theory was associated with a significantly larger 
effect size, but this effect was only observed among non-low SES participants. This 
finding runs counter to some previous research, which has indicated that greater 
use of theory to guide intervention development, maximises intervention 
effectiveness (Bluethmann, Bartholomew, Murphy, & Vernon, 2017; Johnson, 
Carey, Chaudoir, & Reid, 2006). However, the findings regarding the association 
between theory use and intervention effectiveness are largely inconsistent and the 
evidence remains inconclusive. The effects of theory use on intervention 
effectiveness presented here should be interpreted with caution; subgroup sample 
sizes for assessing theory use as a moderator were mostly small, thereby limiting 
the power to robustly assess differential effectiveness. While most studies clearly 
justified why theory use was considered essential in achieving greater CRC 
screening uptake, the actual application of theory use in the planning and 
evaluation stage was largely inadequate. Overall, only one third of all included 
studies reported using theory to inform intervention development, and the majority 
of studies were classed as having sparse or moderate extensiveness of theory use 
and where characterised by a lack of explicit detail with regards to specifying 
exactly how theory was integrated into the design, implementation and evaluation 
of interventions. The ambiguous reporting of theory use application made it difficult 
to distinguish its impact on screening behaviour post-intervention, and highlights 
the ongoing need to effectively assess how theory is applied in intervention 
development. It might be of particular importance for future research to develop a 
framework, that will allow the differentiation between ‘theory-informed’ and ‘theory-
based’ interventions, and to critically assess whether such a distinction impacts on 
intervention effectiveness. Additionally, of particular importance for examining the 
relationship between theory application and intervention effectiveness, is the notion 
of implementation fidelity, which refers to the need for congruency between 
intended design and intervention delivery (Dusenbury, Brannigan, Falco, & 
Hansen, 2003). Implementation fidelity, and indeed the lack of, has been 
recognised as a major methodological limitation in health intervention research and 
is also thought to be a factor that can interfere with how optimally theory is 
operationalised in practice (Prestwich et al., 2014). Unless more studies of higher 
fidelity are conducted, it remains largely unclear what the impact of theory is on 
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intervention effectiveness. Within the context of the current review, the possibility of 
effect sizes being confounded by study fidelity with regard to theory use was 
considered to be high, and therefore this review cannot provide clear 
recommendations on what extent of theory use or which specific theoretical models 
would be well-suited for public health interventions aiming to increase CRC 
screening uptake. 
2.4.4. Participant Characteristics as Moderators 
The present review found that older age was associated with a significant 
reduction in intervention effectiveness, however, this result was only observed 
among more affluent participants. Perhaps older participants did not perceive that 
they needed to adhere to screening recommendations, despite the fact that older 
age is among the most prominent risk factors of CRC. Previous studies have 
shown that greater knowledge of risk factors of cancer and cancer prevention, is 
associated with significantly greater cancer screening uptake (Abotchie & Shokar, 
2009; Atkinson, Salz, Touza, Li, & Hay, 2015; Koo et al., 2010; Liao, Wang, Lin, 
Hsieh, & Sung, 2006; Lyimo & Beran, 2012). Although awareness about CRC may 
be an important determinant, it is likely that it is the combination with other factors 
that will ultimately determine whether people adhere to screening guidelines. 
Further research in similar populations is needed to better understand how age 
might interact with other factors (e.g., knowledge) to influence effectiveness of 
health interventions aiming to increase CRC screening uptake.  
The current findings suggest that gender does not have an impact on 
intervention effectiveness, indicating that men and women benefit equally from 
health interventions with regards to CRC screening uptake. Previous findings have 
suggested that men are less likely to adhere to CRC screening recommendations, 
and hence are at a higher risk for diagnosing CRC during later stages when 
treatment is less likely to be successful, therefore it is promising that interventions 
were equally beneficial for both genders. 
Similarly, prior family history of CRC did not moderate intervention 
effectiveness, and this finding was consistent across populations of both higher 
and lower socioeconomic disadvantage. Being up-to-date with screening at the 
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start of the study was associated with slightly worse screening outcomes among 
less disadvantaged participants. This might indicate the presence of a ‘ceiling-
effect’; participants from more affluent backgrounds that were up-to-date with CRC 
screening at baseline might not allow further improvements in uptake to be 
observed, and for participants already adhering to screening recommendations, 
providing additional materials related to cancer screening, might cause frustration 
and could negatively affect participants’ acceptability of health-related information, 
which could potentially explain the reduction in intervention effectiveness observed 
here.  
2.4.5. Methodological Characteristics as Moderators 
Two methodological characteristics were examined as moderators in the 
present meta-analysis. Firstly, the method of assessing screening uptake was 
examined in subgroup analysis, with results showing a significant, small-to-medium 
effect for studies that used objective measures of CRC screening rates, among 
socioeconomically vulnerable populations. It is worth noting, that among this 
population, a significantly larger effect was evident for objective measures 
compared to self-report measures. These findings suggest that the positive effects 
of health interventions observed among low-income and racially diverse study 
samples, cannot be attributed to self-report indices (e.g., social desirability, 
detection bias, ‘better-than-average’ effect), rather the results are clearly 
observable with measures of screening uptake beyond self-report biases. This 
finding contests previous research that has demonstrated that trials relying on self-
report tend to inflate intervention effects and threaten the validity of the findings 
(Colditz, Miller, & Mosteller, 1989; Klonoff, 2009; Schulz, Chalmers, Hayes, & 
Altman, 1995; Truong, Paradies, & Priest, 2014). Secondly, it was also assessed 
whether the main result was influenced by study quality, using the comprehensive 
Cochrane risk of bias tool. Among interventions delivered to low-income 
subgroups, results indicated that study quality significantly moderated the effects of 
health interventions, and surprisingly, higher-quality studies were found to have a 
significantly greater effect compared to both studies with unclear and poorer 
quality. This result contradicts previous evidence that studies rated as having high 
risk of bias, on average, tend to overestimate intervention effect sizes compared 
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with studies at low risk of bias (Hartling et al., 2009; Higgins et al., 2011; 
Viswanathan et al., 2012). Similar to above, this finding implies confidence that 
results represent the true intervention effects and that the finding, that health 
interventions are significantly beneficial for the purposes of increasing CRC 
screening uptake, among socioeconomically disadvantaged populations, is 
considered valid. For the non-low SES studies, results indicated a significantly 
greater effect size for studies of unclear risk of bias when compared to both high 
and low risk of bias studies. The majority of studies that were considered as having 
unclear risk of bias were classified as such mainly due to missing or poorly 
reported information that did not allow secure risk of bias judgments to be made. 
2.4.6. Behaviour Change Techniques (BCTs) as Moderators 
The use of reminders – defined here broadly and included the use of 
messages reminders (both print and electronic), fridge magnets and brief feedback 
communicated to participants multiple times during the interventions, among others 
– was also examined as a potential moderator of intervention effectiveness. 
Results indicated that reminders generally led to positive effects for improving CRC 
screening rates compared to studies that did not incorporate reminders. This 
finding was consistent for both more and less disadvantaged populations, however, 
it was only for the more affluent participants that this difference in effect was 
statistically significant. Findings from a recent study (Kreuter et al., 2016) found 
that common intervention approaches, such as reminders, that promoted 
preventive health services, were differentially effective among participants with 
different patterns of unmet basic needs (e.g., food, housing, personal and 
neighborhood safety, money for necessities). Specifically, Kreuter et al (2016) 
reported that economically vulnerable populations did not benefit from reminders 
as much as they did from more intensive, patient-centric approaches, such as 
patient navigation. The relative ineffectiveness of reminders among populations of 
higher socioeconomic disadvantage observed here, can perhaps be explained by 
the fact that people that have dealt with prolonged financial insecurity, are more 
likely to avoid paying attention or even forget that such materials were received 
(Osterberg & Blaschke, 2005), in the presence of other pressing concerns and 
more urgent financial, medical and social needs.  These findings suggest that the 
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effectiveness of conventional and minimal-contact intervention approaches, such 
as reminders, may to an extent be undermined among low-income subgroups due 
to unmet basic needs and heightened socioeconomic insecurity. Emerging findings 
from the area of health disparities research, is suggesting that ‘upstream’ 
prevention interventions – for instance, interventions that involve reforming 
healthcare policies that have greater potential of improving population-level health- 
with a focus on helping people meet their basic needs, are more likely to be 
associated with favourable public health implications and lead to more sustained 
behaviour change, compared to ‘downstream’ interventions, which rely solely on 
individuals making and sustaining behaviour change  (Cappelletti, Kreuter, Boyum, 
& Thompson, 2015; McGill et al., 2015).  
In order to account for heterogeneity, this review also aimed to further 
unpick the various BCTs that were used in the included studies, to identify which 
techniques might be associated with more favourable CRC screening-related 
outcomes, for which specific populations. Whilst there is a growing amount of 
review papers and meta-analyses examining whether BCTs increase intervention 
effectiveness (Cradock et al., 2017; Hartmann‐Boyce, Johns, Jebb, & Aveyard, 
2014; Olander et al., 2013; Samdal et al., 2017; Webb et al., 2010), at present, 
there is a lack of understanding of specific BCTs used in health interventions that 
aim to increase CRC screening rates, and there is little available evidence 
identifying BCTs that might lead to improved health outcomes for underserved and 
socioeconomically deprived populations. Across all the 102 trials, 39 out of the 93 
BCTs in the BCTTv1 taxonomy were identified. Among less deprived populations, 
three BCTs were associated with significantly larger effect sizes: ‘Social Support 
(unspecified)’, ‘Social Support (practical)’ and ‘Adding Objects to the Environment’. 
One BCT, ‘Instructions on how to Perform the Behaviour’, was associated with 
significantly smaller effect sizes. The pattern of findings differed substantially 
among interventions delivered to populations of greater socioeconomic 
disadvantage, where two BCTs were associated with significantly greater 
intervention effectiveness: ‘Instructions on how to Perform the Behaviour’ and 
‘Adding Objects to the Environment’, and two BCTs were associated led to a 
significant reduction in intervention effectiveness: ‘Problem Solving’ and ‘Social 
  
107 
Support (practical)’. It is rather surprising that social support had a differential 
impact on intervention effectiveness between less and more disadvantaged 
populations, and it is concerning that social support reduced intervention 
effectiveness among more socioeconomically deprived participants. One 
explanation could be that the type of social support provided was not tailored or 
culturally-relevant to the needs of the specific population. Indeed, there are certain 
factors that have shown to negatively affect the social-support-health relationship; 
for instance, satisfaction of social support depends on the conceptualisation of 
social support by the recipient and this is considered a main determinant of the 
relationship (Ford, Tilley, & McDonald, 1998; Morrison, 2015). Furthermore, a 
recent review has noted that preferences for the type of social support are 
substantially different depending on participants’ race/ethnicity, geographical 
location and gender (Strom & Egede, 2012). Strom and Egede (2012) also 
highlight that the source of social support appears to be crucial with regards to how 
well support is received and that ethnic minority groups tend to rely more on 
support from family and friends, as compared with white populations, who tend to 
rely more on support from healthcare professionals and the media. This could 
explain the differential impact social support had on study effect sizes between low 
and non-low SES studies, since none of the studies involved the provision of 
support from participants’ family and friend networks. Future research should 
consider providing social support in a way that is culturally-tailored and sensitive to 
the needs of the populations being served, which in turn might lead to greater 
engagement with interventions and facilitate the adoption of health promoting 
behaviours among disadvantaged populations. Findings from this review suggest 
that there is no association between the number of BCTs and intervention 
effectiveness.  
2.4.7. Limitations  
Despite using a thorough search strategy, there may be some literature on 
health interventions aiming to increase CRC screening uptake that was, 
unintentionally, not identified in this review. Additionally, this review was not 
exhaustive in that it did not include studies identified through reference lists of 
included studies, neither did it include ‘grey literature’ (i.e., unpublished documents 
and reports) on this topic. Some interventions with negative findings may not have 
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been published, therefore exaggerating the effect sizes reported in the literature; 
however, the  test of publication bias, indicated that there were no statistical risks 
of publication bias.   
Furthermore, there were additional variables that had been scheduled a 
priori to be included as moderators in subgroup analyses, such as variables related 
to past screening history – for example, number of past invites, percentage of 
people ever been screened using gFOBT, percentage of people ever been 
screened through other screening procedures –, intensity of intervention (e.g., 
number of contacts in both intervention and control arms, number of contacts with 
physician), intervention latency (i.e., average duration from screening invite to 
screening behaviour). However, there was insufficient amount of reliable data 
reported in the included studies on these variables to conduct moderator analyses 
suitably. For instance, only one study (comprising of four cluster-randomised 
controlled trials assessed in parallel), conducted by Wardle and colleagues (2016), 
reported whether each participant was being invited for the first time (prevalent 
first-time episode), being sent a screening invitation having previously not 
responded (prevalent episode), or being sent a screening invitation having been 
screened before (incident episode).  Screening history variables such as this have 
been noted as important factors to take into account when examining CRC 
screening uptake (Raine, Moss, et al., 2016; Steele et al., 2010) and their 
consistent reporting would have allowed for their inclusion in analysis in order to 
provide more specific recommendations about how health interventions should be 
designed and for which populations. 
There was also a considerable amount of variability within some of the 
moderator categories. For instance, with regard to intervention materials, ‘paper-
based media’ consisted of many different types of print materials, that are likely to 
have also differed substantially in terms of their content. Additionally, some of the 
categories were combined – for example studies that used both electronic- and 
paper-based media were combined with studies only using electronic-based media 
and the combination of these into one category, allowed for conducting robust and 
adequately-powered moderator analyses. However, in the aforementioned 
example, although it is evident that studies using electronic-based media are 
effective overall, it is unclear whether this effect is observable due to a synergistic 
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action with print materials or because one type of materials acted in isolation to 
increase intervention effectiveness. This meta-analysis restricted its scope to RCTs 
and cluster-RCTs, which might be considered by some authors as limiting, 
however, applying this inclusion criterion enabled the focus of this review to be 
placed on the best available, experimental evidence for the purposes of evaluating 
intervention effectiveness to increase CRC screening uptake.  
Objective measures of SES were often not reported, which increases the 
likelihood for miscategorising studies into low and non-low SES studies. The risk of 
this miscategorisation occurring was considered higher for studies classified as 
non-low SES studies, because the studies that targeted underserved populations 
all clearly specified that the intervention was targeting either low-income, ethnic 
minority or medically underserved populations. Study definitions of socioeconomic 
deprivation were varied possibly leading to the inclusion of studies in the review 
that operationalised socioeconomic disadvantage differently. It is possible that the 
low SES variables used to classify studies in this review are only a proxy for other 
indicators of deprivation. The lack of a clear definition for low SES studies was 
mainly due to papers rarely reporting objective indicators of SES uniformly. The 
reporting of objective measures of SES or other social determinants of health – 
including race/ethnicity, occupation, religion, education and socioeconomic position 
- might be particularly important for identifying and implementing interventions that 
will be effective in improving CRC screening, and broader health outcomes in 
general, among marginalised and socioeconomically disadvantaged populations. 
Currently, race-based and income-based categorisations are becoming obsolete, 
mainly due to the fact that, culturally and historically, such segregations have 
commonly led to unjust discriminations against certain populations. However, 
recognising and tracking social group differences in health has helped identify 
subgroups to whom additional resources need to be directed and is important for 
monitoring the state of health inequities at a societal level (Arcaya, Arcaya, & 
Subramanian, 2015). Objective SES indicators in studies could help distinguish 
both certain participant characteristics that might be related to intervention 
effectiveness, as well as certain intervention features that are associated with 
increased effectiveness among specific populations. An ongoing challenge for 
future research is deciding whether it is better to examine intervention 
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effectiveness on screening inequalities across individuals within a single population 
(e.g., high and low SES populations within a single country), or to focus on 
describing group-level differences across an entire population. Another difficult 
question that remains unanswered, is whether public health research should focus 
on improving screening uptake for the worst-off groups - in order to eliminate 
health disparities - or for the largest groups - in order to improve overall population 
health and reduce the prevalence of CRC. For instance, should prevention 
interventions target screening uptake among ethnic minorities and not among 
whites, or should the aim be for CRC screening uptake to increase in both groups? 
Significant statistical heterogeneity remained even after extensive 
moderator analyses. This was mainly due to the breadth of the current research 
topic and the multiple, differing perspectives it contains. Despite the substantial 
exploration of this heterogeneity, across all subgroup analyses the indices 
available for measuring heterogeneity seldom reached statistically acceptable 
levels. This is not surprising given that even after analysing intervention 
effectiveness by specific subgroups, interventions to increase CRC screening 
uptake were still largely variable across multiple domains, some of which were 
known to the researchers – for example, studies differed with respect to the BCTs 
used, the strategy used to incorporate theory into intervention development, the 
study setting, location etc. – as well as unknown variables. For instance, the direct 
or indirect effect of having a private or universal health coverage system could not 
be examined within the current meta-analysis, but is known to affect the delivery of 
health services (including cancer screening services), overall health system 
performance, and can impact on health inequalities (Asaria et al., 2016; Baum, 
2016; Boerma et al., 2014; Frenk, 2015). A final limitation, is that due to the breadth 
of the research and the high number of studies identified in the literature, there was 
an inevitable delay between the database searches carried out (last search 
October 2016) and the reporting of the findings.  
2.4.8. Conclusions  
In summary, the present meta-analysis identifies intervention approaches 
drawn from all the available randomised evidence, and provides an evidentiary 
basis on which future public health interventions aiming to increase CRC screening 
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can be developed. It is important that future trials provide detailed accounts of 
intervention descriptions in order to establish the relative effectiveness of the 
various intervention components and build on existing evidence. Additional 
rigorous and generalisable studies that target both ‘downstream’ (e.g., cancer 
screening services) as well as ‘upstream’ determinants of health (e.g., policy 
change, poor living conditions) are urgently needed in order to examine their 
capacity to reduce the pervasive problem of CRC screening disparities. The 
practical significance of the present findings as well as the recommendations for 
future interventions based on the trends observed in the review, are discussed in 
further detail in the Discussion chapter of the present thesis.
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CHAPTER 3 
Exploring the Determinants of gFOBT Screening Uptake among an Ethnically 
and Socioeconomically Diverse Population (Study 2) 
3.1. Introduction 
The systematic review and meta-analysis in Chapter 2 examined the 
effectiveness of public health interventions to improve CRC screening rates by 
level of SES and identified a range of variables, including BCTs, which acted as 
moderators of intervention effectiveness. Promisingly, the findings suggested that 
health interventions led to a more than two-fold increase in uptake among low SES 
populations, thereby contributing to the reduction of inequalities observed in CRC 
screening uptake. Yet, despite the significant reduction observed, the difference in 
screening uptake rates in the low and high SES groups remains alarming, 
indicating that a more in-depth exploration of the factors that affect screening 
participation, and how these manifest among different subgroups of the population, 
is crucial in order to achieve a high level of screening participation across the 
overall population but also to effectively reduce screening disparities through future 
interventions. At the same time, the majority of studies included in the meta-
analysis were conducted in the USA and due to system-level differences in the 
delivery of healthcare between the USA and the UK, it was considered important to 
further examine the individual, contextual and cultural influences on screening 
behaviour in a UK-specific context. The primary difference compared to the UK, is 
that in the USA screening remains predominantly opportunistic and requires people 
to either pay or be reimbursed from their health insurance provider, therefore is 
often associated with financial barriers (e.g., inability to acquire health insurance, 
inadequate insurance coverage, lack of regular source of care) that contribute to 
screening nonparticipation particularly among socioeconomically disadvantaged 
populations (Beydoun & Beydoun, 2008; Klabunde et al., 2011). Due to the 
differences in the delivery of screening services in the USA and the UK the 
evidence from the meta-analysis, although informative, cannot be directly applied 
to the UK context. As discussed earlier in the thesis, despite screening being 
offered free at the point of care in the UK, screening inequalities are evident in the 
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UK (Blanks et al., 2015; Lo, Waller, Wardle, & von Wagner, 2013; Von Wagner, 
Baio, et al., 2011), as well as in other countries with universal healthcare that have 
developed structured screening programmes such as Spain (Hurtado et al., 2015), 
Italy (Carrozzi et al., 2015; Turrin et al., 2015), the Netherlands (Deutekom et al., 
2009), Denmark (Frederiksen, Jørgensen, Brasso, Holten, & Osler, 2010) and 
Canada (Decker, Demers, Nugent, Biswanger, & Singh, 2015; Honein-AbouHaidar 
et al., 2013), suggesting that the observed inequalities are caused by factors that 
are not purely economic in nature (e.g., income, financial deprivation) but are also 
influenced by other aspects of socioeconomic disadvantage or vulnerability (e.g., 
age, gender, ethnicity, marital status, education), as well as psychosocial factors, 
including emotional state, sociocultural environment, previous experience of 
illness,  perceived health status and understanding of illness. 
Several studies have identified factors that may motivate or deter individuals 
from participating in bowel cancer screening. Non-participation in screening has 
been attributed to lack of knowledge (Berkowitz, Hawkins, Peipins, White, & Nadel, 
2008; Clarke, Gallagher, Kearney, McNamara, & Sharp, 2016; Gimeno-García, 
Quintero, Nicolás-Pérez, & Jiménez-Sosa, 2011; Hoffman-Goetz, Thomson, & 
Donelle, 2008; O'Sullivan & Orbell, 2004), embarrassment (Bridou et al., 2013), 
cancer fatalism (Chapple, Ziebland, Hewitson, & McPherson, 2008; Goldsmith & 
Chiaro, 2008; Miles, Rainbow, & von Wagner, 2011) and anxiety about screening 
results (Beeker, Kraft, Southwell, & Jorgensen, 2000; O'Sullivan et al., 2004). A 
more recent focus group study conducted with participants from a variety of 
socioeconomic backgrounds in the UK (Palmer, Thomas, Von Wagner, & Raine, 
2014) highlighted the important role emotional barriers play in screening uptake, 
such as affective risk perception and feelings of disgust and shame. Other 
research suggests that the fact that bowel cancer and faeces are widely perceived 
as taboo topics within the wider societal context, and the lack of cultural openness 
in discussing bowel-related issues,  are also factors that negatively affect 
screening participation (Beeker et al., 2000; MacKenzie, Chapman, McGeechan, & 
Holding, 2010). Decisions to not participate in cancer have also been associated 
with forgetfulness, lower perceived susceptibility, lack of cancer symptomatology 
and low perceived self-efficacy (Berkowitz et al., 2008; Hall et al., 2015; Hoffman-
Goetz et al., 2008; Szczepura et al., 2003).  
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Apart from the aforementioned barriers, populations with historically lower 
screening uptake, such as BAME and low SES populations, experience additional 
barriers, including low health literacy, low level of acculturation, low levels of 
education, language-related difficulties and poor patient-physician communication 
(Gimeno Garcia, 2012; Kobayashi et al., 2014; Power et al., 2009; Solmi et al., 
2015). On the other hand, knowing someone with cancer (Lobchuk et al., 2012; 
Molina‐Barceló, Salas Trejo, Peiró‐Pérez, & Málaga López, 2011; Oster et al., 
2013), social support (Brouse et al., 2003; Dolan et al., 2004; Rogers, Mitchell, 
Franta, Foster, & Shires, 2017; Schoenberg et al., 2016; Wardle et al., 2004) and 
the perception that screening is effective in reducing disease threat (Javanparast et 
al., 2010), are factors that have been found to increase bowel cancer screening 
uptake.   
Acceptability of the test has also been highlighted as a critical factor 
predicting screening participation, with evidence suggesting that people are more 
likely to complete a test they prefer and perceive as hygienic and convenient 
(Marshall, McGregor, & Currie, 2010). Recent data have suggested that commonly 
reported barriers, relating to concerns about hygiene and the collection of faecal 
matter, may be overcome with the introduction of the FIT. As indicated earlier in the 
thesis, the replacement of the gFOBT by the FIT was announced by Public Health 
England in June 2016 and unlike other national screening programmes, which 
adopted a phased implementation approach (e.g., Scottish Bowel Cancer 
Screening Programme, Dutch Bowel Cancer Screening Programme), the English 
BCSP has announced that all of the five regional programme hubs will switch to 
using the FIT simultaneously in 2018. 
The main differences between the FIT and the gFOBT is that the latter 
requires a total of six faecal samples to be collected (two samples from three 
separate bowel movements), whereas the FIT requires one sample to be collected 
on a single occasion. Apart from greater service user acceptance (Hol et al., 2010), 
the FIT offers several advantages over gFOBT, including more consistent detection 
of advanced adenomas and precancerous lesions, not being affected by dietary 
choices and medication, and higher sensitivity to a lower concentration of human 
haemoglobin (Hb) within a single faecal sample (Goede et al., 2017; Rabeneck et 
al., 2012).   
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Recent UK-based data have shown promising findings with regards to the 
acceptance of the FIT. For instance, a recent survey (Chambers et al., 2016) 
reported that individuals showed higher intention to complete and return the FIT 
compared to the gFOBT and perceived the FIT as less disgust-provoking and 
easier to complete. Similarly, data from a large, comparative pilot study that was 
performed within the English BCSP in 2014, suggested markedly improved 
participation rates with the FIT compared to the gFOBT (Moss et al., 2016). Use of 
the FIT resulted in a 7% increase in overall screening uptake (66.4% vs 59.3%) 
and almost doubled screening participation among groups with traditionally low 
screening participation rates, such as ethnic minority populations, men and people 
living in areas of greater socioeconomic deprivation (FIT 23.9% vs gFOBT 12.5%). 
Currently, there is little qualitative research that has examined whether a one-
sample test is preferable to a three-sample test and whether this is a factor that 
might be weighted in the decision-making process of different populations. 
Moreover, despite some UK-based, empirical, qualitative evidence (Dharni, 
Armstrong, Chung‐Faye, & Wright, 2017) there is a paucity of studies that have 
assessed the views towards gFOBT by involving participants from both BAME and 
White British backgrounds, men and women, screeners and non-screeners, and 
participants representing varying degrees of socioeconomic deprivation within one 
study sample. Overall, the extent to which some of the psychosocial determinants 
of screening indicated earlier (e.g., avoidance, lower perceiver risk, fatalistic 
beliefs) map onto sociodemographic determinants of bowel cancer screening 
uptake (e.g., ethnic background, SES) remains largely underinvestigated. 
Therefore, the aim of this study was to conduct a series of one-to-one, semi-
structured interviews with a sufficiently diverse sample to enable the investigation 
of ethnicity, SES, screening history, gender and other psychological variables in the 
same analysis and gain better insights into the succeeding decisional process 
toward screening behaviour. Specifically, the four objectives of the present 
research were, firstly, to draw upon participants’ perspectives and lived screening 
experiences to ascertain that factors that influence gFOBT screening uptake; 
secondly, to identify which psychosocial determinants promote or inhibit screening 
participation and whether these differ between different subgroups of the 
population; thirdly, to provide suggestions that inform the development of health 
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interventions to promote screening uptake, with an emphasis on providing 
suggestions for specific subgroups in which participation is particularly low; and 
fourthly, to collect some preliminary qualitative data on participants’ attitudes 
towards the FIT. The findings of this study build the foundation for the following 
study (Study 3), which will quantitatively investigate the relationship between 
psychosocial and sociodemographic predictors of CRC screening intention.  
 
3.2. Method 
3.2.1. Participants and Recruitment 
Participants were eligible for inclusion if they were aged between 60 and 74 
years, lived in Leeds, had received a prior invitation from the NHS to take part in 
bowel cancer screening and did not have prior personal history of bowel cancer or 
other chronic gastrointestinal disorders, including IBD (i.e., including ulcerative 
colitis and Crohn’s disease) and Irritable Bowel Syndrome (IBS). Participants were 
recruited by the researcher through charitable and voluntary organisations in inner-
city areas of Leeds, local community groups, online and poster advertising (see 
Appendix 3.1. for research poster) and through word-of-mouth over a period of 
seven months (February to September 2016). The recruitment strategy was 
shaped by the study objective to examine the psychosocial determinants of gFOBT 
screening uptake in a way that would ensure comparability across diverse 
populations. Specifically, there were four dimensions expected to directly influence 
screening participation and these were designated a priori through consultation of 
the existing bowel cancer screening literature. These dimensions were: (1) 
participants’ ethnic/racial background, with participants being classified as having a 
White British ethnic background or BAME background; (2) participants’ gender; (3) 
participants’ screening history, where interviewees were categorised into those that 
had completed the gFOBT at an earlier invitation and those who had not, and (4) 
participants’ SES, which was based on the Index of Multiple Deprivation 201516 
(IMD2015; Smith et al., 2015), which is a measure that provides area-level 
deprivation data based on participants’ postcodes.  Specifically, the IMD2015 
                                                        
16 The IMD measures relative levels of deprivation in small areas of England known as Lower Layer 
Super Output Areas (LSOAs). Each LSOA is appraised against 38 separate indicators across seven 
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provides a relative score of overall deprivation based on seven domains: (1) 
income deprivation; (2) employment deprivation; (3) education, skills and training 
deprivation; (4) health deprivation and disability; (5) crime; (6) barriers to housing 
and services and (7) living environment deprivation.  Participants were classified 
into two groups, those living in neighbourhoods with high socioeconomic 
deprivation – that is, quintiles 1 and 2 of the IMD2015 – and those living in areas of 
moderate or low socioeconomic deprivation – that is, quintiles 3, 4 and 5 of the 
IMD2015.  
A purposeful sampling approach was adopted in order to facilitate the 
identification and selection of participants that were aligned with the objectives of 
the research. Specifically a maximum variation sampling (MVS) approach was 
adopted, which is a strategy that aims to sample for heterogeneity thereby 
documenting people’s unique or diverse experiences with the phenomenon of 
interest. MVS is commonly employed in qualitative research in order to achieve a 
depth of understanding whilst ensuring representativeness and diversity of 
participants (Patton, 2005). To facilitate the purposeful selection of participants, a 
sampling grid approach was used to direct the recruitment process, which, 
according to previous research (Patton, 2002; Suri, 2011), ensures that participants 
are selected in a systematic way and that the sample of participants is well-suited 
for the purposes of the research project. For instance, as seen in Table 3.1., there 
was a proportional number of males and females, past screeners and past non-
screeners, people from BAME and White British ethnic backgrounds as wells as 
people from areas with higher and lower SES, who participated in the present 
research. 
 
 
 
 
 
                                                                                                                                                                         
domains. A deprivation index is provided for each domain, but the domains are also weighted to 
derive a total IMD score, which reflects the extent of deprivation in any given area.  
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Table 3.  1 Recruitment Sampling Grid 
Note. IMD quintile categories are based on national cutoffs; IMD quintile 1 = most deprived and quintile 5 
= least deprived. 
 
3.2.2. Procedure 
To explore the determinants of bowel cancer screening uptake, a qualitative 
research method was employed, using semi-structured, one-to-one interviews. 
Semi-structured interviews were used, over unstructured or structured interviews, 
because it is widely accepted that they provide increased flexibility to both the 
interviewer and the respondent, whilst ensuring that the same general areas of 
information are collected from each interviewee (Bernard, Wutich, & Ryan, 2016; 
McNamara, 2009). An additional benefit of semi-structured interviewing is that it 
enables researchers to capture data more effectively due to the researcher firstly, 
maintaining the liberty to improvise additional questions related to the central 
question, and secondly, being able to provide additional commentary to clarify 
potentially ambiguous participant responses (Jamshed, 2014).   
In the present study semi-structured interviews enabled the exploration of 
factors that influence people’s decision-making process with regards to gFOBT 
screening. An interview schedule was developed and informed by the findings of 
the literature review and meta-analysis (Chapters 1 and 2), as well as through 
discussions with public health specialists and health and research psychologists at 
the University of Leeds. The interview schedule was extensively discussed with a 
 
Characteristics of 
population (n = 27) 
 
Male 
screeners 
Male non-
screeners 
Female 
screeners 
Female non-
screeners 
White British, IMD 
quintiles 3, 4, & 5 
 
- 1 7 1 
White British, IMD 
quintiles 1 & 2 
 
- - 3 1 
Ethnic minority, IMD 
quintiles 3, 4, & 5 
 
3 3 - 1 
Ethnic minority, IMD 
quintiles 1 & 2 
2 4 - 1 
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cancer improvement specialist and was piloted through a single interview with a 
member of the community who met all inclusion criteria. Minor adaptations were 
made to reflect the feedback from the health specialist and a few questions were 
modified to facilitate clarity as a result of the pilot interview.  
A one-to-one interviewing method was chosen in order to obtain people’s 
individual accounts and experiences with regards to gFOBT screening. Given that 
stool-based screening procedures have been paired with experiencing negative 
affects, including embarrassment, disgust, anxiety and fear (Consedine, Ladwig, 
Reddig, & Broadbent, 2011; O'Carroll et al., 2015), one-to-one interviewing was 
deemed preferable over focus group interviewing in which participants might have 
been more reluctant to openly discuss personal, and perhaps sensitive, issues 
relating to their screening experiences. Moreover, findings from focus-group 
research are more likely to be influenced by groupthink bias, which has been 
recognised as a common disadvantage of focus group research (Dimitroff, 
Schmidt, & Bond, 2005).   
In the first instance, participants were approached through local community 
centres and charitable organisations (e.g. Feelgood Factor, Barca, Women’s 
Health Matters, Black Health Initiative) across Leeds. Appropriate permission from 
each community centre/charitable organisation was obtained to place posters 
advertising the study on relevant notice boards in public spaces within each 
organisation. Additionally, the researcher arranged with organisation stakeholders 
to attend sessions that community centres/charitable organisations organised for 
their members to make an announcement about the study (i.e., outline the 
rationale and aims of the research). Prior to the commencement of the interview 
participants were provided with a participant information sheet (see Appendix 3.2.) 
and were given the opportunity to ask questions before providing written informed 
consent (see Appendix 3.3.). Additionally, each participant was verbally reminded 
about the aims of the study, the open-ended conversational style of the interview, 
the audio-recording requirement for transcription, confidentiality policies and the 
right to withdraw from the study up until one month after the interview. As part of 
the recruitment process, participants were asked to fill in a brief, pre-screening 
demographic questionnaire (Appendix 3.4.) to determine their eligibility to take part 
in the research. The pre-screening questionnaire was also used to inform 
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subsequent recruitment, in line with the purpose and scope of this research, by 
indicating whether cells within the aforementioned sampling grid were 
overpopulated or underpopulated. For instance, during the initial stages of 
recruitment it was apparent that there was an increased number of participants 
from a White British ethnic background and female screeners with high SES, 
suggesting an adequate representation of this group within the dataset but a need 
for increasing the number of cases within the remaining cells.  
The interview schedule comprised of pre-set, open-ended questions and 
topic areas that were explored by the researcher during interviews (See Appendix 
3.5. for the interview schedule). Participants were encouraged to share their 
opinions and experiences on cancer screening using the gFOBT kit and the factors 
they felt influenced their decision-making processes across the cancer screening 
pathway. Questions touched upon participants’ knowledge about bowel cancer and 
the screening process (e.g., “What do you know about the bowel screening kit?”), 
past screening experiences with using the bowel screening kit (e.g., “Did you 
experience any issues you would like to mention when you used your screening 
kit?”), opinions and feelings relating to the screening process in the context of their 
own lives (e.g., “How did you feel about collecting stool samples?”), as well as 
suggestions of how the process could be improved (e.g., “What do you think would 
increase the chances of you using your kit next time?”). Discussions were further 
facilitated by bringing an unused, demo screening kit to the interview (see 
Appendix 3.6. for a picture of the kit) as it was anticipated that it might act as a 
prompt and encourage participants to share more information and/or lead to the 
revelation of new information with regards to participants’ experiences using the kit. 
For non-screeners, it was expected that the presence of the kit might positively 
influence attitudes towards the screening process, possibly by giving them the 
opportunity to engage in open discussion about bowel screening in a non-
judgmental and safe conversational space. On completion of the interview, 
participants were debriefed and were given the opportunity to ask questions or 
share any additional comments. For any clinical questions, relating to bowel cancer 
and the screening process, participants were directed to the NHS webpage about 
bowel cancer and were given the helpline number that addresses general queries 
about bowel cancer and screening. Participants were also given the standard NHS 
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leaflet, which provides detailed information regarding the gFOBT screening 
process.  
All interviews took place between February 2016 and October 2016. 
Nineteen interviews were conducted at inner-city community centres in the areas of 
Chapeltown, Harehills and Woodhouse and eight interviews were conducted at the 
School of Psychology at the University of Leeds. Interview times ranged from 17 to 
62 minutes (M = 31, SD = 13.4). Participants were asked whether the research 
team could keep a record of their contact details to be contacted for future 
research projects on bowel cancer screening. Participants were given £5 cash to 
reimburse them for their time and travel expenses. Interviews were audio-recorded 
with participants’ permission and were transcribed verbatim. Audio recordings were 
stored as password-protected files on a University of Leeds computer. Any 
personally identifiable information (such as names and addresses) were removed 
from the transcript to ensure the anonymity of each participant and each transcript 
was assigned a unique identification code known only to the researcher. The 
completed consent forms, participants’ unique identification codes and anonymised 
transcript data were kept in locked cabinets within the University of Leeds campus 
facilities.  
3.2.3. Method of Analysis 
A thematic analysis methodology was adopted using the guidelines set forth 
by Braun and Clarke (2006). Thematic analysis is a method for systematically 
organising, identifying and synthesising qualitative data into relatively broad 
patterns of meaning, commonly referred to as themes, which aim to reflect the 
content of the entirety of the data (Gbrich, 2012). Thematic analysis was chosen 
over other qualitative methods because, unlike discourse analysis, conversation 
analysis or grounded theory analysis, it is a theoretically flexible methodology. In 
addition, thematic analysis is not characterised by strong theoretical perspectives 
that drive the analytical process, which enables its use within different frameworks 
that are free from strict philosophical postulates and/or epistemological 
conventions.  Due to its ‘broad-brush’ analytical identity it is commonly used in 
research that aims to understand a particular phenomenon from the perspective of 
those experiencing it, which is achieved through analysing textual, narrative 
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information that reflects people’s life stories, opinions and perceptions. It is 
therefore broadly perceived as a predominantly descriptive method, without 
however lacking the interpretative depth that is required to extract meaningful 
research findings (Vaismoradi, Turunen, & Bondas, 2013). To date, the analytical 
framework proposed by Braun and Clarke is considered to be the most rigorous 
and systematic approach for thematic analysis currently available (Howitt & 
Cramer, 2010). The main processes involved in thematic analysis are data 
familiarisation, data coding, data recoding and theme development, however, the 
analytic process is not linear, simply progressing from one stage to the next, rather 
the analytic process is circular and requires frequent reviews (Clarke & Braun, 
2014). 
According to Braun and Clarke’s model there are six stages involved in the 
process of analysing qualitative data; in the first stage the researcher becomes 
familiar with the data, which is achieved both during the phase of transcription but 
also by reading the transcript several times; the second stage involves the 
generation of initial codings, which in turn informs the development of broader 
themes during the later stages of the analysis. This process involves the labeling of 
brief units of analysis within the transcript – usually composed of a line or two of 
textual data –, which aim to capture what was said in the interview as closely as 
possible. It is critical that the initial codings provide an accurate reflection of the 
data so that these can be translated into conceptually meaningful themes during 
stage three of the analysis. The fourth stage involves checking the previously 
generated themes against the coded extracts and the original dataset, whilst the 
fifth stage involves further developing the themes by revisiting the data and 
assessing whether the themes are conceptually unique and distinguishable from all 
the other themes. This stage also involves generating and assigning theme labels 
that accurately reflect each theme. The final and sixth stage relates to synthesising 
the final report. This involves providing a detailed description of all the previous 
analytic stages involved in the research and relating all the stages back to each 
other. In thematic analysis, the final stage also constitutes the last opportunity for 
data analysis as researchers may be inclined to reformulate the research question 
in light of complications that arise during the process of writing-up. The six stages 
of thematic analysis are visualised in Figure 3.1. 
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Figure 3. 1. A visualisation of Braun and Clarke’s model of thematic analysis. 
Adapted from Howitt (2016, p.169). 
 
The interviews were transcribed verbatim (i.e., word for word) using direct 
and literal transcription methods. It was not deemed necessary to include the 
conventions of dialogue transcriptions because the content of the interviews was of 
primary interest. During the transcription stage initial thoughts and ideas were 
recorded (i.e., codes). The transcribed data were revisited several times and also 
interview recordings were listened to a second time, to ensure transcription 
accuracy. The initial codes consisted of words or short phrases that described the 
transcribed data at an abstractive level - that is, the codes corresponded to 
features of the data that were considered pertinent to the research question but 
involved the minimum amount of interpretation, as per the recommendation by 
Braun and Clarke (2006) during this early stage of analysis. The codes identified 
during this stage were recorded using Microsoft Excel as an analytic database, and 
each code was accompanied by all the corresponding representative quotations 
identified through the transcripts.  
Following on from the stages of data familiarisation and the generation of 
initial codes, was the stage of searching for themes based on the initial codings. 
Codings were initially grouped into sub-themes on the basis of similarity. These 
Step 1. Data Familiarisation 
Step 2. Generating initial codes 
Step 3. Searching for themes 
Step 4. Reviewing themes 
Step 5. Theme definition 
Step 6. End report 
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sub-themes explained larger sections of the data and embraced a number of the 
initial codes that were identified as being conceptually alike. Sub-themes were 
subsequently organised into higher order themes, and in turn, themes were 
organised into overarching thematic clusters. Themes were repeatedly reviewed 
throughout the analytic process and any that were too multifarious, or that did not 
have enough transcript extracts to support them, were discarded. The refinement 
of each theme was achieved both by assessing each individual theme for its 
conceptual coherence, but also by considering each formed theme in relation to all 
the other themes and sub-themes within the dataset.  This process was aided 
through the use of thematic maps; an approach also recommended by Braun and 
Clarke (2006), in order to envisage the associations and potential interconnections 
between themes. After reviewing and refining the themes, the entire dataset was 
re-read and further coding took place to ensure that any additional data relating to 
a theme - which could have been missed during the initial coding phase - was 
coded and incorporated into the analysis. After the themes were reviewed and 
refined, analysis moved to stage five, which involved the definition of themes and 
labeling. Labels of themes were carefully considered on the basis of how well they 
conveyed an instantaneous indication of the essence of the theme. The final stage 
of the report production also involved choosing compelling extract examples to 
illustrate essential theme features.  
3.2.3.1. Theoretical and Epistemological Approach  
In the current study, an inductive – also referred to as ‘bottom-up’ - method 
was used to identify themes within the data. An inductive thematic analysis 
procedure postulates that the themes identified are predominantly data-driven, as 
opposed to the deductive approach where themes and codes are determined by 
the researcher’s pre-existing interest in previous theories (also referred to as 
analyst-driven or theoretical thematic analysis; Braun & Clarke, 2006; Hayes, 1997; 
Patton, 1990).  An inductive analytical approach was selected because the 
research question was broad and the research also aimed to explore multiple 
secondary research questions. Furthermore, little previous research has focused 
on the differential experiences of men and women, screeners and non-screeners, 
BAME and non-BAME populations and high and low SES populations within the 
context of bowel cancer screening, and particularly gFOBT screening. Additionally, 
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this research was exploratory in nature, in that it examined the synergistic interplay 
between ethnicity, gender, SES and past screening history to determine variation in 
the self-perceived barriers and facilitators to gFOBT screening; therefore a 
deductive approach would have been limiting and unfit for the purposes of the 
current research.  
A further decision was made relating to the ‘level’ at which themes were 
identified - Boyatzis (1998) has proposed two levels; firstly, a semantic or explicit 
level, whereby themes are detected at the surface - or “semantic appearance” - of 
the data. In this case, the analyst is not in the pursuit of examining any underlying 
ideas, assumptions and/or conceptualisations that shape the semantic content of 
the data. The second level is known as the latent or interpretative level, which 
requires the analyst to go to a level of analysis deeper than the superficial features 
of the data. In the present study, themes were identified at the semantic level 
rather than on a latent level. The rationale behind this choice is that latent thematic 
analysis traditionally results from a constructionist paradigm rather than the 
essentialist or realist paradigm in which the present research was situated. Braun 
and Clarke (2006) suggest, that latent thematic analysis overlaps, to a certain 
extent, with discourse analysis; an analytical approach that has been coined as 
‘thematic discourse analysis’. Thematic discourse analysis has strong influences 
from psychoanalytic models of interpretation, where broader assumptions, ideas 
and/or meanings are thought to be underpinning what is actually articulated in the 
data. In the present research the aim was to interpret the data solely on what was 
said by participants during the interview and to organise the data into patterns of 
semantic content. Therefore, a semantic analytic process, which requires the 
gradual progression from the description to the interpretation of the data, was 
considered to be better suited.  
The epistemological approach adopted for the present research was 
situated within the essentialist/realist paradigm, which represents one of the two 
main epistemologies found in thematic analysis (the other is the constructionist 
paradigm). From the essentialist/realist perspective an individual’s motivations and 
experiences are interpreted without taking into consideration the sociocultural 
context of the individual, rather a unidirectional, straightforward association is 
assumed between experience and language – that is, language directly reflects 
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and enables us to articulate meaning and experience (Braun & Clarke, 2006; 
Potter & Wetherell, 1987; Widdicombe & Wooffitt, 1995).  
3.2.4. Quality Appraisal 
The quality of the present research was assessed using a critical appraisal 
tool for interview studies proposed by Leonidaki (2015). Leonidaki’s tool was 
developed primarily for assessing the quality of interview-based studies exploring 
clients’ experiences with psychodynamic psychotherapy, however, the tool was 
subsequently adapted to broaden its scope and make it applicable to other 
interview studies in psychological research, including health, forensic, education 
and organisational psychology. The tool aims to assess interview studies across 
nine different domains: (1) Context and Purpose; (2) Recruitment; (3) Situating the 
Sample; (4) Data Collection; (5) Analysis and Findings; (6) Auditability/Credibility; 
(7) Impact and Value; (8) Reflexivity and (9) Ethics.  Each domain consists of 
different criteria, which evaluate distinct elements of the study; if the study provides 
sufficient evidence to meet a criterion then it is scored positively (+) and if it does 
not it is scored negatively (-). Some criteria can be judged as being non-applicable 
(N/A). Leonidaki further proposes calculating a total score; studies scoring between 
0-0.45, 0.46-0.69 and above 0.70 are classified as having poor, fair and high 
quality. The present study had a total score of 0.73, which reflects good overall 
quality of the study. See Appendix 3.7 for the detailed scoring of each appraisal 
criterion included in the critical appraisal tool.  
3.2.5. Ethics 
Ethical approval for the study was granted by the School of Psychology 
Research Ethics Committee at the University of Leeds (Reference Number: 16-
0022; Date of Approval: 04/02/2016).  
3.3. Results 
3.3.1. Sample Characteristics 
Interviews were conducted with 27 participants. The sample composed of 
almost an equal split between men (48.1%) and women (51.9%). Similarly, there 
was a balanced analogy between participants from a White British ethnic 
background (48.1%) and participants from a BAME background (51.9%); the latter 
group included participants from Black Caribbean, Indian, Pakistani, Bangladeshi, 
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Iranian, Albanian, Cypriot, German and Greek ethnic backgrounds. Approximately 
half of the sample (55.6%) spoke English at home as their primary language. The 
majority of participants (77.8%) did not report having a family history of bowel 
cancer. All the participants had been sent a screening invitation and kit from the 
NHSBCSP, with the majority (70.4%) having screened at least once in the past. 
Approximately half of study participants (48.1%) were not up to date with bowel 
cancer screening at the time of the interview. Descriptive data for all participants 
are shown in Table 3.2 below. 
 
Table 3.  2. Sociodemographic and screening history characteristics of study 
participants 
 
Characteristics 
 
 
N 
 
% 
 
P 
Total participants 27 100  
Gender    
Male 13 48.1% P7, P11, P16-P17, P19-P27 
Female 14 51.9% P1-P6, P8-P10, P12-P15, P18 
Age    
60-67 12 44.4% P1, P3-P4, P6, P8, P10, P12, P14-P15, P18, P21, 
P26 
68-74 15 55.6% P2, P5, P7, P9, P11, P13, P16-P17, P19-P20, P22-
P25, P27 
Ethnicity    
White British 13 48.1% P1-P8, P10, P12, P14-P15, P18  
BAMEa 14 51.9% P9, P11, P13, P16-P17, P19-P27 
Primary Language     
English 15 55.6% P1-P10, P12, P14-P15, P18, P21 
Other 12 44.4% P11, P13, P16-P17, P19-P20, P22-P27 
IMD Quintileb    
1 (most deprived) 10 37% P1, P6, P9, P14, P17-P18, P20, P22, P26-P27 
2 1 3.7% P19 
3 5 18.5% P4, P10, P11, P12, P23 
4 1 3.7% P3 
5 (least deprived) 10 37% P2, P5, P7-P8, P13, P15-P16, P21, P24-P25 
Family history of 
CRC 
   
Yes 6 22.2% P1, P3-P4, P8-P9, P12 
No 21 77.8% P2, P5-P7, P10-P11, P13-P27 
Screening episode    
Prevalent  8 29.6% P11-P12, P16-P17, P22, P25-P27 
Incident  19 70.4% P1-P10, P13-P15, P18-P21, P23, P24 
Up-to-date with 
screening 
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Yes 14 51.9% P1-P4, P6, P8, P10, P14-P15, P19-P21, P23-P24 
No 13 48.1% P5, P7, P9, P11-P13, P16-P18, P22, P25-P27 
Notes. a Included Caribbean, Indian, Pakistani, Bangladeshi, Iranian, German, Cypriot, Albanian and Greek. 
bQuintiles were based on national cutoffs; areas in quintile 1 are among the most deprived 20% in England, 
whereas areas in quintile 5 represent the least deprived 20% in England. N = Number of participants. P = 
represents the participant in the study. IMD = Index of Multiple Deprivation.  
 
3.4. Thematic Analysis 
Three super-ordinate clusters emerged to describe the decisional process 
towards gFOBT screening behaviour among study participants: (1) ‘Perceived 
barriers of screening’, (2) ‘Perceived facilitators of screening’ and (3) ‘Participants’ 
attitudes towards the FIT versus gFOBT’. These clusters were identified not only 
because of their prevalence – that is, they appeared frequently within the dataset 
and were salient for the majority of participants - but also because they were 
directly relevant to addressing the main research questions, which were: 
1. What are a) the perceived barriers and b) the perceived facilitators of gFOBT 
screening uptake, and do these differ by variation in ethnicity/race, 
socioeconomic deprivation, gender and past screening behaviour? 
2. What are participants’ views on the one-sample screening test (i.e., FIT) 
versus the three-sample screening test (i.e., gFOBT)? 
The main clusters, themes and sub-themes are discussed below, and have 
been organised to address the research questions in the order listed above. 
Indicative excerpts from the interview transcripts are used to illustrate the themes, 
which emerged from the data. The three clusters, each consisting of multiple 
themes and subthemes as well as the frequency of each sub-theme is shown in 
Table 3.3. 
 
Table 3.  3. Overview of thematic analysis of factors affecting bowel cancer 
screening uptake 
 
Cluster 
 
 
Theme 
 
Subtheme 
 
Frequencya 
Perceived barriers to 
gFOBT screening uptake 
Bowel cancer stigma It’s taboo 20 
  Cancer fatalism 
 
10 
  Feeling embarrassed 
 
14 
  Lack of open discussion 
 
10 
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Note. aThe number of participants who identified the theme. 
 Awareness, attitudes 
and beliefs 
Lack of awareness 13 
  Healthcare system 
distrust 
 
4 
 Inconvenient 
screening procedure 
Procedural planning 12 
  Lack of privacy 
 
7 
  Practical difficulties 
 
14 
 Ick factor - 22 
 
 Fear of cancer Avoidance as a 
temporary salve 
 
11 
  The dreaded test result 
 
8 
  Treatment fears 8 
 Gender and 
sociocultural 
influences 
A gender issue 17 
  Language barriers and 
health literacy 
 
9 
  Sociocultural 
environment 
7 
Perceived facilitators to 
gFOBT screening uptake 
Social influences General social support 15 
  Spousal support 
 
5 
  Staying healthy for loved 
ones 
7 
 Helping oneself 
 
- 23 
 Increased awareness Knowing someone with 
bowel cancer 
 
8 
  Being a repeat screener 10 
 Grateful for NHS 
 
- 11 
 Positive attitudes Health 
conscientiousness 
 
13 
  Past experiences with 
screening 
9 
Attitudes towards the FIT 
versus the gFOBT 
I prefer the FIT - 7 
 I prefer the gFOBT - 6 
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3.4.1. Cluster 1 – Perceived Barriers to gFOBT Screening Uptake  
This cluster encapsulates common obstacles that participants encountered 
in relation to bowel cancer screening using the gFOBT kit. All 27 participants cited 
the practical difficulties of screening as a key factor affecting their screening 
experience. The collection of stool samples, storing and sending the kit through the 
post, forgetfulness, lack of time and/or privacy were all identified as practical 
barriers. Throughout the interviews it became clear that the majority of participants 
also experienced emotional barriers, which were triggered as result of taking part in 
the screening, and included a number of negative affects, such as shame, fear, 
anxiety, disgust and vulnerability. The following six themes – each with multiple 
sub-themes – appeared essential in understanding the factors that inhibit bowel 
cancer screening participation: ‘Bowel Cancer Stigma’, ‘Awareness, Attitudes and 
Beliefs’, ‘Inconvenient Screening Procedure’, ‘Ick Factor’, ‘Fear of Cancer’ and 
‘Gender and Sociocultural Influences’. There were aspects of participants’ 
accounts and understandings of the factors that inhibited screening participation 
that overlapped across these themes. Nevertheless, this overlap was seen as a 
good interpretation of attitudes and beliefs in general, which seldom consist of 
isolated ideas and concepts, rather they tend to be interrelated and act 
synergistically to influence behavioural outcomes.  
3.4.1.1. Theme 1: Bowel Cancer Stigma 
Findings from the majority of the interviews, irrespective of participants’ 
gender, socioeconomic deprivation, screening history and ethnic background, 
suggested that bowel cancer is a stigmatised illness and stigmatisation of bowel 
cancer was recognised as a potential barrier to screening. The sub-themes of ‘It’s 
taboo’, ‘Cancer fatalism’, ‘Feeling embarrassed’ and ‘Lack of open discussion’ were 
identified as key factors influencing screening uptake.  
3.4.1.1.1. Sub-theme 1: It’s Taboo 
Participants recognised cancer in general as being a ‘taboo’ topic and 
indicated that bowel cancer in particular is a topic that people tend to be reticent to 
talk about openly. Discussing gut-related bodily functions in public was largely 
perceived by participants as inappropriate and described that they felt pressured to 
use euphemistic and roundabout ways in order to avoid using taboo words (e.g., 
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‘using the restroom’ instead of ‘going to the toilet’, ‘stool’ or ‘number two’ instead of 
‘poo’) 
'There is a massive taboo, and that is cross-gender, talking about this, I 
mean most comedians make their living out of talking about farting. I mean 
Billy Connelly, he is famous about talking about bowel movement and 
everybody giggles nervously. They are pretending to giggle but they actually 
laugh nervously about this, and lots of films are made about people who go 
to say boyfriends, girlfriends, parents and then they use the bathroom 
inappropriately and all that. There has to be a joke or a pun intended to 
make us feel comfortable. So there is still this stigma, isn’t there?’  
(P8, White British, female, screener, high SES) 
 
'Just doing something like that.. The nature of what you have to do. Sorry I 
don’t really want to say the word you know (laughs). Not to you. You know 
what I mean, the action of doing that.'  
(P20, Pakistani, male, screener, low SES) 
Both participants that had and had not previously taken part in gFOBT 
screening, felt confident enough to talk about the screening process during the 
interview, however, expressed feeling hesitant to have a conversation about it with 
friends, family, and even their GP, as it was seen as an improper, unacceptable and 
an overall uncomfortable conversation to be having.  
'The problem is you wouldn’t bring it up in the middle of a dinner party, you 
know. It’s not kind of.. Well ‘Do you know what I did last Tuesday? Let me 
tell you all about it’. I find it awkward and embarrassing. It’s not […] ‘I went 
down to the hospital and had a blood test today’. That probably has more 
chance of entering a conversation than ‘I did this poo test’. So in the strata 
of pleasant to unpleasant it’s fairly at the bottom in every respect.'  
(P7, White British, male, non-screener, high SES) 
 
Shyness as a dimension of personality was described as a factor that 
exacerbated the inhibition to talk about bowel screening. 
 
‘But people are shy. To me, they are just shy. And I am too. It’s too personal 
to talk about with anybody and the test is a bit weird, and maybe shy people 
find it more hard even, who knows? I know many people that don’t want to 
have anything to do with their bodies, their bowels, they are even shy of 
doctors, even if their doctor tells them to lie down to examine them, they will 
resist and say ‘ah, no I don’t want to lie down’ (laughs). So, in a way it’s too 
personal to talk about with anyone really.’  
(P25, Pakistani, male, non-screener, high SES) 
  
132 
It is worth noting that a number of female participants who had experience 
of other national screening programmes such as breast and cervical cancer 
screening, indicated that they felt more comfortable in discussing those screening 
procedures, compared to bowel screening. Women talked about there being more 
awareness-raising campaigns for those cancers but highlighted that there is a lack 
of similar campaigns for bowel cancer screening and that this may be due to the 
increased stigma associated with bowel cancer. Specifically, women referred to the 
Pink Ribbon Breast Cancer Screening campaign, which attracts significant media 
attention each year and talked about female role models and celebrities who have 
been publicly advocating for breast and cervical cancer screening. Female 
participants described feeling that population-based campaigns may promote 
greater levels of public awareness, which in turn encourages more people to 
engage in discussions about these issues. Apart from the lack of population-based 
campaigns for bowel cancer, participants also reported feeling that there were 
fewer important public figures championing for the cause or announcing their 
diagnosis of bowel cancer, and that overall there is smaller media presence from 
bowel cancer advocacy groups and little coverage of the National Bowel Cancer 
Screening Programme.  
'Unlike lung cancer, ovarian, but more so for cervical and breast cancer you 
are talking about more intimate bodily functions, things that you can’t or 
won’t talk about openly. As British it’s not in our mentality to share personal 
stuff, not in our culture. I think some cancers are talked about more openly 
in the media – you know for breast cancer with all the pink ribbon campaign 
for awareness etc. – you don’t see that for bowel cancer. It’s not a pleasant 
thing to think or talk about. '  
(P5, White British, female, screener, high SES) 
Indeed, this issue was also raised by one of the male participants who also 
noticed that bowel cancer received less attention in the media. 
'Lots of women have breast cancer and cervical cancer screening – it is part 
of health to have TV advertisements and TV spots to tell people that it is 
better to let your doctor know, it is in your interest. For breast cancer for 
example you have much more publicity, they have events, they have 
ambassadors whereas with bowel? You don’t hear as much. And I think 
every form of disease should have it’s own campaign because, as I 
indicated, if you diagnose the disease early it is easier to treat it'  
(P19, Cypriot, male, screener, low SES) 
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3.4.1.1.2. Sub-theme 2: Cancer Fatalism 
Participants from all ethnic groups, irrespective of their socioeconomic 
deprivation, strongly equated cancer with death. For some, being screened for 
cancer was seen as exposing oneself to the possibility of receiving a diagnosis of a 
potentially deadly disease, which automatically triggered thoughts of their own 
mortality. Participants’ mental representation of lethality seemed to be particularly 
influential in deciding whether or not to take part in bowel cancer screening, but 
exerted a differential effect depending on the person’s screening history. For 
instance, for past non-screeners, the perception of cancer as a death sentence 
undermined compliance with screening recommendations, whereas for past 
screeners an antithetical pattern of findings was observed; the association between 
cancer and death not only did not discourage them from obtaining the screening 
rather it enhanced bowel cancer screening acceptance.   
'Is it like ‘what you don’t see doesn’t hurt you’ kind of an attitude towards life 
and health? I have many friends that think that way, I mean I do it too and I 
hate that I do it, but sometimes it’s just easier to not think about these things 
you know? Or if you know you are very healthy you don’t worry as much. I 
think I would know if I had cancer to be honest.'  
(P13, Pakistani, female, non-screener, high SES) 
 
'The main benefit I think and the reason why I do it is that you can be 
diagnosed fairly early. And then hopefully you wouldn’t go through horrible 
disease and it could be cured. I suppose with cancer, I have had friends with 
various cancers, you just hope it’s diagnosed early enough to make sure 
that you don’t die from it. And that’s I suppose at the back of your head most 
of the time. You are preventing an illness that could kill you.'  
(P10, White, British, screener, high SES) 
Death-related cognitions were more prominent among people who had 
either received a false positive gFOBT result or among those who had witnessed a 
family member or close friend being diagnosed with cancer. One participant, who 
had received a positive gFOBT result and had successfully undergone a 
colonoscopy to remove precancerous polyps, mentioned that receiving an 
abnormal gFOBT result led to further motivation to adhere to screening 
recommendations in the future. Interestingly, experiencing a ‘scare’ was associated 
with a concern that biennial screening might allow too big a time interval between 
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screening episodes and the participant expressed a preference for having the 
screening offered on an annual basis instead:  
'When I was told that now I am alright, this was after they removed the 
polyps […] they said ‘We will call you back in two years time’ and I said ‘Why 
not in one year’s time?’ and the nurse said ‘It is every two years’. They later 
sent me some kind of questionnaire to give my feedback and I said we 
should have it (i.e., screening) every year. I know that these things cost but 
imagine as I speak to you right now I have another polyp developing and I 
have to wait for another year and a half. I want to have it done more 
frequently' 
 (P19, White Cypriot, male, screener, low SES) 
 Participants seemed to make a stronger association between cancer and 
mortality if they had heard about deaths attributed to bowel cancer within their 
wider community. Indeed, it was more common for participants to recall stories 
about people in their local community – often younger than them - who had died 
from bowel cancer, and there was a lack of participants discussing about people 
who had been successfully treated. The lack of personal accounts of people that 
had successfully treated bowel cancer seemed to further strengthen the 
association between a cancer diagnosis and holding a fatalistic construal of cancer.  
In this first example, bowel cancer is discussed in a dramatical tone with emphasis 
being put placed on suffering and pain. 
'I do know that it can be very painful. I know other people, a friend of mine, 
who was actually quite younger than me, died of bowel cancer. As did my 
mother’s friend and both of them had excruciating stomach pain on the side, 
obviously where the tumors were.'  
(P4, White, British, female, screener, high SES) 
In the second example, another participant provides a strongly fatalistic 
statement, where bowel cancer is associated with a rapid and inevitable death. 
'My grandmother literally got bowel cancer very quickly and died very 
quickly. So I think, people, might in their heads think it’s pointless to do the 
screening because you are likely to die anyway? I know that’s a common 
thought people have.' 
 (P8, White, British, female, screener, high SES) 
Both of the preceding examples illustrate that there is a strong link between 
cancer and death in people’s perception of the disease and the additional 
association between cancer and pain/suffering indicates a widespread negative 
discourse surrounding bowel cancer, which may be associated with a reduction in 
screening participation among people with more fatalistic views.   
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3.4.1.1.3. Sub-theme 3: Feeling Embarrassed 
Discussions relating to feelings of embarrassment were among the most 
prevalent issues participants raised during the interviews. Thirteen participants in 
total described experiencing a degree of embarrassment during the screening 
process. Participants described the feeling of embarrassment as an almost 
instantaneous reaction to the test and this was regularly triggered by a strong 
aversion towards the nature of the screening kit, specifically the aspect involving 
the collection of stool samples.  
 
‘I don’t want to do it, no. Just because it’s dirty. It turns my stomach. Doing 
that and having to put it on a piece of card…ah! No! I can’t even think of 
doing it. And I’m squeamish you see, from the start I kind of thought, nope 
this isn’t for me, can’t do it’  
(P18, White British, Female, Non-screener, low SES) 
Non-screeners expressed being taken aback by, what was described as, an 
unusual screening test and commonly described the screening process as 
‘bizarre’, ‘eccentric’ and ‘odd’. 
'It seems a bit crazy to be honest. It seems such an eccentric thing to do. It 
seems odd. It’s an odd thing to do, isn’t it? Just the whole process is 
strange’ 
 (P12, White British, female, non-screener, high SES) 
One participant, who had received multiple screening invites in the past but 
had never opened the screening kit - and was therefore unaware of the steps 
involved in the screening process - thought of the procedure as off-putting and 
enough to deter people from taking part in the screening. 
‘I wouldn’t have even thought about it, no honestly no chance I would have 
thought about doing it if we hadn't spoken about it now. It's just a bizarre and 
awkward thing to have to do, isn't it?'  
(P17, German, male, non-screener, low SES) 
One participant suggested that preparing people in advance for what to 
expect could be beneficial in that it could help prevent a sudden, negative reaction 
for when patients first receive the kit. 
'Well for me, it is simply doing something outside what you normally do and 
something that you would be naturally inclined to do. And it is hard for 
people, especially this age, to ask them to do something so bizarre. Maybe 
they should prepare people for this test from the time they’re 30 so that they 
are not so shocked when the time comes (laughs)'  
(P17, German, Male, Non-screener, low SES) 
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Despite repugnance at the idea of collecting stool samples being expressed 
by the majority of participants, non-screeners appeared more reluctant to handle 
their own faeces and experienced stronger feelings of aversion, which in turn was 
paired with a blunted perception regarding the benefits of screening. Compared to 
women, men were more likely to describe the sampling process in negative terms 
and perceived it as a significant barrier to screening uptake. Male participants also 
expressed feeling more uncomfortable and self-conscious about discussing the 
screening process with the researcher – although, on occasion, women also felt 
apprehensive about talking about their screening experiences openly. 
'It was overall difficult (i.e., collecting the stool sample). But it’s more difficult 
talking about it with you. I don’t really want to go into too much detail 
speaking with a young lady, sorry (laughs).'  
(P7, White British, Male, Non-screener, high SES) 
 
'Do you only take a bit then (laughs)? I mean even talking about it with you 
now – it’s so awful (laughs). Couldn’t they have come up with something 
better than this? I think I'd do it if the process were different, you know? But 
with this, I don't think I can.  I have heard people moan about it, that said 
that it’s best to have it done but they didn’t say if they had actually done it or 
not.'  
(P18, White British, Female, Non-screener, low SES) 
It was also apparent from the data that discussion regarding defecation and 
bowel movements is culturally perceived as a particularly private and personal 
topic and is treated as an ‘act’ that needs to be concealed. The example below 
illustrates that, societally, defecation functions as a taboo - more so than other 
bodily functions including urination or female menstruation. 
‘Actually, if you think of the whole process of going to the toilet – I never 
thought I would be sat talking to someone like you about going to the toilet – 
but the whole process is something predicated about not seeing anything. If 
you think about the action of what you do – you sit on the toilet, read your 
newspaper, and you flush the toilet – job done. Um, so you know, it isn’t 
something you engage with. And I mean it’s even more personal than 
urinating or women’s periods. I don’t know really. And that’s why I find it so 
horrible, and actually shall we just change the subject? (laughs)’  
(P7, White British, Male, Non-screener, High SES) 
3.4.1.1.4. Sub-theme 4: Lack of Open Discussion 
Participants reported challenges in discussing bowel cancer screening 
openly. Specifically, participants often chose not to talk about the test with their 
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friends and family and mainly attributed this to the nature of the test being too 
distasteful and unpleasant. 
'The problem is you wouldn’t bring it up in the middle of a dinner party, you 
know. It’s not kind of, ‘do you know what I did last Tuesday? Let me tell you 
all about it’. I find it awkward and embarrassing. It’s not, I wouldn’t say, or I 
might say ‘I went down to the hospital and had a blood test today’. That 
probably has more chance of entering a conversation than I did this test. So 
in the strata of pleasant to unpleasant it’s fairly at the bottom in every 
respect.'  
(P7, White British, male, non-screener, high SES).  
Female participants, from a White British ethnic background, from varying 
SES levels, were more likely to initiate a discussion and champion participation in 
screening during discussions with others, however, participants experienced that 
whenever they approached other people in an effort to talk about the kit and share 
experiences, people were often unwilling and negative towards discussing about it. 
It was stated by some participants that other people often felt comfortable 
discussing breast cancer screening for example, but not about bowel cancer or the 
screening kit.  
'I’ve actually spoken to a colleague today regarding this (i.e., kit) and she 
said ‘oh, I haven’t done mine yet, it’s still there, it’s still waiting to be done’ 
and she kind of started blushing about it and mixing her words and we kind 
of dropped it. It’s unusual really, because we talk about mammograms and 
that sort of thing but with this it’s different and it bothers me.'  
(P1, White British, female, screener, low SES) 
Participants that had a family history of bowel cancer described feeling as 
having an obligation to talk about screening with family members, but nonetheless 
felt uneasy having a conversation about it.  
'We have talked about it (i.e., with siblings), we kind of felt like we had to 
because of our family history, but it’s just aghhhh (makes grunting sound), 
you know,. We all think of it as an unpleasant nuisance, a hassle but it’s 
worth it, that sort of thing. Other friends do it as well. We don’t talk about it, 
they have just said that they do it'.  
(P3, White British, female, screener, high SES).  
Several participants mentioned that they had conversations with others who 
had painted a negative image of the screening process, however, whether negative 
opinions of others acted to reinforce or inhibit personal screening participation was 
largely unclear. It might be useful for non-screeners to discuss about the test with 
people who, despite their own negative perceptions of the test, decided to take part 
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in screening anyway. Open discussion might in fact motivate non-screeners to 
reappraise CRC screening as a normal activity instead of disregarding it 
completely.  
'Maybe a couple of years ago I got an invitation. I have heard people moan 
about it, that said that it’s best to have it done but they didn’t say if they had 
done it or not. But hearing about it from you, I swear I’ll do it now (laughs). I 
probably needed to hear it from someone.'  
(P18, White British, female, non-screener, low SES)  
Participants also emphasised that the negative discourse surrounding the kit 
might deter people who are characterised by a natural tendency to feel disgust 
more acutely (i.e., have higher trait disgust) and therefore conversations should 
become more positive in order to improve public perception of the screening 
process. 
'I had a friend, it was his first time doing it and he didn’t like doing it at all, 
but he did it and he said he was a bit disgusting for him, you know. I didn’t 
ask him too many personal questions. He says he didn’t like doing it but he 
actually did it so it goes to show.. But we need to make the whole discussion 
around it more positive I think, it is a thin balance, some people who are 
squeamish might listen to someone else you know, saying this and that 
about the thingy, and how horrible it is and you know, you don't want to 
scare people away! (laughs)'  
(P1, White British, female, screener, low SES).  
Among racial and ethnic minority populations, an additional factor that 
seemed to prevent discussions on screening was low literacy in English, which in 
turn affected health literacy due to the difficulty in understanding medical concepts 
and terminology. Participants spoke about low health literacy preventing patient 
comprehension of the key preventive messages that appear in NHS screening 
materials, including the invite letter, information booklet and screening instructions. 
Uh, they (i.e., other men at the community centre) may be shy. Some of 
them don’t even know about it, or that they should be doing it. How are 
people expected to do it, when they don’t know what it is or why they should 
be doing it? You know what I mean? I think many people simply don’t know 
how to do it. Instructions in our language might help, although many of our 
people don’t know how to read even in our language (laughs)'  
(P23, Pakistani, male, screener, high SES) 
This appears to be an important factor contributing to the non-uptake of 
screening among ethnic minority groups as being able to make an informed 
decision about screening largely relies on the ability to comprehend health-related 
information and/or discuss pros and cons with friends and family. Indeed the ability 
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to interact with others on health-related issues is considered a key aspect of health 
literacy (Smith & Nutbeam, 2013). 
3.4.1.2. Theme 2: Awareness, Attitudes and Beliefs 
The findings indicated that nonparticipation in gFOBT screening was partly 
explained by lack of awareness about bowel cancer and the benefits of screening. 
Most non-screeners reported not knowing that bowel cancer is asymptomatic and 
this led some participants to falsely believe that screening is not necessary. People 
from BAME populations were more likely to report that decision-making regarding 
their health was influenced by their religious beliefs and often expressed feeling 
reassured because they felt God would protect them from harm.  Negative views 
towards the health system and medical mistrust were also factors that deterred 
some participants from screening.  
3.4.1.2.1. Sub-theme 1: Lack of Awareness  
The data indicated that one possible cause of non-participation in screening 
was lack of awareness about the asymptomatic nature of bowel cancer, the 
progression of the disease and the important role of screening as a secondary 
prevention strategy in cancer control. Lower awareness was more prevalent 
among participants from ethnic minority populations and socioeconomically 
deprived areas. People often saw a status of good health as being a reason in 
itself for nonparticipation in screening: 
'Whether I’ve got it or I haven’t got it, those types of thoughts would go crazy 
in my head. But I feel fine you know, I have no pain or discomfort down 
there so everything should be fine I think for me, I’m not too worried.'  
(P18, White British, female, non-screener, low SES) 
 
'I don’t know much about bowel cancer, to be honest. I think it’s about 
having blood in the stool, but I’ve never had anything like that so I'm alright, 
thank God!'  
(P13, Pakistani, female, non-screener, high SES) 
Among non-screeners it appeared that not being well informed about the 
link between cancer screening and early diagnosis, as well as improved disease 
prognosis, was a major determinant of non-uptake of screening. Reduced 
awareness about these links led some participants to trivialise screening and – in 
the absence of any cancer symptomatology - they did not appraise it as being 
necessary. In the following quote a man that had never done the gFOBT said:  
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‘I think that as long as you are healthy it’s fine. I don’t worry as long as I am 
alright and feel good. It’s only once you got so many medical problems that 
you would rather be dead than have to suffer. But you can have all the tests 
in the world and still get sick, so one could think ‘what’s the point’, you 
know?'  
(P17, German, male, non-screener, low SES) 
The above examples illustrate that associating the lack of symptoms with 
being ‘cancer-free’ might be an important barrier to screening participation. 
Additionally, it appears that not forming a direct link between screening and early 
diagnosis of cancer, as well as reduced awareness about the benefits of detecting 
cancer early, are both factors that can negatively impact on people’s decisions to 
participate in screening. 
 Another factor that seemed to influence participants’ understanding of the 
screening process was low health literacy. While many participants across all 
ethnic groups felt confident in understanding screening-related information (i.e., 
screening instructions, NHS Bowel Cancer Screening information booklet) and 
were well informed about bowel cancer screening, several participants from BAME 
populations did not recognise terms such as ‘bowel cancer screening’ or ‘screening 
kit’ and in these instances participants were shown the gFOBT demo, which acted 
as a prompt to facilitate further discussion. Low health literacy led to additional 
misunderstandings regarding the screening procedure and seemed to increase the 
risk of misinterpreting more complex screening-related terminology included in the 
NHSBCSP materials, such as ‘early detection’, polyps’ or ‘cancerous cells’. The 
extracts below illustrate that the difficulty to process and assimilate health-related 
information was an added obstacle among low literacy populations.  
'I wasn’t sure I could read instructions. And I can’t remember seeing the 
invitation. I’m a bit confused as to why exactly I received it. I know what it is 
but I don’t remember how I know what it is. I can’t remember clearly sorry. I 
know that it’s something to check your health with.'  
(P26, Pakistani, male, non-screener, low SES) 
One man, who was a community representative at an inner-city South East 
Asian community group, indicated that poor health literacy is a key factor that 
prevents people from BAME backgrounds from making informed decisions about 
screening. Moreover, he highlighted the importance of social support among low-
literacy populations and being able to rely on peers and family to access and 
understand medical information:   
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'I think some of the guys here (i.e., community men’s club) will find it harder, 
to actually do the test you know, follow the procedures, I think some people 
at least from our community people that I know, are illiterate, and so I don’t 
think they would be able to understand everything that needs to be done. So 
if they live alone and don’t have friends or relatives to help them it is likely 
they won’t even understand that they are being invited to screening.'  
(P21, Indian, male, screener, high SES) 
The inability to seek, process and comprehend health-related information 
seemed to be a critical barrier among non-English speaking participants from 
BAME backgrounds and was associated with nonparticipation in gFOBT screening. 
3.4.1.2.2. Sub-theme 2: Healthcare System Distrust 
Other patient-related factors, that appeared to be associated with non-
uptake of bowel cancer screening, were negative beliefs about the healthcare 
system as well as generalised medical distrust. Although only a small proportion of 
study participants discussed this factor as being a barrier to screening, for those 
that did, it appeared to have a distinctive effect on their decision to engage with 
screening. Non-screeners were more likely to experience doubts with regards to 
whether the healthcare system is acting in their best interest as patients and 
expressed concerns with issues regarding data protection and confidentiality. The 
association between negative attitudes towards the healthcare system and 
screening behaviour is illustrated in the following excerpt: 
'No, I don’t think I would (i.e., do the screening), because I don’t think I am 
putting anyone at risk in my activities, for example it’s not like HIV that you 
can spread, so I would rather not know to be honest. But it’s not just that, I 
do not trust the data protection. I have opted out from my GP making my 
medical information available. […] My views towards screening are not 
totally positive. My views towards medical politics is not.. I don’t necessarily 
trust the system.'  
(P12, White British, female, non-screener, high SES) 
Stronger negative appraisals about the healthcare system and the intentions 
of healthcare providers seemed to correlate with past negative experiences with 
healthcare services and unpleasant encounters with healthcare providers. Medical 
distrust was also associated with concerns and beliefs regarding the gradual 
privatisation of healthcare services and worries about the government being 
controlled by vested interests which were thought to potentially have negatively 
impact on the quality of care patients receive and indicate that patients’ best 
interests are no longer prioritised in light of financial rewards and/or incentives. 
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'There are politics, there is money involved, whose benefit is it? Is it for my 
benefit? And now there’s all these, um, well I don’t know. In my mother’s 
day it was hysterectomies. About half the women had hysterectomies, which 
were unnecessary, right? Nowadays you have these breast mastectomies, 
and it seems to me that there is a sort of trend that men like carving up 
women’s bodies that isn’t necessary. So… I’m skeptical about medical 
politics, trends, data security, practices, fashions if you like.'  
(P12, White British, female, non-screener, high SES) 
Some participants expressed concerns about the NHSBCSP’s decision 
regarding the cut-off age that people are invited to take part in the screening 
programme (i.e., 60-74 years). Beyond the age of 74, Public Health England (PHE) 
recommends that individuals ask for screening by requesting a kit themselves 
‘every two years for as long as they wish’ (Public Health England, 2015). Some 
participants expressed feeling as if they were being ‘written off’ from services as 
they approached older age and found this worrying, given that the risk for bowel 
cancer increases with age. The fact that people are not invited to screen past the 
age of 74 was upsetting for some and this view was shared by both men and 
women, irrespective of SES, ethnic background and screening history.  
'So over 74 (i.e., years) one has to ask for it? So even less people would do 
it? So basically they are written off (laughs)? That’s strange, why would they 
write older people off? Perhaps they don't care about you anymore by that 
age'  
(P17, German, male, non-screener, low SES). 
 
'No, you have got to be proactive to do that (i.e., continue to request kits 
after 74) and a bit obsessive as well, haven’t you, about your health? But 
then, why would they stop it at 74 (i.e., years)? I mean the risk goes up with 
age, the NHS should, um, I think it should really keep sending the screening 
invites past that age. I find it a bit upsetting that they stop then – what is it - 
are you too old so they just right you off?'  
(P5, White British, female, screener, high SES) 
3.4.1.3. Theme 3: Inconvenient Screening Procedure 
Participants from all ethnic and socioeconomic backgrounds reported experiencing 
challenges with gFOBT screening procedures. Views of the test were particularly 
negative among men, irrespective of whether they were up-to-date with screening 
at the time of the interview. That is, both male screeners and male non-screeners 
expressed a strong dislike for the nature of the test and described the process as 
extremely inconvenient. All groups expressed that the dislike for the test stemmed 
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largely from the procedural difficulties related to the screening process, including 
the manual handling and sampling of one’s own stool, storing the kit in one’s home 
and posting the kit to the laboratory for examination.  
3.4.1.3.1. Sub-theme 1: Procedural Planning 
The multiple steps involved in the screening process were recognised by 
respondents as an obstacle towards participation. Participants felt that the 
collection of three stool samples required a certain degree of planning; for 
instance, the time frame in which all three samples should be collected, the time of 
day in which to collect samples in order to ensure they had privacy at home, finding 
a means with which to catch the stool, having time to ‘clean up’ afterwards and 
finding a location within their home, where the kit could be safely stored but not 
forgotten until all samples were collected, were some of the factors interviewees 
mentioned. The many stages required to ensure successful completion of 
screening sometimes left participants feeling confused, which in turn had an impact 
on their confidence and perceived self-efficacy. 
'I had to plan it a little bit, there are a number of steps involved, and you 
know, you don’t want to be doing it wrong and having to do it all over again 
[…]. The most unpleasant part was dealing with the feces and trying to be 
sure that I was handling it, um, with suitable protection, and I feel the only 
way to do this is to make sure you understand what you are doing and think 
ahead, I mean having gloves, having enough loo role, soap and water just to 
have everything nearby helps.’  
(P2, White British, female, screener, high SES).  
 
'A bit of planning is required definitely. You have to work out ‘where do I 
catch the stool’ and that is an important step to this test because it mustn’t 
touch the water and that definitely requires some planning. Especially if you 
hate the idea of the test, you want to find the best way to least interact with 
it.'  
(P19, Cypriot, male, screener, low SES) 
Furthermore, participants highlighted that having good manual dexterity 
skills and also being physically agile were both important factors in ensuring that 
the screening process was carried out smoothly from start to finish. Some 
participants described that having difficulties with either of these could be a 
discouraging factor and may represent an important obstacle to screening 
participation for people experiencing these difficulties.  
  
144 
'I think the most difficult thing was actually capturing your stool without it 
ending up all over your hands and all over the toilet seat. I can have quite 
shaky hands sometimes so I thought the test was tricky. The little windows 
for the sample were too small I think and I had to think about that a little bit.'  
(P5, White British, female, screener, high SES) 
 
'Agility is an issue in my opinion! Yeah, yes. I’m much less agile than I 
was… I think for me this test would be difficult, I can’t imagine how I would 
get my hands back there to hold a container and you know (laughs).'  
(P12, White British, female, non-screener, high SES).  
There was also some confusion regarding the sequence and time frame in 
which the samples needed to be collected. For instance, a number of participants 
thought that they were required to collect the samples on three consecutive days. 
This caused a certain degree of concern among participants with regards to 
whether they would be able to have a bowel movement on three days 
consecutively and if not whether the test would be considered ‘invalid’ and they 
would have to repeat the process. Despite the fact that the screening information 
leaflet clearly states that patients have a 10-day period to collect the sample, this 
was a common misperception even among participants who had taken part in 
screening multiple times (i.e., repeat screeners). 
'You obviously have to think about how you’re going to do it (i.e., the kit)– it 
needs to be done on three consecutive days and so you’ll need it to be, sort 
of in a position to do it whenever, when you’re at home., it needs some sort 
of organising and planning.’  
(P1, White British, screener, high SES).  
 
‘And you have to know that you’ve got the three consecutive days that you 
can do it, don’t you? So you wouldn’t be going away for a weekend if you 
are going to do it (laughs).’ 
(P3, White British, screener, high SES) 
 
3.4.1.3.2. Sub-theme 2: Lack of Privacy  
Although the majority of participants felt that it was easy to carry out the test 
as part of their normal daily routine, lack of privacy was acknowledged as an 
obstacle by some participants, particularly those who shared the house with other 
people or relatives Particularly, interviewees mentioned worrying about having to 
keep the kit in the house and the potential embarrassment they would experience if 
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another person accidentally found it. Participants often resolved to keeping the kit 
in their bedroom but described this as being unpleasant and also often caused 
them to forget taking the kit to the bathroom the next time they had a bowel 
movement. The concern of not having enough privacy was experienced by 
screeners and non-screeners alike and was irrespective of participants’ 
socioeconomic status.  
‘I don’t know, I’ve got a lodger I wouldn’t really want to leave that hanging 
around. So I might have to keep it in my room, but I wouldn’t want to do that. 
It’s kind of disgusting, it might smell. I mean it’s not a very medical looking 
test is it?'  
(P12, White British, female, non-screener, high SES) 
One interviewee, who shared a bathroom with other people, recommended 
that having a strategy to conceal the contents of the kit - for example, through the 
use of a ‘pouch’ – might facilitate the screening process for other people facing 
similar concerns. 
'I don’t keep mine in the bathroom all the time because I share my bathroom 
with others, so I have to keep it in my wardrobe and I have to remember to 
take it with me when I go. But it can be tricky to remember and you can’t 
have it lying around you know what I mean (laughs). Maybe if they sent a 
little pouch with it? Like, you know, something you can seal it with, 
obviously, not a see-through pouch!'  
(P14, White British, female, screener, low SES) 
3.4.1.3.3. Sub-theme 3: Practical Difficulties 
Participants from all ethnic and socioeconomic backgrounds identified 
practical barriers associated with gFOBT screening. Interviewees’ accounts 
demonstrated that sending the completed kit through the post for examination 
raised concerns about whether the screening process was hygienic enough. Some 
participants found the process of posting the kit off-putting and worried about their 
kits being opened by mistake, not reaching the laboratory or even being returned to 
them. Hygiene concerns were expressed by many participants, however, it was not 
emphasised or singled out as being a major factor of nonparticipation. 
'Well, I was quite happy posting it but it did go through my mind that I hope 
people wash their hands properly because they put that envelope through 
the post!  Because I was thinking of other people handling these envelopes, 
some people aren’t as good at these things as others. And it could become 
slightly dangerous if people are not following basic hygiene routines and not 
washing their hands, touching envelopes with dirty hands, you know?'  
(P15, White British, female, screener, high SES) 
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Additionally, all of the interviewees indicated a distaste for handling faeces 
to a lesser or greater extent. Issues that were commonly mentioned included 
having an efficient strategy in place to catch the stool without it touching the toilet 
bowl, storage of the kit, smearing the sample on the card, scheduling the collection 
of samples around other daily commitments (e.g., work), anxiety over ‘spoiling the 
kit’ and having to repeat the process as a result, and safe disposal of kit materials 
after completion of the process. 
'I don’t think the instructions did much to be honest. You are kind of left on 
your own devices, sort of thing. You have got to figure out a way of doing it 
yourself. They should really have a way for you to do it. I think they say 
something about using loo role and that does not work, not for us women! 
It’s very unpleasant and I can’t understand how they could suggest that sort 
of thing. I think for a man it might be easy because they pass urine 
separately don’t they, whereas for us… Using loo role just don’t work well for 
us.'  
(P14, White British, female, screener, low SES) 
 
'Also there’s the logistics of getting the stool sample. And, so you know 
collecting the stool sample, it's really gross and you have to use something 
like a bloody newspaper, or something and that’s all, you know…, fairly 
unpleasant and awkward anyway. And.. I’m busy so I haven’t done anything 
about it.’  
(P12, White British, female, non-screener, high SES) 
Interviewees who had infrequent bowel movements experienced additional 
concerns about effectively managing the screening process. For instance, 
participants suffering from constipation were concerned about their ability to smear 
the stool sample on the designated area of the card. 
'The biggest thing for me was, I can vary from being normal to slightly 
constipated. And at that time I was slightly constipated, not that bad not that 
big a problem – but what I didn’t realise was that when you are like that you 
don’t realise how hard it (i.e., stool) was until I had to use the stick. And I 
was actually taken aback – […] it said ‘spread it thinly’ and I thought ‘I can’t 
even spread it all never mind spreading it thinly' so yeah.’ 
(P15, White British, female, screener, high SES) 
Some participants were also concerned about managing to have three 
motions within the 10-day period due to having infrequent bowel movements. 
Additionally, interviewees described that having hemorrhoids as a complication of 
their constipation added additional worries as they feared they might receive a 
positive gFOBT result. Moreover, participants indicated that the booklet sent by the 
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NHS does not provide adequate information for people with constipation and/or 
hemorrhoids and reported feeling apprehensive doing the test, due to the prospect 
of being asked to undergo a follow-up diagnostic colonoscopy due to a false 
positive kit result.  
'I don’t think there’s enough information there. And I got worried reading this 
because for me if I had piles and there was some bleeding or you have 
been straining there could be a bit of blood and I would be worried that they 
might say it is abnormal and start sending you for this other test and to me 
that is something, um I would say this was one of my biggest worries when I 
read this leaflet and then when I did the test. I got confused and frustrated 
as I wasn’t sure I understood what result meant what depending on my 
individual circumstances.’  
(P15, White British, female, screener, high SES) 
3.4.1.4. Theme 4: Ick Factor 
Results indicated that the ‘ick factor’ – that is, the feeling of disgust 
prompted by engaging with medical procedures (Morgan, Harrison, Afifi, Long, & 
Stephenson, 2008; O'Carroll, Foster, McGeechan, Sandford, & Ferguson, 2011) - 
was identified as being a significant theme due to frequency of its occurrence in the 
dataset. The majority of participants felt that the screening process elicited feelings 
of disgust and this finding was common across all subgroups. For non-screeners, 
the decision of nonparticipation in screening was largely influenced by their 
expectation that completing the test kit would be a disgusting process, indicating 
that disgust is an emotional barrier that is strongly linked to avoidant behaviour in 
the context of bowel cancer screening. Moreover, the data suggested that disgust 
sensitivity in relation to the kit varied by gender, with disgust being a more 
prominent barrier among men.  
'I think on a descending scale the top barrier is the process itself. Which is a 
big barrier and you can't get away from it, you can’t get around it, you can’t 
go over it, it’s there. It bring out very negative feelings at least for me 
personally. It is a generational thing probably. And everything else is very 
minimal compared to that. […] I also think that you have got a sex thing 
here. I would suggest - with of course no empirical data to suggest it - I 
would think, women would be more comfortable with this than men.’ 
(P7, White British, male, non-screener, high SES).  
 
Female interviewees also talked about their husbands not wanting to take 
part in screening due to the test involving the collection of a stool sample. 
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'My husband is not the type that’s going to mess around with, um.. Dealing 
with his own excrement and all the rest of it. And that’s the attitude he’s got. 
His mother had bowel cancer before she died and he still won’t do it.'  
(P10, White British, female, screener, high SES) 
 
'I certainly know with my husband that with a lot of these sort of things he 
will go ‘ugh ugh’ it is just his reaction and I find it funny. Even with blood and 
operations he is just like ‘ugh gross’.'  
(P15, White British, female, screener, high SES) 
 
Similar to men, female interviewees also described the screening kit as 
being a disgust elicitor, however, at the same time women were more likely to 
mention that other aspects of womanhood - including childbirth and taking care of a 
newborn, menstruation, menopause and attending breast and cervical cancer 
screening across the lifespan - were all factors that contributed to women having 
more positive attitudes towards healthcare partly due to an increased 
familiarisation with accessing healthcare services. The data indicated that women 
may be less disgust-sensitive due to increased familiarity in engaging with 
healthcare services more regularly than men, who do not have equivalent regular 
‘check-up’ opportunities across the lifespan. The unfamiliarity with accessing and 
navigating the healthcare system may in turn lead to men being more reluctant to 
engage with health services such as cancer screening as they age.  
'I mean for women, when we have babies, we see all sorts of things, we 
have periods all our lives, we have to deal with our bodies from a lot 
younger. Men I think freak out when they have to do something like this in 
their 60s for the first time. For us it’s piece of cake (laughs). We have to deal 
with nasty things all the time. We have babies you know? We clean the 
house and the things somebody just has to do it and it’s usually us, yeah?'  
(P9, Afro-Caribbean, female, non-screener, low SES) 
 
‘When you have smears, mammograms and all the other messy things that 
us women have, like menstruation, these thing don’t phase you as much’  
(P4, White British, female, screener, high SES) 
 
Similar opinions were expressed by male interviewees as well: 
 
‘Women are more involved with their bodies because of their periods and so 
on. They are more dependent really on the monthly period. That is an 
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indication of many things. They also have other consistent screenings, they 
have breast screening and so on and are generally more used to that kind of 
thing, unlike us men.'  
(P17, German, male, non-screener, low SES) 
 
Some female interviewees suggested that the effect of aversion and disgust 
elicited during the sampling process could, to an extent, be minimised by being 
organised and preparing for the screening procedure. For instance, it was 
considered important to have all the required equipment readily available and 
making the process as sanitary as possible; for example, using disposable gloves 
during the process, hand-washing with antibacterial soap after the collection of 
stool samples and immediate disposal of any equipment used, were all suggested 
to make the process more manageable and mitigate the effect of disgust. 
 
   'The most unpleasant part was dealing with the feces and trying to be sure 
that I was handling it, um, with suitable protection, and I feel the only way to 
do this is to make sure you understand what you are doing and think ahead, 
I mean having gloves, having enough loo role, antibacterial soap and water 
just to have everything nearby helps.'  
(P2, White British, female, screener, high SES) 
 
'I use those little plastic gloves that are disposable – I couldn’t do it without 
the gloves! I would find it revolting, so got to have the gloves.'  
(P3, White British, female, screener, high SES) 
 
3.4.1.5. Theme 5: Fear of Cancer 
This superordinate theme illustrates how the emotional barrier of fear in the 
event of a positive test result might further complicate participants’ decision to take 
part in bowel cancer screening. Despite interviews being conducted with a healthy 
participant sample, fears about the consequences of a cancer diagnosis were 
discussed by the majority of interviewees. Participants’ narratives on cancer fear 
and fatalism appeared to originate from concerns relating to the whole of the 
cancer pathway. For instance, participants were fearful of getting sick and 
potentially having to be hospitalised, receiving painful treatment and/or life-
changing surgery and living with long-term health complications even beyond 
successful treatment of cancer. Fears about the emotional, physical and practical 
implications of cancer and how these affected motivation to attend cancer 
screening differed between BAME and White British populations, as well as 
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between interviewees who had previously taken part in screening and interviewees 
who had not. The following sub-themes are used to describe the multiple pathways 
via which fear, and indeed the interaction between multiple cancer fears, may 
affect screening participation. 
3.4.1.5.1. Sub-theme 1: Avoidance as a Temporary Salve 
This sub-theme identified the tendency of some people to ignore the 
screening invites due to the perception that taking part would unnecessarily expose 
them to the possibility of a cancer diagnosis. Therefore nonparticipation in 
screening was misperceived by some participants as a means of ‘dealing with’ and 
avoiding future emotional, physical and practical consequences from finding 
cancer. Non-screeners were more likely to express fears that had to do with the 
practical implications of receiving a cancer diagnosis and being a cancer patient. In 
the excerpt below one participant discusses a hypothetical scenario of being 
diagnosed with bowel cancer, where her primary concern was having to undergo 
treatment, which in turn would require making a series of difficult decisions 
regarding work – for instance, having to choose between giving up work completely 
or carrying on working during treatment – indicating that worries about one’s 
finances and work arrangements, especially for individuals who are self-employed, 
are factors that are likely to affect people’s decisions with regards to screening 
uptake.  
'I think people are afraid to know because of what might be the next step – 
what happens next. Another thing that did actually cross my mind is that if 
they found cancer and I had to have treatment, my work comes in the 
summer so I can’t not work. You know, so there are sort of practical issues 
there. '  
(P12, White British, female, non-screener, high SES).  
It is worth noting that avoidance of cancer screening was often discussed by 
participants in the third person, potentially due to social desirability. For instance, 
some interviewees chose to talk about avoidance of screening in an indirect 
manner by referring to instances of people they knew that decided not to 
participate in cancer screening as a means of evading the possibility of finding 
cancer, rather than directly referring to their own experiences and emotions.  
'Is it like ‘what you don’t see doesn’t hurt you’ kind of an attitude towards life 
and health? I have many friends that think that way, I mean I do it too and I 
hate that I do it, but sometimes it’s just easier to not think about these things 
  
151 
you know? Or if you know you are very healthy you don’t worry as much. I 
think I would know if I had cancer to be honest.'  
(P13, Pakistani, female, non-screener, high SES) 
Non-screeners, and especially those with a negative family history of bowel 
cancer, were less likely to be afraid of cancer, perhaps due to a lower cancer risk 
perception, which in turn was associated with screening avoidance. A lack of 
cancer fear was also often linked to not having experienced any symptoms and 
feeling healthy in that given moment in time. Not having experienced any cancer-
related symptomatology seemed to instill a feeling of reassurance among some 
interviewees and was accompanied by the false belief that screening was 
unnecessary in the absence of any symptoms. The data suggested that the 
relationship between fear and perceived risk has an important role to play and may 
affect motivation to take part in screening, by reinforcing avoidant behaviour due to 
the misperceived lack of urgency. Specifically, in the first example one participant 
describes that having a family history of bowel cancer acted as a cue to action to 
screening participation, whereas the second excerpt demonstrates how a 
participant, without familial cancer risk, did not experience cancer fear due to a lack 
of experiencing any symptoms.  
'I also felt like I needed to follow it through because in the back of my mind I 
was thinking you know, yeah, it could be in the family… I don’t know… the 
history we have with bowel cancer… the idea of it scared me'  
(P1, White British, female, screener, low SES) 
 
'Perhaps the main thing for me is that if I don’t feel anything is wrong, if I 
don’t see blood in my stool, why should I bother to go see the doctor? […] I 
am not like other people that count days and worry all the time about death, 
I don’t get obsessed with it. I have other friends that are obsessed and talk 
to me about illness and dying all the time and I tell them ‘stop it, stop it’. I 
live in the now. And that’s what’s important. You can’t think about illness all 
the time.'  
(P11, Iranian, male, non-screener high SES) 
3.4.1.5.2. Sub-theme 2: The Dreaded Test Result 
Interviewees who had had the experience of waiting and receiving gFOBT 
results indicated that it was an anxiety-provoking process. Waiting for results fueled 
strong fatalistic thoughts about cancer among past screeners, however, this was 
often described as being a short-term barrier that was easy to overcome given the 
long-terms benefits of regular screening. Importantly, anxiety regarding the 
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potential outcomes of screening had a tendency to promote participation among 
White British, female interviewees from all SES backgrounds, but not among men 
and BAME populations.  
'I think fear could intimidate people, that something might be 
found. Sometimes, I think, I’d rather not know, but I still go do it (i.e., 
screening). And I have known people say that about other tests so I really.. 
you can just shut it out and say ‘I just don’t want to know’. It is a bit like 
going to a fortune teller (laughs). Some people might want to go and others 
say I’d rather not know what my future is.'  
(P5, White British, female, screener, high SES) 
BAME populations and past non-screeners were more likely to directly 
associate cancer with dying and often referred to friends and loved ones who had 
passed away from cancer but seldom acknowledged the long-term benefits of 
screening or discussed positive stories from cancer survivors. In the excerpts 
below it is highlighted that strongly fatalistic beliefs – that is, the belief that death is 
inevitable following a diagnosis of cancer - are likely to be a strong predictor of 
nonparticipation in screening, mainly due to the lower perceived value of early 
detection tests. In this first example, the respondent discusses the idea of the 
inevitability of death following a cancer diagnosis.  
‘I’m not a person inclined to worry too much especially about health. 
Whatever will be, will be and there’s not much you can do to stop these 
things, especially cancer. Once you have it, you have it and it is good to 
come to terms with these things. I suppose it is a bit of fatalism.’ 
(P17, German, male, non-screener, low SES) 
In the second example, the participant’s religious faith seemed to have an 
effect on their perceptions about their health as well as the value of screening. 
Specifically, the respondent described a perception of health that goes beyond 
one’s control and also spoke of the notion that ‘everything is predetermined’ and 
reliant on ‘God’s will’, implying a more fatalistic view of life.  
'Well it’s personal, people think about these things differently. For me 
I think it’s my problem, it’s my health, it’s my life, I will decide when and if to 
check for these things. Nobody else can do that for me, not you, not my 
doctor, not anybody you know? Nobody knows about these things, nobody 
can see what is happening inside me, it is God who knows, and only He will 
know when it's my time. But I think this is important and it is my decision and 
how I think of my health that will help me do it, you know.'  
(P22, Pakistani, male, non-screener, low SES) 
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Some participants also described experiencing increased anxiety over the 
possibility of finding out they had cancer through the means of a letter and 
ultimately being left with serious information concerning their health that they did 
not know how to interpret. One participant particularly, described that being notified 
of a bowel cancer diagnosis through a standardised letter would be traumatising 
and difficult to cope with, which indicates that direct access to test results may 
have important drawbacks. In the excerpt below the participant described the 
agonising experience of waiting for the kit results, which was further exacerbated 
by the thought of not having a medical professional offering the context and the 
opportunity to discuss the diagnosis and treatment options. It is worth noting that 
the majority of participants automatically interpreted a positive test result as having 
cancer and only few participants seemed to understand the difference between 
screening and diagnostic procedures for bowel cancer.  
‘If that test result had come back positive - it was obviously negative that I 
didn’t have bowel cancer - but if it had come back anything other than that, if 
it came back saying there was something wrong, then I don’t know how I’d 
feel to be informed in a letter, you know? Because when you have the 
personal touch with your doctor, or whoever, consultant? Then they can 
possibly reassure you? But if it’s through a letter, then it’s whoa!’ 
(P1, White British, female, screener, low SES).  
 
3.4.1.5.3. Sub-theme 3: Treatment Fears 
This sub-theme describes participants’ fears about receiving cancer 
treatment and its long-lasting physical and emotional consequences. Interviewees 
particularly discussed the fear of having to undergo surgical treatment, and having 
a section of their bowel removed (i.e., colectomy). Participants described feeling 
fearful of having to wear a colostomy or ileostomy bag if they were diagnosed with 
cancer. Treatment for bowel cancer was often described by interviewees as 
‘horrible’ and ‘scary’; particularly negatively-charged words were used by 
participants to describe operative treatments for bowel cancer, with surgery being 
described as ‘chopping’ and ‘cutting off’ body parts. Fear of surgery was more 
frequently expressed by participants that had consistently adhered to screening 
recommendations in the past, perhaps due to greater awareness of cancer and 
increased involvement in cancer information seeking. Nevertheless, non-screeners 
also expressed a fear of surgical treatment for bowel cancer, without however this 
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factor being identified as a main driving factor for non-participation. It was more 
common for participants from White Ethnic backgrounds to discuss fears 
associated with cancer treatment and only few people from BAME backgrounds 
demonstrated awareness of bowel cancer treatment procedures. The following 
examples demonstrate the fear experienced by some participants with regards to 
the physical implications of surgical treatment.  
‘One of my neighbors has had it (i.e., bowel cancer), thank god she was 
okay in the end. Well, I say okay, I mean she is alive and I don’t know the 
details but she ended up having a bag on the outside, which must be such a 
horrible thing to have to endure. I think she got rid of that now, and I see her 
out and about and I think she is doing well. But I don’t know the idea of 
having to carry around a bag, I find that scary, I think it must have a 
detrimental impact on quality of life.’ 
(P15, White British, female, screener, high SES) 
 
‘Well would you like a bag stuck to you? And it’s permanent as well. Just 
horrendous, I wouldn’t be able to cope with that.’ 
(P12, White British, female, non-screener, high SES) 
Some participants also expressed feeling fearful towards the possibility of 
having to undergo a follow-up colonoscopy if they received a positive kit result.  
‘I don’t get embarrassed but the thought of getting a bad result back, and 
then if then there’s something do you have to get a tube up your bottom or 
something (i.e., refers to colonoscopy)? If that could be avoidable then it 
would be better..  I wouldn’t want to have to go through that.’ 
(P12, White British, female, non-screener, high SES) 
 
3.4.1.6. Theme 6: Gender and Sociocultural Influences  
This superordinate theme illustrates that gender and other sociocultural 
factors, including health literacy, religiosity and culture-specific norms and health 
beliefs are key determinants of bowel cancer screening behaviour. The data 
suggested that men from all ethnic backgrounds were more likely to trivialise 
engagement with screening and exhibited higher perceived invulnerability 
compared to female participants. Additionally, a range of sociocultural factors were 
embedded within this theme. Among BAME participants the importance of culture-
specific health norms, religious beliefs and the association between health literacy 
and screening behaviour were all factors that appeared to influence screening 
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decisions. The impact of these factors is illustrated in the following three sub-
themes.  
3.4.1.6.1. Sub-theme 1: A Gender Issue 
Participants of both genders appeared to hold the normative belief that men 
are less likely than women to engage with preventive behaviours, including bowel 
cancer screening. The data suggested that there are gender differences regarding 
attitudes towards screening and seeking medical help in general and there were 
greater levels of embarrassment/anxiety/distress reported by men in relation to the 
screening process. The majority of participants discussed attitudinal barriers that 
were specific to men and these were often positioned within the context of the 
social construction surrounding masculinity, where men were often characterised 
as unwilling to ask for help or engage with screening, even after they had 
experienced symptoms.  
'It depends. Women are always wiser aren’t they? They would probably find 
it easier. Men, especially after a certain age, are not as, I don’t know what 
the word is.. Sometimes I think men just don’t bother as much as women 
do? I think we like to think 'oh it's nothing, I'll be fine' and brush it off just to 
avoid going to the GP. Especially with bowel stuff I think that's the case'  
(P16, Cypriot, male, screener, high SES) 
 
Participants’ views were often aligned with and seemed to endorse popular 
masculinity stereotypes and ideologies that portray men as less willing to seek help 
and more likely to view symptoms as minor and insignificant leading them to adopt 
a ‘wait-and-see’ attitude or downplay the importance of medical procedures.  
'Men don’t care about things like this. They can’t be bothered. […] For men 
it’s easy to forget to do checkups, and be mindful of what they need to do. I 
think women are better at this kind of thing (laughs) and they often remind 
their husbands to do what they need to do also.'  
(P23, Pakistani, male, screener, high SES) 
Other recurring barriers specific to men were a lack of familiarity with routine 
check-ups, a tendency for non-disclosure of medical problems and not feeling 
connected to healthcare services as much as women are.  
 'I think men find these things (screening, medical procedures) harder than 
women. I don’t know why. Women are more adapted to these sorts of things 
than men are. […] And men don’t talk about stuff like that, women do, don’t 
they?  They are more open, men aren’t.'  
(P18, White British, female, non-screener, low SES) 
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3.4.1.6.2. Sub-theme 2: Language Barriers and Health Literacy 
Language barriers and poor health literacy appeared to be major obstacles 
for obtaining screening among BAME populations for whom English was not their 
primary language. Participants from BAME backgrounds reported that the 
screening invitation and booklet were not sent to them in their primary language, 
often leaving them confused and unable to understand, appraise and act upon the 
screening-related information. Some participants indicated that although they felt 
confident in their ability to read most materials written in plain English, they found it 
slightly more challenging to understand and derive meaning from information when 
more complex medical terminology used in the NHS screening materials, which 
seemed to further complicate their understanding of the information presented to 
them, potentially impacting on their ability to decide whether to take part in 
screening or not. One participant expressed that it would be important to 
implement strategies that would make health materials more accessible to people 
from BAME backgrounds. The excerpt below also suggests that involving 
community leaders, making health materials more culturally relevant to BAME 
groups (e.g., culturally-tailored materials), and translating materials or using 
English language in a simpler form, might motivate BAME populations to engage 
with screening. 
'The only way to overcome that is to explain it to them in their own language, 
and have instructions in Urdu or in whatever language they speak. And pass 
that onto them, and even if they are not literate in their own language…  
Maybe in English as well but very simply. Maybe a practical demonstration – 
that’s doesn’t involve taking your trousers down or anything like that 
(laughs) – it would be alright. I think it would be alright, they would accept 
that and it would help them. Something should be included on this piece of 
paper (i.e., screening invite) that will make them understand it is for them. 
Maybe involving the wider Pakistani community and getting somebody that 
we trust from our community that understands how we think and can talk to 
us you know. We are a large and tight-knitted community and we would 
support each other.'  
(P21, Pakistani, male, screener, high SES).  
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3.4.1.6.3. Sub-theme 3: Sociocultural Environment 
In some instances, the health beliefs and attitudes towards screening were 
influenced by participants’ religious beliefs. The impact of religiosity of screening 
decisions was more prominent among ethnic minority participants, and particularly 
Asian participants of a Pakistani origin. Specifically, some beliefs relating to 
spirituality and faith appeared be associated with a reduction in the perceived 
benefits of screening. The perceived role of God as a causal agent seemed to be a 
primary influence on the decision-making process to take part in screening among 
ethnic minority populations indicating that spiritual beliefs might be affecting health 
outcomes independently. For some participants, religion provided a framework for 
interpreting and understanding health-related events with the core belief that God 
is responsible for illness and health. The excerpt below indicates that 
spiritual/religious beliefs may be inextricably linked to beliefs about health, disease 
and behaviour. Whether people with external health locus of control express this 
through religiosity is something that remains unclear. It may be that people justify 
their non-uptake by placing greater importance and feeling reassured that their 
faith is a protective factor in its own right.  
‘Sometimes these things (i.e., illness, cancer) are God’s will and no matter 
what you do, things that are supposed to happen will happen and that’s how 
I see life in general. That’s how I coped with my wife’s death, this thinking 
helped me. […] Because when people are destined to die they will die. And 
if they are destined to live, they will live. Some people will die from cancer, 
others from something else. It’s all part of my life. So no I’m not scared of 
cancer or death. If it’s destined then it is what it is and I can’t interfere with 
that, you know? Only God knows. What is gone is gone!'  
(P27, Pakistani, male, non-screener, low SES) 
Data from an interview with a Black Caribbean participant highlighted 
another sociocultural variable that might influence health-related decisions and 
referred to the potential importance of cultural literacy, defined here as the ability to 
recognise and use collective beliefs, customs, world-view and social identity in 
order to interpret and act on health information (Zarcadoolas, Pleasant, Greer, 
2005). Specifically, the participant described that the norms and the values of the 
culture she grew up in in the West Indies dictated that negative experiences and/or 
emotions are not to be expressed and that conversations concerning aspects of a 
person’s private life, including health and illness, should be internalised and dealt 
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with by the person independently. The excerpt below demonstrates how cultural 
influences might independently influence health behaviours.  
'The way we were brought up in the West Indies was ‘be seen, not heard’. 
You can’t express yourself. You will be shut down if you ask too many 
questions. So all my life I was brought up to be quiet and now I find it hard to 
talk openly about things or complain about things. And even if it’s for my 
health, especially if I can’t express myself easily – it’s the communication I 
also find hard you see. I won’t talk easily about things and I think we 
generally are more private. Even if I have a problem, or a pain. I don't want 
to make a fuss you see. And if I have something wrong with me it's okay, I 
will deal with chin-up, tough you know.'  
(P9, African Caribbean, female, non-screener, low SES) 
The data suggests that the participant’s cultural values led to the belief that 
seeking help, even when feeling unwell, is perceived as a weakness. Such culture-
specific conseptualisations of health might be one of the many pathways via which 
screening uptake is affected, suggesting that future interventions that aim to 
increase screening among BAME populations could benefit from considering the 
influence of culturally normative practices and beliefs. 
3.4.2. Cluster 2 - Perceived Facilitators to gFOBT Screening Uptake  
This cluster encapsulates participants’ thoughts and views with regards to 
the factors that motivated them to take part in bowel cancer screening. 
Interviewees discussed the importance of having positive social influences and 
prioritising long-term health over temporary discomfort associated with completing 
the gFOBT kit. Previous participation in screening increased awareness about the 
symptomatology and progression of bowel cancer and was associated with more 
positive attitudes regarding the benefits of screening and preventive healthcare, 
which were both strong facilitators of screening adherence. Familial history of 
bowel cancer, being a healthcare professional by background and an appreciation 
towards the NHS were also factors that promoted screening participation. Overall, 
both male and female participants from all ethnic and socioeconomic backgrounds 
identified benefits in screening. However, White British women were more likely to 
mention more than one factor that led to their decision to participate in screening. 
Non-screeners also expressed some positive views about screening during the 
interviews and for some the interview itself acted as a prompt to participate in 
gFOBT screening in the future. The following five themes – each with multiple sub-
  
159 
themes – appeared essential in understanding the factors that promote bowel 
cancer screening participation: ‘Social Influences’, ‘Helping Oneself’, ‘Increased 
Awareness, ‘Grateful for the NHS’ and ‘Positive Attitudes’. Similar to Cluster 1, 
there were aspects of participants’ understandings that overlapped across these 
themes.  
3.4.2.1. Theme 1: Social Influences 
Participants that were up-to-date with screening reported having a social 
network within which they felt comfortable to discuss their screening experiences. 
Participants particularly emphasised positive social interactions with important 
others who often encouraged them to complete the screening kit. Some 
participants also highlighted that having a conversation about the gFOBT kit with 
their GP was a driving factor that led to screening uptake. Among ethnic minority 
participants with low literacy, having family members and/or friends who shared 
their knowledge and experiences and advised them on screening issues played a 
significant role. Overall, seeking help and support from others appeared to be a 
key mechanism through which low-literacy populations accessed and engaged with 
screening.  
3.4.2.1.1. Sub-theme 1: General Social Support 
Several participants expressed the importance of social support – 
specifically, participants underlined the benefits of feeling it was acceptable to talk 
about screening openly and being prompted by others to complete the screening 
kit. One participant described having a conversation with a colleague and feeling 
comforted by the fact that her colleague took interest in whether she had 
completed the screening kit:  
' At that time a young colleague of mine, whose father actually had been 
diagnosed. And we got talking about this, and I told him this, that I had 
actually got the kit. And he said ‘do it do it do it’ and every time he saw me 
he asked me ‘have you done it yet?’. He saw I wasn't keen and I think he 
thought I was not going to do it. But it was nice that you know someone 
nudged me into doing it, that sort of thing.'  
(P2, White British, female, screener, high SES) 
The data suggested that participants also felt motivated to engage with 
screening after having had a discussion about it with healthcare professionals. 
Among BAME participants especially, it seemed that receiving a direct 
recommendation from their GP was a crucial facilitator of screening uptake. The 
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excerpt below suggests that this participant would not have used his screening kit 
had it not been repeatedly recommended to him by his GP, indicating the patient-
physician interaction might be an important driver of screening uptake, especially 
for ethnic minority populations.  
'If anybody asks me now about it or tells me about it I show them how to do 
it now! And I always tell them that they definitely must send it back. It helped 
that I had talked about this with my doctor, because I am certain I would 
have thrown it away. And he changed my mind.'  
(P20, Pakistani, male, screener, low SES) 
Moreover, BAME participants with low literacy seemed to rely heavily on 
their children and/or grandchildren to assist them with screening-related health 
information. For example family members went through the information booklet 
with them and explained the screening procedure to them, indicating that the 
processes of shared decision making and co-learning were important facilitators of 
screening uptake. In the following excerpt, one participant indicated that younger 
family members, with greater levels of acculturation may act as advocates of 
screening and provide social and decisional support: 
'My daughters help me with these things and they will pester me to do things 
about my health. I think our people can be helped by their daughters. By 
their family, you know, younger family members that know the language and 
explain to them what’s going on.'  
(P23, Pakistani, male, screener, high SES) 
The reciprocity of social support within friend groups and being able to 
exchange personal health experiences and information were also factors 
highlighted by some interviewees as facilitators of screening uptake.  
'The group of friends we were in where all kind of ‘we’ll do it, it’s a sensible 
kind of thing to do’. We were all in it together and we will kind of talk about 
these issues and encourage each other from time to me, it’s that sort of 
thing.'  
(P8, White British, female, screener, high SES) 
Some participants felt motivated to act as advocates of screening and 
indicated that sharing their knowledge and experiences was important and 
contributed to the wellbeing of important others. 
'Some people bring it to me, friends you know, and they ask me about ‘why 
do I need to do it?’ and I tell them it is for cancer and that if they do it and 
something goes wrong they will be looked after, sent to hospital and 
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everything will be okay. But I tell them that if they don’t it they simply will not 
know. And many of my friends do it now let me tell you'. 
(P20, Pakistani, male, screener, low SES) 
3.4.2.1.2. Sub-theme 2: Spousal Support 
Participants considered spousal support to be important; both men and 
women reported that their partners often played a vital role in their decision to 
participate in screening. Traditional gender roles did seem to have some influence 
however; female spouses/partners were more likely than male spouses/partners to 
act as advocates of screening, initiate discussion about the screening procedure 
and encourage their partners to use their screening kit. Wanting to stay healthy for 
their partner and the perception the screening as a means to maintain long-term 
health were also key features of participants’ narrative.  
'I think if you have someone close to you, nudging you about it that could be 
good. In fact, to be fair my husband when he got his he through it to one 
side and went ‘ew’ and I said ‘No, you will get it done, and get it done now’ 
and kept saying for some days ‘Have you done it yet?’ (laughs). So yeah, I 
did influence him and in a way I did it and will carry on doing it because it is 
really important for me to know he is healthy.'  
(P8, White British, Female, Screener, High SES) 
The excerpts bellow demonstrate that the element of interdependence, 
which naturally exists between partners, may influence screening behaviour:  
'My wife was very disgusted, more so than me, and I told her ‘look, it’s just a 
process that they are using to find out what’s going on, so whether you like it 
or not it doesn’t matter’. It’s like if you are diabetic and taking insulin it 
doesn’t matter if you like it or not you have to take it because it is necessary. 
It is a medical procedure. That’s how I explained it to her and she accepted 
it you know.'  
(P21, Indian, Male, Screener, High SES) 
 
'My husband and I encouraged each other to do it. We are roughly the same 
age. Um, it was possibly me that got the kit first but I can’t remember – I 
think they must’ve come relatively close to each other. Um, but we kind of 
pushed each other into doing it. We kind of made sure that the other person 
had done it. I think he just wanted me to do it, he wanted us both to do it.'  
(P6, White British, Female, Screener, Low SES) 
 
3.4.2.1.3. Sub-theme 3: Staying Healthy for Loved Ones 
Participants often reported feeling a sense of responsibility and wanting to 
stay healthy for important others. Female participants in particular stated that they 
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had a moral responsibility to engage in screening to maintain best possible health, 
which in turn would assist in securing their independence and refraining from 
becoming a burden on their family members. Female participants’ narratives of not 
wanting to be ‘a bother on anyone’ highlighted the endorsement of traditionally 
feminine norms of altruism, selflessness and sensitivity to the needs of others.  
'But as I have got older it’s gotten more and more important. I want to keep 
everything healthy, so you do as much as possible to do that. Health is a 
priority, not for everyone, but for me it is and I want to keep myself healthy, 
you know thinking of my kids and grandkids especially, I would not want 
them to have to deal with me being ill, therefore I try to stay as healthy as 
possible.'  
(P10, White British, female, screener, high SES) 
Male interviewees also emphasised the importance of self-care, but spoke 
less about keeping healthy for others and more about the importance of 
maintaining control over their lifestyles in order to promote and retain their quality 
of life. In the following citation one man expressed that he would prefer having the 
gFOBT screening annually because it would contribute to stronger sense of control 
over his self-care: 
‘As I said, my suggestion that they do it every year is linked to my general 
attitude of wanting to monitor my health. I want to be able to restore my 
health if anything is wrong with me. I care very much about being able to do 
the things I enjoy doing and enjoy life in general. This screening, despite 
being unpleasant, gives me a sense of control. I always attend the tests I 
am told - screening, PSA, cholesterol. I just care too much about being 
healthy (laughs)'  
(P19, Cypriot, Male, Screener, low SES) 
Despite the distinctly gendered ways in which participants spoke about their 
perceived obligation to engage in screening, all past screeners were more likely 
than non-screeners to articulate feeling fulfilled by making conscious efforts to 
minimise their health risks and subscribe to healthy living ideals. Participants’ self-
care efforts were not limited to screening uptake alone, and extended to engaging 
with various health practices, including having a good diet, being physically active 
and attending annual check-ups. 
3.4.2.2. Theme 2: Helping Oneself  
Screeners from all ethnic backgrounds and SES groups mentioned that the 
main motivation for participating in cancer screening was keeping healthy. 
Participants who were up-to-date with screening formed a direct association 
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between screening uptake and longevity and perceived the temporary discomfort 
related to doing the test as a small price to have to pay for maintaining long-term 
health. Consistent participation in screening was predominantly facilitated by the 
understanding that early detection via screening would lead to greater possibility of 
successful treatment and thus extended life. The excerpts below demonstrate 
screeners’ perception that screening can be lifesaving.  
'If you know you can make the best decision for yourself, obviously I want to 
protect my health and if there is a problem to restore my health, if there is a 
sickness, if you don’t know about it you can’t do much at all. It can really be 
a matter of life and death.'  
(P19, Cypriot, Male, Screener, low SES) 
 
'Well, it’s good you know. If, uh, maybe there is some sort of problem that 
you don’t know about, it is important to find out about it at the right stage. 
Then you can take medication you know, and something can be done about 
it. If you don't know about it you could die very quickly'  
(P23, Pakistani, Male, Screener, high SES) 
Repetition of screening every two years was largely discussed in the context 
of participants wanting to ensure a continuity of monitoring any changes that could 
indicate the presence of bowel cancer. Specifically, participants’ narrative regarding 
biennial screening indicated that they associated this with having ‘peace of mind’. 
Past non-screeners and past screeners alike experienced a certain degree of 
anxiety whilst waiting for screening results, however, screeners were more likely to 
perceive repeat screening as a way of managing those fears: 
 '[…] But at least I know there is a sort of sense of security, that if there is a 
problem I will hear from them.  When you do these tests there are instances 
where you think something might be wrong but they offer you some peace 
of mind after you’ve done them and everything is good. Doing it every two 
years put my mind at ease.'  
(P3, White British, female, Screener, High SES) 
Among screeners, screening was perceived as a way of ‘staying ahead of 
the game’ and taking control over an unpredictable disease course. Some 
participants found it challenging to cope with the prospect of reduced quality of life 
due to advanced-stage cancer and felt that by consistently returning the kits every 
two years they were taking action to prevent the disease from becoming 
untreatable. Unlike non-screeners, who were more likely to become avoidant and 
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fearful in the prospect of receiving results that indicated a cancer diagnosis, 
screeners were keen to know whether they had cancer or not: 
‘I still believe that if you get cancer you are unlucky you are looking at 
potential fatality but I would still want to know – at least then I might be able 
to do something about it, you know, get treatment for it.'  
(P3, White British, female, screener, high SES) 
As mentioned previously, fear of cancer treatment festered behavioural 
avoidance for non-screeners, whereas screeners formed fewer negative 
associations with regards to receiving treatment (e.g., pain, recovery times, 
invasive surgery) and placed greater emphasis on the benefits of receiving 
treatment for cancer at the earliest stage possible. Indeed, screeners perceived 
screening as an opportunity to not only be successfully treated, but also to 
increase their chances of receiving minimally invasive treatment, which would also 
have fewer negative implications on their psychophysical recovery. One participant 
particularly highlighted that early detection of cancer would reduce her chances of 
needing a stoma, which was perceived as something that would greatly reduce 
quality of life: 
‘This (i.e., kit) is nothing compared to other things people go through, and 
it’s so important to have it done. Bowel cancer is a horrible illness, so yes, 
this test is worth doing and by doing it every two years you might avoid 
needing a bag, which is an awful thing. The earlier you know, the more you 
can do, the less you will suffer and that’s the bottom line form me’  
(P4, White British, female, screener, high SES) 
Overall screeners showed greater awareness about the benefits of 
prevention and early detection and formed direct associations between screening 
uptake and the maintenance of good health.  
3.4.2.3. Theme 3: Increased Awareness  
Participants with the most knowledge of bowel cancer screening tended to 
be more inclined to screen compared to those who were less knowledgeable. 
Increased awareness was also associated with less fatalistic views about bowel 
cancer and more positive attitudes towards the screening kit, with both of these 
factors being associated with an increased motivation and intention to participate in 
screening. Greater awareness about bowel cancer was also associated with less 
anxiety and embarrassment with regards to the screening process. Knowing 
someone who had been affected by bowel cancer and past experience with bowel 
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cancer screening were both instrumental factors associated with increased 
awareness.  
3.4.2.3.1. Sub-theme 1: Knowing Someone with Bowel Cancer  
Participants who had a close friend and/or family member who had either 
been diagnosed with or had died of bowel cancer were more likely to be up-to-date 
with screening. Having a personal experience of friends and relatives diagnosed 
with bowel cancer appeared to be an important facilitator of screening uptake and 
participants mainly attributed this to the fact that they had experienced first-hand 
the detrimental impact bowel cancer can have on people’s lives and did not want to 
endure the same suffering themselves.  
'Somebody who I know who lives in B****** he has done it and in fact was 
found to have bowel cancer through the screening yes – which was certainly 
a wake-up call. He certainly ended up having surgery and some other 
treatment for it. It shook me a think seeing my neighbour being so ill. 
Nobody is immune to cancer and I had to remind myself of that, because 
you tend to think these things happen only to others. Well, they don't.'  
(P5, White British, female, screener, high SES) 
Additionally, participants who had a family history of bowel cancer were 
more likely to perceive themselves as being more susceptible to the disease, and 
described this as being the main underlying motivation for participating in 
screening.  
'Well yes, all my life I have been careful, I know I am at increased risk and  
also I worked in healthcare so while I was at work, you know, I definitely was 
measured before we even did the stool tests  just to check that I’m okay'  
(P4, White British, female, screener, high SES) 
Thus, it appears that increased perceived susceptibility and greater 
awareness about the seriousness of bowel cancer might be factors that mediate 
the relationship between familial history and/or knowing someone with bowel 
cancer and subsequent screening participation.  
3.4.2.3.2. Sub-theme 2: Being a Repeat Screener  
Having participated in gFOBT screening at least once before motivated 
participants’ decision to repeat the screening subsequently. This appeared to be 
related to participants’ perceptions of self-efficacy related to the screening process. 
Specifically, participants described feeling less fearful and felt more confident in 
their ability to execute all the steps required for completing the kit. Irrespective of 
SES, participants expressed that completing the first ever kit was the most 
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challenging screening experience, partly due to misunderstandings relating to how 
the kit should be used and not knowing what to expect from the process, but that 
after having completed the kit once, they felt more positive about subsequent 
screening rounds:  
'I think particularly after the first experience, which was difficult, it becomes 
very normal. I didn’t have the same reaction after the second time. It is just 
that initial one which is new and different. […] You know what to expect, 
what you are doing and how it should be done. It gives you greater 
confidence I think.'  
(P8, White British, female, screener, high SES) 
'I read them (i.e., instructions) just the first time and the I kind of 
remembered what I had to do. It’s the first time that I found the hardest 
because the whole process kind of surprises you. After that it was okay.'  
(P14, White British, female, screener, low SES) 
Some interviewees indicated that completing the kit for the first time was 
also associated with greater levels of stress, particularly whilst waiting for 
screening results, but also described feeling that the value of screening became 
more pronounced with repeat participation.  
‘When you do these tests there are instances where you think something 
might be wrong but they offer you some peace of mind after you’ve done 
them for a while and everything is good. Doing it every two years put my 
mind at ease.'  
(P3, White British, female, screener, high SES) 
In this example, one participant described that repeated screening also 
contributed to feeling less embarrassed about the stool-sampling process due to 
increased familiarity: 
'I think I found the test was easier with every time that I did it, because I had 
sort of worked out a technique for capturing the stool.  I think I also found it 
less embarrassing and awkward as well? And I became more comfortable 
with doing it because I knew the process which helped.'  
(P5, White British, female, screener, high SES) 
These findings therefore indicate that there may be a particular need to 
bolster self-efficacy beliefs, and particularly among first-time invitees, about 
completing the screening kit in future interventions.  
3.4.2.4. Theme 4: Grateful for the NHS 
Participants who were up-to-date with screening held more positive attitudes 
towards the NHS and spoke highly of the underlying structure and core principles 
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of the NHS – for instance, that it is free at the point of use, provision of high quality 
care, wide range of services available, high competency of NHS staff etc. Past 
screeners expressed greater appreciation for having the bowel screening service 
available to them especially in light of the funding pressures the NHS has been 
experiencing over the last decade.  
'I definitely would want to request it (i.e., after the age of 74). I wouldn’t even 
mind paying for it. I know the NHS is in a lot of trouble for money but it has 
the best health service provision and it’s just so great that we have it.'  
(P2, White British, female, screener, high SES) 
At the same time, many of the participants frequently described feeling that 
they had a moral obligation towards the British taxpayer and they perceived non-
uptake of screening as a misuse of NHS expenditure, thereby placing even greater 
economic burden on the health system by ‘wasting’ already scarce public health 
resources.  
‘I was really motivated to do this test. I think it’s just the way I am. I was 
thinking ‘I’m doing this test, it’s for my benefit, people’s resources, almost by 
respect for the people of doing it, and money it’s costing – which I suppose 
is coming out of all our taxes – but ostensibly it’s free – it’s an opportunity.'  
(P2, White British, female, screener, high SES) 
Feelings of increased gratitude towards the NHS were more commonly 
expressed by participants whose parents had died from bowel cancer and felt that 
if there had been an equivalent screening programme available to their parents, 
they may not have died of bowel cancer.  
'I did feel relieved because I didn’t have and don’t have any symptoms of 
what, say I can remember my father having. You just still don’t know, do 
you? So I guess you’re thinking as, as you’re being tested, well you know, 
actually that’s okay, my father never got that opportunity, he died 17 years 
ago when these tests weren’t around.'  
(P1, White British, female, screener, high SES) 
Similar to non-screeners, past screeners also felt fearful towards the 
possibility of needing treatment for bowel cancer in the event of a bowel cancer 
diagnosis, however, at the same time they felt reassured that they would receive 
high quality care by the NHS and this belief somewhat alleviated participants’ fears 
related to cancer treatment.  
'The best part of this screening, and any screening you do as part of the 
NHS, if they do find anything that you will get treatment. Because we are 
very lucky here, we do get treatment, and we have amazing, super-hero 
NHS staff and we are well looked-after.'  
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(P3, White British, female, screener, high SES) 
Participants who held positive views towards the NHS were also more likely 
to report positive interactions with healthcare professionals. Particularly, 
participants seemed more likely to seek medical advice from their GPs when they 
perceived them as friendly, understanding, as taking a positive approach to their 
concerns and considerate in addressing sensitive healthcare issues. Good 
relationships with GPs fostered communication that participants felt increased the 
GPs’ ability to provide appropriate medical advice that prioritised their wellbeing. 
One man, who was initially convinced he did not wish to complete the kit, decided 
to talk to his GP about it, who emphasised the importance of screening and 
managed to eventually convince him to participate in screening:  
'I didn’t throw it away but that’s what I was thinking. But then I went to the 
doctor you know? And I took that card with me and the invitation and I talked 
to him about it. And he said ‘no, you must send it to them’. I told him I 
wanted to throw it away, I don’t want to do it and he said ‘no you must do it 
and send it back to them’. So since then I have been sending them back! 
And I know that if I have similar issues in the future I can go to my GP and 
they will talk with me and we will work it out. I trust my GP with these things, 
his view you know and that he wants what’s best for me.'  
(P20, Pakistani, male, screener, low SES) 
Therefore, it appears that GP involvement and patient-physician 
communication are factors that may act as cues to screening uptake. 
3.4.2.5. Theme 5:  Positive Attitudes  
Positive attitudes toward living a healthy lifestyle appeared to be a key 
facilitator of gFOBT uptake. Participants who were up-to-date with screening were 
more likely to express motivation to manage their own health and wellbeing and 
tended to portray themselves as being proactive in monitoring their health. At the 
same time, participants’ sense of responsibility about taking action to promote 
and/or maintain good healthy was particularly pronounced. Seeking health-related 
information was also a characteristic of participants up-to-date with screening, and 
particularly women. Overall, participants were more likely to express positive views 
toward and be up-to-date with gFOBT screening, if they a) demonstrated greater 
levels of health conscientiousness and b) reported having previous, positive 
experiences with cancer screening.  The sub-themes ‘Health Conscientiousness’ 
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and ‘Past experiences with screening’ below, illustrate how positive attitudes may 
affect bowel cancer screening behaviour.  
3.4.2.5.1. Sub-theme 1: Health Conscientiousness  
Past screeners demonstrated greater levels of health conscientiousness. 
Specifically, they were more aware and concerned about wellness and appeared 
more motivated to take every step towards improving and/or maintaining their 
health and quality of life. Having a general interest in health appeared to be a 
primary motive for engaging in screening, as well as other health behaviours, and 
being self-conscious regarding health. Greater health conscientiousness seemed 
to be associated with a more positive perception of the screening kit and greater 
awareness about the benefits of screening uptake.  
'I feel quite confident with my health and I am looking after myself very, very 
well umm.. I don’t feel that I have problem. But at least with this I know there 
is a sort of sense of security, that if there is a problem I will hear from them. 
I'm not just sitting back waiting for things to happen to me and then run 
around to fix it. It is all about prevention for me. […] I have also always been 
interested in my health. So no matter what, I think I would have still done it. I 
care about my health, I exercise, I eat right, everything really, that I can do I 
will do it.'  
(P3, White British, female, screener, high SES) 
Participants repeatedly described having a sense of moral obligation 
towards themselves to lead healthy lifestyles and they felt it was important to take 
an active rather than a passive role in the improvement and/or maintenance of their 
health.  
‘It’s important for people to understand that there is noting more important 
than health and looking after yourself. If they don’t and just let it go, they 
may find they have something after 2-3 years when it is too late! And then 
they will regret not doing it earlier. So simply go do it for your own sake if not 
anything else. The test is not a big deal but the possibility of having cancer 
is.'  
(P24, Pakistani, male, screener, high SES) 
At the same time, past screeners were more likely to adopt a more 
pragmatic stance towards bowel cancer screening saying that it is ‘something that 
just needs to be done’ and there seemed to be less deliberation about whether 
they should be doing the screening or not.  
'I think people just have to realise that this is part of normal life. Um, like 
going to the toilet is part of normal life. And the ‘ifs and buts’ people find as 
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reasons not to do it is just not helpful, is it? I mean why don’t people get it 
over and done with?’  
(P2, White British, female, screener, high SES) 
Greater health conscientiousness was also associated with the perception 
that staying healthy requires conscious effort and personal decision-making on the 
individual’s behalf: 
'Any screening I have been asked to attend I have always attended. These 
things are in place to help us and if people think about this in a serious way 
they will understand that all they have to do, what's required on their part is 
to just do the screening. That's all it is and that's how I look at it.'  
(P6, White British, female, screener, low SES) 
At the same time, participants maintained that good health was invariably 
the result of the extent to which individuals prioritised wellness and their ability to 
exercise self-discipline and subscribe to healthy living ideals. Comments such as 
‘you have to be proactive’ and ‘your health is up to you’ were relatively 
commonplace among past screeners. For instance, one man emphasised that one 
could and should control their health to the extent possible:  
'I think so, but I see that for the people that don’t talk about it or do anything 
about it, it is often too late after you know. You can’ control what happens to 
you health-wise but doing everything humanly possible to look after your 
health is really important. Whether that means taking your medication 
consistently, seeing your doctor, doing screenings, anything that helps keep 
you healthy really!'  
(P24, Pakistani, male, high SES, screener) 
Participants also articulated the sense that good health is something ‘fragile’ 
that needs to be protected and frequently monitored:  
‘If you care about your health and I mean really care you do everything you 
can to protect it. It’s a matter of priorities every person has. And things can 
change very quickly and you can become ill very quickly so you need to be 
careful.'  
(P19, Cypriot, male, screener, low SES) 
Greater health conscientiousness was also linked to increased health 
information seeking behaviour.  Participants who were motivated to lead healthy 
lifestyles were more likely to report greater intention and active efforts to obtain 
health-related information (e.g., health risks, illnesses, health-protective 
behaviours) above and beyond NHS materials. In particular, women were more 
likely to report seeking health information online: 
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'Haven’t exactly worked in the health sector but I am interested in sort of, … 
I am just interested in the world, so I am interested in medical things. I have 
an interest in all things health and I like to take care of my health. I also 
quite like to read health articles in the papers, if there ever is one, and I do 
research online as well.’ 
(P6, White British, female, screener low SES) 
 
'I am quite one for reading up for this sort of thing. If I see a health article I 
do like to read it. I’m not obsessed but I’m just generally interested in health 
and now with the internet, you know, it’s easier. And I want to take good 
care of my health especially the older I get it’s more and more of a priority?'  
(P15, White British, female, screener, high SES) 
It was also common for participants who were up-to-date with bowel cancer 
screening to demonstrate positive health behaviours in general. Specifically, 
screening participants were well-versed in what they should be doing to achieve 
overall good standards of healthy living and retain the best possibly quality of life 
as they get older/age. For instance, interviewees described the importance of 
having a healthy diet, being physically active and attending regular check-ups, etc.  
'I changed my lifestyle because I had some bowel problems but I have also 
always been interested in my health. So no matter what, I think I would have 
still done it. I care about my health, I exercise, I eat right, everything really, 
that I can do I will do it.'  
(P3, White British, female, screener, high SES) 
3.4.2.5.2. Sub-theme 2: Past Experiences with Screening  
The findings indicated that participants who had had previous experiences 
with screening that were positive, contributed to having more overall favourable 
attitudes towards bowel cancer screening and increased intention in participating in 
subsequent screening rounds. Positive past experiences were also associated with 
greater acceptance of the screening kit and stool-sampling process, with many 
participants describing it as ‘convenient’, ‘easy to use’, ‘practical’, ‘painless’ and 
‘non-invasive’.  
'I think the way they do it is good, sending it to your house, you can do it in 
your own privacy, nobody bothers you, you feel comfortable at home you 
know. Its good the way they do it, it’s quick and easy, doesn’t hurt.'  
(P21, Indian, male, screener, High SES) 
Some of the female interviewees who had also been screened for breast 
and/or cervical cancer, were even more likely to highlight positive elements of the 
gFOBT screening process. For instance, women expressed that they much 
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preferred having to collect stool samples than having to undergo a mammogram or 
a Pap smear examination. Women described having rather negative previous 
experiences with mammograms in particular and perceived these as invasive, 
painful and embarrassing. It appeared that women may have had more favourable 
view of the gFOBT kit due to having experienced other, more invasive forms of 
screening.  
'Well, to me it is totally non-invasive. It is not like the mammogram where 
you have everything being squashed and pushed up you, this is just doing 
what is natural and simply testing it so to me, out of all the three tests that 
women have regularly this is the least invasive'  
(P15, White British, female, screener high SES) 
Some women even perceived mammograms as being harmful and 
described experiencing pain for days after the mammogram procedure: 
‘If you ask me I think the breast screening is worse than this. It is more 
painful. I don’t like the breast screening thing at all. They nearly took my 
breast off and I was in pain for days so you know. And I think that’s worse, I 
don’t even think that’s natural, it might cause some harm I think to the 
tissues and so one. At least this is painless. And you get the results back 
fast as well, which is good.'  
(P14, White British, female, screener, low SES) 
Therefore, it appears that positive past experiences with bowel cancer 
screening, but also negative past experiences with more invasive forms of 
screening for women, may facilitate screening participation.  
3.4.3. Cluster 3 – Attitudes towards the FIT versus the gFOBT  
Given the imminent introduction of the FIT in England, the present research 
aimed to gather participants’ preliminary views regarding the one-sample stool test 
and whether they thought the FIT would be preferable to the gFOBT. It is worth 
noting that findings from the present research to not provide a direct comparison 
between the FIT and the gFOBT, because at the time of the interviews being 
conducted, none of the study participants had a lived screening experience using 
the FIT. Rather participants were prompted to discuss their initial perception of 
being offered a one-sample stool test instead of a three-sample stool test. Overall, 
participants were more likely to indicate a preference for the FIT, however, a few 
participants were more inclined towards the gFOBT, mainly due to the 
misperception that the collection of more faecal samples increased the reliability of 
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test results. The findings are summarised in two themes ‘I prefer the FIT’ and ‘I 
prefer the gFOBT’, which are presented below.  
3.4.2.1. Theme 1: I Prefer the FIT 
The majority of interviewees expressed a preference for the FIT mainly 
because it was perceived as easier to complete due to requiring one stool sample 
on a single occasion. Preference for the FIT was evident across both screeners 
and non-screeners, however, men, participants with low SES and ethnic minority 
participants were more likely to indicate a preference for the FIT. One of the main 
reasons interviewees perceived the FIT as more convenient than the gFOBT, was 
that it does not require being stored in the house: 
'Yeah, one sample would definitely be easier because then you’ve got the 
problem of that (i.e., gFOBT kit) hanging around. Where are you going to 
put it? Visitors come, ‘What’s this in your bathroom?’ I mean you know, 
where are you going to put it?'  
(P11, Iranian, male, non-screener, high SES) 
Another man also described that the general ‘unpleasantness’ of the test 
would be lessened, simply due to not having to repeat the stool-sampling process 
many times, thereby making the screening procedure more manageable:  
'You see to have to deal with your feces is what makes this hard, the less 
you have to do that the easier the test will be. Having to do it multiple times 
and keeping it in your home is unpleasant, at least for me.'  
(P20, Pakistani, male, screener, low SES) 
Another participant, who had reported lack of time as one of the main 
barriers to screening uptake, expressed a preference for the FIT because of the 
process becoming more instantaneous and therefore less time-consuming:   
'It’s not difficult and it’s a little bit more time-consuming than anything else. I 
think that could make it complicated for people like me. Because you have 
to do it on three different days and if you have for example to do one sample 
or even something like a blood test, then it’s a just a one-off […] it’s instant, 
whereas this (i.e., gFOBT kit) isn’t, do you see my point?’ 
(17, German, male, non-screener, low SES) 
3.4.2.2. Theme 2: I Prefer the gFOBT 
Some participants indicated a preference towards the gFOBT and this 
seemed to be predominantly influenced by the erroneous belief that the collection 
of more stool samples from three separate bowel movements increased the 
reliability of test results. This view was more commonly shared among individuals 
who had previously participated in gFOBT screening, but was not affected by 
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gender, ethnicity or level of SES.  Moreover, this belief was more prominent among 
participants presenting with greater irregularity in their bowel movements: 
'I think it is important to have to do it over three days because I think one 
sample is not enough.  Especially for me, my bowels change a bit and if it is 
changing all the time one sample might not be enough to see if everything is 
alright, you know.'  
(P14, White British, female, screener, low SES) 
 A number of participants expressed concerns about the association 
between the number of stool samples collected and the diagnostic accuracy of the 
test. Specifically, participants described being worried of a one-sample stool test 
being ‘hit or miss’ in its potential to detect cancer accurately:  
'Actually, I quite like the three (i.e., samples). Because I thought it gives you 
an extra chance.. One thing I had questioned in my mind is whether the 
cancer will show up all the way through the stool or is it only in certain bits? 
In which case it could be missed couldn’t it? So if you’ve got three separate 
days… I think the test becomes a bit more accurate. Whereas one, it’s more 
hit and miss isn’t it?'  
(P2, White British, female, screener, high SES) 
 
'Because you know, it is possible there is a mistake, so at least if you have 
given three samples you know that it’s kind of safe that your result is correct. 
You can trust the outcome.'  
(P23, Pakistani, male, screener, high SES) 
The view that one-sample stool test may lead to a false positive test result 
was also discussed by one participant:  
'No, three is definitely better. That’s because one sample might have a 
problem, but the next could be alright. You wouldn’t be able to know that if 
you only gave one sample. So by having three it’s better, more reliable. 
Because one sample will not necessarily give you an accurate finding and 
you might be told you’ve got cancer.’ 
(P24, Pakistani, male, screener, high SES) 
These preliminary findings suggest that preempting service users’ 
expectations regarding concerns over the diagnostic accuracy of the FIT may be 
important in determining the acceptability of the test.  
3.5. Discussion  
Building on the work undertaken in Study 1, this study aimed to explore the 
barriers and facilitators in relation to gFOBT cancer screening uptake among 
different subgroups of the population. This study reports on qualitative interview 
data with an ethnically and socioeconomically diverse group of people from inner-
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city areas of Leeds, adding to the literature on barriers and facilitators of bowel 
cancer screening uptake. The decision-making processes for bowel screening 
uptake were explored using Thematic Analysis, and revealed novel findings which 
have not yet been reported by previous qualitative research in this area. There is 
currently insufficient literature examining views towards the gFOBT kit by variation 
in SES, ethnicity/race, gender and screening history; rather the majority of previous 
studies have focused on exploring factors influencing uptake among particular 
subgroups; for example, among either White Caucasian or ethnic minority 
populations exclusively. Therefore the comparative nature of the present study 
extends previous research by involving multiple population subgroups, in an 
attempt to address in a more holistic manner the issue of inequalities in gFOBT 
uptake. The narrowness in past qualitative studies on the topic of bowel cancer 
screening uptake has made it challenging to decipher whether there are factors 
that are specific to populations with lower screening coverage (e.g., deprived, 
ethnic minority, men) and whether there are attitudes/beliefs that are common 
across different population subgroups. The present analysis identified that services 
users’ reasoning for non-participation in screening was related to six themes, 
whereas the factors that promoted participation were summarised in five themes.  
3.5.1. Summary of Principal Findings  
Evidence from the study suggests that many beliefs were shared across 
population subgroups. For instance, emotional barriers, including the perception 
that bowel cancer screening is a taboo topic, feelings of embarrassment and/or 
disgust elicited during the faecal sampling process and experiencing anxiety whilst 
awaiting screening results, were all raised as broader issues that negatively 
affected screening participation among people from all socioeconomic 
backgrounds, as well as BAME and White British populations. Practical barriers, 
including the collection of samples and storing the kit, were more commonly 
reported by men, irrespective of SES, ethnic background and screening history.  
Despite some commonalities across subgroups, a number of barriers were 
endorsed primarily by BAME populations.  For instance greater cancer fatalism 
was observed among BAME populations, a finding which echoes results from 
previous research conducted in bowel (Lyratzopoulos, Liu, Abel, Wardle, & 
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Keating, 2015; Miles et al., 2011), breast (Facione, Miaskowski, Dodd, & Paul, 
2002), cervical (Austin, Ahmad, McNally, & Stewart, 2002; Johnson, Mues, Mayne, 
& Kiblawi, 2008), lung (Bergamo et al., 2013) and prostate cancer screening 
(Odedina et al., 2011). Participants from BAME backgrounds were more skeptical 
about the value associated with early cancer detection and were more likely to 
perceive cancer as a condition that would unavoidably result in death. Moreover, 
ethnic minority participants, and particularly past non-screeners, expressed the 
view that cancer screening or efforts to treat cancer in the event of cancer 
diagnosis are futile and this often stemmed from perception that cancer is fated. 
Fatalistic beliefs appeared to be associated with participants’ religious beliefs; for 
instance, individuals who adopted a God-centred framework of health, whereby 
disease prevention was perceived as being beyond human control and 
responsibility for health outcomes was deferred from oneself to God, were less 
likely to be up-to-date with screening. It has been reported elsewhere that religious 
values may affect preventive health behaviours in ways that acculturative or 
socioeconomic factors do not (Hayward, Krause, Ironson, & Pargament, 2016; 
Padela, Peek, Johnson-Agbakwu, Hosseinian, & Curlin, 2014), however it remains 
unclear whether religious beliefs and values deter or promote cancer screening, 
with some studies reporting negative (Padela et al., 2016) and others positive 
effects on uptake (Rajaram & Rashidi, 1999). Nevertheless, these findings indicate 
that fatalistic beliefs need to be addressed in future behaviour change interventions 
and/or public health campaigns, and that the consideration of particular belief 
structures and worldviews of BAME populations, when creating health promotion 
materials, may enhance screening uptake compared to more generic health 
messages.  
It is a well-established finding that low awareness about bowel cancer and 
screening is not conducive to screening uptake (Goodman, Ogdie, Kanamori, 
Canar, & O Malley, 2006; Greiner, Born, Nollen, & Ahluwalia, 2005; McAlearney et 
al., 2008; Weller, 2005). Lack of knowledge is an independent predictor of negative 
attitudes towards screening and is associated with reduced intention to participate 
in future screening. Moreover, previous research shows that BAME and low SES 
populations report greater lack of awareness about bowel cancer (Javanparast et 
al., 2010; Liss & Baker, 2014). Evidence from the present research also suggested 
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that greater socioeconomic deprivation and ethnic minority status were associated 
with lower awareness regarding the benefits of screening and the risk factors of 
bowel cancer. Similarly, awareness levels were lower among past non-screeners, 
irrespective of level of SES and race/ethnicity, suggesting that screening 
participation does not rely solely on sociodemographic variables and is a behaviour 
that needs to be examined by simultaneously considering contextual factors 
affecting screening decisions. For instance, non-screening White British women, 
reported that the influences of traumatic past experiences with other forms of 
cancer screening (e.g., mammograms), unfavourable views towards the NHS and 
negative interactions with healthcare professionals, negatively impacted on their 
decision to participate in screening. Findings from the cancer screening literature 
also suggest that factors such as medical mistrust and negative healthcare 
experiences are factors that contribute to lower cancer screening attendance 
(Bynum et al., 2012).  
Moreover, engagement with screening was heavily influenced by whether or 
not participants had familial cancer history; participants without familial cancer 
history were more likely to perceive themselves as less susceptible to bowel 
cancer and were more likely to misinterpret the lack of cancer symptomatology for 
confirmation of good health, which behaviouraly translated into nonparticipation in 
screening. On the other hand, participants that had a personal experience of 
cancer occurring within their families were more likely to be up-to-date with 
screening and were more likely to highlight aspects from their personal experience 
that related to the enduring physical and psychosocial consequences. Indeed, 
participants with familial cancer history were more likely to view the diseases as 
common and serious, suggesting greater levels of perceived severity. This finding 
in particular suggests that social influence factors can affect screening uptake and 
therefore require important consideration for intervention planning.  
Health literacy also arose as a barrier among individuals with limited 
English-language proficiency and appeared to contribute to the, overall, lower rates 
of bowel cancer screening among BAME populations. Poor health literacy skills 
meant that participants relied more heavily on the provision of social support by 
their wider community and/or close networks in order to process and understand 
screening-related information. This is in line with findings from a recent systematic 
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review, which examined whether community-based initiatives can improve health 
literacy among older adults (de Wit et al., 2018) and showed that co-learning – a 
process whereby individuals interact and exchange health knowledge with family, 
community members and peers – was associated with substantial improvements in 
critical health literacy (defined here as “the understanding and ability to judge, sift 
and use information provided in the context of one’s own life”; Kickbusch, 2001; 
p.294). However, despite the benefits of social support, these sources of support 
were not available to all study participants – for instance, some study participants 
reported chronic health problems that prevented them from attending community 
group meetings, - thereby removing the option to interact and exchange 
information with others in order to make health decisions.  
Health literacy has repeatedly been recognised as a critical factor that drives 
and sustains health inequalities in bowel cancer screening (Kobayashi et al., 2014; 
Oldach & Katz, 2014; Smith et al., 2016). The improvement of health literacy to 
promote health outcomes has been recognised as a major public health challenge 
(Harris et al., 2015) with current evidence suggesting that there are few effective 
interventions that manage to address health literacy issues and lead to substantial 
and sustainable behaviour change (Jacobs, Lou, Ownby, & Caballero, 2016; 
Nutbeam, 2000). Given that the current literature suggests that health literacy is 
not an easily modifiable construct, perhaps greater emphasis should be placed on 
alternative strategies to eliminate cancer screening disparities. For example, the 
present research highlighted the usefulness of implementing community-based 
initiatives and involving ‘trusted’ community leaders/representatives to advise 
community members about health issues. People from BAME backgrounds, who 
often lack other sources of social support, can gain much health knowledge 
through collaborative learning within their community, suggesting that it is important 
to increase our focus on strengthening social support and social networks in order 
to enhance uptake among BAME populations.  
The present findings also suggest that greater GP involvement in the 
decision-making process might increase engagement with cancer screening for 
populations with lower levels of health literacy and acculturation; a finding also 
supported by previous research on patient-provider communication (Lafata et al., 
2014; Nápoles, Gregorich, Santoyo‐Olsson, O'brien, & Stewart, 2009; Nápoles et 
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al., 2015) service users might feel more willing to participate in screening if GPs 
were more engaged from the outset. Enhancing GP involvement might be 
particularly critical for improving uptake among BAME populations, given previous 
research showing that ethnic minorities in both the UK (Lyratzopoulos et al., 2012) 
and the USA (Saha, Arbelaez, & Cooper, 2003) report interpersonal quality of care 
overall more negatively than White Caucasian populations and experience poorer 
communication with physicians. Surprisingly, although the majority of study 
participants reported having positive views towards the NHS, medical mistrust was 
a barrier for screening for a small proportion of White British participants. Concerns 
about data protection, issues of confidentiality and/or suspicions about the 
provision of healthcare being influenced by financial motivations, were a few 
factors that contributed to negative perceptions of the NHS. However, such views 
also seemed to be influenced by past negative interactions with healthcare 
professionals as well as traumatic past experiences with other cancer screening 
programmes – for instance, some female non-screeners reported adverse 
experiences (e.g., pain, invasiveness) with breast and cervical cancer screening, 
which they seemed to transfer into the context of bowel cancer screening, despite 
the non-invasiveness of the gFOBT kit.   
Similar to findings by previous research, social influence by close networks 
also played an important role in shaping bowel cancer screening behaviour 
(Adams, Richmond, Corbie-Smith, & Powell, 2017; Bynum et al., 2012). Important 
others represented a source of support, and often participants reported feeling 
motivated by their friends, family and even people within their wider community, to 
take part in screening. Across all population subgroups, particularly important was 
the influence of spousal/partner support, with findings from both quantitative 
(Manne, Kashy, Weinberg, Boscarino, & Bowen, 2012) and qualitative studies 
(Ekberg, Callender, Hamer, & Rogers, 2014; Manne, Etz, et al., 2012) suggesting 
that partners can influence screening decisions both directly - for example, by 
leading by example, by encouraging one’s spouse, and by using the relationship as 
a motivating influence – and indirectly – for example, by having a shared 
commitment and being supportive of each other to engage in practices that 
maintain and promote health.  
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One factor that stood out for motivating gFOBT uptake among past 
screeners, was the belief that one is morally responsible for one’s own health 
choices. Interviewees, who were up-to-date with bowel cancer screening, tended to 
endorse proactive self-care and argued they had a moral responsibility to maintain 
good health and prevent cancer. Screeners strongly demonstrated a ‘will to health’, 
whereby cancer screening uptake was perceived as a behaviour that directly 
promoted self-care. Screening participants indicated that adhering to screening 
guidelines was driven, both by self-respect and the motivation to preserve personal 
wellbeing – a factor that was also associated with maintaining individual autonomy 
with older age - but also by respect towards their families and not wanting to 
become a burden on important others. The fact that the present research 
highlighted a strong sense of personal responsibility as a facilitator of bowel cancer 
screening uptake is particularly promising, given recent data published by the 
World Health Organisation (WHO) showing that lifestyle-related diseases, including 
cardiovascular diseases, cancer, chronic respiratory diseases and diabetes 
currently account for 77% of the total disease burden and 68% of total deaths 
globally (WHO, 2014). Indeed, the role of personal responsibility has growing 
pertinence in the literature (Ayo, 2012; Greener, Douglas, & van Teijlingen, 2010; 
Kähkönen et al., 2015; Lupton, 2012; Steinbrook, 2006) which proposes that 
screening promotional information may benefit from the inclusion of social-
responsibility statements to motivate action to change.  
Screeners were also more likely to emphasise the convenience, privacy and 
autonomy with which the gFOBT test can be completed. The fact that bowel cancer 
screening does not require scheduling and attending a medical appointment was 
particularly highlighted as a positive aspect of the screening kit and appeared to 
improve the sense of self-efficacy and perceived behavioural control over the 
screening process; both factors that have been positively associated with 
participating in cancer screening (Beydoun et al., 2008; Orbell, Hagger, Brown, & 
Tidy, 2006). Of note, perceived self-efficacy appeared to increase as a result of 
repeat participation in screening, with multiple screening participants expressing 
that the first episode of screening was the most challenging. This is important 
information for consideration in the design of interventions targeting first-time 
invitees (i.e., prevalent screening episode). It is also possible that including 
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statements that accentuate the convenience of home-based screening may lead to 
greater uptake, which in turn may promote repeat participation.  
Perceptions of the FIT versus the gFOBT revealed somewhat unexpected 
findings; despite interviewees mostly agreeing that the FIT would be easier due to 
the convenience of having to collect one stool sample, a number of participants 
expressed concerns over the diagnostic reliability of a one-sample screening kit. 
Participants with irregular bowel movements in particular, were more likely to 
indicate a preference for the three-sample stool test in fear that one sample could 
lead to a misdiagnosis of cancer. This is somewhat unexpected, as one might 
expect that the requirement of one stool sample would automatically lead to more 
positive test perceptions. Nonetheless, this finding highlights the importance of 
emphasising the superiority of the FIT in terms of diagnostic accuracy during the 
initial phases of the introduction of the FIT in order to avoid any public 
misperceptions of the new kit.  
3.5.2. Limitations 
Despite using a maximum variation sampling approach during participant 
recruitment, it was evident that female participants in the present sample were 
predominantly from a White British ethnic background and tended to have a higher 
SES. Few women in the sample were from BAME backgrounds and there was a 
particular lack of women from Asian/British Asian backgrounds, which represents a 
large ethnic group in the UK. However, there was a strong representation of 
Asian/British Asian men within the sample, suggesting that the views of this 
particular ethnic group were adequately represented within the data. Nevertheless, 
given that the results highlighted important differences among men and women in 
relation to gFOBT screening participation it would have been useful to recruit more 
women from this ethnic group to further explore their views in relation to screening.  
A further limitation was that screening uptake was assessed retrospectively, 
via self-report. It is therefore likely that participants may have misreported past 
screening behaviours, either due to difficulties in remembering past screening 
episodes accurately or due to social desirability bias, which is more pronounced in 
qualitative research, and particularly 1:1 interviews, due to the more intimate 
nature of research conversations, which are likely to intensify participants’ 
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tendencies to want to make a positive impression on the researcher (Collins, 
Shattell, & Thomas, 2005).  
3.5.3. Researcher Reflections 
In this section, I, the primary researcher reflect on the processes and 
logistical challenges posed by conducting qualitative research (i.e., Study 2) with 
ethnic minority and low SES participants. The aim of this section is two-fold: firstly, 
to provide an overview of some of the main barriers I experienced with regards to 
gaining access to, recruiting and conducting interviews with participants from 
BAME and low SES populations, and secondly, to provide some practical 
guidance, recommendations and key learning points that other researchers may 
find useful when planning and/or conducting research with marginalised 
populations. My intention for this section is to provide a summary of post-research 
reflections, which may be informative to new qualitative researchers, like myself, as 
well as more experienced researchers with an interest in health inequalities 
research. This section does not however provide an exhaustive list of all the 
possible components important to conducting research with marginalised 
communities. 
3.5.3.1. Key Learning Point 1: Collaboration with Community ‘Leaders’ 
The involvement of BAME and low SES populations in my doctoral research 
was a complex and multi-layered challenge; the resources, energy and time 
required to firstly, identify eligible participants from the communities of interest and 
secondly, recruit participants were substantial. From the onset of the research it 
became apparent that enlisting the active assistance of community ‘leaders’ (also 
referred to as community gatekeepers or community stakeholders) was imperative 
for enhancing people’s motivation to participate in the research. Previous research 
has emphasised the importance of collaborating with community ‘leaders’ in order 
to gain access to ethnic minority and low SES groups (Rugkåsa & Canvin, 2011; 
Shedlin, Decena, Mangadu, & Martinez, 2011; Sheikh et al., 2009). Community 
‘leaders’ not only understand the networks and wider socio-cultural norms and 
beliefs of the communities of interest, but also have an inherent understanding of 
the population-specific barriers in accessing healthcare services (Fassinger & 
Morrow, 2013). I came to deeply recognise their value and support was central to 
the success of accessing and recruiting participants otherwise reluctant to engage 
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with research. However, it must be emphasised that developing and establishing 
relationships with important stakeholders and community representatives is a 
complex and time-consuming process. Firstly, as reported elsewhere, there are 
challenges in defining who does and does not hold the position of ‘community 
leader’ or ‘community representative’ and the extent to which these individuals 
have influence their communities (Sheikh et al., 2009); in this respect, it was 
helpful that my doctoral research was funded by Leeds City Council (LCC), which 
works in partnership with community representatives and could readily provide 
their contact details. Having LCC as a link between myself and community ‘leaders’ 
greatly increased the possibility of gaining access and having the personal contact 
details of community ‘leaders’ was a key deciding factor when deciding which 
organisations to approach during the pre-implementation phase of Study 2. It is 
worth highlighting that it took a lot of time and personal effort to get from the point 
of initial contact with an organisation and/or community ‘leader’ to the point of 
gaining access. For instance, I organised and attended meetings with healthcare 
professionals (HCPs) I knew through the wider LCC network, who had previously 
conducted research with community organisations in order to improve my 
understanding regarding the correct protocol of requesting access, I dedicated time 
to phone calls and email communication liaising with community ‘leaders’ and on 
numerous occasions I arranged pre-meetings with community ‘leaders’ in order to 
discuss the study in further detail before they decided whether they were willing to 
grant access or not. Initiating and maintaining good working relationships with 
community ‘leaders’ required very clear communication on my behalf regarding 
both the procedural aspects of the research (e.g., when, where and how the 
research would be implemented) as well as the broader context of the research 
(e.g., aims, wider implications). Most importantly the key question I had to be 
conscious of and clearly communicate to community ‘leaders’ was, how can this 
research be conducted with the minimum inconvenience and maximum benefit for 
the participating organisation and its members? Organisations involved in doing 
community work with low SES and BAME groups often receive an overwhelming 
number of requests to be involved in research; in some discussions I had with 
community ‘leaders’ they reported that their previous engagement in studies had 
been largely negative, which in turn led them to being uncertain, anxious and 
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skeptical to participate in research anew and to grant access to future researchers. 
Some of the negative past experiences stakeholders reported included: 
researchers not being punctual, not attending/cancelling scheduled interviews with 
participants, not being clear about the time commitments involved to participate in 
the research for both the organisation and participants, being vague about the 
purposes of the research and not displaying cultural competence and/or cultural 
sensitivity tailored to the community of interest. These discussions further engaged 
me in reflecting on the research process from the stakeholder’s perspective and 
helped me gain a better understanding of the reservations they might have when 
agreeing to participate in research.  A few key learning points from my research 
were: a) that planning and resources bust be invested in initiating and developing 
collaborations with community leaders from the outset; b) having a pre-existing link 
between the researcher and a community organisation and/or community ‘leader’ 
can facilitate the process of gaining access (in the case of my research the link 
was LCC); c) conducting all research activities in a way that minimises 
inconvenience for organisations and participants and making an organisation’s 
participation in research a positive experience, as not doing so will have negative 
implications for future researchers aiming to gain access to these communities.  
3.5.3.2. Key Learning Point 2: Translator/interpreter Services 
Another reflection concerns the non-use of interpreters/translators in my 
research. It would have been beneficial to involve interpreters/translators as it is 
likely that more people from BAME communities might have been willing to take 
part but were unable to due to having no, little or insufficient knowledge of written 
or spoken English. Unfortunately, due to financial and time constraints it was not 
possible to involve interpreters/translators in Study 2, which meant that some 
individuals from the communities of interest did not stand an equal chance of 
having their views expressed on the topic of CRC screening uptake. Therefore, 
future research interested in understanding, responding to, or even investigating 
the challenges BAME populations face with regards to accessing health services 
would benefit from involving interpreters/translators in order to bridge the language 
barriers between researchers and participants. Through conversations with public 
health specialists and healthcare professionals involved in commissioning and /or 
providing local services for LCC, it became clear that accessing and utilising 
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interpreter/translator services poses its own challenges due to a shortage of 
professional interpreters/translators - which is particularly relevant to accessing 
certain communities (e.g., Kurdish) - and due to a lack of availability and long 
waiting times. Therefore, it is important that sufficient time is allowed for sourcing 
and engaging interpreters/translators and that such considerations are made 
throughout the research process (i.e., from the pre-implementation phase to the 
recruitment and implementation phases); for instance, an interpreter/translator will 
be involved in both conducting interviews and completing transcriptions, which 
represents a substantial time commitment. Other research has highlighted a range 
of potential methodological barriers which should be considered when involving 
translators/interpreters into the research process – for instance, challenges in 
assessing the interpreter’s linguistic credentials, difficulties in differentiating 
languages from dialects, ensuring that the interpreter/translator is committed to 
accurately conveying what is being said (i.e., conceptual equivalence), verifying 
accuracy of transcription/translation from an independent source and assessing 
whether the translator’s presence affects the narratives constructed by participants, 
and therefore the reliability of the research (Larkin, Dierckx De Casterlé, & 
Schotsmans, 2007; Squires, 2009; Sutrisno, Nguyen, & Tangen, 2014).   
3.5.3.3.Key Learning Point 3: The importance of cultural reflexivity and 
interviewing style 
Cultural reflexivity was also a crucial element in the study. As a researcher 
and as a person from a non-ethnic minority myself, from a younger age group, who 
has not been invited or competed a CRC screening kit, it was essential that I made 
a consistent effort to examine the subject of CRC screening uptake from the 
position of the participant and to not allow my own preconceived notions about 
participants to influence my interpretation of their experiences. Due to being a 
novice researcher myself with no prior experience of conducting interviews with 
BAME and low SES populations in the community, I initially found this challenging 
and was constantly conscious to not misrepresent the views of study participants 
due to communication difficulties that inevitably arise when researchers and 
research participants have disparate worldviews. Upon reflection, it was particularly 
helpful that the interviews followed a semi-structured format as this offered the 
opportunity to explore participants’ realities and how they made sense of the 
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screening process without being confined to a strict interview guide that I needed 
to rigidly adhere to.  Post-research reflections also concerned the importance of my 
interviewing style; it was particularly helpful to acknowledge in and for myself my 
inexperience in conducting interviews in community settings with marginalised 
populations and to remind myself to stay curious and open to participants’ stories. 
Staying curious and open was key to learning to deal with the unexpected and gain 
a more in-depth understanding or each participant’s social world irrespective of 
their cultural or socioeconomic background. I think the fact that I am a foreigner in 
the UK myself was helpful in not having deeply engrained, pre-conceived ideas 
regarding the NHS and the quality of and access to healthcare services in England; 
in a way my ‘foreignness’ helped me maintain a neutral stance to some strong 
views that were expressed by interviewees (e.g., negative experiences within the 
NHS, medical mistrust) and helped expand my understanding with regards to the 
multiple ‘stories’ of the same topic. Central to building rapport with participants from 
a variety of ethnic and socioeconomic backgrounds was being an active, interested 
and non-judgmental listener. I believe that these qualities (i.e., openness, staying 
curious) not only helped establish good rapport but also made the interview 
process more meaningful to participants; a few participants disclosed to me after 
the interview that they found our conversation empowering and that they felt they 
had contributed to something of value, which I think was largely due to participants 
feeling ‘heard’ during the interview process. The fact that interviews were 
conducted in participants’ communities, where people felt comfortable and 
welcomed to, was important in facilitating recruitment and building trust and also 
eliminated barriers relating to transportation, time and location. I also feel that the 
fact that I was the ‘outsider’ in those communities, neutralised the power that, by 
definition, researchers have, and therefore helped prevent the development of any 
power imbalances between myself and interviewees. Overall, my experience with 
conducting Study 2 highlighted that the researcher’s interviewing style is central to 
conducting meaningful qualitative interviews with people from all walks of life. 
There are lessons to be learned about the importance of approaching the interview 
from a position of curiosity and attending closely to participants’ personal narratives 
rather than being focused on entertaining our own predilections.  
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3.5.3.4. Concluding Remarks and Key Messages 
Currently, there is an invisibility of diversity in the majority of published 
research concerning access to and use of cancer screening services (and 
healthcare services more broadly) among minority ethnic communities and low 
SES populations in the UK. This has potential to contribute to the perpetuation of 
existing barriers and to the preservation of inaccessible health services, which in 
turn is damaging for the experience of and/or health outcomes for BAME and low 
SES communities. Unless current practices on how research is funded and 
conducted change and are adapted to the needs of these specific communities, it 
is unlikely that progress will be made in understanding the difference and 
complexity of how people from ethnically and socioeconomically diverse 
backgrounds experience healthcare services. Increasing the number of people 
from BAME and low SES communities in health research is therefore vital to 
improve academic knowledge and in turn inform policy and practice.  Reflections in 
this section on the topic of recruiting and conducting interviews with BAME and low 
SES participants to explore the factors that influence CRC screening participation 
highlighted a number of issues that can influence the access to and experience of 
taking part in research. In summary, this section highlighted some key factors that 
should be considered by future research, which are:  
a) Collaboration with community ‘leaders’/gatekeepers/stakeholders should 
be prioritised as a means of approaching BAME and low SES populations  
b) Researchers may benefit from having a wider professional network of 
HCPs and/or organisational support (e.g., local council) as both may act as 
valuable sources of support and expertise with regards to accessing and 
developing relationships with community ‘leaders’ and, more widely, the 
communities of interest. 
c) Researchers should consider the possibility of involving 
translators/interpreters where possible whilst at the same time being aware of the 
complexities attached to this process. 
d) Researchers should ensure that they are actively making an effort to 
develop a culturally reflective interviewing style and that they are demonstrating 
their respect for the communities being studied. 
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e) Researchers should be actively listening to participants’ narratives and 
should maintain an ‘open and curious listener’ position, which may make 
participation more meaningful for the members of the community under 
investigation. 
f) Researchers should be aware of the additional resources, time and effort 
required in accessing and recruiting participants from minority ethnic and 
socioeconomically disadvantaged communities in health research; greater 
awareness about the complexities in accessing and recruiting these populations 
may facilitate their recruitment in healthcare research in the future, which has 
important implications for improving access to services and health outcomes for 
everyone in society, regardless of their socioeconomic or ethnic background.   
3.5.4. Conclusions 
This study provided an opportunity to explore the views of a range of 
different population subgroups in relation to the barriers and facilitators that may 
affect people’s decision making in relation to gFOBT screening uptake. Overall, the 
findings indicated that service users experience both practical and emotional 
barriers and expressed concerns relating to the entirety of the cancer pathway 
including the pre-diagnosis, diagnosis and post-diagnosis/treatment phases. 
Substantial differences were observed among men and women, with men reporting 
greater practical barriers in relation to stool-sampling procedures compared to 
women, as well as between BAME and White British populations, with participants 
from BAME backgrounds experiencing greater practical difficulties often due to 
lower levels of health literacy, which in turn negatively impacted on levels of 
knowledge and awareness in relation to gFOBT screening. Some differences were 
observed among past non-screeners and screeners, with past screeners being 
more likely to express feelings of gratitude towards the NHS and exhibiting greater 
health conscientiousness compared to non-screeners. Differences between 
participants with higher and lower SES were less pronounced. The next chapter of 
this thesis (Study 3) seeks further explanation for the variation in screening uptake 
between the population subgroups presented within this chapter. Specifically, the 
next study will explore the direct and indirect associations between 
sociodemographic factors, psychosocial variables and gFOBT screening intention.
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CHAPTER 4 
An Exploration of Sociodemographic and Psychosocial Factors as 
Predictors of gFOBT Screening Intention (Study 3) 
4.1. Introduction  
Study 2 examined the factors that either facilitated or inhibited bowel cancer 
screening uptake. Specifically, Study 2 provided a qualitative analysis of 
participants’ perceived barriers and facilitators and explored how these affected 
gFOBT screening by variation in SES, ethnicity, gender and past screening history. 
Results revealed that some barriers, both emotional (e.g., embarrassment, disgust) 
as well as practical (e.g., stool sampling difficulties), were common across all 
population subgroups. At the same time, findings indicated that there were 
substantial differences between White British and BAME populations, men and 
women and past screeners and non-screeners. Some differences, such as level of 
awareness about screening and knowledge about bowel cancer risk factors, were 
highlighted between high and low SES populations, however, the effects of SES on 
gFOBT screening uptake were overall less clear. Study 2 enabled the preliminary 
exploration of psychosocial factors that might determine the different ways that 
service users understand bowel cancer screening, including the ways they 
perceive it and their attitudes towards it. However, due to the exploratory nature of 
qualitative research, it was not possible to pinpoint specific sociodemographic and 
psychosocial constructs that influence people’s intention to participate in screening. 
The present study draws upon findings from the previous chapter and uses a 
quantitative methodology to test whether: a) sociodemographic and psychosocial 
factors directly influence gFOBT screening intention, b) psychosocial variables 
mediate the influence of sociodemographic variables on intention, and c) whether 
sociodemographic factors moderate relations between psychosocial variables and 
gFOBT screening intention.  
A psychological approach, informed by social cognition models (SCMs), for 
the exploration of gFOBT screening behaviour was considered appropriate within 
the context of the present thesis for a number of reasons. Firstly, findings from the 
previous chapters identified and demonstrated the importance of number of 
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psychosocial factors that appeared to affect people’s decision-making processes 
with regards to CRC screening, thereby prompting the need for additional 
exploration. Secondly, it has been proposed that cancer screening is a behaviour 
that involves a dual psychological process, whereby on the one hand individuals 
weigh the risk for consequences – that is, the upsetting possibility that screening 
could lead to the detection of a potentially deadly disease – whilst on the other 
hand they are considering the benefits of action – that is, that taking part in 
screening provides greater assurances that in the event cancer diagnosis does 
occur, detecting it at the earliest stage possible will lead to greater chances of 
survival and important long-term health benefits. Indeed, psychological theories of 
health behaviour propose that an individual’s risk perception can motivate health 
behaviour (Janz & Becker, 1984; Rosenstock, 1974; Rothman et al., 1997; 
Weinstein, 1988). Theory-driven, health behaviour change interventions that have 
tested such theories have shown that targeting and changing risk perceptions (e.g., 
perceived severity, perceived susceptibility) has important consequences for health 
behaviour change (Brewer et al., 2007; Ferrer & Klein, 2015; Noar & Zimmerman, 
2005; Orbell, Crombie, & Johnston, 1996; Orbell, Perugini, & Rakow, 2004). 
Thirdly, within the wider health behaviour change literature, SCMs have provided 
useful frameworks that have enabled and advanced our understanding with 
regards to the choices and actions that people make in relation to their health.  
Psychosocial constructs proposed by SCMs, have consistently been found 
to be predictors of health behaviours and targeting such variables through health 
interventions has successfully elicited behaviour change (Conner & Norman, 
2015). Meta-analyses have shown that SCMs such as the Theory of Planned 
Behaviour (TPB; Armitage & Conner, 2001; Godin & Kok, 1996)  and its precedent, 
the Theory of Reasoned Action (TRA; Shepherd, Hartwick, & Warshaw, 1988) have 
good predictive ability both in terms of behavioural intention and actual behaviour 
for a range of health behaviours. The predictive ability of SCMs is particularly well-
established in relation to physical activity (PA) and dietary behaviour with several 
studies showing that social cognitive constructs explain 40-71% of the variance in 
relation to PA behaviour among adults (Ayotte, Margrett, & Hicks-Patrick, 2010; 
Phillips & McAuley, 2013; Rovniak, Anderson, Winett, & Stephens, 2002; White, 
Wójcicki, & McAuley, 2011), and approximately 36-61% of the variance in fruit and 
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vegetable consumption (Anderson-Bill, Winett, & Wojcik, 2011; Anderson, Winett, & 
Wojcik, 2007).  
Within the context of cancer screening behaviour, few meta-analytic reviews 
have examined the application of the integrated TRA/TPB in relation to cancer 
screening uptake. A meta-analysis on the application of the TPB to health 
behaviour by Godin and Kok (1996) reported that constructs of the model 
combined, explained a significant proportion of the variance in screening 
behaviour. Moreover, the authors reported strong, positive associations between 
TPB-based constructs - including subjective norms, attitudes and perceived 
behavioural control (PBC) - and intention and behaviour; findings similar to those 
reported for other health behaviours (Armitage & Conner, 2001). A more recent 
meta-analysis by Cooke and French (2008) , which included 33 studies, quantified 
the extent to which TRA/TPB predicted intentions to attend cancer screening 
programmes, as well as actual attendance behaviour. Similar to the findings by 
Godin and Kok (1996), the authors reported large-sized relationships between 
attitudes and intention (r = 0.51), and medium-sized relationships between both 
subjective norms-intention (r = .033) and PBC-intention (r = 0.46). Intention was 
also positively correlated with subsequent attendance to cancer screening 
programmes (r = 0.35). The weakest correlation was observed between PBC and 
behaviour (r = 0.29). Common to the two meta-analyses was the fact that the 
strongest association was observed for the attitude-intention relationship, whereas 
smaller-sized associations were observed for the subjective norm-intention, PBC-
intention, PBC-behaviour and intention-behaviour relationships, suggesting that 
attitudes might be a particularly important construct to be considered in the context 
of cancer screening behaviour.  
More recent evidence in the cancer screening literature further 
demonstrates the usefulness of SCMs; Farhadifar and colleagues (2016) examined 
the effectiveness of two-theory based interventions – an intervention based on the 
Health Belief Model (HBM) and a TPB-based intervention - in improving 
mammography screening among women who were previously non-adherent to 
screening. Results indicated that the women in the HBM-based group obtained 
significantly more mammograms compared to the control group due to greater 
perceived susceptibility and self-efficacy. A similar pattern of findings was observed 
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among the TPB-based group for which mammography rates were significantly 
higher relative to the control group due to greater PBC. Another study by 
Sieverding, Matterne and Ciccarello (2010) investigated the role of TPB variables 
to predict uptake of cancer screening (including both prostate cancer and CRC 
screening) among a sample of 2,426 men and found that, after controlling for 
sociodemographic variables, attitudes and PBC were predictive of cancer 
screening intention and that intention was a significant determinant of subsequent 
screening participation. In addition, Sieverding and colleagues (2010) examined 
the influence of social norms on cancer screening behaviour in an extended model 
of the TPB and differentiated between two types of normative social influence – 
firstly, the injunctive norm, which pertains to behaviours which are commonly 
approved by important others (also known as subjective norm) and secondly, the 
descriptive norm, which pertains to what is typically done by others in a given 
setting (Reno, Cialdini, & Kallgren, 1993). The findings indicated that the injunctive 
norms construct was an important predictor of intention, however, the descriptive 
norms construct was able to further increase the variance explained over and 
above classical TPB variables, suggesting that screening behaviour is influenced 
both by what important others expect us to do, but also by our perception of how 
others, comparable to ourselves, behave with regards to cancer screening.  
Within the context of CRC screening specifically, two recent UK-based 
studies have also examined the influence of psychological factors on gFOBT 
screening participation. Firstly, a study by Lo, Waller, Vrinten, Kobayashi and von 
Wagner (2015) examined whether social cognitive factors – and specifically, 
screening knowledge, social norms and perceived barriers – mediated 
sociodemographic differences in gFOBT uptake among a sample of 1,309 
participants and found that all three variables mediated SES differences in uptake. 
Findings further indicated that differences in uptake by marital status were primarily 
mediated through social norms and to a lesser extent through knowledge, while 
age differences were largely unmediated, except for a small mediated effect via 
social norms. Similarly, the second study examined (Orbell, Szczepura, Weller, 
Gumber, & Hagger, 2017) whether psychological factors – specifically, perceived 
severity, perceived vulnerability, response efficacy, response costs and self-efficacy 
– mediate the relationships between SES and gFOBT uptake, as well as ethnicity 
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and uptake, among a sample of an ethnic minority, South-Asian population (Hindu-
Guajarati/Hindi, Muslim-Urdu and Sikh-Punjabi; N = 1,678). Findings indicated that 
lower self-efficacy and higher perceived response costs fully mediated the 
relationship between ethnic minority status and gFOBT uptake. Furthermore, the 
association between ethnicity and gFOBT uptake was partially mediated by SES 
with the model indicating statistically significant two-path indirect effects via self-
efficacy and response costs. Collectively, these findings suggest that shifting out 
attention towards social cognitive constructs and extending our scientific 
understanding of the mechanisms through which structural factors, such as SES 
and race/ethnicity, affect gFOBT screening uptake is important because, unlike 
sociodemographic factors, social cognitive factors are amenable to change and 
thus can promote the development of effective and targeted interventions. In turn, 
such interventions may have important implications for improving overall gFOBT 
uptake and reducing CRC screening inequalities.  
In addition, although much research has focused on the importance of 
sociodemographic variables in relation to CRC screening, few studies have 
examined the potential sociodemographic moderators of the relationship between 
screening intention/uptake and psychosocial variables. One study by von Wagner, 
Good, Smith and Wardle (2012) investigated whether intentions were moderated 
by an individual’s disposition to evaluate health actions according to the 
consideration of future consequences (CFC) – that is, their short versus long-term 
consequences and how this affected consideration of benefits and practicalities of 
CRC screening. Results indicated that people in the low CFC group were more 
likely to focus on the practicalities of screening rather than the benefits, whereas 
for the high SES group the opposite pattern of results was found. Von Wagner and 
colleagues had originally aimed to assess the role of ethnicity as a potential 
moderator, however, most of the study participants were from White Ethnic 
backgrounds and therefore it was not deemed feasible to conduct this analysis. 
Some studies from the wider cancer screening literature, have also tested 
moderation models; for instance a study conducted in the US (Perez, Elder, 
Haughton, Martinez, & Arredondo, 2017) tested whether sociodemographic factors 
– specifically, education, income and level of acculturation - moderated 
associations between psychological factors – specifically, perceived barriers to 
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breast cancer screening, stress and depressive symptoms - and mammography 
uptake among Latino women. Among other findings, the authors reported that level 
of education moderated the relationship between perceived barriers and 
mammography uptake, with an inverse association only among the low-education 
group. In other words, for women who had less than a high school education, 
greater perceived barriers were associated with lower screening uptake. After 
controlling for access to healthcare the moderation effect by education 
disappeared, suggesting that access to care may have a greater influence on 
mammography participation than the interaction effect between perceived barriers 
and education. Overall, very few studies have examined moderation models, 
therefore additional research is needed to understand the effect of potential 
sociodemographic moderators of the associations between psychosocial factors 
and CRC screening uptake and/or intention. Given what is known about the role of 
SES – including individual-level SES (e.g., education) and area-level SES (e.g., 
neighbourhood deprivation) - and ethnicity in CRC screening participation 
(Meissner et al., 2006; Robb, Power, Atkin, & Wardle, 2008; Steele et al., 2009; 
Von Wagner, Good, et al., 2011), potential moderators that need to be carefully 
examined include race/ethnicity, education and SES. Such factors are expected to 
influence the magnitude of any associations between social cognitive constructs 
and CRC screening intention.   
4.1.1. Theoretical Framework 
As indicated earlier, the objectives of the present study were to examine 
three models of influence – direct, mediation and moderation - to elucidate the 
types of complex relations between sociodemographic variables (e.g., SES, 
education), psychosocial (e.g., social cognitive constructs) variables and gFOBT 
screening intention. Social cognitive constructs included in the present analysis 
were drawn from two theoretical frameworks, and specifically the HBM and the 
integrated TRA/TPB. The reason the present study focused on these two 
theoretical frameworks specifically, is three-fold: firstly, the qualitative analysis 
reported in Chapter 3 indicated that social cognitive factors, such as perceived 
barriers and facilitators (tenets of the HBM) are important determinants of gFOBT 
screening uptake across all population subgroups. Similarly, the qualitative 
  
195 
analysis highlighted that gFOBT screening among study participants was also 
largely attributable to TPB-based constructs, including both intrapersonal factors, 
such as attitudes towards the gFOBT and PBC, as well as contextual factors, such 
as the perceived importance of CRC screening by participants’ social networks, 
including spouses, family and friends. Secondly, the use of the TRA/TPB and the 
HBM as theoretical frameworks, is further supported by the fact that the majority of 
theoretically-driven studies included in the meta-analytic review (Chapter 2) 
incorporated tenets of these models in the development of their proposed 
interventions to improve uptake, suggesting that such theoretical constructs are 
largely thought to be associated with gFOBT screening behaviour. Lastly, tenets of 
both theoretical models have been posited to be relevant to cancer screening. For 
instance, HBM constructs are known to reflect people’s perception of risk, which, 
as indicated earlier, has important implications for health behaviour change and 
particularly precautionary behaviour such as cancer screening. On the other hand, 
attitudes - one of the main constructs of the TRA/TPB - appear to have the 
strongest positive association with behavioural intention, which was the outcome 
variable of interest in the present study. Other potentially relevant theories would 
have been the Protection Motivation Theory (PMT; Rogers, 1975), the Health 
Action Process Approach (HAPA, Schwarzer, Lippke, & Ziegelmann, 2008) and the 
Precaution Adoption Process Model (PAPM; Weinstein, 1988), however, it was not 
deemed feasible to examine all the factors proposed by all these potentially 
relevant theories. 
Given the consensus that attitudes, social norms, PBC and perceived risk 
and susceptibility are key determinants of behaviour, it was decided that jointly the 
TRA/TPB and HBM provided the most suitable and comprehensive conceptual 
framework for examining the multiple pathways between psychosocial constructs, 
sociodemographic factors and screening intention. To the author’s knowledge only 
two other UK-based studies, whose findings were discussed earlier (i.e., Lo et al., 
2015; Orbell et al., 2017) have empirically tested such mediation models within the 
context of gFOBT screening and these studies did not examine the potential 
mediating role for the whole range of psychosocial constructs proposed by the 
HBM and the integrated TRA/TPB model, rather they focused on single constructs 
or a selection of a few constructs as a substitute for the whole theory. Moreover, to 
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the author’s knowledge none of the existing studies have examined separately the 
influence different sub-types of attitudes (i.e., cognitive-instrumental and affective-
experiential) and subjective norms (i.e., injunctive/subjective and descriptive) in 
relation to gFOBT screening intention. Lastly, very few studies have tested 
moderation models examining whether sociodemographic factors, such as SES 
and education, influence the magnitude of the association between psychosocial 
variables and screening intention.  
The decision for selecting intention as the primary outcome was based on 
both theoretical and empirical grounds. Firstly, as indicated above, the integrated 
TRA/TPB model proposes that attitudes and subjective norms influence behaviour 
only indirectly via their impact on behavioural intent. Furthermore, as indicated 
earlier in the thesis, empirical research has demonstrated that cues to action, 
perceived susceptibility, perceived severity, perceived benefits, perceived barriers, 
self-efficacy/PBC, health knowledge and social support substantially influence 
intention and behaviour. Given these premises, and on the basis that intention is 
considered to be a necessary step in the behaviour implementation process, it was 
decided that intention to participate in gFOBT screening would be a suitable 
outcome variable to explore the role of sociodemographic and psychosocial 
variables in relation to CRC screening intention.  
Novel to the present study is the consideration of two of the five personality 
traits proposed in Costa and McCrae’s (1992) five-factor model of personality, 
conscientiousness and neuroticism, as potential mechanisms via which 
sociodemographic variables may influence screening intention. Personality 
constructs have consistently been linked to health outcomes with studies reporting 
that greater conscientiousness is a predictor of longevity and is linked to overall 
healthier behaviours (Jokela et al., 2013; Kern & Friedman, 2008; Roberts, Kuncel, 
Shiner, Caspi, & Goldberg, 2007).  However, currently there is little known about 
the role of personality – defined as a largely stable set of traits and characteristics 
that influences a person’s pattern of behaviour, thoughts and feelings – in relation 
to cancer screening intention. In one study examining the influence of 
conscientiousness, extraversion and openness in relation to cervical cancer 
screening, results indicated that greater levels of conscientiousness was 
associated with fewer perceived barriers to undergoing Pap/smear tests (Hill & 
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Gick, 2011). A study in Japan, found that lower levels of neuroticism were 
associated with greater likelihood of regular participation in the National Gastric 
Cancer Screening Programme (Arai et al., 2009). To the best of the author’s 
knowledge only one UK-based study has examined the links between personality 
and participation in bowel cancer screening. In this study, by Gale, Deary, Wardle, 
Zaninotto and Batty (2015) the authors examined whether participation in 
screening varied according to personality among a sample of 2,681 participants 
and found that greater conscientiousness was linked with a slightly increased 
likelihood of participation in bowel cancer screening, with the authors suggesting 
that further evidence is required to properly gauge the extent to which personality 
traits might influence participation in the NHS Bowel Cancer screening programme. 
Therefore, a further aim of the present research was to examine the relationship 
between these two personality traits and gFOBT screening intention. The focus on 
conscientiousness and neuroticism alone was justified by the fact that previous 
research has suggested a stronger association between these two personality 
traits and health, compared to associations between the remainder personality 
constructs (i.e., extraversion, agreeableness and openness) and health (Hampson 
& Friedman, 2008; Turiano et al., 2011). An overview of the two theoretical 
frameworks followed by the aims of Study 3 are outlined below. 
 
4.1.1.1. The Health Belief Model (HBM) 
The HBM represents one of the most widely used conceptual frameworks in 
health behaviour research and has been extensively used to explain both health 
behaviour change, as well as a guiding framework for the development of health 
interventions (Becker, 1974; Skinner, Tiro, & Champion, 2015). The HBM was 
developed in the 1950’s and originated from the need to investigate why people fail 
to engage with preventive health behaviours (Hochbaum, 1958; Rosenstock, 1960). 
They key components of the HBM, that have been proposed to predict whether 
and why people will take action to prevent, detect and control ill health, are: 
perceived susceptibility, which refers to a person’s perceived risk for contracting 
the health condition/illness, perceived severity, which relates to beliefs about the 
seriousness and the consequences of contracting a health condition/illness, 
perceived benefits, which refers to the perception of the positive things or 
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advantages that could result from engaging with a recommended health behaviour, 
perceived barriers (or costs), which describes the perception of the possible 
obstacles/difficulties and/or negative consequences that would come from 
engaging with a specific health behaviour, cue(s) to action, which concerns the 
exposure to factors that have capacity prompt action, and self-efficacy, which 
refers to the confidence in one’s ability to perform a specific health behaviour. 
Figure 4.1. below depicts the HBM.  
 
Figure 4.  1. Overview of the HBM  
 
The HBM for understanding gFOBT screening behaviour 
Within the context of bowel cancer screening it could be proposed that all of 
the HBM constructs could act as potential mediators between sociodemographic 
variables and screening intention. For instance, people with a family history of CRC 
might perceive themselves as being more susceptible to bowel cancer and this in 
turn might motivate participation in screening. Similarly, a family history of CRC 
could potentially trigger internal cues to action (e.g., experiencing a symptom that 
may heighten perceived threat of CRC) or external cues to action (e.g., a 
recommendation from a family member or a physician). Education might be 
another factor that affects screening intention via HBM-based constructs; for 
instance, people who are more educated might have greater awareness about the 
seriousness of bowel cancer (tapping into the construct of perceived severity), 
which could in turn enhance motivation to screen. Similarly, higher education levels 
might increase people’s PBC in relation to screening - perhaps due to greater 
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confidence in reading, understanding and engaging with health-related information 
and activities – thereby resulting in more positive screening behaviours. People 
with low SES, might perceive more obstacles/barriers and fewer benefits to 
obtaining screening, due to more difficult and complex life circumstances and 
therefore may be less motivated to adhere to screening guidelines. 
4.1.1.2. The Theories of Reasoned Action and Planned Behaviour (TRA/TPB) 
The Theory of Planned Behaviour (TPB; Ajzen, 1991) and its predecessor, 
the Theory of Reasoned Action (TRA; Ajzen & Fishbein, 1980) are among the most 
extensively used SCMs that have provided an explanatory framework for 
conceptualising and predicting a wide range of health behaviours including 
physical activity (Hagger, Chatzisarantis, & Biddle, 2002), nutrition-related 
behaviours (Riebl et al., 2015), alcohol consumption (Cooke, Dahdah, Norman, & 
French, 2016), sun protection behaviour (Starfelt Sutton & White, 2016)  and 
cancer screening (Cooke & French, 2008). As displayed in Figure 4.2, the 
integrated TRA/TPB model asserts that the most proximal predictor of behaviour is 
intention, which in turn is influenced by three key components: firstly, intention is 
determined by attitudes – which refer to one’s favourable or unfavourable 
evaluation(s)/beliefs about the outcomes or attributes of performing the behavior; 
secondly, intention is influenced by subjective norms – which refer to perceptions 
about normative pressure from important referent individuals to perform or not 
perform a specific behavior and, thirdly, intention is determined by one’s perceived 
behavioural control (PBC) – which refers to a person’s control beliefs with regards 
to the presence or absence of factors that inhibit or facilitate behavioural 
enactment, and the weighting/impact of each of those factors on their ability to 
perform a specific behaviour. Originally, PBC was not a component of the TRA 
model, however, it was later added by Ajzen and colleagues (Ajzen, 1991; Ajzen & 
Driver, 1991; Madden, Ellen, & Ajzen, 1992) to account for factors that are outside 
an individual’s control but that nonetheless have capacity to affect ability to perform 
a behavior. The addition of PBC to the model led to the formation of the TPB. More 
recently, Fishbein and Ajzen (2011)  proposed that subjective norms incorporate a 
second component apart from injunctive norms, and included descriptive norms as 
an additional construct to the model.  
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Figure 4.  2. Overview of the integrated TRA/TPB model 
 
 
The integrated TRA/TPB for understanding gFOBT screening behaviour 
Within the context of the present study and based on the TRA/TPB model 
described above, it would be reasonable to suggest that people who hold the belief 
that CRC screening would be associated with positive health outcomes will have a 
positive attitude toward participating in gFOBT screening. Conversely, people who 
do not value or believe that negative outcomes would be associated with CRC 
screening will have a negative attitude towards gFOBT screening participation. 
Moreover, people whose loved ones believe they should participate in CRC 
screening and are heavily influenced by what important others think they should do, 
would be more likely to hold a positive subjective norm, which in turn would 
translate into the person being more motivated to meet their expectations and 
therefore comply with screening recommendations.  Finally, individuals who 
perceive the screening procedure as manageable and uncomplicated may sense 
that they have greater control over completing the screening kit and this will affect 
their intention to participate in screening. Alternatively, given that the TPB model 
proposes that both PBC and intention can be direct and independent predictors of 
behaviour, it could be suggested that individuals with both greater intention and 
greater perceived ability to perform the screening would be more likely to adhere to 
screening recommendations. Finally, the integrated TRA/TPB model proposes that 
a multitude of background factors, including ethnicity, SES and personality are 
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distal predictors that are mediated by the more proximal predictors of intention and 
behaviour (Conner & Norman, 2005). People’s different life circumstances are 
expected to influence tenets of the model (e.g., attitudes), which would in turn be 
expected to influence intentions and actions.  
4.1.2. Study Aims and Objectives 
The aim this study was to conduct a population-based survey to explore the 
psychosocial and sociodemographic determinants of gFOBT screening intention. 
Specifically, this research aimed to investigate the multiple pathways of influence, 
firstly by examining the direct effects of psychosocial and sociodemographic 
variables on screening intention, and secondly by examining indirect effects using 
mediation and moderation analyses.  Due to the limited empirical evidence 
examining the relationships of psychosocial constructs proposed by both the 
TRA/TPB and HBM across different subgroups of the British population in relation 
to gFOBT screening intention, no hypotheses were put forth with regards to the 
strength and directionality of the associations between psychosocial and 
sociodemographic constructs and screening intention. Rather the present study 
was exploratory in nature and aimed to inform the conceptualisation of the role 
different sociodemographic and psychosocial variables have in predicting gFOBT 
screening intention and consequently behaviours. Such findings are anticipated to 
be important in terms of generating testable hypotheses that could be addressed in 
future empirical research.  
 Despite not formulating specific hypotheses, it was anticipated that: 1) both 
sociodemographic variables and psychosocial variables would predict screening 
intention; 2) tenets of the TRA/TPB and HBM - as well as other psychosocial 
constructs included in the analyses - would mediate any associations between 
sociodemographic variables and screening intention; and 3) sociodemographic 
variables would moderate the relationship between psychosocial factors and 
screening intention. 
In summary the study objectives were: 
1. To examine whether sociodemographic and psychosocial characteristics are 
direct predictors of gFOBT screening intention. 
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2. To explore whether psychosocial factors mediated any associations between 
sociodemographic characteristics and gFOBT screening intention. 
3. To investigate whether sociodemographic variables moderated any 
associations between psychosocial constructs and gFOBT screening intention. 
4.2. Method 
4.2.1. Design  
The present study employed a cross-sectional survey design to explore the 
relationship between sociodemographic and psychosocial factors and gFOBT 
screening intention.  
4.2.2. Participants and Recruitment  
Inclusion and exclusion criteria were set prior to recruitment. The inclusion 
criteria for participants were: firstly, to be between the ages of 60 and 74 years; 
secondly, to have received an invitation from the NHS to take part in bowel cancer 
screening; thirdly, to have the ability to read and understand study materials written 
in English language; and fourthly, to have capacity to provide informed consent. An 
additional requirement for participants that were recruited online was to have 
access to the internet. Participants were excluded if they had personal history of 
bowel cancer. As a final exclusion criterion, participants who did not sign the 
consent form were not included in the research.  
Two participant recruitment strategies were implemented; participants were 
recruited online and in-person. For the online recruitment, the study was advertised 
across a range of online platforms, including dedicated participation sites (e.g., 
Social Psychology Network, Online Psychology Research, Call for Participants 
etc.), electronic community message/bulletin boards and newspapers (e.g., rotary 
clubs, community council e-bulletins), social media platforms including Facebook, 
Twitter and LinkedIn. The study was further advertised in dedicated research 
interest groups available via the above-mentioned social media platforms – for 
instance, LinkedIn has dedicated pages, such as PhD Survey Support, Psychology 
Students Network, PhD Students and Supervisors that post research-related 
content. Moreover, the researcher promoted the study using relevant mailing lists 
(e.g., Association of Internet Researchers, Psychology Postgraduate Affairs 
Group). Upon completion of the online survey, participants had the opportunity to 
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enter a prize draw to win one of four £50.00 Amazon vouchers. The final online 
medium that was used for participant recruitment was Prolific Academic, which is a 
crowdsourcing platform tailored for research, which allows potential participants to 
view a list of ongoing online studies for which they meet the relevant inclusion 
criteria. Participants completing the survey via Prolific Academic received £1.00 per 
10 minutes and were not allowed to make an entry for the prize draw. 
Due to the objective of the present research to examine the relationship 
between sociodemographic variables, psychosocial variables and screening 
intention it was important that all population subgroups of interest (e.g., low and 
high SES) were adequately represented within the study sample. For the 
recruitment of traditionally hard-to-reach populations (i.e., older adults, low-income, 
BAME populations), it was particularly important to identify and foster 
collaborations with local community organisations and community stakeholders. 
Therefore, in-person participant recruitment efforts were implemented by 
identifying and enlisting the help of community representatives, who held informal 
leadership roles and were highly respected and socially connected to the 
communities of interest. Community stakeholders provided the main access to the 
more vulnerable participants that took part in the present research. Potential 
participants were approached during weekly events organised for older adults, at 
local community centres, charitable organisations, churches, and any other 
organisation across Leeds that served the population of interest. Organisations 
were selected and approached on the basis that they promoted well-being for older 
adults by providing activities, projects and services to improve their access to 
health opportunities. For instance, two of the organisations that were involved in 
the present research were, Feel Good Factor – an organisation that works with 
communities across Leeds providing activities, projects and services to improve 
access to health opportunities for vulnerable and disadvantaged populations – and 
Black Health Initiative – an organisation that aims to improve equality of access to 
health and social care within for Black African and Black British populations across 
Leeds. Partnerships with these organisations and community stakeholders had 
been initiated during earlier phases of the doctoral research (see section 3.2.2. of 
Chapter 3 for further details) and were maintained throughout the duration of the 
PhD. The study was also advertised through the researcher’s participation in health 
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fairs and/or other community outreach activities relating to the prevention and early 
diagnosis of cancer. Participants who expressed an interest in taking part were 
provided with a questionnaire pack containing an information sheet (Appendix 4.1), 
a consent form (Appendix 4.2) and the full questionnaire (Appendix 4.3). Similar to 
the process described earlier, upon completion of the survey participants that were 
recruited in-person were asked whether they wished to enter the prize draw for 
winning Amazon vouchers. Participants who did not have an email account 
provided either their mobile phone number so that the voucher code could be 
texted to them or their postal address to which the voucher could be posted.  
4.2.3. Measures 
A number of factors were considered to influence intention to take part in 
gFOBT screening. A comprehensive literature review (Chapter 1 and 2) and a 
series of qualitative interviews (Chapter 3) were conducted, which contributed to 
the identification of psychological scales and measures used in the present study. 
As indicated earlier the development of the questionnaire incorporated items from 
two theoretical frameworks, the HBM and the TRA/TPB, but also included other 
factors that were considered pertinent to achieving a conceptual understanding of 
screening intention (e.g., personality constructs). 
4.2.3.1. Sociodemographic Variables 
The questionnaire included ten items to assess a range of 
sociodemographic factors including age, gender, education, employment, marital 
status, area-level socioeconomic deprivation and ethnic background. Participants 
were asked to self-report whether or not they were registered with a GP, whether 
English was the primary language they spoke at home and whether they had a 
family history of bowel cancer. To measure area-level socioeconomic deprivation 
the 2015 Index of Multiple Deprivation (IMD; Smith et al., 2015) was used for which 
participants were asked to indicate their postcode, which was then used to 
calculate a relative score of overall area-level deprivation (a detailed description of 
the IMD measure is provided in section 3.2.1. in Chapter 3).  
4.2.3.2. Screening History Variables  
Four items were included to assess gFOBT screening history: ‘Have you 
received an invitation to participate in bowel cancer screening?’ (1 = Yes, 2 = No); 
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2) ‘Have you ever used and returned the home screening kit for bowel cancer?’ (1 
= Yes, 2 = No); 3) ‘If yes, have you ever hard a result that was unclear or positive?’ 
(1 = unclear result, 2 = positive result, 3 = both a positive and an unclear result, 4 = 
negative result each time, 5 = other). In order to assess whether participants were 
up-to-date with gFOBT screening the following item was used: ‘When was the last 
time you used and returned the home screening kit for bowel cancer?’ (1 = within 
the last two years, 0 = more than two years ago / not applicable). 
4.2.3.3. Psychosocial Variables 
HBM-based and TRA-TPB-based items included in the questionnaires were 
constructed in line with current recommendations (Ajzen & Fishbein, 1980; Conner 
& Norman, 2015) and based on items used in previous studies in the area of 
cancer screening using these two SCMs to explore cancer screening behaviour 
(Champion, 1984; Mason & White, 2008; Michie, Dormandy, French, & Marteau, 
2004; Norman & Cooper, 2011; Norman & Hoyle, 2004; Sieverding et al., 2010). 
HBM-based Variables. HBM items were developed based on Champion’s 
(1985) study, which used the HBM to examine breast self-examination behaviour. 
Participants were asked to state the extent to which they agreed with each item by 
circling one of seven responses (1 = strongly disagree, 7 = strongly agree).  
Perceived Susceptibility. Two items were used to assess perceived 
susceptibility to bowel cancer (e.g., ‘My chances of getting bowel cancer are great’; 
greater scores denoting higher perceived susceptibility).  
Perceived Severity. Two items measured perceived severity of bowel 
cancer (e.g., ‘If I had bowel cancer my whole life would change’; greater scores 
denoting greater perceived susceptibility).  
Perceived Benefits and Perceived Barriers. Two items measured 
perceived benefits (e.g., ‘Doing the bowel cancer screening test will give me peace 
of mind about it’; higher scores denoting more perceived benefits) and 11 items 
were used to assess perceived barriers to completing and returning the gFOBT 
screening kit (e.g., ‘I find it difficult to collect the stool samples for the bowel cancer 
screening test’; greater scores denoting more perceived barriers).  
PBC. Four items assessed participants’ confidence in their ability to do the 
gFOBT screening; items were jointly adapted from Champion (1984) and Fishbein 
and Ajzen (1980; 2011), as dictated by the HBM and the TRA/TPB respectively, to 
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assess participants’ self-efficacy and PBC. Previous research has highlighted the 
great degree of overlap among these two components (Ajzen, 2002a; Manstead & 
Eekelen, 1998) and therefore in the present study PBC was considered to 
incorporate self-efficacy. Specifically, it has been suggested that PBC incorporates 
two distinct components of self-efficacy, firstly capacity and capability and 
secondly, autonomy and controllability, with the former two constructs relating more 
strongly to one’s perceived confidence about their ability to enact a given 
behaviour, whereas the latter two constructs refer to one’s appraisal of whether 
enactment of the behaviour is completely reliant on oneself (Trafimow, Sheeran, 
Conner, & Finlay, 2002). Therefore, PBC was measured in terms of all four 
components; capacity was measured by one item (‘I am confident that I can do the 
bowel cancer screening test even if I find it difficult’), as were capability (‘I am 
confident that I can do the bowel cancer screening test even if I don’t like doing it’), 
autonomy (‘Doing the bowel cancer screening test is up to me’) and controllability 
(‘Doing the bowel cancer screening test is in my control’). Greater scores for the 
four items denoted greater PBC.  
Integrated TRA/TPB Variables.  
Attitudes. Although attitudes have traditionally been measured using single 
components (e.g., overall evaluation of attitudes towards a given behaviour), it has 
been suggested that attitudes comprise of two specific subcomponents; 
specifically, attitudes are composed of cognitive- instrumental evaluations (e.g., 
beneficial/harmful, wise/foolish, safe/unsafe) and affective-experiential evaluations 
(e.g., pleasant/unpleasant, nice/nasty, gratifying/revolting) towards a particular 
behaviour. This two-component attitude structure has been empirically supported 
across a range of attitude-measurement methodologies both specific to TPB-
related research (Ajzen, 1991; Ajzen & Driver, 1991, Conner & Armitage, 1998)  but 
also outside the scope of the TPB model (Crites Jr, Fabrigar, & Petty, 1994; Olson 
& Zanna, 1993) and Ajzen (2002) has suggested that both cognitive and affective 
attitude items should be included in order to accurately reflect participants’ attitudes 
towards a given behaviour.  
Cognitive-instrumental Attitudes. Two items, that were adapted from 
Crites et al (1994), were used to assess ‘cognitive-instrumental attitudes’ along 7-
point semantic differential scales with the extreme anchors: useful-useless and 
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beneficial-harmful (e.g., ‘Doing the bowel cancer screening test is useful-useless’). 
The two items were reverse-coded so that higher scores indicated more positive 
attitudes.  
Affective-experiential Attitudes. Similar to above, two items adapted from 
Crites et al (1994) were used to assess ‘affective-experiential attitudes’ along 7-
point semantic differential scales with the extreme anchors: pleasant-unpleasant 
and disgusting-not disgusting (e.g., ‘Doing the bowel cancer screening test is 
pleasant-unpleasant’). The pleasant-unpleasant sematic differential item was 
reverse-coded so that higher scores reflected more positive attitudes.  
Behavioural Beliefs. The TRA/TPB proposes that consideration about the 
behavioural outcomes influences attitudes towards that behaviour (Ajzen, 2002; 
Fishbein & Ajzen, 2011). Two items on 7-point Likert scales (1 = disagree strongly, 
7 = agree strongly) were used to assess behavioural beliefs about positive 
outcomes (i.e., positive behavioural beliefs) associated with CRC screening (‘Doing 
the bowel cancer screening test would help keep me healthy for my loved ones’ 
and ‘Doing the bowel cancer screening test would help prevent me from needing 
painful treatment’; higher scores denoted more positive attitudes).  
Behavioural beliefs about negative outcomes (i.e., negative behavioural beliefs) 
associated with CRC screening were assessed using one item (‘Doing the bowel 
cancer screening test does not guarantee I won’t get bowel cancer in the future’; 
higher scores reflected more negative attitudes). 
Subjective Norms. As mentioned earlier in the chapter, previous research 
has emphasised the need to distinguish between injunctive and descriptive 
subjective norms as both are considered to have unique effects on behaviour 
(Rhodes & Courneya, 2003). Therefore, one item was used to assess injunctive 
norms (‘People who are important to me want me to do the bowel cancer screening 
test’) and another to assess ‘descriptive norms’ (‘People who are important to me 
have done the bowel cancer screening test’). Higher scores denoted higher 
subjective norms.  
Knowledge. CRC knowledge was measured by two sections that firstly, 
assessed knowledge of symptoms indicative of CRC and secondly, knowledge of 
risk factors that are known to increase the likelihood of developing CRC. The 
development of the symptoms and risk factors awareness scales were informed by 
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previous research in the cancer screening literature (Forbes et al., 2013; Low, 
Simon, Waller, Wardle, & Menon, 2013; Wong et al., 2013). Knowledge was 
assessed by asking participants ‘What are the symptoms of bowel cancer?’ and 
‘What are the risk factors for bowel cancer?’. With regards to assessing knowledge 
about CRC symptomatology, participants were presented a list of 10 symptoms – 
including, blood in the stool, change of bowel habit, diarrhoea or constipation, pain 
in abdomen, pain in back passage, bleeding in back passage, bowel does not 
empty, unexplained weight loss, tiredness , lump in abdomen and rectal bleeding. 
All of these symptoms are universally agreed, evidence-based, guideline-accepted 
symptoms of bowel cancer. For each symptom participants identified correctly they 
were awarded one point, with scores ranging on a continuous scale from 0 
(poorest knowledge about CRC symptomatology) to 10 (best knowledge about 
CRC symptomatology). Similarly, participants were presented with a list of 10 risk 
factors, all of which are recognised as increasing the risk of CRC and these were: 
older age, close relative with bowel cancer, drinking alcohol, low physical activity, 
low intake of fruits or vegetables, high intake of fatty food, red and processed meat, 
overweight, diabetes and bowel disease. Similar to before, for each risk factor 
participants selected from the list, they were awarded with one point, with scores 
ranging on a continuous scale from 0 (poorest knowledge about CRC risk factors) 
to 10 (best knowledge about CRC risk factors).  
Response Efficacy. Response efficacy was measured along a 7-point 
Likert scale by the following item: ‘Using the bowel cancer screening kit will help 
detect problems so they can be treated earlier’ (adapted from Myers et al., 2008; 
higher scores denoted greater response efficacy).  
Perceived Importance of Social Support. This construct was measured 
by including one item assessing the importance of ‘practical social support’ (‘I 
would be more likely to do the bowel cancer screening test if I had practical support 
from others’) and one item assessing the importance of ‘emotional social support’ 
(‘I would be more likely to do the bowel cancer screening test if I had emotional 
support from others’). To the author’s knowledge these items have not been used 
previously in the cancer screening literature, however, they were included due to 
the evidence in Chapter 3 suggesting that social support was an important factor 
for increasing the motivation to participate in gFOBT screening.  
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Health Motivation. The measure of health motivation was based on items 
developed by Lau, Hartman and Ware (1986) and included four items: ‘If you don’t 
have your health you don’t have anything’; ‘There are many things I care more 
about than my health’; ‘Good health is only of minor importance in a happy life’; 
‘There is nothing more important than good health’. Higher scores denoted greater 
health motivation. 
Personality Variables. Personality variables were assessed using four 
items from the Ten-Item Personality Inventory – (TIPI) measure developed by 
Gosling, Rentfrow and Swann (2003) and included responses to two items 
measuring conscientiousness (e.g., ‘I am dependable and self-disciplined’) and two 
items measuring neuroticism (e.g., ‘I am anxious and get easily upset’). Items were 
reverse-coded so that grater scores indicated greater conscientiousness and 
greater neuroticism.  
Outcome Variable: gFOBT Screening Intention. Two items assessed 
‘gFOBT screening intention’ to participate in gFOBT screening along 7-point Likert 
scales (‘I intend to do the bowel cancer screening test’ and ‘I expect to do the 
bowel cancer screening test’). Higher scores indicated greater intention to 
participate in screening. This measure has previously been found to have good 
internal consistency (Schifter & Ajzen, 1985). 
4.2.4. Ethics 
The present study received ethical approval from the School of Psychology 
Research Ethics Committee at the University of Leeds (Reference Number: 17-
0123; Date of approval: 10/04/2017). 
4.2.5. Statistical Analyses 
4.2.5.1. Preparing the Data for Analysis 
All analyses were conducted using SPSS (IBM SPSS Statistics Version 21). 
Firstly, in order to prepare the data for analysis, reverse coding was conducted on 
raw data items that were negatively worded so that higher values for all 
questionnaire items were consistent. Specifically the two cognitive-instrumental 
attitudes items (‘Doing the bowel cancer screening test is useful/useless’; ‘Doing 
the bowel cancer screening test is beneficial/harmful’) as well as one of the 
affective-experiential attitudes items (‘Doing the bowel cancer screening test is 
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pleasant/unpleasant’) were recoded so that higher values denoted more positive 
attitudes. Similarly, two of the health motivation items (‘There are many things I 
care more about than my health’; and ‘Good health is only of minor importance in a 
happy life’) were reverse coded so that higher values denoted higher health 
motivation. Finally, one conscientiousness item (‘I see myself as disorganised and 
careless’) and one neuroticism item (‘I see myself as calm and emotionally stable’) 
were reverse coded so that higher values denoted greater presence for each trait.  
Secondly, reliability analysis was conducted to assess whether multiple 
questionnaire items underlying the same constructs were internally consistent. This 
was done to reduce the risk of multicollinearity by including similar items separately 
in subsequent regression models. Cronbach’s alpha (i.e., α) values were calculated 
to measure internal consistency for constructs measured by more than two items 
and Pearson’s correlations coefficients were conducted for constructs measured by 
two items. Items with a Cronbach’s alpha value that was 0.70 and above were 
considered as having relatively high internal consistency and were therefore 
considered to measure the same constructs (Nunnally & Bernstein, 1994). New 
scales were computed for intention, which originally consisted of two items (r = 
0.949, p < .001), for perceived severity, which consisted of two items (r = 0.592, p 
< .001), perceived susceptibility (two items; r = .359, p < .001), positive behavioural 
beliefs (two items; r = .663, p < .001), social support (two items; r = .814, p < .001), 
health motivation (four items, α = .754), conscientiousness (two items; r = .723, p < 
.001), neuroticism (two items; r = .558, p < .001), cognitive-instrumental attitudes 
(two items; r = .842, p < .001) and affective-experiential attitudes (two items; r = 
.553, p < .001). Questionnaire items measuring the perceived barriers and 
perceived benefits constructs were considered to act as formative indicators of 
screening intention – that is, all items corresponding to these constructs were 
considered to have an independent influence on screening intention. For instance, 
it is possible that screening intention may be determined by a number of formative 
indicators, each covering a unique and distinguishable aspect of the construct 
perceived barriers (e.g., forgetfulness, embarrassment, lack of time). Therefore, as 
suggested by previous research (Christophersen & Konradt, 2011; 
Diamantopoulos & Winklhofer, 2001) , reliability analysis for constructs measured 
by formative indicators (i.e., perceived barriers and perceived facilitators) was not 
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considered appropriate because these were expected to reflect conceptually 
different types of barriers and benefits that might affect intention to take part in 
screening. Therefore, irrespective of the Cronbach’s α values, new scales were 
computed for both perceived benefits (consisting of two items) and perceived 
barriers (consisting of 11 items). For the PBC construct a new scale was computed 
consisting of four items (α = .897). 
Third, the variables education and up-to-date with gFOBT were 
dichotomised. Specifically, for the variable education the data were coded as either 
having a university degree (i.e., undergraduate or postgraduate degree) and above 
or not having a degree (i.e., GCSE O level, GCSE A level, vocational training 
certificate or diploma or no formal qualification). Participants who responded other 
were placed in the no degree group as they did not provide evidence of any 
qualification. For the up-to-date with gFOBT variable data was coded as either 
being up-to-date with gFOBT (i.e., having used and returned a gFOBT kit within the 
last two years) or not up-to-date with gFOBT (i.e., not having used and returned a 
gFOBT kit within the last two years). Participants who responded ‘other’ or ‘not 
applicable’ were placed in the ‘not up-to-date’ group had they not provided any 
additional qualitative feedback in the designated field of the questionnaire clarifying 
their screening status.  
Fourth, Missing Values Analysis (MVA) was conducted in order to examine 
the patterns of missing values within the dataset. Overall, only six cases appeared 
to have at least one missing value across all variables. Due to the small number of 
cases that had missing values, listwise deletion of cases was considered the most 
appropriate technique for managing missing values as it was not anticipated that 
the deletion of six cases (i.e., resulting in a total of N = 206 participants included in 
the analysis) would adversely affect power and therefore the ability to detect 
meaningful effects.  
In order to check that the assumptions for conducting multiple regression 
were met, a series of analyses were conducted. Firstly, to ensure that the residuals 
of the regression followed a normal distribution, the Normal Predicted Probability 
(i.e., P-P) plot was examined and results indicated that the residuals were normally 
distributed (Hair, Black, Babin, Anderson, & Tatham, 1998; Lewis-Beck & Lewis-
Beck, 2015). Secondly, the data was checked for homoscedasticity by plotting the 
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standardised residuals against the standardised predicted value, with results 
indicating that residuals were centred around 0 and were randomly distributed 
across the entire range of the horizontal axis, indicating that the assumptions of 
normality and linearity were met (Miles & Shevlin, 2001). Lastly, collinearity 
diagnostic tests were conducted to check for multicollinearity. Specifically, the 
Tolerance statistic was below 0.1 and the Variance Inflation Factor (VIF) statistic 
was below 10 for all variables included in regression analyses. Therefore, the 
assumption of multicollinearity was deemed to have been met (Hair et al., 1998).  
4.2.5.2. Statistical Analysis Plan 
Firstly, descriptive statistical analysis was conducted in order to examine the 
sample’s sociodemographic characteristics as well as the mean scores, 
frequencies and percentages for all included variables. Additionally, Pearson’s 
correlation coefficients were calculated to assess the inter-relationships between 
included variables and to identify any strong, significant correlations to inform 
subsequent regression and mediation analyses. An initial hierarchical multiple 
regression analysis was conducted, by firstly, entering into the model the 
sociodemographic variables and secondly, the psychosocial variables to examine 
whether each group of variables accounted for a significant amount of variance in 
gFOBT screening intention.  
For the purposes of mediation analyses, multiple linear regression analysis 
was conducted using Hayes’s Macro PROCESS model for SPSS (Version 3), 
which was installed directly into SPSS. PROCESS is a conditional process 
modelling programme developed by Preacher and Hayes (2008) and uses an 
ordinary least squares- or logistic-based path analytical framework to test for both 
direct and indirect effects (Hayes, 2013). In the present analysis, mediation effects 
were tested by conducting parallel mediation analysis (PROCESS Model 4) 
including multiple potential mediators simultaneously. All indirect effects were 
tested using a bootstrap estimation approach using 95% bias-corrected confidence 
intervals (CIs) with 5,000 resamples as recommended by Preacher and Hayes 
(2008). Bootstrapping is a computational method that involves resampling from the 
data and estimating the indirect effect in each of the resampled datasets (Preacher 
& Hayes, 2008). 
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Moderation analysis was conducted through the use of hierarchical multiple 
regression analyses and the computation of interaction terms between moderator 
and predictor variables (Aiken, West, & Reno, 1991). Specifically, it was examined 
whether education and SES interacted with predictor 
psychosocial/sociodemographic variables in order to influence gFOBT screening 
intention and to examine the conditions under which the interaction effects occur 
(i.e., high/low SES, education/no education).  
 
 
4.3. Results  
4.3.1. Sample Characteristics 
A total of 206 respondents were included in the present analysis (see Figure 4.3.). 
 
Figure 4.  3. Flow chart of participants included in the survey.  
 
Descriptive data of survey participants are indicated in Table 4.1 below. 
Survey respondents were predominantly female (62.9%), from a White 
British/Welsh/Scottish/Irish ethnic background (91.3%) and were aged 60 to 67 
(78.9%). The majority of the sample spoke English as their primary language 
(95.3%) and approximately a fourth of participants held an undergraduate degree 
Participants recruited (N = 231) 
Via Prolific Academic (N = 220) 
Paper-based responses (N = 11) 
 
 
Included in the final analysis (N = 206) 
Excluded (N = 25): 
Not aged 60-74 years (N = 4) 
Duplicate entry (N = 1) 
Did not complete consent items (N = 11) 
Missing age and/or postcode data (N = 3) 
Deletion of cases with missing values 
listwise (N = 6) 
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(28.6%). Approximately 33% were retired, 64.8% were married or had a civil 
partnership, 48.4% reported being in good health. When asked about the number 
of chronic illnesses participants had, responses indicated that the majority of 
participants (55.9%) did not have any chronic illnesses, 26.8% had one chronic 
illness, while 17.3% had two or more chronic illnesses. Approximately one third of 
the sample (29.1%) lived in deprived areas of the UK, 17.4% lived in moderately 
deprived areas and the majority (53%) lived in more affluent areas of the country. 
The majority of participants were from England (80.8%) and did not report having a 
family history of bowel cancer (88.7%). The majority of participants (79.7%) had 
received a screening invite and had done the screening (classed as an incident 
screening episode), and 77.5% of participants were up-to-date with bowel cancer 
screening at the time of completing the survey. For surveys completed online the 
average duration for survey completion in minutes was M = 13.21, SD = 8.87.  
Table 4. 1. Demographic and screening history characteristics of survey 
participants 
Characteristics Mean (SD) (N = 206) 
Continuous variables  
Age 
 
64.2 (3.92) 
Categorical variables N (%) 
Gender  
Male  76 (36.9%) 
Female 130 (63.1%) 
Ethnicity  
White British/Welsh/Scottish/Irish 192 (93.2%) 
 BAMEa 14 (6.8%) 
Primary Language   
English 198 (96.1%) 
Other 8 (3.9%) 
Educational attainment  
Degree or equivalent 104 (50.5%) 
No degree 102 (49.5%) 
Occupational status  
Unemployed 5 (2.4%) 
Homemaker 14 (6.8%) 
Retired 68 (33.0%) 
Voluntary worker 5 (2.4%) 
Modern professional occupation 35 (17.0%) 
Clerical occupation 26 (12.6%) 
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Senior manager 13 (6.3%) 
Financial coordinator 2 (1.0%) 
Technical & craft occupations 1 (0.5%) 
Semi-routine manual & service occupations 6 (2.9%) 
Routine manual and service occupations 3 (1.5%) 
Middle or junior managers 10 (4.9%) 
Traditional professional occupations 18 (8.7%) 
Marital statusb  
Married/Civil partnership 135 (65.9%) 
Living with partner 8 (3.9%) 
In a relationship 6 (2.9%) 
Single 16 (7.8%) 
Separated/Divorced 26 (12.7%) 
Widowed 14 (6.8%) 
Self-reported general health  
Very good 42 (20.4%) 
Good 100 (48.5%) 
Fair 43 (20.9%) 
Poor 17 (8.3%) 
Very poor 4 (1.9%) 
Chronic Illnesses  
None 116 (56.3%) 
1 55 (26.7%) 
2 26 (12.6%) 
3 7 (3.4%) 
4+ 2 (1.0%) 
IMD Quintilec  
1 (most deprived) 25 (12.1%) 
2 35 (17.0%) 
3 33 (16.0%) 
4 48 (23.3%) 
5 (least deprived) 65 (31.6%) 
Family history of CRC  
Yes 24 (11.7%) 
No 182 (88.3%) 
Up-to-date with screening  
Yes 147 (71.4%) 
No 59 (28.6%) 
Notes. a Black and Minority Ethnic Group. bOne case missing (i.e., N = 205) but this variable was 
not included in subsequent regression analyses. c IMD=Index of Multiple Deprivation. Quintiles 
were based on national cutoffs; areas in quintile 1 are among the most deprived 20% in England, 
whereas areas in quintile 5 represent the least deprived 20% in England. 
 
4.3.2. Pearson’s Correlation Coefficients Analysis  
An initial correlation analysis was conducted in order to evaluate the 
strength and directionality of the relationship between psychosocial measures, 
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sociodemographic measures and screening intention. Resulting correlation 
coefficients are shown in Table 4.2, along with means and standard deviations of 
examined variables.
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Table 4. 2. Means, standard deviations and correlation coefficients between intention and psychosocial and sociodemographic 
variables 
 
 
Measure 
 
 
M 
 
SD 
 
Correlations 
   1 2 3 4 5 6 7 8 9 10 11 12 
Sociodemographic variables               
1. Gender 0.37 0.48 - - - - - - - - - - - - 
2. Age 64.22 3.92 .131 - - - - - - - - - - - 
3. Area-level deprivation (IMD) 3.45 1.39 -.046 .075 - - - - - - - - - - 
4. Ethnic Group 0.93 0.25 .007 .114 .087 - - - - - - - - - 
5. Education 0.49 0.50 .128* -.106 .097 .036 - - - - - - - - 
6. Family history of CRC 0.12 0.32 .130* -0.17 -.020 .038 -.027 - - - - - - - 
7. Up to date with gFOBT 0.71 0.45 .039 .000 .151* .128 .048 .130 - - - - - - 
Psychosocial variables               
8. Knowledge 1 6.00 2.93 -.017 -.122 .028 .066 .063 .103 .040 - - - - - 
9. Knowledge 2 5.42 2.67 .043 -.140* .049 .071 .125 .028 .023 .648*** - - - - 
10. Cognitive instrumental attitudes 6.48 1.02 .018 -.109 .016 -.071 .002 .028 .374*** .090 .105 - - - 
11. Affective experiential attitudes 3.22 0.82 -.104 -.018 .031 .038 .109 -.117 -.037 -.089 -.031 -.246*** - - 
12. Perceived susceptibility 3.20 1.20 .108 -.083 -.014 -.034 -.118 .234** .037 .030 -.050 .056 .011 - 
13. Perceived severity 5.69 1.17 -.133* -.076 -.023 -.128 -.025 -.053 -.047 .100 .005 -.047 .074 .005 
14. Perceived benefits 5.17 1.43 -.031 .020 -.012 -.088 .030 -.040 .146 .020 .015 .406*** 0.088 -.027 
15. Perceived barriers 2.73 0.92 -.133* -.028 -.071 -.061 -.129 -.059 -.399*** -.131 -.113 -.510*** .345*** .036 
16. PBC 6.35 1.11 -.009 -.185* .066 -.047 .123 .005 .213** .202** .162* .387*** -.194** -.118 
17. Positive beliefs 5.24 1.48 -.038 -.009 -.107 -.053 -.082 -.050 .109 .144** .069 .332*** -.101 -.013 
18. Negative beliefs 6.54 0.87 -.038 .016 .077 .146* .017 .034 .124 .121 .065 .098 -.152* -.100 
19. Injunctive norm 5.44 1.62 .061 -.015 .035 -.130 -.058 .099 .205*** .165* .198** .350* -.119 .068 
20. Descriptive norm 4.76 2.15 -.023 .036 .180* .078 .069 .069 .245*** .103 .178* .139* -.128 .101 
21. Social support 2.76 1.53 -.043 .006 -.058 -.066 -.120 .040 -.148* -.076 -.044 -.039 .095 .118 
22. Health motivation 5.62 1.17 -.078 -.073 .094 -.020 .030 -.079 .058 .090 .058 .139* .009 -.030 
23. Conscientiousness 5.85 1.13 .040 .072 .195* .059 -.134 .027 .136 .036 -.018 .270*** -.057 .040 
24. Neuroticism 2.80 1.43 -.175* -.147* -.065 -.009 -.023 .017 .028 -.020 -.102 -.140* .086 .101 
Dependent variable               
25. Intention  6.14 1.56 .074 -.089 .087 .044 .176* .141* .602*** .139* .173* .630*** -.162* -.003 
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Notes. *p<.05, **p<.01, ***p<.001. 1Gender was coded as 1 = male, 0 = female. 2IMD quintiles range from 1 (most deprived) to 5 (least deprived). 3Ethnicity was coded as 
1 = White British and 0 = BAME. 4Degree was coded as 1 = degree and 0 = no degree. 5Family history of CRC was coded 1 = has family history and 0 = no family history. 
6Being up-to-date with gFOBT screening was coded as 1 = up-to-date and 0 = not up-to-date.
 
Measure 
 
 
M 
 
SD 
 
Correlations 
   13 14 15 16 17 18 19 20 21 22 23 24 
14. Perceived benefits 5.17 1.43 .130 - -          
15. Perceived barriers 2.73 0.92 .202** -.265*** -          
16. PBC 6.35 1.11 .262*** .169* -.232*** -         
17. Positive beliefs 5.24 1.48 .076 .587*** -.262*** .341*** -        
18. Negative beliefs 6.54 0.87 .272*** .051 -.119 .392*** .154* -       
19. Injunctive norm 5.44 1.62 .054 .294*** -.266*** .225*** .436*** .159* -      
20. Descriptive norm 4.76 2.15 .017 .137* -.220*** .067 .108 .111 .416*** -     
21. Social support 2.76 1.53 -.022 .213** .207*** -.161* .216** -.186** .107 .063 -    
22. Health motivation 5.62 1.17 .064 .076 -.045 .013 .100 .010 -.020 -.081 -.115 -   
23. Conscientiousness 5.85 1.13 .033 .005 -.229*** .200*** .110 .121 .117 .050 -.084 .211*** -  
24. Neuroticism 2.80 1.43 .115 -.141* .228*** -.075 -.166* -.093 -.074 -.009 -.009 -.084 -.420*** - 
Dependent variable               
25. Intention  6.14 1.56 -.048 .444*** -.535*** .423*** .390*** .242*** .447*** .291*** -.103 .090 .209*** -.176* 
  
219 
4.3.2.1. Inter-correlations between sociodemographic and psychosocial 
variables 
As shown in Table 4.2, correlation analysis between sociodemographic 
and psychosocial variables resulted in a number of disparate effects. Results 
indicated that male gender was weakly and negatively correlated with perceived 
severity (r = -.133, p < .05), perceived barriers (r = -.133, p < .05) and 
neuroticism (r = -.175, p < .05). Older age was associated with reduced 
knowledge for both CRC symptomatology and risk factors, however, only the 
latter association was statistically significant (r = -.122, p > .05, r = -.140, p < .05 
respectively). Older age was also negatively associated with reduced PBC (r =-
.185, p < .05) and neuroticism (r = -.147, p < .05). Higher SES was associated 
with greater likelihood of being up-to-date with gFOBT screening (r = .151, p < 
.05), greater descriptive normative beliefs (r = .180, p < .05) and higher scores 
on conscientiousness (r = .195, p < .05). Surprisingly, White British ethnicity 
was associated with more negative beliefs (r = .146, p< .05) and did not 
demonstrate any significant relationships with any of the other constructs in the 
analysis. As expected, having a family history of CRC was associated with 
greater perceived susceptibility (r = .234, p < .01). Being up-to-date with bowel 
cancer screening was moderately associated with more positive cognitive 
instrumental attitudes (r = .374, p < .001) and fewer perceived barriers (-.399, p 
< .001), and was weakly correlated with greater PBC (r = .213, p < .01), greater 
injunctive and descriptive normative beliefs (r = .205, p < .001 and r = .245, p 
<.001 respectively) and less perceived importance of social support (r = -.148. p 
<.05).  
With regards to knowledge about bowel cancer, greater awareness about 
CRC symptomatology indicated, as expected, a moderate to strong positive 
association with awareness about CRC risk factors (r = .648, p < .001). 
Furthermore, knowledge of CRC symptoms was weakly and positively 
associated with greater PBC (r = .202, p <.001), stronger positive beliefs about 
screening (r = .144, p < .001) and stronger injunctive normative beliefs (r = .165, 
p < .05). On the other hand, knowledge about the factors that increase CRC risk 
were positively correlated to PBC (r = .162, p < .05), injunctive and descriptive 
normative beliefs (r = .198, p < .01 and r = .178, p<.05 respectively). Cognitive 
instrumental attitudes indicated moderate and positive correlations with 
perceived benefits (r = .406, p < .001), PBC (r = .387, p < .001), and positive 
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beliefs about CRC screening (r = .332, p < .001) and injunctive normative 
beliefs (r = .350, p < .05). Weaker, positive correlations were observed between 
cognitive instrumental attitudes and descriptive normative beliefs, health 
motivation (r = .139, p< .05) and conscientiousness (r = .270, p < .001). As 
anticipated, a moderate, negative correlation was found for between cognitive 
instrumental attitudes and perceived barriers (r = -.510, p < .001). Interestingly, 
there was a negative correlation between cognitive-instrumental and affective 
experiential attitudes (r = -.246, p < .001) indicating that although participants 
found gFOBT screening useful and beneficial, they also viewed it as disgusting 
and unpleasant at the same time. There was a negative association between 
perceived susceptibility and PBC (r = -.118, p < .05). Perceived severity was 
positively correlated to perceived barriers (r = .202, p < .01), PBC, (r = .262, p < 
.001) and negative beliefs (r = .272, p < .001). Perceived benefits were 
moderately and positively correlated with positive beliefs (r = .587, p < .001) and 
weakly correlated with PBC (r = .169, p < .05), injunctive normative beliefs 
(.294, p < .001), descriptive normative beliefs (r = .137, p < .05) and perception 
about the importance of social support (r = .213, p < .01). As expected, greater 
perceived benefits were associated with less perceived barriers (r = -.264, p < 
.001) and lower scores on neuroticism (r = -.141, p < .05). Greater perceived 
barriers were also significantly associated with less PBC (r = -.232, p < .001), 
less positive beliefs (r = -.262, p < .001), weaker injunctive and descriptive 
normative beliefs (r = -.266, p < .001 and r = -.220, p < .001 respectively), lower 
scores on conscientiousness (r = -.229, p < .001) and were positively correlated 
with greater perceived importance of social support (r = .207. p < .001) and 
greater scores on neuroticism (r = .228, p < .001). More positive beliefs were 
positively correlated with injunctive normative beliefs (r = 225, p < .001) and 
greater conscientiousness (r = -.229, p < .001), however, results surprisingly 
indicated that more positive beliefs were at the same time positively correlated 
with more negative beliefs (r = .392, p < .001). Greater health motivation was 
associated with greater conscientiousness (r = .211, p < .001) and lower scores 
on neuroticism (r = -.420, p < .001).  
4.3.2.2. Inter-correlations between predictor variables and intention  
A number of predictor variables – including sociodemographic and psychosocial 
variables – were significantly correlated with intention (Table 4.2). Having a 
degree-level education was associated with grater intention (r = .176, p < .05), 
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as was having a family history of CRC (r = .141, p < .05). Knowledge about 
CRC symptomatology and the risk factors of CRC were also significantly 
positively correlated with intention (r = .139, p < .05 and r = .173, p < .05 
respectively). As expected, being up to date with gFOBT screening was 
strongly, positively correlated with screening intention (r = .602, p < .001). 
Affective experiential attitudes were negatively associated with intention (r = -
.162, p < .05) suggesting that despite finding the test unpleasant, and even 
disgusting, intention to participate in the future remained high. Unsurprisingly, 
more perceived benefits were positively associated with intention (r = .444, p < 
.001) and more perceived barriers were negative associated with intention (r = -
.535, p < .001). Similarly, greater PBC was positively associated with intention 
(r = .423, p < .001). Contradictingly, both positive and negative beliefs about 
gFOBT screening indicated positive correlation with intention (r = .390, p < .001 
and r = .242, p < .001 respectively). Injunctive and descriptive norms were both 
positively and significantly correlated with intention (r = .447, p < .001 and r = 
.291, p < .001). 
4.3.3. Hierarchical Multiple Regression  
Study Objective 1: Examining whether sociodemographic and 
psychosocial variables directly predict gFOBT screening intention 
To test whether sociodemographic and psychosocial constructs 
predicted screening intention, a two-stage hierarchical multiple regression 
analysis was conducted with screening intention as the dependent variable. 
Sociodemographic variables were entered at Stage one of the regression 
model, followed by psychosocial variables. Regression statistics are reported in 
Table 4.3.  
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Table 4. 3. Summary of hierarchical multiple regression analysis for variables 
predicting screening intention  
Variables 
 
B SE β R R2 R2 
change 
Step 1    0.629 0.396 - 
  Constant  6.492 1.452     
  Gender1 0.111 0.184 0.034    
  Age -0.029 0.023 -0.074    
  Area-level deprivation 
(IMD)2 
-0.005 0.063 -0.004    
  Ethnicity3 -0.186 0.347 -0.030    
  Education4 0.431 0.176 0.139    
  Family history of CRC5    0.309 0.273 0.064    
  Up-to-date with gFOBT 
screening6 
2.028*** 0.195 0.590    
Step 2    0.841 0.708 0.312*** 
Constant 0.498 1.578     
Gender 0.026 0.140 0.008    
Age -0.019 0.017 -0.048    
Area-level deprivation 
(IMD) 
-0.019 0.048 -0.017    
Ethnicity 0.134 0.269 0.022    
Education 0.372** 0.139 0.120    
Family History of CRC 0.385 0.209 0.080    
Up-to-date with gFOBT 
screening 
1.204*** 0.167 0.350    
Knowledge Symptoms -0.016 0.029 -0.029    
Knowledge Risk Factors 0.032 0.033 0.055    
Cognitive instrumental 
attitudes 
0.366*** 0.087 0.240    
Affective experiential 
attitudes 
0.043 0.087 0.023    
Perceived Susceptibility  -0.010 0.057 -0.008    
Perceived Severity -0.110 0.063 -0.083    
Perceived Benefits 0.219*** 0.061 0.201    
Perceived Barriers -0.113 0.095 -0.067    
PBC 0.151* 0.076 0.108    
Positive beliefs 0.042 0.063 0.040    
Negative beliefs 0.149 0.084 0.084    
Injunctive norms 0.140** 0.051 0.145    
Descriptive norms 0.028 0.035 0.038    
Social Support -0.052 0.047 -0.051    
Health Motivation 0.012 0.058 0.009    
Conscientiousness 0.028 0.069 0.021    
Neuroticism -0.061 0.053 -0.056    
Notes. N = 206, B = unstandardised regression coefficient, SE = Standard Error, β = Standardised 
regression coefficient, ΔR2 = Adjusted R-squared.*p<.05, **p<.01, ***p<.001. 1Gender was coded as 1 = 
male, 0 = female. 2IMD quintiles range from 1 (most deprived) to 5 (least deprived). 3Ethnicity was coded 
as 1 = White British and 0 = BAME. 4Education was based on having a degree-level education and was 
coded as 1 = degree and 0 = no degree. 5Family history of CRC was coded 1 = has family history and 0 = 
no family history. 6Being up-to-date with gFOBT screening was coded as 1 = up-to-date and 0 = not up-to-
date.  
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The hierarchical multiple regression revealed that, at Step one, 
sociodemographic variables contributed significantly to the regression model F 
(7, 198) = 18.53, p < .001 and accounted for 39.6% of the variation in gFOBT 
screening intention. Introducing the psychosocial variables at Step two 
explained an additional 31.2% of variation in gFOBT screening intention F (24, 
181) = 18.23, p < .001, and this change in R2 was significant (R2 change = .312, 
F = 11.33, p <.001). Together, sociodemographic and psychosocial constructs 
accounted for 70.9% of the variance in gFOBT screening intention. When all the 
independent variables were included in stage two of the regression model, only 
education, up-to-date with gFOBT screening, cognitive-instrumental attitudes, 
perceived benefits and injunctive norms were significant predictors of gFOBT 
screening intention.  
4.3.4. Mediation Analyses   
Study Objective 2: Exploring potential psychosocial mediators of 
the association between sociodemographic variables and gFOBT 
screening intention   
A mediation analysis was conducted to examine whether social cognitive 
constructs mediated the association between sociodemographic variables and 
gFOBT screening intention. Potential mediators were tested using a multiple 
mediation model. Inclusion of mediators in the model was decided based on the 
guidelines set forth by Baron and Kenny (1986), who propose that predictor 
variables should be significantly correlated with the mediator (at a p < .05 
significance level) and that both predictor variables and mediators should be 
significantly correlated with the dependent/outcome variable. Specifically, based 
on the Baron and Kenny approach, in order to establish mediation, four criteria 
must be met: first, the predictor variable must be significantly associated with 
the dependent variable; second, the predictor variable must be associated with 
the mediator; third, the mediator must be significantly associated with the 
dependent variable; and fourth, the significant association between the 
predictor variable and the outcome variable should no longer be significant in 
order to assume full mediation, or should be reduced in order to assume partial 
mediation.  
According to the Pearson’s correlation coefficients presented in Table 4.2, 
the sociodemographic variables of gender, age, SES (based on IMD quintiles) 
were not significantly correlated with screening intention, and therefore, based 
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on the criteria proposed by Baron and Kenny’s (1986), these variables could not 
be included in mediation analyses. Moreover, although education was 
significantly correlated with intention, it was not correlated with any of the 
psychosocial variables (i.e., potential mediators in the present analysis). Lastly, 
family history of CRC was correlated both to intention and two of the social 
cognitive constructs (i.e., the two perceived susceptibility items), however, none 
of the perceived susceptibility items were significantly correlated with intention. 
Therefore, the only sociodemographic variable eligible for inclusion in the 
multiple mediation model was ‘up-to-date with gFOBT’, which related to past 
screening behaviour. This predictor variable was significantly correlated to 
screening intention, as well as six social cognitive constructs; ‘cognitive-
instrumental attitudes’, ‘PBC’, ‘injunctive’ and ‘descriptive norms’, ‘perceived 
barriers’ and ‘social support’. All six social cognitive factors were significantly 
correlated to gFOBT screening intention. Therefore, a parallel mediation model 
was used to test whether ‘up-to-date status with gFOBT’ (X) would indirectly 
influence ‘gFOBT screening intention’ (Y) through multiple mediators: ‘cognitive 
instrumental attitudes’ (M1), ‘perceived barriers’ (M2), ‘PBC’ (M3), ‘social support’ 
(M4), ‘injunctive norms’ (M5), and ‘descriptive norms’ (M6). The significance of 
the indirect effects was tested using bootstrapping procedures; specifically 
indirect effects were computed for each of 5,000 bootstrapped samples at a 
95% confidence interval (CI).  
Parallel Mediation (Model 4) 
The parallel mediation tests the potential mediating role of each mediator 
variable whilst accounting for the shared variance between all the mediator 
variables include in the model (Hayes, 2013). The parallel mediation model is 
illustrated in Figure 4.4 below. 
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Figure 4.  4. Parallel mediation model including six social cognitive variables 
as mediators of the effect of up-to-date screening status with screening 
intention. 
Notes: * p < .05, ** p <.01, *** p < .001; All presented effects are unstandardised regression coefficients (i.e. B); an 
represents the indirect effects of ‘up-to-date with gFOBT screening’ on social cognitive constructs; 0 is coded as ‘not 
up-to-date’ and 1 is coded ‘up-to-date’; bn represents the indirect effects of social cognitive constructs on screening 
intention; c is the direct (i.e., unmediated) effect of ‘up-to-date with gFOBT screening’ on screening intention; c is total 
(i.e., mediated) effect of ‘up-to-date with gFOBT screening’ on screening intention. 
 
Results showed that social support (M4) and descriptive norms (M6) did 
not predict screening intention. In order to conduct the parallel mediation 
without violating the model’s assumptions, these two mediators were excluded 
from the analysis. The ‘trimmed’ parallel mediation model is illustrated in Figure 
4.5. 
 
 
 
 
 
Perceived barriers (M2) 
a1 = 0.830*** b1 = 0.434
*** 
PBC (M3) 
Cognitive instrumental 
attitudes (M1) 
Social support (M4) 
Injunctive norms (M5) 
Descriptive norms (M6) 
a2 = -0.816*** 
a3 = 0.513** 
a5 = 0.773
*** 
a4 = -0.588* 
b2 = -0.223
* 
b3 = 0.200
** 
b5 = 0.177
*** 
b4 = -0.040 
Up-to-date with gFOBT 
screening (X) 
gFOBT screening 
intention (Y) 
 
c’ =  0.870, 95% CIs (.543, 1.247) 
a6 = 1.176
*** 
b6 = 0.053 
c = 1.258, p<.001 
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Figure 4.  5. ‘Trimmed’ parallel mediation model including four psychosocial 
variables as mediators of the effect of up-to-date screening status with 
screening intention. 
 
Notes: * p < .05, ** p <.01, *** p < .001; All presented effects are unstandardised regression coefficients (i.e., B); an 
represents the indirect effects of ‘up-to-date with gFOBT screening’ on social cognitive constructs; 0 is coded as ‘not up-
to-date’ and 1 is coded ‘up-to-date’; bn represents the indirect effects of social cognitive constructs on screening 
intention; c is the direct (i.e., unmediated) effect of ‘up-to-date with gFOBT screening’ on screening intention; c is total 
(i.e., mediated) effect of ‘up-to-date with gFOBT screening’ on screening intention.  
 
The indirect effect was significant (B = .807, 95% BCa CIs: .496, 1.170). 
Specifically, results from the parallel mediation analysis indicated that up-to-
date screening status was indirectly related to screening intention through its 
relationship with cognitive instrumental attitudes (B = .343, 95% BCa CIs: 
0.080, 0.731), perceived barriers, (B = .204, 95% BCa CIs: 0.010, .455) and 
injunctive norms (B = .153, 95% BCa CIs: 0.035, .306). In contrast, the indirect 
effect of PBC, albeit marginally, was not different than zero (B = .105, 95% BCa 
CIs: -0.005, .284). Due to the direct effect remaining significant even after 
inclusion of the mediators into the model, it was concluded that the three 
mediators partially mediated the relationship between up-to-date screening 
status and intention to participate in gFOBT screening in the future. 
Perceived barriers 
(M2) 
a1 = 0.830
*** 
Up-to-date with 
gFOBT screening 
(X) 
gFOBT screening 
intention (Y) 
 c’ = 0.807, 95% CIs (.496, 1.170) 
b1 = 0.414
*** 
a2 = -0.816
*** 
a3 = 0.513
** 
a4 = 0.773
*** 
b2 = -0.250
** 
b3 = 0.205
** 
b4 = 0.199
*** 
PBC (M3) 
Cognitive instrumental 
attitudes (M1) 
Injunctive norms (M4) 
c = 1.320***, p<.001 
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4.3.5. Moderation Analyses 
Study Objective 3: Exploring whether sociodemographic factors 
moderate the associations between psychosocial factors and gFOBT 
screening intention   
Moderation analysis was conducted to investigate the potential 
moderating effects of two sociodemographic variables, education and SES, on 
the association between screening intention and other demographic variables 
included in the analysis, including gender, age, race/ethnicity, CRC-related 
variables, including having a family history of CRC and being up to date with 
gFOBT screening, as well as psychosocial variables, including social cognitive 
and personality constructs. Moderation analysis focused on these two variables 
in particular, due to the strong links presented in the literature for the 
association between education, as an indicator of individual-level SES, and 
screening  (e.g., Smith et al., 2016), and neighbourhood deprivation, as an 
indicator of area-level SES (e.g., von Wagner et al., 2009). It is worth noting, 
that the present study had initially aimed to examine ethnicity/race as an 
additional moderator, however, the underrepresentation of BAME participants in 
the study sample did not allow robust testing of ethnicity/race as a potential 
moderator and therefore it was not included in the present analysis.   
In order to simplify analyses, moderator variables were dichotomised to 
create groups containing roughly equal numbers of participants. Specifically, in 
order to examine whether education moderated the relationship between 
predictor variables and intention the sample was split into two sub-samples: a) 
participants who had a degree-level education (N = 106) and b) participants 
without a degree-level education (N = 106). Separate hierarchical regression 
models were conducted to examine whether sociodemographic and 
psychosocial variable predicted intention in each education sub-sample. Table 
4.5 below show results from the hierarchical regression analyses for those with 
and without a degree-level education and differences in the power of each 
variable to predict intention were tested by examining the significance of the 
interaction terms between each predictor variable and education when 
controlling for other predictors. The significance of the interaction term 
(indicating significant differences between the group with and without a degree-
level education) is shown in the right-hand column in Table 4.4. A significant 
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interaction was interpreted as significant differences in unstandardised beta 
weights between the sub-samples with and without a degree  
Table 4. 4. Results from hierarchical regression analyses showing the 
moderation effect of education (M) on the relationship between demographic 
and psychosocial constructs (X) and screening intention (Y) 
 
Variables 
 
 
No Degree1 
 
Degree 
p-value  
Interacti
on  
(X x M) 
Moderator     B SE    β      B SE β  
Step 1        
Constant 6.952** 2.198  6.277** 1.771   
Gender2 0.141 0.308 0.037 -0.069 0.209 -0.027  
Age -0.043 0.035 -0.098 -0.011 0.027 -0.033  
Area-level deprivation 
(IMD)3 
-0.117 0.101 -0.093 0.123 0.074 0.135  
Ethnic Group4 0.395 0.539 0.060 -0.861* 0.426 -0.163  
Family History of CRC5 0.274 0.430 0.051 0.213 0.322 0.053  
 Up to date with 
gFOBT6 
2.344*** 0.307 0.612 1.661*** 0.230 0.590  
Step 2        
Constant -2.409 2.165  3.483 2.089   
Gender 0.169 0.232 0.044 -0.030 0.172 -0.030 0.643 
Age 0.011 0.026 0.025 -0.032 0.023 -0.076 0.532 
Area-level deprivation 
(IMD) 
-0.165* 0.076 -0.133 0.160** 0.062 0.203 0.004*** 
Ethnic Group 0.130 0.416 0.020 -0.242 0.366 -0.065 0.337 
Family History of CRC 0.429 0.315 0.080 0.323 0.261 0.097 0.966 
Up to date with gFOBT 1.080*** 0.269 0.282 1.305*** 0.210 0.462 0.599 
Knowledge 
Symptomatology 
-0.080 0.049 -0.137 0.044 0.034 0.108 0.692 
Knowledge Risk 
Factors 
0.118* 0.051 0.188 -0.032 0.040 -0.074 0.247 
Cognitive Instrumental 
Attitudes 
0.336* 0.142 0.204 0.290** 0.104 0.213 0.037* 
Affective 
Experiential Attitudes 
0.011 0.126 0.005 0.052 0.113 0.026 0.103 
Perceived Susceptibility -0.066 0.094 -0.042 -0.021 0.065 0.095 0.611 
Perceived Severity -0.117 0.092 -0.080 -0.066 0.081 -0.042 0.773 
Perceived Benefits 0.314** 0.089 0.267 0.165* 0.078 0.178 0.043* 
Perceived Barriers -0.279 0.145 -0.153 0.120 0.125 0.063 0.014* 
PBC 0.227 0.118 0.166 0.025 0.102 0.030 0.235 
Positive beliefs -0.009 0.101 -0.008 -0.006 0.079 -0.007 0.181 
Negative beliefs 0.230 0.128 0.123 0.080 0.117 0.016 0.425 
Injunctive Norm 0.053 0.085 0.047 0.297*** 0.060 0.407 0.425 
Descriptive Norm 0.073 0.055 0.095 -0.033 0.042 -0.051 0.360 
Social Support 0.010 0.073 0.009 -0.092 0.063 -0.097 0.499 
Health Motivation 0.158 0.097 0.097 -0.143 0.070 -0.109 0.052 
Conscientiousness 0.048 0.124 0.032 -0.032 0.083 0.006 0.793 
Neuroticism 0.061 0.092 0.053 -0.173*** 0.060 -0.176 0.279 
Notes. N = 206, B = unstandardised regression coefficient, SE = Standard Error, β = Standardised regression 
coefficient, p<.05, **p<.01, ***p<.001. 1 Education was based on whether or not participants had a degree-level 
education and was coded as 1 = degree and 0 = no degree. 2Gender was coded as 1 = male, 0 = female. 3IMD quintiles 
range from 1 (most deprived) to 5 (least deprived). 4Ethnicity was coded as 1 = White British and 0 = BAME. 5Family 
history of CRC was coded 1 = has family history and 0 = no family history. 6Being up-to-date with gFOBT screening was 
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coded as 1 = up-to-date and 0 = not up-to-date. Step 1 ‘No Degree’: R = .641, R2 =.410, ΔR2 = .374, Step 2 ‘No Degree’: 
R = .886, R2 =.784, ΔR2 = .723, R2 change: .374 (p < .001). Step 1 ‘Degree’: R = .637, R2 =.405, ΔR2 = .368, Step 2 
‘Degree’: R = .858, R2 =.736, ΔR2 = .658, R2 change: .330 (p < .001). 
 
Results indicated that for 19 independent variables there was no 
evidence for significant moderation effects (p-value range: .052 - .966). 
However, education significantly moderated the impact of four variables on 
screening intention: SES (based on IMD quintiles), cognitive-instrumental 
attitudes, perceived benefits and perceived barriers. Examination of the 
unstandardised regression coefficients indicated that SES was significantly 
negatively related to intention for participants without a degree-level education 
(B = -.165, SE = .076, p < .05), whereas for participants with a degree-level 
education SES was significantly positively related to intention (B = .160, SE = 
.062, p <.01). These findings suggest that increasing SES (i.e., higher IMD 
scores) was associated with an increase in screening intention among 
participants with a degree-level education, whereas decreasing SES (i.e., lower 
IMD scores) was associated with stronger screening intention among people 
without a degree-level education. With respect to cognitive-instrumental 
attitudes, examination of the standardised regression coefficients indicated that 
although cognitive-instrumental attitudes were significantly positively related to 
intention in both the ‘no degree’ (B = .336, SE = .142, p < .05) and the ‘degree’ 
sub-samples (B = .290, SE = .104, p < .01), they had a significantly stronger 
effect in the former compared to the latter group. A similar pattern of findings 
was observed with regards to perceived benefits, which were significantly and 
positively associated to intention in both the ‘no degree’ (B = .314, SE = .089, p 
< .01) and the ‘degree’ sub-samples (B = .165, SE = .078, p < .05), however, 
the effect of perceived benefits was significantly greater in the former group 
compared to the latter. Education also moderated the relationship between 
perceived barriers and screening intention, however, this variable did not 
significantly predict intention in either of the two education sub-samples.  
A similar strategy to the one described above was used to examine 
whether ‘SES’ (based on IMD data) moderated the relationship between 
predictor variables and intention. For this analysis, the sample was split into two 
sub-samples: a) participants whose postcodes corresponded to IMD quintiles 1, 
2 and 3 were coded as 0 and represented a lower SES group of participants (N 
= 99) and b) participants whose postcodes corresponded to IMD quintiles 4 and 
5 were coded as 1 to represent a higher SES group of participants (N = 113). 
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Separate hierarchical regression models were conducted to examine whether 
sociodemographic and psychosocial variables predicted intention in each SES 
sub-sample. Table 4.5 shows results from the hierarchical regression analyses, 
with interaction terms between predictor variables and SES being shown in the 
right-hand side column.  
 
Table 4. 5. Results from hierarchical regression analyses showing the 
moderation effect of SES (M) on the relationship between demographic and 
psychosocial constructs (X) and gFOBT screening intention (Y) 
 
Variable 
 
Low SES1 
 
High SES 
p-value  
Interactio
n  
(X x M) 
Moderator    B   SE    β    B   SE    β  
Step 1        
Constant 9.141*** 2.264  4.011* 1.849   
Gender2 0.175 0.263 0.055 0.061 0.250 0.019  
Age -0.053 0.035 -0.126 -0.015 0.028 -0.038  
Education3 0.126 0.248 0.041 0.736*** 0.239 0.234  
Ethnic Group4 -1.236*** 0.447 -0.225 1.229 0.515 0.176  
Family History of 
CRC5 
0.217 0.378 0.047 0.581 0.379 0.114  
Up to date with 
gFOBT6 
2.015*** 0.270 0.617 1.971*** 0.265 0.543  
Step 2        
Constant 0.712 2.376  -0.775 2.198   
Gender 0.239 0.209 0.075 -0.085 0.201 -0.026 0.694 
Age -0.022 0.027 -0.052 -0.022 0.023 -0.058 0.366 
Education 0.115 0.205 0.037 0.663*** 0.194 0.211 0.007*** 
Ethnic Group -0.683 0.367 -0.124 1.255** 0.399 0.180 0.005*** 
Family History of 
CRC 
0.328 0.300 0.071 0.424 0.316 0.083 0.587 
Up to date with 
gFOBT 
1.176*** 0.245 0.360 1.241*** 0.247 0.342 0.291 
Knowledge 
Symptomatology 
-0.023 0.044 -0.041 0.030 0.042 0.059 0.233 
Knowledge Risk 
Factors 
0.024 0.051 0.040 -0.005 0.045 -0.009 0.363 
Cognitive 
Instrumental 
Attitudes 
0.722*** 0.150 0.453 0.212 0.117 0.143 0.846 
Affective 
Experiential 
Attitudes 
-0.034 0.124 -0.018 0.075 0.120 0.039 0.223 
Perceived 
Susceptibility 
-0.011 0.090 -0.009 0.009 0.078 0.006 0.980 
Perceived Severity -0.042 0.085 -0.035 -0.207* 0.092 -0.143 0.549 
Perceived Benefits 0.133 0.090 0.125 0.336*** 0.089 0.303 0.383 
Perceived Barriers 0.013 0.144 0.008 -0.015 0.127 -0.009 0.385 
PBC -0.091 0.122 -0.061 0.261* 0.101 0.197 0.278 
Positive beliefs 0.120 0.106 0.112 -0.085 0.086 -0.081 0.803 
Negative beliefs 0.036 0.126 0.019 0.206 0.111 0.119 0.194 
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Injunctive Norm 0.091 0.074 0.100 0.158* 0.074 0.156 0.726 
Descriptive Norm 0.070 0.052 0.101 0.055 0.051 0.073 0.345 
Social Support -0.057 0.071 -0.057 0.002 0.065 0.002 0.577 
Health Motivation -0.009 0.086 -0.007 0.016 0.084 0.012 0.538 
Conscientiousness 0.083 0.099 0.066 0.000 0.102 0.000 0.679 
Neuroticism -0.010 0.077 -0.010 -0.073 0.072 -0.065 0.633 
Notes. N = 206, B = unstandardised regression coefficient, SE = Standard Error, β = Standardised regression coefficient, 
p<.05, **p<.01, ***p<.001. 1SES was coded based on area-level deprivation derived from IMD data; quintiles 1, 2 and 3 
were coded as 0 and reflected lower SES, whereas quintiles 4 and 5 were coded as 1 and reflected higher SES.. 2Gender 
was coded as 1 = male, 0 = female. 3Education was based on whether or not participants had a degree-level education. 
Having a degree was coded as 1 = degree and 0 = no degree 4Ethnicity was coded as 1 = White British and 0 = BAME. 
5Family history of CRC was coded 1 = has family history and 0 = no family history. 6Being up-to-date with gFOBT screening 
was coded as 1 = up-to-date and 0 = not up-to-date. Step 1 ‘Low SES’: R = .669, R2 =.448, ΔR2 = .409, Step 2 ‘Low SES’: R 
= .886, R2 =.784, ΔR2 = .712, R2 change: .337 (p<.001). Step 1 ‘High SES’: R = .671, R2 =.451, ΔR2 = .420, Step 2 ‘High 
SES’: R = .869, R2 =.755, ΔR2 = .691, R2 change: .304 (p<.001). 
 
Table 4.5 indicated that SES significantly moderated the impact of two 
predictor variables on screening intention: education and ethnic group. 
Examination of the unstandardised regression coefficients indicated that 
education had a positive (but non-significant) effect on intention in the low SES 
(B = .115, SE = .205, p >.05) and a positive, strongly significant effect in the 
high SES sub-samples (B = .663, SE = .194, p < .05), indicating that, although 
education is positively associated with intention in both groups, its effect is 
significantly more prominent among the higher SES sub-sample compared to 
the lower SES sub-sample. Examination of the unstandardised regression 
coefficients for ethnic group indicated a contrasting pattern of findings for the 
low and high SES sub-samples; for the low SES sub-sample, ethnic group was 
negatively associated, but did not significantly predict, screening intention (B = -
.683, SE = .367, p < .05), whereas for the high SES sub-sample, ethnic group 
was positively and significantly associated with intention (B = 1.255, SE = .399, 
p < .05). This finding suggests that White-British participants compared to non-
White British participants with high SES were significantly more likely to intend 
to participate in screening, while there were no significant differences in 
screening intention between White British and non-White British participants for 
those with low SES.  
Past screening behaviour was also examined as a moderator; 
specifically, the sample was split into: a) participants who were up-to-date with 
gFOBT screening (N =147) and b) participants who were not up-to-date with 
gFOBT screening (N = 59). As above, separate hierarchical regression models 
were conducted to examine whether sociodemographic and psychosocial 
variables predicted intention in the past screeners and non-screeners sub-
samples. Table 4.6 shows the results from the hierarchical regression analyses 
  
232 
with interaction terms between predictor variables and past screening behaviour 
being shown in the right-hand column.  
 
Table 4.6. Results from hierarchical regression analyses showing the 
moderation effect of past screening behaviour (M) on the relationship between 
demographic and psychosocial constructs (X) and screening intention (Y) 
 
Variables 
 
 
Non-screeners1 
 
Screeners 
p-value  
Interacti
on  
(X x M) 
Moderator     B SE    β      B SE β  
Step 1        
Constant 6.729 4.150  7.969 1.086   
Gender2 0.255 0.581 0.060 0.019 0.130 0.013  
Age -0.034 0.066 -0.071 -0.023 0.017 -0.115  
Area-level deprivation 
(IMD)3 
0.032 0.185 0.023 0.029 0.046 -0.052  
Ethnic Group4 -0.626 0.847 -0.101 0.179 0.289 0.051  
Family History of CRC5 1.497 1.230 0.164 0.095 0.177 0.044  
Degree6 0.839 0.536 0.209 0.251* 0.127 0.168  
Step 2        
Constant 1.363 3.379  4.244 1.301   
Gender -0.449 0.332 -0.106 0.049 0.106 0.032 0.467 
Age -0.012 0.036 -0.024 -0.017 0.013 -0.087 0.686 
Area-level deprivation 
(IMD) 
0.068 0.104 0.049 -0.057 0.039 -0.104 0.880 
Ethnic Group -0.312 0.471 -0.050 0.070 0.234 0.020 0.122 
Family History of CRC -0.215 0.663 -0.024 0.172 0.144 0.081 0.786 
Degree 0.375 0.324 0.093 0.155 0.103 0.104 0.599 
Knowledge 
Symptomatology 
-0.009 0.063 -0.013 -0.003 0.022 -0.012 0.832 
Knowledge Risk 
Factors 
0.086 0.072 0.126 0.011 0.025 0.039 0.665 
Cognitive Instrumental 
Attitudes 
0.545** 0.164 0.374 -0.013 0.079 -0.012 0.000*** 
Affective 
Experiential Attitudes 
-0.114 0.217 -0.051 -0.012 0.069 -0.013 0.364 
Perceived Susceptibility -0.024 0.127 -0.015 -0.021 0.043 -0.033 0.236 
Perceived Severity -0.197 0.149 -0.113 -0.074 0.048 -0.118 0.041* 
Perceived Benefits 0.478** 0.133 0.393 0.004 0.047 0.008 0.000*** 
Perceived Barriers -0.302 0.185 -0.149 -0.052 0.077 -0.055 0.000*** 
PBC -0.338 0.204 -0.179 0.136* 0.053 0.201 0.669 
Positive beliefs 0.073 0.153 0.056 0.028 0.045 0.054 0.000*** 
Negative beliefs -0.026 0.177 -0.011 0.400*** 0.065 0.471 0.001*** 
Injunctive Norm 0.252* 0.114 0.214 0.063 0.038 0.128 0.000*** 
Descriptive Norm 0.117 0.072 0.125 0.041 0.029 0.114 0.010** 
Social Support 0.020 0.101 0.013 -0.024 0.036 -0.049 0.010** 
Health Motivation -0.044 0.133 0.027 0.050 0.047 0.076 0.519 
Conscientiousness 0.177 0.179 0.107 -0.007 0.051 -0.011 0.316 
Neuroticism 0.027 0.132 0.021 -0.048 0.039 -0.090 0.236 
Notes. N = 206, B = unstandardised regression coefficient, SE = Standard Error, β = Standardised regression 
coefficient, p<.05, **p<.01, ***p<.001. 1 Screeners were defined as being up-to-date with gFOBT screening and were 
coded as 1 = up-to-date (i.e., used and returned a gFOBT kit within the last two years) and non-screeners were defined 
as not being up-to-date with gFOBT screening and were coded as 0 = not up-to-date (i.e., not used and returned a 
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gFOBT kit within the last two years).2Gender was coded as 1 = male, 0 = female. 3IMD quintiles range from 1 (most 
deprived) to 5 (least deprived). 4Ethnicity was coded as 1 = White British and 0 = BAME. 5Family history of CRC was 
coded 1 = has family history and 0 = no family history. 6Education was based on whether or not participants had a 
degree-level education and was coded as 1 = degree and 0 = no degree. Step 1 ‘Non screeners’: R = .326, R2 =.107, 
ΔR2 = .003, Step 2 ‘Non-screeners’: R = .931, R2 =.867, ΔR2 = .779, R2 change: .760 (p < .001). Step 1 ‘Screeners’: R = 
.229, R2 =.052, ΔR2 = .012, Step 2 ‘Screeners’: R = .734, R2 =.538, ΔR2 = .452, R2 change: .486 (p < .001). 
 
Table 4.6 indicated that past screening behaviour significantly moderated 
the impact of nine predictor variables: 
1) Cognitive-instrumental attitudes 
Examination of the unstandardised regression coefficients indicated that 
cognitive-instrumental attitudes were significantly positively related to intention 
among the non-screeners subgroup (B = .545, SE = .164, p = .001) whereas for 
the screeners subgroup this variable had a negative (but non-significant) effect 
on intention (B = -.013, SE = .079, p > .05).  
2) Perceived severity  
Past screening behaviour moderated the relationship between perceived 
severity and intention, showing a negative (but non-significant) association with 
intention in both the non-screeners subgroup (B = -.197, SE = .149, p > .05) 
and the screeners sub-group (B = -.074, SE = .048, p > .05).  
3) Perceived Benefits 
Perceived benefits were significantly positively associated with intention 
in the non-screeners subgroup (B = .478, SE = .133, p = .001) and positively, 
but non-significantly, associated with intention in the screeners subgroup (B = 
.004, SE = .047, p > .05).  
4) Perceived Barriers 
Past screening behaviour also moderated the relationship between 
perceived barriers and intention, however this variable did not significantly 
predict intention in either past screening behaviour subgroup (B = -.302, SE = 
.185, p > .05 and B = -.052, SE = .077, p > .05 for the non-screeners and 
screeners subgroup respectively).  
5) Positive Behavioural Belief 
Past screening behaviour also moderated the relationship between 
positive behavioural belief and screening intention. Results indicated that 
positive behavioural belief was positively associated with intention in both past 
screening behaviour subgroups, however, this variable did not significantly 
predict intention in either subgroup (B = .073, SE = .153, p > .05 and B = .028, 
SE = .045, p > .05 for the non-screeners and screeners subgroup respectively). 
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6) Negative Behavioural Belief 
Examination of the unstandardised regression coefficients for negative 
behavioural belief indicated a contrasting pattern of results for the non-
screeners and screeners subgroup; for the former subgroup this variable was 
negatively associated, but did not significantly predict intention (B = -0.026, SE 
= .177, p > 0.05), whereas for the latter subgroup this variable as positively and 
significantly associated with intention (B = .400, SE = .065, p < .001). 
7) Injunctive Norm 
Results indicated that injunctive norm had a positive and significant 
association with intention in the non-screeners subgroup (B = .252, SE = .114, 
p< .05) and a positive but non-significant effect in the screeners subgroup (B = 
.063, SE = .114, p < .05), indicating that although injunctive norm was positively 
associated with intention in both subgroups, its effect was more salient among 
non-screeners compared to screeners.  
8) Descriptive Norm  
Past screening behaviour also moderated the association between 
descriptive norm and intention and despite being positively associated with 
intention in both non-screeners and screeners, this variable did not significantly 
predict intention in either subgroup (B = .117, SE = .072, p > .05 and B = .041, 
SE = .029, p > .05 for each subgroup respectively). 
9) Social Support 
Results indicated that past screening behaviour moderated the 
association between social support and intention; however, this variable did not 
significantly predict intention in either subgroup (B = .020, SE = .101, p > .05 
and B = -.024, SE = .036, p > .05 for the non-screeners and screeners 
subgroup respectively). 
Overall, results from the third moderation analysis (i.e., past screening 
behaviour as a moderator) indicated there were four variables in total for which 
there was both a significant moderation effect and at least one significant effect 
for either the past screeners or past non-screeners group; these were: cognitive 
instrumental attitudes, perceived benefits, negative behavioural belief and 
injunctive norm. There were five variables for which there was a significant 
moderation but no significant effect for either past screening group; these were: 
perceived severity, perceived barriers, positive behavioural belief, descriptive 
norm and social support.  
  
235 
4.3.6. Sample Size and Post-hoc Power Analysis 
As indicated earlier in the thesis, the final sample size consisted of N = 
206. Initially, it had been intended to recruit a sample of at least N = 242 based 
on the approach proposed by Tabachnick & Fidell (2007), which states that N > 
50 + 8M (where M is the number of independent variables). However, due to 
recruitment challenges relating to targeting and accessing older-adult 
populations - and particularly older adults from low SES populations and BAME 
communities - the initial recruitment target was not achieved. Data collection 
was mainly facilitated using online questionnaires, which presents with 
additional challenges for older adult populations compared to younger 
respondents (Weil, Mendoza, McGavin, 2017), which most likely contributed to 
the smaller sample size included in the present study. Based on the reflections 
presented in Study 2, it would have been preferable to implement community-
based and/or patient-centered recruitment strategies (e.g., translating survey 
materials, identifying and engaging community stakeholders to access hard-to-
reach populations), however, the resources and time required to establish and 
maintain partnerships with community organisations over the study period were 
significant and not feasible given the strict timeframe for the completion of the 
PhD. 
A post-hoc power analysis was conducted using the software package 
G*Power (Faul, Erdfelder, Lang, & Buchner, 2007; Faul, Erdfelder, Buchner, & 
Lang, 2009). The sample size of N = 206 and a total of 24 predictor variables 
were used for the statistical power analyses. The recommended effect sizes for 
this assessment were as follows: small (f 2 = .02), medium (f 2 = .15), and large 
(f 2 = .35) (see Cohen 1977). The alpha level used for this analysis was p < .05. 
The post-hoc analyses revealed that the statistical power for this study was .14 
for detecting a small effect, .95 for detecting a moderate effect and greater than 
.99 for detecting a large effect size. Therefore, there was a more than adequate 
power (i.e., .80) at the moderate and large effect size level, but less than 
adequate statistical power at the small effect size level.  
4.4. Discussion 
The present study aimed to examine associations between 
sociodemographic and psychosocial variables in the context of intention to 
participate in gFOBT screening. This study used two theoretical frameworks in 
order to explore these associations, the integrated TPB/TRA and the HBM. 
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Mediated and moderated effects of these variables on intention were also 
tested. The findings from this community-based sample of socioeconomically 
diverse men and women suggested that intention to participate in gFOBT 
screening was associated with traditional measures of SES, such as education 
and neighbourhood-level deprivation data, but was also associated with several 
social cognitive constructs including attitudes, perceived barriers, PBC and 
subjective norms. Some of these associations varied by education and SES. 
The next section will provide an overview of the main findings in the context of 
previous research, describe the implications for interventions and lastly, discuss 
the strengths and limitations of the study. 
4.4.1. Summary of Main Findings  
Results indicated that intention to participate in gFOBT screening is 
underpinned by a combination of sociodemographic and psychosocial 
variables. Multiple regression analysis showed that, among sociodemographic 
variables, education and past screening behaviour were direct predictors of 
screening intention. Furthermore, specific psychosocial constructs also 
predicted screening intention, including cognitive-instrumental attitudes, 
perceived benefits, PBC and injunctive norms. Mediation analysis was 
conducted to explore the underlying mechanisms in the relationship between 
past screening behaviour and intention, which indicated that psychosocial 
factors partially mediated this relationship. Specifically, the key social cognitive 
mediators were cognitive-instrumental attitudes, perceived barriers and 
injunctive norms. Moderation analysis was conducted to examine whether the 
strength of the association between psychosocial constructs and intention was 
impacted by level of educational attainment, SES and past screening 
behaviour. Results indicated significant interactions between the three 
moderators and predictor variables. The direct and indirect mediator and 
moderator effects are discussed in detail in the sub-sections below. 
4.4.2 Direct Predictors of Screening Intention  
The finding that past screening behaviour predicted screening intention 
is in agreement with the extensive empirical evidence showing that past 
behaviour is a fundamental determinant of both intention and prospective 
behaviour (Bagozzi, 1981; Bagozzi, Wong, Abe, & Bergami, 2000; Orbell, 
Hodgldns, & Sheeran, 1997). Studies show that past behaviour provides 
  
237 
additional explanatory power in the prediction of behavioural intent; for instance, 
studies that have explored the implications of past behaviour within the context 
of the TRA and TPB have shown that past behaviour uniquely predicts 
intention, even after controlling for other components of the model (Ajzen, 1991; 
Conner & Armitage, 1998; Ouellette & Wood, 1998) . For example, in an 
application of the TRA to fast-food consumption, Bagozzi et al (2000) included 
past behaviour as a co-predictor of intention and behavioural expectations – 
another facet of volitional behaviour – and found that it added considerably to 
the amount of variance accounted for in both intention and expectations. 
Moreover, the addition of past behaviour elicited changes in the strength of the 
associations in the attitude-intention and subjective norm-intention 
relationships. The predictive ability of attitudes and norms on intentions and 
expectations was weakened after inclusion of past behaviour into the model. 
This attenuation effect has been observed in a number of studies, including 
research on physical activity (Amireault, Godin, Vohl, & Pérusse, 2008; Hagger, 
Chatzisarantis, Biddle, & Orbell, 2001; Hagger et al., 2002) and various 
consumer and health-related behaviours (Kidwell & Jewell, 2003; Kor & Mullan, 
2011; McEachan, Conner, Taylor, & Lawton, 2011; Sheeran & Abraham, 2003). 
Therefore, data from them present analysis suggest that a person’s intention to 
participate in screening is, to an extent, a function of past behaviour. This 
strong past behaviour-intention association is in agreement with the findings 
reported in Chapter 3, which highlighted that individuals who had participated in 
gFOBT screening at least once were more likely to indicate that they would 
intend to participate in future screening rounds and this was mainly attributed to 
improved attitudes regarding the screening procedure and increased perception 
of self-efficacy. 
Among sociodemographic variables, educational attainment was the only 
factor to directly predict screening intention. Unlike findings from previous 
studies area-level SES, ethnic background and family history did not predict 
screening intention, although the directionality of associations was in agreement 
with past reports showing that screening intention and participation are higher 
among higher SES populations (e.g., von Wagner et al., 2009; 2011), White 
ethnic groups (e.g., Szczepura, Price & Fumber, 2008) and people with a 
positive family history of CRC (Rees, Martin, & Macrae, 2008). Nonetheless, the 
finding that participants with greater educational attainment were more likely to 
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intend to participate in screening is consistent with a plethora of empirical 
evidence that shows that more years of education are associated with 
increased screening uptake (Smith et al., 2016; von Wagner et al., 2009; 2011). 
It is worth noting, that educational attainment is viewed as an important 
indicator of social position, where higher level of education is indicative of 
greater socioeconomic advantage. In fact, it is considered that education is 
often a better objective indicator of SES compared to income, employment or 
neighborhood deprivation, because there is usually little fluctuation in 
educational attainment past the age of 25 years, thereby providing a more 
stable measure of SES (Carr-Hill, Chalmers-Dixon, Lin, & Britain, 2005). 
Moreover, education remains largely uninfluenced by illness for adults - unlike 
income and occupation - and therefore the relationship between education and 
health can be considered an independent predictor of SES due to not being 
confounded by other SES-related metrics. Education has also been found to 
have the strongest effect on mortality in comparison to other SES indicators 
with studies showing that greater educational attainment often translates into 
greater likelihood of being employed full-time rather than part-time, obtaining 
higher status professions, earning more, accruing greater wealth, avoiding 
financial dept, developing more social connection and engaging in healthier 
behaviours (Mirowsky & Ross, 2008; Schnittker, 2004). Therefore, in the 
present analysis it appears that education as an indicator of SES was in line 
with the expectation that greater SES is associated with greater screening 
intention. The fact that there was an almost equal number of respondents with a 
degree- and non-degree level education in the survey sample further 
strengthens the validity of the present findings. It is worth noting that the 
correlation between area-level SES (based on IMD) and education was below 
0.1 suggesting that they correspond to facets of SES that are independent from 
one another. 
The finding that cognitive-instrumental attitudes were a direct predictor of 
intention is interesting, especially considering that affective-experiential 
attitudes were not associated with screening intention in any of the analyses. In 
fact, this finding lends its support to the notion that the two attitudinal measures 
are independent from one another and therefore they are likely to differentially 
impact on intentions, further supporting Ajzen’s (2011) position of including both 
attitudinal constructs in research. In the context of gFOBT screening in 
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particular, it appears that attention should be placed on the importance of 
cognitive-instrumental attitudes in relation to screening intention, rather than 
affective-experiential attitudes, suggesting that targeting and strengthening 
people’s positive beliefs about the usefulness of screening might be particularly 
important in increasing their motivation to participate in screening. 
The finding that more perceived benefits positively predicted screening 
intention is unsurprising, given that much empirical evidence that has 
consistently reported that an increased appreciation of the health benefits is 
strongly associated with greater participation in screening (e.g., Smith et al., 
2016). Similarly, greater PBC was a significant direct predictor of intention. 
Although there is not much prior evidence examining the association between 
PBC and intention for gFOBT screening, and some of the available evidence 
remains inconclusive about its importance within the context of gFOBT 
screening, it is plausible to suggest that increasing PBC might have important 
implications for screening uptake. This suggestion is in light of the fact that 
home-based gFOBT screening is a complex behaviour, which involves a multi-
step process and requires a degree of confidence in one’s ability to follow 
instructions, plan and collect the three separate faecal samples and manage 
negative affects associated with handling faeces. Strengthening perceptions of 
agency and/or PBC in relation to gFOBT screening might be particularly 
important among first-time invitees; based on the qualitative evidence in the 
present thesis, a recurrent finding among past screeners was that completing 
their first screening kit was the most challenging and that participation became 
easier with each screening episode. This finding hints that greater ease of 
completion of the screening kit with each subsequent screening round is partly 
due to stepped increases in PBC. Currently, there is little evidence about the 
unique barriers that first-time invitees might face and whether lower PBC is a 
key driver of behaviour among this specific sub-group, however, given the 
evidence that past screening predicts future intention and screening 
participation, it might be particularly timely to test the hypothesis that increased 
PBC will increase the likelihood of first-time invitees returning their screening kit.  
The current findings also indicated that injunctive norms predicted 
screening intention, while descriptive norms did not. This is in contrast to the 
findings reported by Sieverdig and colleagues (2010), who reported that 
descriptive norms explained additional variance in CRC screening intention 
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beyond injunctive norms. The present study suggests that only injunctive norms 
– which pertains to what important others expect us to do – are predictive of 
intention. The fact that descriptive norms did not show an association with 
intention, may be partly due to the fact that important others may not disclose 
whether they have completed the screening kit or not due to CRC screening 
being a sensitive health topic and/or a ‘taboo’ subject as indicated earlier in the 
thesis and elsewhere in the CRC literature (Jones, Devers, Kuzel, & Woolf, 
2010; Reynolds, Consedine, Pizarro, & Bissett, 2013). Lack of open discussion 
could in turn lead to an inaccurate indication of how others have acted in 
relation to the gFOBT screening kit, which is what is measured by descriptive 
norms. Indeed, findings from the qualitative research indicated that the lack of 
open communication with regards to the completion of the screening kit was a 
barrier to screening uptake among non-screeners, whereas past screeners 
were more likely to have openly discussed about the gFOBT kit with important 
others. Nonetheless, the present research shows that injunctive social 
influences play an important role in relation to gFOBT screening intention, and 
the differential impact of the two types of norms on screening intentions 
suggests that they should both be considered in future preventive health 
research. It would be interesting to examine whether the descriptive norms 
construct is a predictor for other types of cancer screening such as breast and 
cervical cancer screening, whose benefits have been widely advocated through 
mass media campaigns and have a long history of being more openly 
discussed in the public sphere compared to the much less publicity CRC has 
received (Wakefield, Loken, & Hornik, 2010).  
4.4.3. Mediators of the past behaviour-intention relationship  
Findings from the mediation analysis indicated that the positive 
relationship between past screening behaviour and higher intention was partly 
mediated by cognitive instrumental attitudes, perceived barriers and injunctive 
norms. Specifically, results revealed that past behaviour indirectly influenced 
intention via more positive attitudes, an increase in injunctive norms and fewer 
perceived barriers. With regards to the mediational effect of attitudes, it is worth 
noting that only cognitive-instrumental attitudes, and not affective-experiential 
attitudes, were highlighted as a mechanism in the past behaviour-intention 
relationship. As highlighted above, beliefs about how useful/useless or 
beneficial/harmful the screening test is (measured by cognitive-instrumental 
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attitudes) may be more pertinent in the context of cancer screening than beliefs 
about how pleasant/unpleasant or how disgusting/not disgusting the procedure 
is. As evidenced by the findings from the qualitative interviews, past non-
screeners and past screeners alike perceived the screening process as 
‘disgusting’ and ‘embarrassing’, however, valuing the benefits of screening 
seemed to have a buffering effect and promoted screening behaviour among 
past screeners, suggesting that there is a stronger relationship between 
cognitive-instrumental attitudes compared to affective-experiential attitudes. To 
the author’s knowledge, apart from the present study, there is currently no 
research that has evaluated the influence of both of these attitudinal constructs 
in relation to gFOBT screening, therefore future research should aim to replicate 
the present findings.  Nonetheless, the fact that at least one of the attitudinal 
measures was a key mechanism in the past behaviour-intention association is 
consistent with previous studies that have shown that attitudes have the 
strongest influence in predicting behaviours among TPB variables across a 
range of health behaviours including among others dietary intake (Riebl et al., 
2015), screening uptake (Cooke & French, 2008) and condom use (Armitage & 
Conner, 2001). Within the context of cancer screening, positive attitudes 
towards cervical screening have been associated with increased intention to 
attend Pap/smear testing (Kuitto, Pickel, Neumann, Jahn, & Metelmann, 2010; 
Ogilvie et al., 2013) as well as CRC screening (McCaffery, Wardle, & Waller, 
2003).  
The finding that perceived barriers was a mediator of screening intention 
is consistent with previous findings. A study by Smith and colleagues (2016) 
examined the association between perceived benefits/barriers and inequalities 
in cancer screening participation; results indicated that individuals with lower 
educational attainment were more likely to report higher emotional and practical 
barriers and were less likely to intend to participate in screening, suggesting 
that targeting specific barriers could reduce CRC screening inequalities. In the 
present research perceived barriers were examined through the use of a single 
scale that was computed from a wide range of barriers previously associated 
with gFOBT screening uptake, including both practical barriers – for example, 
concerns about privacy and stool-sample collection - as well as emotional 
barriers – for example, cancer fatalism, worry and disgust. Given the important 
role perceived barriers play in relation to gFOBT screening, it might be useful 
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for future research, to examine practical and emotional barriers separately, 
which could help reduce existing disparities. Increased specificity about the 
types of barriers that impact on screening-related decision-making among 
different population subgroups might be particularly useful for the development 
of targeted interventions. It would also be beneficial for future research to 
assess the extent to which the introduction of the FIT will impact on the 
influence perceived barriers have on both screening intention and participation. 
Some preliminary evidence from a Scottish study on the attitudes towards the 
gFOBT versus the FIT (prior to the introduction of the FIT in Scotland) showed 
that participants reported higher intentions to complete the FIT versus the 
gFOBT and perceived the FIT as easier to complete and less disgusting 
(Chambers et al., 2016). Once the FIT is introduced, it would be useful to 
investigate whether changes in actual screening uptake are directly or indirectly 
associated with a reduction in practical barriers. Overall, the findings presented 
here suggest that efforts to remove or reduce the impact of both practical and 
emotional barriers would have a positive effect on screening intention, which 
could have promising implications for screening participation.  
Interestingly, perceived benefits only had a direct effect but did not 
indirectly predict screening intention. Furthermore, perceived benefits negatively 
correlated with perceived barriers, indicating that perhaps the mechanism of 
influence was through its significant correlation with perceived barriers. The 
causal pathways through which benefits and barriers influence intention and 
behaviour to participate in gFOBT screening should further be examined. 
Similarly, mediation analysis indicated that, although PBC did not significantly 
mediate the association between past behaviour and screening intention, past 
behaviour predicted higher PBC. As mentioned earlier, the role of PBC in the 
context of CRC screening remains ambiguous. For instance, in their meta-
analysis Cooke and French (2008) concluded that PBC was not an important 
predictor of screening behaviour and argued that one’s perception of 
behavioural control is unlikely to correspond to actual behavioural control when 
it comes to cancer screening, with only actual control being considered as more 
likely to translate into increased intention (Armitage & Conner, 2000; Webb & 
Sheeran, 2006). Still, it is worth noting that mediation analyses indicated that 
PBC was only marginally non-significant, suggesting that its role in relation to 
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gFOBT screening intention and behavioural enactment should be further 
examined. 
Evidence that subjective norm is a mediator of the past behaviour-
intention relationship is in line with the findings presented in Chapter 3, which 
reported that the influence of important others was a key motivating factor for 
repeat CRC participation among past screeners. The finding that subjective 
norm is both a direct and an indirect predictor of behaviour is consistent with a 
previous findings showing a positive association between subjective norm and 
intention, even after controlling for attitudes (Baumann, Brown, Fontana, & 
Cameron, 1993; Lauver, Nabholz, Scott, & Tak, 1997; Montaño, Thompson, 
Taylor, & Mahloch, 1997; Zapka, Stoddard, Costanza, & Greene, 1989). These 
findings suggest that subjective norm is an important determinant of gFOBT 
screening that should be targeted by future interventions. It might be particularly 
important to target subjective norms for people who score high on barriers or 
have negative attitudes, as it is likely that awareness about positive beliefs 
important others have towards screening could urge people to reconsider their 
negative beliefs and increase intention to participate in screening.  
4.4.3. Education as a Moderator 
The results suggested that educational attainment moderated the 
relationship between SES and intention, as well as each of the relationships 
between cognitive-instrumental attitudes, perceived benefits, perceived barriers 
and intention. Higher SES was predictive of stronger intention to participate in 
gFOBT screening only among participants that had a degree-level education. 
This finding is consistent with previous evidence that shows that education 
plays an important role in health behaviours and that differences in educational 
attainment can influence the perceived value of preventive care and in turn 
explain differences in preventive care participation (Mirowsky, 2017).  
Surprisingly, results showed that participants who had lower educational 
attainment there was an inverse relationship between SES and intention, 
indicating that greater neighborhood deprivation was associated with greater 
intention to participate in screening. This contrasts with findings from previous 
studies that have shown that higher education level is associated with greater 
cancer screening participation (Bíró, 2013; Lange, 2011; Wübker, 2014), 
therefore, it is considered unlikely that this finding would be replicated in future 
research. 
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There has been growing recognition of the need for further insights about 
how educational attainment is associated with cancer screening. A recent study 
conducted in Canada by Jiang and Velasquez-Garcia (2017) analysed 
secondary data obtained from a sample of 38,863 respondents in order to 
examine the association between education and CRC screening participation 
and found that more years of education were associated with an increased 
likelihood to comply with recommended screening guidelines both for stool-
based and endoscopic screening procedures. Similar findings have been 
observed for mammography adherence; for instance Hubbard and colleagues 
(2016) reported that mammography uptake increased with stepped increases in 
educational attainment, with a mammography rate of 58.3%, 69.5% and 80.8% 
among women with less than a high school education, high school education 
and college degrees respectively. 
Research shows that educational attainment is strongly associated with 
health literacy, which is thought that it may act as a partial mediator of the 
contribution of education to screening inequality (Solmi et al., 2015). Indeed, 
health literacy is considered to be a key contributing factor for socioeconomic 
and ethnic disparities observed in CRC screening in the UK and worldwide; 
individuals with low health literacy report limited knowledge of health services, 
greater difficulty in understanding abstract concepts such as risk and more 
barriers in understanding procedural information and completing screening 
(Gimeno-Garcia, 2012; Kobayashi et al., 2014; Power et al., 2009). Health 
literacy may be an important reason that certain populations have not benefitted 
equally from cancer screening, however, the measurement of health literacy 
remains challenging because it encompasses multiple components, including 
cultural and conceptual knowledge, print literacy skills (i.e.,  ability to read, write 
and understand text), numeracy skills (i.e., ability to complete numerical tasks), 
oral literacy skills (e.g., listening, speaking), and media literacy skills (i.e., the 
ability to access and process media information including e-health). Future work 
should investigate the pathways through which low educational attainment 
influences the uptake of CRC screening uptake and should particularly examine 
the mediational effects of health literacy to gain a better understanding of the 
role it plays in the completion of cancer screening.  
Given that low educational attainment is likely to impact on knowledge 
about health services and diseases (von Wagner et al., 2009) it is possible that 
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individuals with lower educational attainment may benefit from interventions 
involving public education and awareness campaigns that raise the profile of 
CRC screening and reiterate the recommendations of its use. Alternatively, the 
patient-navigation model, which involves individual health education delivered 
by community health-advisors (e.g., home visits, phone calls) has also shown 
promising results in the USA for improving knowledge about the benefits of 
screening and screening participation (e.g., Green et al., 2013), and is 
particularly effective for ethnic minority and low income populations (Documet et 
al., 2015). Moreover, the meta-analysis in Chapter 2 also indicated that paper-
based materials in addition to telephone outreach was associated with greater 
intervention effectiveness (e.g., Church et al., 2004; Levy et al., 2013). Since 
some evidence exists on the effectiveness of higher intensity health 
communication and patient navigation approaches in increasing CRC screening 
uptake, future studies should aim to integrate such approaches to investigate 
the extent of their effect in reducing screening inequalities in the UK.  
4.4.4. Area-level SES (IMD) as a Moderator 
The results suggested that area-level SES moderated the relationship 
between both education and intention and ethnic group and intention. Higher 
educational attainment was predictive of greater intention to participate in 
screening among both low and high SES groups, however, the effect of greater 
educational attainment on intention was much more pronounced among the 
high SES group compared to the low SES group.  The fact that higher 
educational attainment was associated with greater intention for both SES 
levels further highlights the important influence of education in relation to CRC 
screening. However, the more prominent positive effect of education on 
intention among participants with higher SES, is consistent with previous 
studies reporting that higher SES is associated with overall more favourable 
cancer screening behaviours. One possibility is that educated individuals from 
poorer SES backgrounds contend with a unique combination of chronic, 
frequent and high-impact stressors (e.g., financial instability, social devaluation 
as a function of SES, fewer employment opportunities) that are not faced by 
their higher SES peers, which in turn may influence their capacity and 
motivation to process and engage with health-related behaviours and services 
in a similar manner that populations with higher SES would. Moreover, 
unhealthy behaviours are relatively commonplace among individuals with lower 
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SES due to the stress that low SES causes, suggesting that, apart from the 
direct causal pathway from low SES to poor health, there is an indirect pathway 
through the stresses associated with greater socioeconomic disadvantage. 
Research shows that one process that is important for the conscious enactment 
of health behaviours is self-regulation defined as “an individual’s ability to guide 
his/her goal-directed activities over time and across changing circumstances” 
(Karoly, 1993) and the capacity to modulate thoughts, emotions, behaviour 
and/or attention. Health behaviours, such as attending regular CRC screenings, 
require engagement on an ongoing basis and individuals themselves must be 
invested in the execution of necessary and appropriate behaviours. Research 
shows that problems in self-regulation are patterned by SES ad people with 
lower SES may feel that they do not have capacity to commit to health-related 
goals when there are more urgent concerns to address (Ouwehand, de Ridder, 
& Bensing, 2009). These findings suggest that it might be important to 
encourage and support low SES populations to form specific goals in relation to 
gFOBT screening, for example, through the use of implementation-intentions, 
which may consequently lead to improvements in self-regulation and help 
promote healthier screening behaviours. Moreover, interventions focusing on 
enhancing self-regulation should aim to incorporate strategies that promote goal 
setting and goal striving whilst taking into account people’s external and/or 
situational factors such as limited time, money and access to necessary 
resources and adapting interventional materials. It is unlikely that the same 
intervention strategies will be effective in high and low SES populations alike, 
therefore awareness about the particular barriers low SES populations face and 
linking these contextual circumstances to the application of self-regulatory 
intervention techniques may strengthen goal commitment among more 
socioeconomically deprived populations. Future experimental research is 
warranted to explore whether enhancing goal-directed behaviour using self-
regulatory intervention techniques would be useful in improving CRC screening 
intention and participation among low SES populations.  
The interaction between ethnicity and area-level SES indicated that 
White British participants with higher SES were significantly more likely to 
intend to participate in screening, whilst there appeared to be no link between 
ethnicity and intention in the low SES group. Whilst these findings make clear 
that being from a White ethnic backgrounds bears a significant, positive 
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association with intention to participate in screening for the high SES group, the 
lack of evidence regarding the link between intention and ethnicity for the low 
SES group was surprising. This finding is not consistent with other research, 
that has shown that IMD scores are correlated with individual makers of SES, 
including non-white ethnic background, and that high area-level deprivation is 
associated with worse screening-related outcomes (Moss et al., 2012). The 
analysis presented in this chapter was limited in that the numbers of participants 
from BAME backgrounds were too small to examine the effect of ethnicity. 
There is great need to involve more participants from BAME backgrounds to 
provide more detailed and accurate examinations of patterns between ethnicity 
and CRC screening intention and uptake. 
4.4.5. Past Screening Behaviour as a Moderator 
Results indicated that past screening behaviour moderated the 
relationship between several psychosocial variables and intention. Specifically, 
more positive cognitive-instrumental attitudes – a construct measuring beliefs 
about how useful/useless and beneficial/harmful gFOBT screening is – were 
predictive of stronger intention to participate in gFOBT screening only among 
participants who were not up-to-date with gFOBT screening. The positive 
association between attitudes and intention is in agreement with previous 
empirical evidence that has shown that positive attitudes towards CRC 
screening are predictive of increased screening intention (McCffrey, Wardle, & 
Waller, 2003), however it is surprising that this positive relationship was 
observed only among non-screeners and not both screening sub-groups. This 
finding is inconsistent with results from Study 2, which highlighted that non-
screeners were less likely to intend to participate in future screening rounds 
partly due to negative attitudes about the screening process. Equally surprising 
was the finding that perceived benefits and injunctive norm were significantly 
and positively predictive of intention in the non-screeners subgroup only, 
whereas weaker, positive associations between each of these variables and 
intention were observed in the screeners subgroup. These results indicate hat 
there appears to be a discrepancy between the way in which non-screening 
participants perceive CRC screening uptake on the one hand (i.e., useful, 
beneficial, a behaviour that important others would approve) and their actual 
screening behaviour on the other (i.e., not having completed and returned a 
screening kit). This discrepancy may be partly explained by the stronger 
  
248 
negative association between perceived barriers and intention observed in the 
non-screeners subgroup; a finding which is consistent with results from Study 2, 
which indicated that non-screeners - despite often being aware about the health 
benefits of CRC screening participation – also were more likely to perceive the 
screening process as more challenging and unpleasant compared to past 
screeners. Notably, a number of  non-screeners in Study 2 attributed their non-
participation predominantly to the unpleasantness of the screening procedure.  
Another explanation for the discrepancy between the attitudes-past 
screening behaviour relationship observed in the non-screeners subgroup could 
be that non-screening participants, despite completing the survey anonymously, 
felt pressurised to respond in a more socially desirable manner. CRC screening 
is a behaviour associated with clear social norms – that is, a large proportion of 
the population will generally perceive CRC screening as positive (Cullati, 
Charvet-Bérard, & Perneger, 2009; Douma, Uiters, & Timmermans, 2016; 
Schwartz, Woloshin, Fowler, & Welch, 2004; Waller, Osborne, & Wardle, 2015)  
– and therefore non-screening participants might have felt inclined to provide 
responses that do not deviate from the norm, resulting in the observed 
discrepancy. Items relating to the usefulness or benefits associated with CRC 
screening might be more sensitive for non-screeners compared to screeners, as 
it exposes non-screeners to the possibility of providing a socially unacceptable 
or undesirable response (Tourangeau & Yan, 2007) suggesting that perhaps 
past non-screeners were more likely to misreport having positive attitudes 
towards screening compared to past screeners. Perhaps it is this misreporting 
by past screening behaviour that contributed to an overestimation of the 
strength of the relationship between attitudes/perceived benefits and intention 
among non-screening participants.  
Results from the present analysis further indicated that, as anticipated, 
PBC was positively and significantly associated with screening intention in the 
screeners subgroup – a finding which is in agreement with findings reported in 
Study 2 suggesting that repeat participation was associated with increases in 
self-efficacy/PBC -, however, it was surprising that PBC was negatively 
associated with intention among non-screeners. This finding suggests that past 
non-screeners with higher PBC had weaker intentions to participate in 
screening. The direction of this association contrasts the prediction proposed by 
the TPB/TRA model and it is unlikely this finding would be replicated in future 
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studies. Given the discrepancies between past screening behaviours and the 
associations between attitudes, perceived benefits, injunctive norms and 
screening intention observed in the non-screeners subgroup, it may be useful to 
test interventions that aim to enhance self-regulation and/or goal setting 
behaviour in order to motivate participants to act in line with their 
attitudes/values. Moreover, given the findings from Study 2, which indicated that 
non-screeners experienced more emotional barriers with regards to the gFOBT 
screening process compared to screeners, it may be important for interventions 
to incorporate components relating to emotion regulation. This may help with 
managing negative affects associated with gFOBT screening often experienced 
by individuals (e.g., disgust, embarrassment). Some evidence suggests that 
decision aids and anticipated regret interventions may reduce decisional conflict 
and promote attitude-behaviour consistency (Dormandy, Hankins, & Marteau, 
2006), however, there is little research in the CRC screening literature that has 
assessed the effectiveness of such interventions among past non-screeners 
specifically. Therefore, there appears to be a need for studies investigating and 
testing interventions that target emotional barriers among non-screeners in 
particular. 
4.4.6. Limitations 
The limitations of the study should be considered. The first limitation 
concerns the inclusion of intention as a primary outcome instead of using an 
objective measure of screening uptake. The present study had originally aimed 
to objectively measure screening uptake, however, due to NHS organisational 
restructuring that affected access to the UK’s cancer screening databases and 
a newly implemented process concerning the removal of Type 2 Objectors (i.e., 
a process that concerns patient objections about the types of data that can be 
provided for purposes outside their primary care) it was not possible to have 
objective data on uptake. Therefore screening intention was used as a 
behaviour ‘proxy’. Intention formation plays a critical role in the enactment of 
health behaviours (for an overview see Abraham & Sheeran, 2003; Armitage & 
Conner, 2000), and meta-analyses have shown that behavioural intention has 
the strongest relationship with prospective behaviour; for instance, a meta-
analysis by McEachan, Conner, Taylor and Lawton (2011) reported a mean 
correlation of r = .043 between intention and behaviour, and a meta-analysis by 
Armitage and Conner (2001) reported an intention-behaviour correlation of r = 
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.047, suggesting that intention is an important predictor of behaviour. The study 
by McEachan and colleagues further indicated, that even after controlling for 
past behaviours, intention still emerged as an important predictor of prospective 
behaviour. Although these findings lend their support to the use of behavioural 
intention as an outcome variable, research has shown that intentions may not 
always translate into action, a phenomenon referred to as the ‘intention-
behaviour gap’. The study would have benefited from including an objective 
measure of behaviour and it would have been particularly useful to examine 
whether screening uptake rates varied by differences in the level of screening 
intention. 
Secondly, as indicated earlier, BAME populations were 
underrepresented in the present sample of participants. It is possible that a 
different pattern of findings would have been observed had there been a more 
equal representation of all ethnic groups. Perhaps the lack of significant findings 
in relation to ethnicity may be due to the small representation of BAME 
populations in the analysis. Moreover, intention to participate in gFOBT 
screening was overall high in the present sample and it is unclear whether the 
observed patterns of findings would hold in a more ethnically diverse 
population. Nonetheless, previous research examining associations between 
ethnicity and CRC screening in the UK have reported equally low sample sizes 
for BAME populations (e.g., Solmi et al., 2015; Lo et al., 2015), which reflects 
the field-wide challenges in health inequalities research with regards to 
recruiting and retaining participants from ethnic minority populations (Wendler et 
al., 2005). Recruitment of ethnic minority participants from the particular age 
group that was of interest in the present study (i.e., 60-74) represented an 
additional barrier, due to the low prevalence of BAME populations among older 
age groups in the national population of England (Office of National Statistics, 
2013). Nonetheless, substantial efforts were made during this research in order 
to target and recruit individual from low SES and BAME backgrounds – 
including involvement and building rapport with local communities and 
charitable organisations and use of diverse recruitment strategies (e.g., online 
and face-to-face).  
Increasing research participation among vulnerable subgroups of the 
populations is imperative, therefore future studies may benefit from the inclusion 
of multiethnic staff, greater involvement and collaboration with third-sector 
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organisations that have close links with BAME communities and the use of 
translated research materials; all actions that are likely to minimise the unique 
challenges BAME populations face in participating in research (Brannon et al., 
2013; Otado et al., 2015). In turn, more ethnically diverse samples will ensure 
representativeness and generalisability of findings.  
Third, the cross-sectional nature of the data does not allow making 
causal statements about the links between sociodemographic or psychosocial 
variables and gFOBT screening intention or the direction of these associations. 
Additionally, the fact that the present analyses were based on correlational data 
may have led to an overestimation of the magnitude of the associations 
between theoretical constructs and gFOBT screening intention. Experimental 
studies that manipulate each of the theoretical constructs separately and 
examine the impact of the manipulation on screening intention and participation 
would provide more precise results. An RCT study design could also contribute 
to the elimination of potential confounding variables.  
4.4.7. Conclusions 
Despite its limitations, the present study provided useful insights into the 
processes underlying participants’ intention to participate in gFOBT screening. 
Whilst past studies have examined the associations between sociodemographic 
and psychosocial constructs in relation to CRC screening, few studies have 
examined both of these together and used mediation and moderation analyses 
to explore the potential mechanisms. The present study has identified some 
important sociodemographic (e.g., education) as well as psychosocial (e.g., 
cognitive-instrumental attitudes) determinants of gFOBT screening intentions 
and has further identified some variation by level of educational attainment and 
area-level deprivation. Most importantly, the findings demonstrated that past 
behaviour was a significant predictor of gFOBT screening intention and this 
effect was present across high and low SES populations, as indicated by the 
results using both individual-level SES measures such as education as well as 
area-level SES measures such as IMD data. This finding is consistent with 
results from previous studies that have demonstrated that past experience is an 
important predictor of intention. This reinforces the need for future studies to 
consider the importance of addressing the screening experience of invitees, 
and particularly first-time invitees, as it is possible that a negative screening 
experience during an individual’s first screening round has the capacity to 
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substantially and negatively affect subsequent screening decisions. 
Promisingly, findings indicated that the path from past screening behaviour to 
gFOBT screening intention was partially mediated via three psychosocial 
constructs: cognitive-instrumental attitudes, perceived barriers and injunctive 
norms, which are all factors that are modifiable and therefore suitable for being 
targeted in intervention studies. A next step would be for the present findings to 
be replicated through experimental studies which manipulate identified 
constructs in order to test their influence on intention, but most importantly, on 
screening behaviour. Another recommendation for future research would be to 
identify specific BCTs that can be used to target the psychosocial constructs 
that have been identified as potential mechanisms of screening intention and 
behaviour. Whether different BCTs should be used for different population 
subgroups remains a matter of continuing research and debate. Chapter 2 of 
the present thesis has provided some indication about the types of BCTs that 
could promote CRC screening participation for populations of varying SES, 
however, more theory-driven interventional research that tests the use of 
different BCTs is urgently needed in order to elucidate the types of strategies 
that will help reduce the socioeconomic gradient of screening uptake. In 
conclusion, the present study utilised two key SCMs and has identified possible 
sociodemographic and social cognitive pathways through which screening 
intentions can be affected among a socioeconomically diverse sample in Britain. 
Some potential strategies to improve screening intention and facilitate 
screening behaviour among different population subgroups are outlined in the 
next and final chapter of the present thesis. 
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CHAPTER 5 
General Discussion 
5.1. Chapter Summary  
The research in this thesis was prompted by the ongoing concern about 
the inequalities observed in CRC screening uptake. As outlined in Chapter 1, 
screening and the early detection of asymptomatic cases constitute important 
elements in the control of CRC. The UK is among the many countries that have 
successfully implemented population-based CRC screening programmes using 
the gFOBT screening kit, however screening uptake is not uniform across the 
population. There is compelling evidence that certain subgroups of the 
population (e.g., low SES, BAME) have lower participation rates compared to 
the general population. Further understanding is needed regarding, firstly, the 
approaches that are most likely to succeed in improving uptake among 
populations of varying SES, and secondly, the reasons that underpin these 
differences in uptake. Therefore, the aims of this thesis were to examine the 
effectiveness of existing interventions to improve CRC screening uptake and to 
examine the potential impact of sociodemographic and psychosocial factors in 
relation to gFOBT screening.  This final chapter firstly, provides a brief 
description of the research studies conducted to address the thesis aims, as 
outlined in Chapter 1; secondly, summarises the key thesis findings alongside a 
discussion of implications and recommendations for future research; thirdly, 
provides a proposal of a conceptual framework for increasing CRC screening 
based on the thesis findings; and lastly, this chapter concludes by providing an 
overview of the strengths and limitations of the thesis.   
5.2. Overview of Thesis Findings 
Aim 1: To evaluate the effectiveness of existing interventions to improve 
CRC screening uptake and to examine whether intervention effectiveness 
varies by level of SES (Study 1) 
In order to address this aim a systematic review of the literature was 
conducted that included 102 RCTs designed to promote CRC screening uptake. 
The systematic review and meta-analysis included is the first in the field to 
examine the effectiveness of a wide range of interventions to increase CRC 
screening uptake and is also the first to examine effectiveness by level of SES. 
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Moreover, thus far there has been no prior research that has analysed the 
effectiveness of particular BCTs using the taxonomy by Michie and colleagues 
(2013) or that has examined the effectiveness of techniques across different 
population subgroups. In addition, existing systematic reviews have not 
systematically assessed the association between reported theory use and the 
effectiveness of health interventions to increase CRC screening uptake.  
Results from the meta-analysis offered clear support for the 
implementation of health interventions to improve CRC screening uptake; 
results showed a small, yet statistically significant, positive effect across all 
included studies. Promisingly, results further indicated that interventions were 
more effective for low SES groups and this difference in effect was statistically 
significant compared to non-low SES groups. Results further indicated a 
reduction in the gap in screening uptake observed between higher and lower 
SES groups (i.e., the difference in uptake between high and low SES groups 
was reduced from 19% to 7.5%), thereby suggesting a reduction in screening 
disparities as a result of health intervention implementation. 
Use of subgroup and meta-regression analyses allowed the identification 
of strategies that were associated with increased intervention effectiveness. The 
evidence compiled from the meta-analysis revealed a number of strategies that 
have capacity to promote effective public health interventions for low SES 
populations. Firstly, with regards to intervention characteristics, it appears that 
delivering interventions one-to-one rather than in groups, involving clinically 
trained health professionals (e.g., GPs) in intervention delivery, using materials 
that combine paper-based information about screening plus 
electronic/technological elements (e.g., web-based interventions, text 
messages) and including a component that involves telephone outreach, to 
reiterate the purpose of CRC screening and address barriers, are all 
intervention components associated with increased intervention effectiveness 
among low SES groups. Moreover, intervention delivery within a community 
setting, rather than in primary care, was associated with greater effect sizes. 
The content of interventions was assessed through the coding of BCTs 
present in the experimental condition versus the control condition. The most 
frequently used BCTs were ‘Information about Health Consequences’, 
‘Prompts/Cues’ (i.e., reminders), ‘Social Support’, ‘Adding Objects to the 
Environment’ (i.e., supplying participants with a free screening kit and therefore 
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only relevant to USA-based studies) and ‘Problem Solving’. Different BCTs were 
associated with greater CRC screening uptake for the non-low and low SES 
groups. For non-low SES groups interventions that incorporated arrangements 
for or the provision of social support (e.g., from friends, relatives, colleagues) 
indicated significantly larger effect sizes. For the low SES group, instructions 
about how to perform the behaviour (beyond what participants received as part 
of their usual care) was associated with greater intervention effectiveness. For 
both SES groups, providing a free screening kit and incorporating reminders 
into the intervention were associated with increased intervention effectiveness, 
although the addition of reminders was significantly more beneficial for the non-
low SES group. The meta-analysis also examined the extent of reported theory 
use using Michie and Prestwich’s Theory Coding Scheme (2010) and also 
examined whether there was any association between intervention 
effectiveness and theory use. Overall, results indicated that there was limited 
reporting of theory use in the development and/or evaluation of health 
intervention to increase CRC screening. The majority of interventions did not 
make reference to theory and only a third of studies reported using theory to 
develop the intervention. The theoretical frameworks most frequently used in 
interventions were the HBM and the Transtheoretical model of change (TTM). 
Moderation analysis indicated that higher levels of reported theory use were not 
associated with greater intervention effectiveness.   
Aim 2: To identify the perceived barriers and perceived facilitators to 
gFOBT uptake among different population subgroups (Study 2) 
Study 2 explored the barriers and facilitators related to gFOBT screening 
among an ethnically and socioeconomically diverse sample of both men and 
women, as well as past screeners and past non-screeners. Many similarities in 
the factors that facilitated or hindered screening participation were apparent 
across all subgroups. Common barriers to gFOBT screening expressed by 
study participants included emotional barriers – for example, experiencing 
negative affects (e.g.,  disgust and embarrassment) -, practical barriers – mainly 
concerning collecting and storing faecal samples -, and the perception of CRC 
screening as a taboo topic; all factors that had a negative impact on screening 
intention. Barriers more commonly experienced by low SES and BAME 
populations included greater cancer fatalism, reduced awareness about the 
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benefits of screening, poorer health literacy and culture-specific factors (e.g., 
religiosity). Language barriers appeared to be a key problem for participants 
whose first language was not English and although participants often expresses 
willingness to participate in screening, the inability to fully understand and 
process the information in the screening invitation was a deterring factor. 
Participants expressed efforts to overcome this barrier by relying on family 
members to assist but not all participants had this option available. A barrier 
specific to male interviewees was the lack of familiarity with routine check-ups. 
Among past non-screeners, barriers that were more prominent included 
reduced perceived susceptibility, more negative attitudes towards the screening 
process and a stronger belief that the absence of cancer-related 
symptomatology was, falsely, an indication of good health. The findings 
particularly highlighted that reduced perceived severity and susceptibility were 
associated with greater behavioural avoidance for participants not up-to-date 
with gFOBT screening. Another barrier among non-screeners was medical 
mistrust. Issues discussed included the lack of data protection, past negative 
medical experiences, the gradual privatisation of the NHS and concerns over 
the cut-off age of people invited to participate in screening (i.e., 60-74 years). 
On the other hand, one of the main facilitators of screening participation 
was the influence of social networks on participants’ decision to be screened for 
CRC. Across all subgroups, a recurrent finding was that participants relied on 
their spouses, family, friends and wider communities to learn about CRC. 
Interviewees expressed the view that the sharing of CRC experiences and 
testimonials from other people that had undergone screening served as a 
motivator for CRC screening. White British participants were more likely to seek 
support and discuss screening with their spouses, whereas participants from 
BAME backgrounds were more likely to seek support and gain information 
about CRC screening from members within their wider community and/or 
younger family members with greater levels of acculturation. GP endorsement 
of CRC screening appeared to be particularly valued by participants from BAME 
backgrounds and results indicated that GP endorsement/recommendation 
strongly influenced their decision to participate in screening. Across all study 
subgroups, knowing someone who either had a positive diagnosis of CRC 
and/or had died from CRC was a key motivating factor for screening 
participation. Those who had a familial history of CRC were more likely to 
  
257 
participate in screening and this was often attributed to increased perceived 
susceptibility. Participants who had lost a loved one to CRC were also more 
likely to express their appreciation for the NHS and the provision of free cancer 
screening services. Past screeners reported more positive attitudes towards 
gFOBT screening, were more likely to form direct links between screening and 
long-term health and expressed greater motivation to participate in subsequent 
screening rounds compared to non-screeners.  
One of the most salient findings was that past screeners felt that they 
were morally responsible for their own health choices and considered screening 
participation to be a behaviour that is reflective of self-care. Lastly, results 
indicated that participants who were up-to-date with screening perceived their 
first screening episode as the most challenging, however, ease of completion 
increased with each subsequent screening round (if completed), perhaps due to 
increased self-efficacy. Past screeners also seemed to associate less practical 
and emotional barriers with repeat screening. For instance, participants 
described feeling less anxiety and increased reassurance with each kit they 
completed and felt that the likelihood of test results indicating advanced cancer 
were reduced, which was a factor that strongly facilitated repeat screening 
compliance.  
Aim 3: To explore acceptability of the FIT screening kit (Study 2) 
Study 2 also examined participants’ initial perceptions of being offered a 
one-sample stool test soon to be introduced in the UK (i.e., FIT) instead of the 
three-sample stool test currently used (i.e., gFOBT). Results indicated that 
overall participants were more likely to express a preference for the FIT. 
Participants associated the FIT with greater ease of completion and greater 
convenience due to not having to store the kit in their homes before posting. 
Male participants in particular expressed that the one-step process involved in 
completing the FIT would substantially reduce the ‘unpleasantness’ of the test. 
Participants also indicated that the FIT would be less time-consuming than the 
gFOBT. Surprisingly, some participants indicated a preference for the gFOBT 
over the FIT. This was primarily attributed to the misconception that the number 
of stool samples collected will affect the diagnostic accuracy of the test and that 
the collection of one sample could result in a misdiagnosis of cancer. 
  
258 
Aim 4: To assess the direct and indirect pathways via which 
sociodemographic and psychosocial factors influence gFOBT screening 
intention (Study 3) 
Study 3 presented the results from hierarchical regression, mediation 
and moderation analyses that were undertaken to examine whether: a) 
sociodemographic and psychosocial factors directly predicted gFOBT screening 
intention, b) psychosocial variables mediated the influence of sociodemographic 
variables on intention, and c) whether sociodemographic factors moderated 
relations between psychosocial variables and gFOBT screening intention.  
Results indicated that both sociodemographic and psychosocial variables 
uniquely and significantly explained a proportion of the variance in screening 
intention. Education and past gFOBT screening were significant, direct 
predictors of screening intention. Moreover, a number of psychosocial variables 
were found to directly predict screening intention, including cognitive-
instrumental attitudes, perceived benefits, PBC and injunctive norm. Mediation 
analysis indicated that the relationship between past screening behaviour and 
screening intention was partially mediated by more favourable cognitive 
instrumental attitudes, fewer perceived barriers and greater injunctive norm. 
Evidence for the mediating role of PBC indicated there was a trend towards 
significance. These results suggest that interventions that: a) enhance the 
formation of more positive attitudes regarding the usefulness of screening, b) 
that address commonly encountered barriers - whether practical or emotional - 
and c) prompt invitees to consider the views of important others about 
screening (e.g., Social Norms Approach) could strengthen screening intention, 
which could in turn lead to greater screening uptake rates. Findings from the 
mediation analysis were also consistent with findings reported in Chapter 3, 
which found that past participation in gFOBT screening was associated, among 
others, with more positive attitudes regarding the benefits of screening and 
engaging in preventive healthcare behaviours and was also associated with a 
reduction in emotional barriers; for instance, past screeners reported feeling 
less embarrassed with regards to the stool-sampling process, after having 
completed their screening kit at least once, and less anxious whilst waiting for 
screening results.  
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In addition, the importance of injunctive norms as a mechanism to 
increase screening intention, was also a finding reported in the qualitative 
analysis. Specifically, participants that were up-to-date with screening 
repeatedly emphasised the significance of being encouraged by important 
others to participate in screening. Notably, past screeners highlighted the 
importance of spousal influences in their decision to participate in gFOBT 
screening, as well as the importance of wider social networks including 
friendship groups and people from their local community. The data suggested 
that spouses influenced the dynamic of each other’s health habits and use of 
the screening kit, indicating that future attempts to increase screening 
participation may be enhanced by understanding the association between 
marital/cohabiting relationships and screening behaviours.  
Moderation analysis was used to examine whether education (i.e., an 
indicator of individual-level SES), and neighborhood deprivation (i.e., an 
indicator of area-level SES) had an impact on the magnitude of any 
associations between screening intention and other predictor variables included 
in the analysis. With regards to the moderating effects of education, after 
controlling for other predictor variables, results indicated that higher SES was 
associated with a reduction in screening intention among less educated 
participants, whereas higher SES was associated with an increase in screening 
intention among more educated participants. Positive cognitive-instrumental 
attitudes were associated with greater screening intention for both education 
groups (i.e., no degree versus degree), however, it was surprising that more 
positive attitudes were associated with significantly greater screening intention 
among participants without a degree compared to participants with a degree. 
Similarly, more perceived benefits were associated with greater screening 
intention in both groups, however, the association between perceived benefits 
and screening intention was significantly stronger among participants without a 
degree compared to participants with a degree. This finding contradicts 
previous research that has shown that greater educational attainment is 
associated with increased awareness about the benefits of screening and more 
positive attitudes (Gimeno Garcia, 2012; Jiang et al., 2017; Power et al., 2008). 
It is known from other research examining the impact of education on cancer-
related decision making, that educational attainment is strongly associated with 
health literacy and that this is a key factor contributing to CRC screening 
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inequalities, over and above educational attainment (Solmi et al., 2015). 
However, Study 3 did not include a measure of health literacy and therefore its 
impact as a potential moderator could not be examined. The inclusion of a 
health literacy measure might have allowed for a greater resolution of findings 
with regards to the association between educational attainment, knowledge and 
screening intention. It is possible that broadly categorising individuals into those 
with a degree and those without a degree-level education, was insufficient in 
that it probably did not capture data from populations with very low literacy, 
given that individuals without a degree-level education are likely to have basic 
levels of literacy.  
5.3. Thesis Reflections and Recommendation for Future Research 
The present research has drawn together disparate strands of research 
to highlight the multiple possible pathways through which sociodemographic 
and psychosocial factors might impact CRC screening intention and 
participation. The next section will firstly, provide an overview of certain key 
findings alongside recommendations for future research, and secondly, briefly 
describe the development of a conceptual model based on findings from the 
thesis, which could be used to guide future research focusing on increasing 
CRC screening participation.  
5.3.1. Key Findings, Implications and Future Directions to Improve CRC 
Screening Uptake 
Results from the meta-analytic review provided strong support for the 
delivery of public health interventions to low SES groups. It is promising that the 
impact of interventions reduced the observed gaps in screening inequalities. 
The meta-analysis provided clear directions with regards to specific strategies 
and intervention characteristics that were associated with greater intervention 
effectiveness among both low and non-low SES populations. The importance of 
utilising and specifying BCTs in interventions has been discussed extensively in 
the literature and the present meta-analysis was the first in the field to evaluate 
whether specific BCTs increased intervention effectiveness. Despite identifying 
some effective BCTs for the two SES sub-groups, the lack of detail with regards 
to the description of interventions in included studies warrants further attention. 
It was surprising that some of the most efficacious BCTs in behaviour change, 
including ‘Goal Setting’, ‘Action Planning’, ‘Commitment’, ‘Anticipated Regret’ 
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and ‘Salience of Consequences’ were seldom used in interventions prompting 
CRC screening. A suggestion for further study would be to explore whether 
these BCTs increase motivation and/or participation in CRC screening.  
Based on the premise that gFOBT screening is a behaviour that is 
composed of multiple steps and requires careful planning, the BCT ‘Action 
Planning’ from the ‘Goals and Planning’ category could be suggested as an 
appropriate technique for supporting individuals in the planning and execution of 
gFOBT screening. This BCT is thought to facilitate behaviour change by 
providing a clear pathway in identifying context, duration and frequency of the 
required behaviour change and provides the opportunity for the individual to 
develop effective strategies to overcome behavioural barriers. Implementation 
intentions (IMPs) interventions (synonymous to ‘Action Planning’ interventions) 
have been shown to be effective across a wide range of behaviours and several 
studies have associated the use of this BCT with successful health behaviour 
change (Avery, Flynn, Van Wersch, Sniehotta, & Trenell, 2012; Cradock et al., 
2017; Hankonen et al., 2014; Lara et al., 2014). Despite the robust evidence 
that support its use, IMPs have rarely been applied to cancer screening 
(Browne & Chan, 2012; Sheeran et al., 2000) and only two studies (also 
included in Study 1) have applied IMPs to CRC screening (Lo, Halloran, et al., 
2014; Neter et al., 2014) and have shown contradictory findings regarding its 
effectiveness. Therefore, this is one area that merits further research. 
As indicated earlier in the thesis, intention is considered a primary 
determinant of health behaviour and results from previous meta-analyses have 
indicated strong, positive correlations between behavioural intention and 
screening uptake (Cooke et al., 2008; Godin et al., 1996). Based on these 
premises, the use of BCTs that target and strengthen behavioural intention may 
yield additional gains in CRC screening rates. Findings in Study 2 indicated that 
increased confidence about the screening procedure was an important 
motivator for repeat screening participation, suggesting that it may be useful to 
incorporate in intervention research BCTs that target the construct of self-
efficacy/PBC. For instance, BCTs embedded within the ‘Self-belief’ domain of 
the BCTTv1, such as ‘Verbal Persuasion about Capability’ and ‘Mental 
Rehearsal of Successful Performance’ could be useful within this context. It 
must be noted, that findings from the thesis were inconclusive with regards to 
the exact role of self-efficacy in gFOBT screening; Study 2 indicated that greater 
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PBC was associated with greater intention to participate, whilst findings in Study 
3 suggested that PBC was not a mediator of the association between past 
screening behaviour and screening intention (albeit marginally non-significant).  
Nonetheless, gFOBT screening is a behaviour that requires the individual to 
follow a specific sequence of steps and overcome both practical and emotional 
barriers, therefore the role of self-efficacy as a potential mechanism of 
screening uptake and the use of specific BCTs for targeting and improving self-
efficacy requires further investigation.  
Moreover, the BCT ‘Information of Other People’s Approval’ was not 
incorporated in any of the interventions included in the meta-analysis, however, 
the empirical chapters of the thesis emphasised the important influence of 
participants’ environmental context and social milieu on their perception of CRC 
screening. Specifically, Study 2 suggested that individuals felt more motivated 
to participate in screening when important others wanted them to, and Study 3 
indicated that injunctive norm mediated the association between past behaviour 
and screening intention, thereby suggesting that this is an important mechanism 
in the process of screening-related intention formation. Therefore, it is 
suggested that future studies examine the effectiveness of BCTs that are well-
suited for targeting injunctive norm for increasing both screening intention and 
screening uptake. 
Theory proposes that successful enactment of a behaviour has two 
distinct phases: firstly, a motivational (or intentional) phase, and secondly, a 
volitional (or post-intentional) phase (Heckhausen & Gollwitzer, 1987). Targeting 
both phases is thought to be more effective in promoting behaviour change. It is 
recommended that future interventions test the effectiveness of BCTs that firstly, 
increase the individual’s motivation to engage in CRC screening and secondly, 
strengthen their capacity to plan their screening behaviour. The integrated 
motivational-volitional approach represents a promising avenue of inquiry for 
improving CRC screening uptake and has been shown to be effective for 
increasing physical activity (Milne, Orbell, & Sheeran, 2002; Prestwich, Lawton, 
& Conner, 2003), improving dietary behaviour (Prestwich, Ayres, & Lawton, 
2008) and reducing alcohol consumption (Hagger et al., 2012). However, the 
combination of motivational-volitional approaches has not yet been examined 
within the context of CRC screening. In light of the potentially relevant BCTs for 
CRC screening behaviour discussed above, it would be useful for future 
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research to examine whether the combination of: a) the BCT ‘Action 
Planning’/implementation intentions (IMPs) to assist people in forming plans 
about completing the gFOBT screening kit with b) the BCT ‘Information of Other 
People’s Approval’ to inform people about what important others think about 
CRC screening (e.g., Social Norms Approach) would be effective in improving 
screening uptake.  
Despite present findings highlighting that injunctive norm may facilitate 
CRC screening behaviour – and particularly, the provision of encouragement 
and help from important others seems pertinent for the initiation of screening - , 
it is important to consider that not all individuals will have positive social 
influences. For instance, in individuals whose partner/friends/family are 
ambivalent or have negative attitudes towards screening, a Social Norms 
Approach may not be relevant. Indeed, it could have the opposite effect and 
may act as a barrier to screening participation. Moreover, thesis results 
indicated that the influence of injunctive norms was patterned by differences in 
ethnic background; White British participants were more frequently encouraged 
by spouses/partners to participate in screening whereas BAME populations 
were more likely to rely for support and encouragement on younger family 
members. These findings indicate that interventions that aim to target injunctive 
norms should, if possible, personalise materials to the population to which the 
intervention is being delivered.  
It is worth noting that one of the most commonly used BCTs was 
‘Information about Health Consequences’, however, results indicated that this 
technique was not effective in increasing screening uptake in either SES group 
(i.e. low and non-low SES); a finding which has been reported in previous 
research as well (Vestjens, Kempen, Crutzen, Kok, & Zijlstra, 2015). This 
finding suggests that providing information on screening behaviour-health links 
was not associated with greater intervention effectiveness. Supposedly, 
information about the health consequences of screening participation is 
considered useful for the purposes of enhancing informed decision-making and 
prompting participants to weigh the pros and cons of screening participation. 
Indeed, past research has identified informed decision-making as an important 
process in achieving better overall health-related outcomes. However, informed 
decision-making, as well as indicators of informed decisions (e.g., knowledge, 
deliberation about pros and cons), are highly dependent on an individual’s 
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ability to understand and use information. It is highly problematic to assume that 
all individuals can process and understand information about screening in an 
analytical and deliberate manner, and therefore it is crucial for national CRC 
screening programmes to design and implement strategies that increase the 
ability of those in the poorest socioeconomic strata and those from BAME 
backgrounds to make decisions that enhance their long-term well-being - 
including decisions about preventive healthcare such as cancer screening. The 
implementation of interventions tailored to the needs of specific communities 
requires an understanding of the important mechanisms – psychological and 
sociocultural – that underpin screening decisions in a range of life settings.  
Moreover, the BCT ‘Information about Health Consequences’ may be 
better applied to behaviours that have more immediate outcomes and 
repercussions for an individual’s health. Research suggests that behaviour is 
less likely to be initiated and maintained for long-term outcomes – which is the 
case in CRC screening - compared to behaviours that have immediate benefits 
such as engaging in physical activity. In their paper,  Kwasnicka, Dombrowski, 
White and Sniehotta (2016) highlight that: “Motivation to avoid negative health 
consequences is hypothesised to be insufficient to maintain preventive 
behaviour that requires maintained effort” (p.282). Therefore it appears highly 
unlikely that targeting risk perception simply by providing information about the 
risks of non-participation in CRC screening will materialise into greater 
screening uptake, particularly for people that do not make their own long-term 
health a priority and people who may have to focus on unmet basic needs (e.g., 
food, housing).  
Findings from Study 3 showed that greater perceived severity and 
perceived susceptibility – both constructs of risk perception - were negatively 
associated with screening intention. When examined in conjunction with 
findings from Study 2, it could be suggested that information about the 
importance of CRC screening might be more salient among individuals who 
have been personally affected by CRC – for example, through the passing of a 
loved one. For such individuals, information about the long-term health benefits 
of CRC screening is likely to be of high personal relevance and therefore it may 
reinforce motivation to participate in screening. For individuals without such 
experiences, however, CRC screening might be considered of low personal 
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relevance, which could lead to a lower motivational response in relation to 
screening participation. 
This section so far has provided recommendations that are actionable for 
future interventions. It is also important to consider the links between BCTs and 
the use of theory in the development and/or implementation of interventions. 
Study 1 indicated that approximately a fourth of included studies mentioned use 
of theory or a theoretical model in designing the intervention. Although the 
majority of these studies reported using theory to select and/or develop 
intervention techniques, only a third reported that all intervention techniques 
were explicitly linked to at least one theory-relevant construct. Findings 
indicated that use of theory was not extensive for the majority of studies and the 
relationship between effectiveness and extent of theory use was weak. This 
finding contests previous research that has shown that theory-driven 
interventions may be more effective in changing health behaviours compared to 
studies not using theory (Glanz et al., 2010). Moreover, previous research has 
supported the idea that the evaluation and development of complex 
interventions requires a strong theoretical understanding in order to identify and 
strengthen mediational links in the causal chain (Craig et al., 2008). Over the 
last decade, there has been increased interest in linking BCTs with key 
determinants and/or mediators of behaviour included in SCMs, such as 
intention and attitudes (Michie, Johnston, Francis, Hardeman, & Eccles, 2008). 
Michie and colleagues (2008) have argued that successful behaviour change 
largely relies on: a) specifying the range of techniques available to change the 
determinants of behaviour and b) developing a basis for selecting relevant 
techniques to map on to differing determinants of behaviour. The lack of 
theoretical integration between determinants of behaviour and BCTs in the 
majority of published studies included in Study 1, indicates a discrepancy 
between what is recommended scientifically and what is implemented in terms 
of intervention research. Therefore, it is recommended that future studies 
specify the theoretical underpinnings of the research as well as the BCTs 
employed to target theory-driven, behavioural determinants. It is worth noting 
that the process of coding BCTs was, to an extent, limited by the brief 
intervention descriptions and the lack of detail provided in the included studies. 
BCTs were coded based on what was explicitly described in intervention 
descriptions, and while double screening was applied to the BCT data 
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extraction, the full range of BCTs utilised may not have been captured in all 
studies. It is, therefore, a scientific priority for research papers to provide more 
transparent and comprehensive descriptions of the BCTs used. 
Evidence from the present thesis provides some insights about the 
potential intervention characteristics that could influence intervention 
effectiveness in increasing CRC screening for different population subgroups. It 
appears that a range of strategies could be beneficial for improving screening 
participation among more vulnerable groups. For instance, findings from 
Studies 1 and 2 indicated that low SES populations benefitted more from 
interventions delivered by clinically-trained health professionals (e.g., GPs) 
compared to lay health educators, but results also showed that interventions 
delivered in community settings - which are traditionally delivered by non-
clinically trained health professionals - were more effective than interventions 
delivered within the realms of primary care. Moreover, findings from Study 2 
suggested that BAME populations found it beneficial to talk about CRC 
screening within a lay network indicating that health information exchange may 
promote co-learning among individuals with poorer health literacy. These 
findings indicate that there may be an interaction between the intervention 
provider and intervention setting – for instance, it would be useful to assess 
whether the delivery of interventions by GPs in community settings (rather than 
primary care) would be beneficial for increasing CRC screening uptake. 
Nonetheless, interventions that include components that involve GPs (e.g., 
patient-provider health communication, GP endorsement in screening invite) 
have consistently shown to lead to higher screening participation (albeit modest 
increases) among socioeconomically deprived and underserved populations; a 
finding observed between studies and across different countries (Allgood et al., 
2016; Baker et al., 2014; Shankleman et al., 2014). It is therefore, anticipated 
that primary care endorsement would result in increases in participation.  As 
indicated earlier in the thesis, there was some evidence that the addition of 
telephone calls was useful for improving intervention effectiveness among low 
SES populations and therefore it is recommended that future strategies aiming 
to improve CRC screening uptake, incorporate a telephone component.  
Similarly, evidence from a small pool of studies indicated that 
incorporating electronic media to communicate screening-related messages 
(e.g., videos, websites) increased intervention effectiveness among low SES 
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populations, suggesting that the integration of such approaches in health 
interventions have the potential to positively influence CRC screening uptake. 
This contradicts some previous studies that have shown that the access and 
use of technologies is far from equal among different SES groups and that the 
use and access to technologies is likely to be more rapidly adopted by 
individuals with higher SES (Baum, Newman, & Biedrzycki, 2012; Gonzales, 
Ems, & Suri, 2016). Moreover, access and use among more disadvantaged 
groups is more likely to be disrupted due to unstable access (Baum et al., 2012; 
Gonzales et al., 2016), which could create greater health inequalities. 
Nonetheless, in recent years, there has been an increased focus on integrating 
innovative health-related technologies both in healthcare services as well as 
public health interventions and there has been a particular interest on the 
internet and internet-based tools (e.g., health portals, internet sites, mobile 
apps) to promote healthy behaviours (Korda & Itani, 2013; Webb et al., 2010). 
The most appealing aspect of having internet-based health interventions is the 
magnitude of the audience; recent UK data suggests that 90% of households in 
Great Britain have internet access and internet use among adults aged 65 to 74 
years has increased from 52% in 2011 to 78% in 2017 (Office of National 
Statistics, 2018). Moreover, UK data examining internet use by ethnicity and 
age group indicates that in the 55 to 74 age group Internet use is approximately 
68%, 72% and 84% among Asian, Black and White population subgroups 
respectively (Office of National Statistics, 2017), suggesting that internet use is 
relatively high among older adults from all ethnic groups. Even if internet-based 
interventions have low completion rates, the benefits from a public health 
perspective could be substantial. One challenge for future research would be to 
determine whether such strategies improve or worsen screening inequalities 
and whether it is feasible for internet tools to translate e-health interventions in 
order to create more impactful and long-lasting health behaviour change for 
people from different backgrounds. A recent systematic review (Weiss et al., 
2018) investigating the impact of innovative technologies on social inequalities 
in health, indicated that the use of such technologies is more likely to 
significantly and positively benefit end users from poorer social strata, if the use 
of such technologies is ‘nested’ within the wider health care environment rather 
than being predominantly individual-oriented. For example, public health 
campaigns and interventions targeting socioeconomically vulnerable subgroups 
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to increase awareness about e-health strategies or using offline materials that 
perhaps supplement online health information might be useful strategies for 
promoting e-health intervention materials without increasing inequalities. 
 
5.3.2. Proposed Conceptual Framework for Guiding CRC Screening 
Research 
The findings from the meta-analytic review and two empirical studies 
included in the thesis, suggest that a range of influencing factors exist and 
should be considered in relation to improving CRC screening uptake and 
reducing CRC screening inequalities. Influencing factors comprise individual 
determinants - including psychological (e.g., attitudes, norms) and/or 
behavioural (e.g., past behaviour) factors -, sociodemographic determinants – 
including factors such as SES and education as well as other socio-cultural 
factors (e.g., religion, values) - and healthcare system (e.g., medical mistrust, 
GP recommendation) and socio-contextual determinants (e.g., health 
campaigns, media exposure). The results of studies this thesis support the 
movement of screening inequalities research away from a narrow focus on 
either sociodemographic factors or psychosocial variables and supports the 
notion of an integrated, comprehensive, conceptual model of the influences on 
CRC screening.  Therefore, it is anticipated that only through the integrated 
understanding of the connections between sociodemographic and psychosocial 
determinants of CRC screening, and the integration of psychosocial 
determinants of CRC screening themselves, that CRC screening inequalities 
can be effectively addressed through evidence-based intervention research. 
Based on the findings from the thesis, Figure 5.1 outlines a proposal for a 
conceptual framework, which could be useful for guiding future research in 
which the relationships between factors can be empirically tested.
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Perceived barriers 
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control 
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tailored screening 
information 
Support systems 
Complex screening process 
Lack of CRC public health 
Figure 5. 1. Conceptual framework for CRC screening uptake based on thesis findings 
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The conceptual framework (Figure 5.1) has potential to shift our 
understanding of CRC screening behaviour. However, for this to be achieved 
robust empirical support for all of its components is needed in order to inform 
future policies in cancer screening and have impact in reducing CRC screening 
inequalities. Important considerations for future research include: 
1) Whose screening behaviour are you seeking to improve? 
2) Which sociodemographic/psychosocial/contextual factors need to be 
taken into account? 
3) Which sociodemographic/psychosocial/contextual factors directly 
and/or indirectly affect screening intention and/or behaviour? 
4) Can these factors be tackled/modified? 
5) Is it feasible to personalise interventions to the needs of specific 
population subgroups? 
5.4. Thesis Strengths and Limitations 
The strengths and limitations of each study were discussed following the 
presentation of studies in each appropriate chapter (i.e., Chapter 2, 3 and 4). 
This section is concerned with outlining the overall strengths and weaknesses 
of the thesis.  
The first strength of the present thesis, was the consideration of 
sociodemographic factors alongside psychosocial factors in relation to CRC 
screening. Although previous research has extensively examined the 
importance of sociodemographic determinants of CRC screening uptake, and 
there is growing recognition about the importance of psychological variables 
such as attitudes and beliefs, these factors have often been examined 
separately and the current literature offers few recommendations with regards 
to the strategies that will be successful for improving uptake for different 
population subgroups. Researchers have acknowledged the need to develop a 
robust evidence base for effective interventions for diverse populations in the 
UK (Kobayashi et al., 2014; Moss et al., 2012; Solmi et al., 2015; Von Wagner, 
Baio, et al., 2011) as well as the need to invest extra efforts in reducing 
inequalities in cancer screening uptake. It is to this recognised need within the 
wider field of cancer screening inequalities that this thesis contributes by 
focusing on the interaction between key sociodemographic factors, such as 
socioeconomic deprivation, ethnicity and education, and key psychosocial 
factors, identified through SCMs.  
  
271 
A second strength of the thesis is its structure; all three studies presented 
in the thesis approached the topic of CRC screening inequalities and the factors 
that affect screening participation in a systematic manner and from different 
angles. Firstly, Study 1 helped identify whether intervention effectiveness varied 
as a function of contact type, mode of delivery, intervention provider, 
intervention materials, intervention setting, screening modality, BCTs and extent 
of reported use of theory and provided clear recommendations for the types of 
interventions that could lead to substantial improvements in screening uptake 
among socioeconomically disadvantaged populations. Overall, Study 1 laid the 
foundations for gaining an overview of the empirical research currently available 
with regards to the effectiveness of interventions in different SES groups. Study 
2 allowed the exploration of a range of sociodemographic and psychosocial 
factors affecting gFOBT screening behaviour. In Study 3, the integrated 
TRA/TPB and HBM were used as the basis to quantitatively examine whether 
key determinants identified in Study 2 were predictors of gFOBT screening 
intention. The inclusion of a meta-analysis, qualitative and quantitative 
component have enabled the development of a preliminary conceptual 
framework (Figure 5.1.) to help increase current understanding of CRC 
screening participation in different population subgroups and lay a foundation 
for future hypotheses with clinical and research implications. 
A limitation of the thesis is that it used the IMD area-level of deprivation 
as the main measure of SES for Studies 2 and 3. Although the IMD is 
considered to be a good measure of overall deprivation through the collection of 
data on the socioeconomic circumstances of people that live in a particular 
area, there are criticisms for its use as a measure of SES. Criticisms mainly 
concern the fact that it cannot directly measure whether areas are improving in 
terms of deprivation against the average because each area’s score will shift as 
a function of scores changing in other areas. Therefore, this interdependence of 
IMD scores makes it challenging to decipher whether any change in IMD score 
reflects true change in area-level deprivation or whether it reflects changes in 
the scores of other areas, which in turn makes it difficult to understand how 
local area are changing across time (Campbell, 2010). Moreover, the fact that it 
measures deprivation on an area level rather than on an individual level, implies 
that in areas with a high IMD score there will still be people who are 
socioeconomically deprived and vice versa. This can be problematic if 
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conclusions about associations between SES and health outcomes made at 
one level of the analysis (e.g., area) are extrapolated to another level (e.g., 
individual). Nonetheless, the IMD is considered an accurate measure for the 
broader concept of ‘multiple deprivation’, and represents a key dataset that has 
been used by government programmes, both at a national and local level, to 
identify areas that are in greater need for service commissioning and resources 
in order to help tackle deprivation (Payne, 2012). In addition, utilisation of the 
IMD was considered as not being subject to biases related to self-report, as 
opposed to asking participants to disclose their income, for which the risk of 
social desirability effects would be higher.   
Another potential limitation is that the thesis did not explore the important 
role of health literacy in relation to CRC screening behaviour. Throughout the 
course of the research it became increasingly apparent that the link between 
health literacy and screening behaviour should be further investigated. Studies 
have shown that inadequate health literacy is associated with lower CRC 
screening uptake and that this relationship may be mediated by reductions in 
knowledge and overall less positive attitudes towards CRC screening. 
Acculturation was another factor not specifically measured in the thesis, though 
research suggests it may be an important factor for consideration when 
studying health behaviours among BAME populations. Acculturation may be 
measured indirectly with variables such as language fluency and years of 
residence in the UK, which were not variables included in any of the thesis 
studies. It should be noted that both health literacy and acculturation are 
considered challenging variables to measure (Birman & Simon, 2014; Nutbeam, 
2008), nonetheless it would have been useful to examine any associations 
between CRC screening related variables and healthy literacy and 
acculturation. A final limitation of the thesis, is that thesis studies did not use 
translated research materials and/or translators in order to examine 
determinants of CRC screening among BAME populations.  
5.5. Concluding Comment 
CRC remains a concerning public health problem despite the fact that a 
substantial number of new CRC cases can be prevented through participation 
in screening and early diagnosis. Persistent screening inequalities in the UK 
and worldwide by race and SES have highlighted the need for a renewed 
research focus of identifying the interventions that will be effective in reducing 
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inequalities in CRC screening. Findings from the thesis indicated the need for 
targeted interventions for socioeconomically disadvantaged groups and it is 
anticipated that in doing so CRC screening uptake rates will increase more 
rapidly than the rest of the population and therefore progress will be made in 
eliminating CRC screening disparities. Overall, this thesis was an important 
hypothesis-generating body of research and contributed to the identification of 
both psychosocial and sociodemographic determinants specific to gFOBT 
screening. The findings presented in Study 3 regarding the associations 
between intention and race/ethnicity, SES and education were partly consistent 
with previous research. However, these findings should be interpreted with 
caution due to small proportions of BAME   populations and the greater 
proportions of higher SES participants in the sample.  Nonetheless, the thesis 
presented various avenues for future research including the development of 
interventions that target attitudes, perceived barriers and injunctive norms. In 
addition, thesis results suggested that consideration should be given to specific 
BCTs, which could all be targeted points for future intervention research and 
have capacity to strengthen the screening-related intention-behaviour 
association. The thesis has also provided a recommendation of a conceptual 
framework based on thesis findings mapping the links between individual, 
sociodemographic and contextual determinants of CRC screening uptake. 
Although there is much more to be learned about maximising the impact of 
interventions to reduce observed gaps in CRC screening, the present thesis 
provides substantial evidence and provides some clear directions for future 
research that could prove promising for reducing the socioeconomic gradient in 
gFOBT screening uptake in the UK.   
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review. The preferred format includes details of both inclusion and exclusion 
criteria. 
Studies were included if they recruited participants that were at least 50 years of 
age and had no family history of colorectal cancer. 
20 Intervention(s), exposure(s) 
Give full and clear descriptions of the nature of the interventions or the exposures 
to be reviewed 
Studies were included that tested the effect of an intervention (of any intensity) on 
increasing colorectal cancer screening adherence. Studies that did not measure 
and report colorectal cancer screening rates as an outcome were excluded. 
21 Comparator(s)/control 
Where relevant, give details of the alternatives against which the main 
subject/topic of the review will be compared (e.g., another intervention or a non-
exposed control group). 
The main interventions were compared against alternative interventions, usual 
care, no-intervention control groups and/or delayed treatment conditions. 
22 Types of study to be included 
Give details of the study designs to be included in the review. If there are no 
restrictions on the types of study design eligible for inclusion, this should be stated. 
Studies to be included are restricted to a randomised controlled trial study design. 
As such, studies that were descriptive, including survey and qualitative studies, 
and studies that were observational, including cohort, cross-sectional and case-
control studies, were excluded. 
23 Context 
Give summary details of the setting and other relevant characteristics which help 
define the inclusion or exclusion criteria. 
Studies were included if they incorporated screening adherence by using guaiac 
Fecal Occult Blood Test (gFOBT), Fecal Immunochemical Test (FIT), Flexible 
Sigmoidoscopy (FS), colonoscopy or barium enema. Studies were excluded if they 
were an abstract, a dissertation, a review, a protocol, a poster, a think-piece or 
guidelines. Studies were excluded if they were not reported in English. Studies that 
did not report statistics in the results or were subset or secondary analyses to 
previous papers, were excluded. 
24 Primary outcome(s) 
Give the most important outcomes. 
To assess whether certain interventions are more effective than others in 
increasing colorectal cancer screening uptake (both self-reported and based on 
objective measures). 
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Give information on timing and effect measures, as appropriate. 
Screening adherence must be reported post-intervention. Where studies had more 
than one experimental groups compared with a single control condition, the 
number of participants in the control condition was evenly divided across the 
experimental conditions to ensure each participant was included only once in the 
analysis. Where there are multiple time-points within a study, the last time-point 
will be used to calculate an effect size.  
25 Secondary outcomes 
List any additional outcomes that will be addressed. If there are no secondary 
outcomes enter None. 
To assess whether sociodemographic factors, such as gender and socioeconomic 
status, moderate the intervention effect on colorectal cancer screening adherence 
To assess whether the use of theory in a given intervention moderates the 
intervention effect on colorectal cancer screening adherence. 
  Give information on timing and effect measures, as appropriate. 
26 Data extraction (selection and coding) 
Give the procedure for selecting studies for the review and extracting data, 
including the number of researchers involved and how discrepancies will be 
resolved. List the data to be extracted. 
Titles and abstracts of studies retrieved using the search strategy and those from 
additional sources will be screened independently by one member of the review 
team to identify studies that potentially meet the inclusion criteria outlined above. 
The full text of these potentially eligible studies will be retrieved and independently 
assessed for eligibility by one member of the research team. A standardised, pre-
piloted form will be used to extract data from the included studies for assessment 
of study quality and evidence synthesis. Extracted information will include: details 
of the intervention and control conditions; study population and participant 
demographics and baseline characteristics; study setting; study methodology; 
suggested mechanisms of intervention action; information for assessment of the 
risk of bias; identified behaviour change techniques; use of theory; mode of 
delivery; bowel cancer screening outcomes. Two review authors will extract data 
independently and discrepancies will be identified and resolved through discussion 
(with a third author where necessary). Missing data will be requested from study 
authors. 
27 Risk of bias (quality) assessment 
State whether and how risk of bias will be assessed, how the quality of individual 
studies will be assessed, and whether and how this will influence the planned 
synthesis. 
Bias risk will be assessed using the Cochrane Collaboration’s tool for assessing 
risk of bias. Based on the Cochrane guidelines, risk of bias in included studies is 
assessed by considering the following characteristics: 1) Random sequence 
generation (selection bias) 2) Allocation concealment (selection bias) 3) Blinding of 
participants & personnel (performance bias) 4) Blinding of outcome assessment 
(detection bias) 5) Incomplete outcome data (attrition bias) 6) Selective reporting 
(reporting bias) Risk of bias for included studies in the present review was further 
assessed by considering whether studies followed an intention-to-treat analysis. 
28 Strategy for data synthesis 
Give the planned general approach to be used, for example whether the data to be 
used will be aggregate or at the level of individual participants, and whether a 
quantitative or narrative (descriptive) synthesis is planned. Where appropriate a 
brief outline of analytic approach should be given. 
Effect sizes will be calculated for each study reflecting the impact of the 
intervention on colorectal cancer screening adherence. Where there are multiple 
subgroups within a study, an average effect across subgroups will be computed. 
Where there are multiple time-points within a study, a single effect size will be 
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computed. Meta-analyses will be conducted to estimate overall effect size with 
meta-regression to test the association between specific sociodemographic 
variables, intervention characteristics and specific behaviour change techniques, 
and intervention effect size. 
29 Analysis of subgroups or subsets 
Give any planned exploration of subgroups or subsets within the review. ‘None 
planned’ is a valid response if no subgroup analyses are planned. 
Post-hoc sensitivity analyses will be conducted to examine the impact of removing 
studies - That did not follow an intention-to-treat analysis - That were assessed as 
being of high risk of bias - That involved endoscopic screening procedures only 
Review general information 
 
30 Type and method of review 
Select the type of review and the review method from the drop down list. 
Intervention, Systematic review 
31 Language 
Select the language(s) in which the review is being written and will be made 
available, from the drop down list. Use the control key to select more than one 
language. 
English 
Will a summary/abstract be made available in English? 
Yes 
32 Country 
Select the country in which the review is being carried out from the drop down list. 
For multi-national collaborations select all the countries involved. Use the control 
key to select more than one country. 
England 
33 Other registration details 
Give the name of any organisation where the systematic review title or protocol is 
registered together with any unique identification number assigned. If extracted 
data will be stored and made available through a repository such as the 
Systematic Review Data Repository (SRDR), details and a link should be included 
here.  
34 Reference and/or URL for published protocol 
Give the citation for the published protocol, if there is one. 
Give the link to the published protocol, if there is one. This may be to an external 
site or to a protocol deposited with CRD in pdf format. 
 
I give permission for this file to be made publicly available 
Yes 
35 Dissemination plans 
Give brief details of plans for communicating essential messages from the review 
to the appropriate audiences. 
A summary report will be produced prior to preparing a paper for publication. 
Findings will be presented at conferences. 
Do you intend to publish the review on completion? 
Yes 
36 Keywords 
Give words or phrases that best describe the review. (One word per box, create a 
new box for each term) 
colorectal cancer screening 
interventions 
screening adherence 
37 Details of any existing review of the same topic by the same authors 
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Give details of earlier versions of the systematic review if an update of an existing 
review is being registered, including full bibliographic reference if possible. 
38 Current review status 
Review status should be updated when the review is completed and when it is 
published. 
Ongoing 
39 Any additional information 
Provide any further information the review team consider relevant to the 
registration of the review. 
40 Details of final report/publication(s) 
This field should be left empty until details of the completed review are available.  
Give the full citation for the final report or publication of the systematic review. 
Give the URL where available. 
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Appendix 2.2. Data extraction form 
 
General Information 
Title of Research: Effectiveness of public health interventions to increase colorectal 
cancer screening: a systematic review and meta-analysis.  
Research team: Anastasia Tsipa, Mark Conner, Daryl O’Connor, Dawn Branley, 
Fiona Day, Louise Hall, Bianca Sykes-Muskett, Natalie Taylor 
Researcher performing data extraction:  
 
Date form completed:  
 
Author: Year of publication: Country: 
 
Article Title:  
Study Characteristics 
Aims of study clearly stated: 
YES / NO 
 
Study Design clearly stated: 
YES / NO 
 
Participant Characteristics – Intervention Group:  
Age (m/SD):  
 
Gender:  
Ethnicity: 
 
 
SES: 
 
 
History of CRC cancer: 
Familial history of CRC: 
 
 
Yes / No 
Yes / No 
 
 
Average number of past screening invites  
Ever had gFOBT (%yes)  
Ever had any CRC screening (%yes)  
Up-to-date with screening at baseline 
(%yes) 
 
Comorbidities: 
 
Yes / No 
 
N =    
Participant Characteristics – Comparison Group:  
Age (m/SD):  Gender:  
Ethnicity: 
 
 
 
SES: 
 
 
 
Personal history of CRC cancer: 
Familial history of CRC: 
 
Yes / No 
Yes / No 
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Average number of past screening invites  
Ever had gFOBT (%yes)  
Ever had any CRC screening (%yes)  
Up-to-date with screening at baseline 
(%yes) 
 
Comorbidities 
 
Yes / No 
 
N =   
Total number of study participants =   
Intervention and Setting 
Setting:  
Type of Intervention:  
Description of Intervention: 
 Delivery: group/individual 
 Provider 
 Contact type: face-to-face/remote 
 Intervention materials: e.g., paper-
based/phone/mixed and content of 
materials 
 Use of theory: yes/no and what theory 
(or theories). Report use of theory using 
Theory Coding Scheme table 
 Use of reminders: yes/no 
 BCTs: report use of BCTs in both 
intervention and control groups in Excel 
file (using 0 and 1 to indicate the 
presence and absence of a BCT 
respectively). Report also total number 
of BCTs used in intervention.  
 
Number of contacts in Intervention 
condition 
 
Number of contacts in Control condition  
Number of contacts with physician (if 
applicable) 
 
Duration / Follow-up time points:  
Description of co-interventions (if 
applicable): 
 
Outcome Data – Results  
Statistical Analysis:  
 
Primary Outcome: Completed CRC 
screening 
  
Definition of outcome used in study:  
Screening modality:  
Length of follow-up:  
Times of follow-up measurement:  
Outcome Assessment Objective / Self-report 
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Secondary Outcomes: e.g., Intention, 
knowledge (if so, report whether these 
measured and how) 
 
 
Risk of bias based on Cochrane Risk 
of Bias tool (assess using designated 
risk of bias table and report outcome 
here) 
Low risk / unclear risk / high risk  
Summary Outcome Data: 
 
 
Author’s Conclusion:  
 
Include / Exclude 
 
Reason for Exclusion 
 
General Comments  
 
 
Appendix 2.3. Description of studies coded as low SES 
 
Study ID, 
Year, 
Country of 
Publicatio
n  
Study 
desig
n 
(arms
) 
Setting Low SES 
classificati
on 
Extracts from study supporting 
classification  
1. 
Aragones 
et al (2010) 
USA 
RCT 
(2) 
Primary 
care clinic 
of a large 
NYC 
teaching 
hospital 
 
 Ethnic 
minority 
populatio
n (Latino 
immigran
ts) 
‘This study tested the 
effectiveness of a culturally and 
linguistically sensitive, multi-level 
intervention to improve CRC 
screening rates in an urban, Latino 
immigrant population.' (pg. 565) 
'We conducted a randomized 
controlled trial in the primary care 
clinic of a large New York City 
teaching hospital caring for a 
large, diverse, underserved 
population.' (pg. 565) 
2. Baker et 
al (2014) 
USA 
RCT 
(2) 
Community 
health 
centres in 
Chicago, 
Illinois 
 
 Low SES  
 Ethnic 
minority 
populatio
n 
(predomi
nantly 
Latino) 
 Low 
health 
literacy 
'87% of participant were Latino; 
83%stated that Spanish was their 
preferred language; and 77%were 
uninsured.' (pg. 1235) 
'Even among a vulnerable 
population with low socioeconomic 
status, high rates of no insurance, 
limited English proficiency, and 
low health literacy, our 
multifaceted intervention achieved 
a rate of adherence to annual 
gFOBT screening (82.2%) far 
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 Without 
health 
insurance 
above the usual care group 
(37.3%).' (pg. 1240) 
3. Basch et 
al (2006) 
USA 
RCT 
(2) 
Health 
benefits 
programme 
in NYC 
 Ethnic 
minority 
populatio
n (100% 
African-
American
) 
‘We therefore conducted a 
randomized 
trial to evaluate tailored telephone 
outreach compared with mailed 
printed material to increase CRC 
screening in a predominantly 
Black population of low to 
moderate income.’ (pg. 2246) 
4. 
Blumenthal 
et al (2010) 
USA 
RCT 
(4) 
Community 
sites (e.g., 
churches) in 
Atlanta 
 Ethnic 
minority 
populatio
n (100% 
African-
American
) 
‘For the current study, the authors 
tested 3 interventions that were 
intended to increase the rate of 
CRC screening among African 
Americans.’ (p.g 922) 
5. Christie 
et al (2008) 
USA 
RCT 
(2) 
Community 
health 
centre in 
NYC 
 Ethnic 
minority 
populatio
n (mainly 
Hispanic) 
 Low level 
of 
education 
‘This prospective clinical trial was 
approved by the institutional 
review board and designed to 
determine 
whether a patient navigator 
enhances CRC screening by 
colonoscopy in minorities who 
completed a visit with 
his/her primary care physician and 
received a referral for screening 
colonoscopy. (pg. 279)’  
 
‘Most patients were uninsured or 
had public insurance (Table 1). 
The average age was 58 years old 
(range = 49–70). Seventy-five 
percent were females and 
71% Hispanic. The majority of 
patients had less than a high-
school education and earned 
<$20,000 per year.’ (pg. 282) 
6. 
Coronado 
et a (2011) 
USA 
RCT 
(3) 
Community 
clinic in 
Seattle 
 Ethnic 
minority 
populatio
n (100% 
Hispanic) 
‘Specifically, we tested an 
individual 
randomized trial wherein patients 
of Hispanic ethnicity between the 
ages of 50 and 79 years were 
assigned to 1 of 
3 conditions: 1) usual care; 2) 
mailed gFOBT card and 
instructions on how to complete 
the test (mailed gFOBT 
only); and 3) mailed gFOBT card 
and instructions on how to 
complete the test, telephone 
reminders, and home visits 
(mailed gFOBT and outreach).’ 
(pg. 1746) 
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‘More than half of respondents 
were aged 50 to 59 years, the 
majority were female, and three-
quarters had less 
than a high school education 
(Table 2). The remainder had a 
high school diploma or GED (13%) 
or had completed 
some college (12%). Slightly more 
than one-quarter of respondents 
had private healthcare coverage. 
Less than 20% were covered by 
the Washington State Basic 
Health Care Plan. Nearly one-
quarter of respondents reported 
either relying on a government 
plan (Medicare, Medicaid, or 
medical coupons) or having no 
healthcare insurance’ (pg. 1749) 
7. Dietrich 
et al (2006) 
USA 
RCT 
(2) 
Community 
and migrant 
health 
centres in 
NYC 
 Ethnic 
minority 
 Low-
income  
‘Objective—To evaluate the effect 
of a telephone support intervention 
to increase rates of breast, 
cervical, and colorectal cancer 
screening among minority and 
low-income women.’ (pg. 2) 
 
‘Over two thirds of women (68%) 
had been receiving care from their 
health center for at least 3 years. 
Many women had chronic disease, 
and more than half were obese. 
Ethnicity and income are not 
presented in Table 2 because 
ethnicity was unknown for 39% of 
women and income was inferred 
from the participants’ home ZIP 
codes. Of those with documented 
ethnicity, 38% were black and 
39% were white. More than one 
third (34%) of women lived in ZIP 
codes with a median household 
income of less than $25 000, 39% 
lived in ZIP codes with a median 
income between $25 000 and 
$40000, and 27% lived in ZIP 
codes with a median income of 
greater than $40 000.’ (pg. 6-7) 
8. Dietrich 
et al (2007) 
USA 
RCT 
(2) 
Community 
health 
centres in 
NYC 
 Low-
income 
 Medicaid 
insurance 
‘This study evaluated the impact of 
a streamlined Prevention care 
management (PCM) delivered 
through a Medicaid managed care 
organization (MMCO), an 
infrastructure with the potential to 
sustain this program for the long 
term.’ (pg. 320) 
 
‘Dartmouth Medical School, 
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Affinity Health Plan and Clinical 
Directors Network22 collaborated 
on this project. Affinity was 
founded in 1986 as 
an independent, not-for-profit 
managed care company dedicated 
to serving the needs of low- and 
moderate-income populations in 
and around New York City.’ (pg. 
321) 
9. Dietrich 
et al (2013) 
USA 
RCT 
(2) 
Medicaid 
community 
health 
centres in 
NYC 
 Low-
income 
 Medicaid 
insurance 
‘We explored whether telephone 
outreach, delivered by Medicaid 
managed care organization 
(MMCO) staff, could increase 
colorectal cancer (CRC) screening 
among publicly insured urban 
women, potentially reducing 
disparities.’ (pg. 335) 
10. 
Ferreira et 
al (2005) 
USA 
RCT 
(2) 
Primary 
care 
outpatient 
firms at a 
Veteran 
Affairs (VA) 
Medical 
Centre in 
Chicago 
 Largely 
ethnic 
minority 
populatio
n 
 Poor 
literacy 
 Low level 
of 
education 
‘More than half of the VA users 
report an income below $20,000, 
and only 58% have a 12th grade 
education level. Many 
have limited literacy skills and are 
unable to read or understand 
health-related materials.’ (pg. 
1549) 
 
‘Our study population included 
male veterans, approximately half 
of whom were African American, 
who were at average risk for 
colorectal cancer and who were 
currently not compliant with 
colorectal cancer screening.’ (pg. 
1552) 
11. Fiscella 
et al (2011) 
USA 
RCT 
(2) 
An inner 
city, family, 
medicine 
practice in 
NYC 
 
 Low SES 
populatio
n 
‘Objective: To examine the impact 
of a multimodal intervention on 
mammography and colorectal 
cancer (CRC) screening rates in a 
safety-net practice caring for 
underserved patients. (pg. 762) 
 
‘We recruited one large family 
medicine safety-net practice in 
upstate New York to participate in 
the intervention. We specifically 
targeted a practice that served 
large numbers of low-income and 
minority patients.’ (pg. 763) 
12. 
Fitzgibbon 
et al (2007) 
USA 
RCT 
(2) 
Primary 
care clinics 
in a Veteran 
Affairs 
medical 
centre in 
Chicago 
 
 Largely 
ethnic 
minority 
populatio
n 
 Poor 
literacy 
‘The VA Health Study found that 
58% of veterans had a 12th grade 
high school education or lower, 
more than half had an income 
below $20,000, and more than 
45% were African-American.’ (pg. 
273-274) 
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 Low level 
of 
education 
‘The average age (SD) for all 
eligible patients was 67.9 years 
(10.6 years), and the ethnic 
breakdown was evenly split 
between Blacks and Whites, with 
only 5% in the “Other” category.’ 
(pg. 277) 
13. Ford et 
al (2006) 
USA 
RCT 
(2) 
A cancer 
screening 
trial site in 
Detroit 
 Ethnic 
minority 
populatio
n (100% 
African-
American
) 
‘The purpose of this study was to 
enhance adherence among older 
(aged 55 years and older) African 
American men enrolled in a cancer 
screening trial for prostate, lung, 
and colorectal cancer.’ (pg. 545) 
14. 
Fortuna et 
al (2014) 
USA 
RCT 
(4) 
Urban, 
internal 
medicine 
practice in 
NYC 
 Predomin
antly 
ethnic 
minority 
populatio
n 
 Low-
income 
 Medically 
underser
ved 
setting 
‘We examined the reminder, recall 
and outreach (RRO) model in an 
urban internal medicine practice in 
Rochester, New York, a city of 
∼211,000 inhabitants (37.6 % non-
Hispanic white, 41.7 % black). The 
study practice cared for a largely 
low-income and disproportionately 
minority patient population, and 
was situated in an urban federal-
designated underserved setting.’ 
(pg. 91) 
15. 
Goldberg 
et al (2004) 
USA 
RCT 
(2) 
Urban, 
public 
hospital in 
Boston 
 Predomin
antly 
ethnic 
minority 
populatio
n 
(African-
American
) 
 Low-
income 
 Populatio
n with 
multiple 
chronic 
illnesses 
‘A total of 119 patients with 
primary care appointments 
scheduled in May or June 2000 for 
an urban, public hospital clinic that 
serves predominantly low-income, 
African Americans with chronic 
diseases.’ (pg. 431) 
16. 
Goldman 
et al (2015) 
USA 
RCT 
(2) 
A health 
centre 
network 
based in 
Chicago 
 Largely 
ethnic 
minority 
populatio
n 
 Uninsure
d 
 Never 
screened 
before for 
CRC 
 One or 
‘The study was conducted at Erie 
Family Health Center (EFHC), a 
federally qualified health center 
network based in Chicago, Illinois 
with eight clinics serving adult 
patients. At EFHC, 55 % of 
patients are best served in 
Spanish, 95 % fall below 200 % of 
the federal poverty line, and 35 % 
are uninsured.’ (pg. 1179) 
 
‘In the final sample, patients’ mean 
age was 57.3 years (SD=6.2), 
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more 
chronic 
illnesses 
66.0 % were female, 62.1 % 
identified their race/ethnicity as 
Latino/Hispanic (79.7 % Spanish- 
and 20.3 % English-speaking), 
70.7 % were uninsured, and 
74.8 % had one or more chronic 
medical conditions.’ (pg. 1181) 
17. Gupta 
et al (2013) 
USA 
RCT 
(3) 
A safety net 
health 
system in 
Texas 
 Predomin
antly 
ethnic 
minority 
populatio
n 
 Uninsure
d 
‘We conducted a randomized, 
comparative effectiveness trial 
among underserved patients, not 
up to date with CRC screening. 
Our aims were to determine (1) if 
organized mailed outreach boosts 
screening compared with usual 
care and (2) if FIT is superior to 
colonoscopy outreach for 
screening participation.’ (pg. 1726) 
 
‘The sample was 24% black, 29% 
Hispanic, 7% other race/ethnicity 
and 41% White. The primary 
language was Spanish for 17%of 
all patients.’ (pg. 1727) 
18. 
Hendren et 
al (2013) 
USA 
RCT 
(2) 
An inner 
city, primary 
care family 
practice in 
NYC 
 
 Low-
income 
 Large 
ethnic 
minority 
populatio
n 
 Large 
proportio
n insured 
with 
Medicaid 
or no 
insurance 
‘We sought to combine lower cost, 
feasible interventions into a 
multimodal cancer screening 
promotion for mammography and 
colorectal cancer screening for low 
income patients past due for 
screening.’ (pg. 42) 
 
‘A large primary care practice in 
Rochester, New York, serving a 
large proportion of low-income and 
minority patients was recruited to 
participate’ (pg. 42) 
19. Holt et 
al (2012) 
USA 
RCT 
(2) 
African 
American 
churches in 
Alabama 
 Ethnic 
minority 
populatio
n (100% 
African-
American
) 
 
‘The purpose of the present study 
was to evaluate the efficacy of a 
spiritually based CHA intervention 
aimed at increasing CRC 
screening among African 
Americans in church settings, 
using a group randomized 
controlled design.’ (pg. 459) 
20. Horne 
et al (2015) 
USA 
RCT 
(2) 
Medicare 
health 
centres and 
community-
based 
venues 
 Ethnic 
minority 
populatio
n (100% 
African-
American
) 
 Medicare 
insurance 
 
‘In a community-based 
randomized controlled trial, we 
investigated the effect of patient 
navigation on increasing CRC 
screening adherence among older 
African Americans.’ (pg. 2) 
‘Participants were deemed eligible 
for the study if they were a 
Baltimore City resident, aged 65 
and older, and enrolled in 
Medicare Parts A and B.’ (pg. 3) 
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21. Jandorf 
et al (2013) 
USA 
RCT 
(3)  
Primary 
care clinic in 
NYC 
 
 Ethnic 
minority 
populatio
n (100% 
African-
American
) 
 Low 
income 
 Predomin
antly 
Medicare
/Medicaid 
insurance 
‘This study focuses on predicting 
outcomes of screening 
colonoscopy for colorectal cancer 
among African Americans using 
different patient navigation 
formats.’ (pg. 1577) 
 
 
22. Jean-
Jacques et 
al (2012) 
USA 
RCT 
(2) 
Community 
health 
centres, 
Chicago 
 Low-
income 
 Predomin
antly 
ethnic 
minority 
populatio
n  
 Limited 
English 
proficienc
y 
‘We examined whether the direct 
mailing of gFOBT kits to patients 
overdue for such screening is an 
effective way to improve screening 
in a poor, racial and ethnic 
minority population, and 
individuals with limited English 
proficiency.’ (pg. 412) 
 
‘This study was conducted at 
Heartland International Health 
Center (HIHC), a federally 
qualified health center that 
provides comprehensive primary 
care to 
a predominantly low income, 
uninsured, and racially diverse 
population on the north side of 
Chicago, Illinois.’ (pg. 413) 
23. Katz et 
al (2012) 
USA 
RCT 
(2) 
Community 
health 
centre, Ohio 
 Predomin
antly 
ethnic 
minority 
populatio
n 
 Low-
income 
 Predomin
antly 
without 
health 
insurance 
 Limited 
health 
literacy 
skills 
‘Patients were African American 
(72.2%), female (63.7%), had 
annual household incomes less 
than $20,000 (60.7%), no health 
insurance (57.0%), and limited 
health literacy skills (53.7%).’ (pg. 
1) 
 
‘The study was conducted from 
November 2007 to May 2010 in 
one Federally Qualified Health 
Center (FQHC) that serves a 
mostly minority and low SES 
population in Columbus, Ohio.’ 
(pg. 2) 
24. Lasser 
et al (2011) 
USA 
RCT 
(2) 
Community 
health 
centres, 
Massachus
etts  
 Predomin
antly 
ethnic 
minority, 
non-
‘We identified 465 primary care 
patients from 4 community health 
centers and 2 public hospital–
based clinics who were not up-to-
date with CRC screening and 
spoke English, Haitian Creole, 
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English 
speaking 
populatio
n 
 Low-
income  
 Majority 
had low-
cost or 
no-cost 
health 
insurance 
coverage 
Portuguese, or Spanish as their 
primary language.’ (pg. 906) 
 
‘To build on this limited research, 
we conducted a randomized 
controlled trial of patient navigation 
that included immigrants from the 
Azores, Brazil, 
Haiti, and Portugal receiving care 
at 4 different health centers and 2 
public hospital–based clinics in the 
safety net 
health care system (ie, a health 
care system that provides a 
significant level of care to low-
income, uninsured and vulnerable 
populations.’ (pg. 907) 
25. 
Maxwell et 
al (2010) 
USA 
RCT 
(3) 
Community-
based 
organisation
s and 
churches in 
Los Angeles 
 Ethnic 
minority 
populatio
n (100% 
Filipino-
American
s) 
‘We conducted 1 of the first 
community-based trials to develop 
a multicomponent intervention that 
would increase colorectal cancer 
screening among an Asian 
American population.’ (pg. 2228) 
26. 
Maxwell et 
al (2015) 
USA 
RCT 
(2) 
Community-
based 
organisation
s 
 Ethnic 
minority 
populatio
n (100% 
Filipino-
American
s) 
‘The aim of this study is to 
evaluate two strategies to 
implement an evidence-based 
intervention to promote CRC 
screening in Filipino American 
community organizations.’ (pg. 
296) 
27. Menon 
et al (2011) 
USA 
RCT 
(3) 
Medical 
centres 
 Predomin
antly 
ethnic 
minority 
sample 
 Low-
income 
‘The majority of our sample was 
male (69.7%), African American 
(72.4%), and currently not working 
(79%).’ 
While more than half of the 
participants had a bachelor’s 
degree or higher (55.3%), almost 
half had an income of less than 
$15,000 per year (48.5 %). Less 
than a third of participants were 
married or had a partner (28.2%). 
The majority of participants were 
recruited from the VA sites (65%).’ 
(pg. 6) 
28. 
Percac-
Lima et al 
(2008) 
USA 
RCT 
(2) 
Community 
health 
centre 
 Predomin
antly 
ethnic 
minority 
sample 
 Low-
income 
‘OBJECTIVE: To evaluate a 
culturally tailored intervention to 
increase CRC screening, primarily 
using colonoscopy, among low 
income and non-English speaking 
patients.’ (pg 211) 
 
‘The study was set at MGH 
Chelsea HealthCare Center is the 
largest provider of care for the 
residents of Chelsea, MA, a city of 
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35,080 people that has been a 
gateway for refugees and 
immigrants for more than a 
century. Recent immigrants have 
come from Bosnia, Somalia, 
Afghanistan, Northern and 
Western 
Africa, and Central America. 
Latinos account for more than 
48% of Chelsea’s population. 
More that 58% of residents speak 
languages other than English, and 
nearly 44% speak only Spanish. 
Poverty levels are more than twice 
the state-wide average: More than 
27% of households earn less than 
$15,000 annually and 43% live 
below 200% of national poverty 
thresholds.’ (pg. 212) 
29. Price-
Haywood 
et al (2014) 
USA 
RCT 
(2) 
Community 
clinics in 
New 
Orleans 
 Predomin
antly 
ethnic 
minority 
populatio
n  
 Limited 
health 
literacy  
‘We designed a continuing medical 
education (CME) program to teach 
primary care physicians (PCP) 
how to engage in cancer risk 
communication 
and shared decision making with 
patients who have limited health 
literacy (HL).’ (pg 1113) 
 
‘This 4-year study (2008 to 2012) 
targeted seven clinics in New 
Orleans that serve patients at risk 
for low HL—minorities, middle-
aged or older, publicly insured and 
uninsured.’ (pg. 1114) 
30. 
Resnicow 
et al (2014) 
USA 
RCT 
(2) 
Integrated, 
health care, 
delivery 
system in 
greater 
Detroit 
 Ethnic 
minority 
populatio
n (100% 
African-
American
s) 
‘Objective: Test the impact of 
tailoring CRC screening messages 
for African Americans (AAs) using 
novel theoretical variables and to 
examine moderating effect of 
communication preferences.’ (pg. 
370) 
31. 
Roetzheim 
et al (2004) 
USA 
RCT 
(2) 
Primary 
care clinics 
in Florida 
 Predomin
antly 
ethnic 
minority 
populatio
n  
 Medically 
underser
ved 
populatio
n; 
majority 
had low-
cost or 
no-cost 
‘We assessed the efficacy of the 
Cancer Screening Office Systems 
(Cancer SOS), an intervention 
designed to increase cancer 
screening in primary care settings 
serving disadvantaged 
populations.’ (pg. 294) 
‘To target an underserved 
population, clinics were recruited 
from among 16 clinics participating 
in a county-funded health 
insurance plan in Hillsborough 
County, Fla. The county health 
plan provides health care for 
uninsured persons who do not 
  
337 
health 
insurance 
coverage 
 Majority 
(>65%) 
had more 
than 5 
chronic 
illnesses  
qualify for Medicaid or Medicare 
and who have a serious chronic 
health condition.’ (pg. 295) 
32. 
Shanklema
n et al 
(2014) 
UK 
RCT 
(3) 
GP 
surgeries in 
London  
 Areas 
with 
populatio
ns of low 
income 
and 
ethnic 
diversity 
in 
London 
‘We report on the evaluation of two 
interventions to improve uptake in 
an area including populations of 
low socioeconomic status and 
considerable ethnic diversity.’(pg. 
1440) 
33. 
Stokamer 
et al (2004) 
USA 
RCT 
(2) 
Veteran 
Affairs 
primary 
care clinic in 
NYC 
 Predomin
antly 
ethnic 
minority 
populatio
n 
‘The majority of study participants 
were male, and the patients were 
racially/ethnically diverse.’ (pg 
280) 
34. Tu et al 
(2006) 
USA 
RCT 
(2) 
Community 
clinic in 
Seattle 
 Ethnic 
minority 
populatio
n (100% 
Chinese-
American
s) 
 Low-
income 
 
‘To promote CRC screening 
among lower-income and less-
acculturated Chinese Americans, 
we conducted 
a randomized controlled trial to 
evaluate a clinic-based, culturally 
appropriate program that 
promoted gFOBT screening 
through a health educator.’ (pg. 
960) 
35. Walsh 
et al (2010) 
USA 
RCT 
(3) 
Public 
hospital in 
Santa Clara 
 Ethnic 
minority 
populatio
n (100% 
Latino 
and 
Vietname
se) 
‘In this context, this study 
addressed the following question: 
Can an intervention that includes 
culturally tailored brochures with or 
without tailored telephone 
counselling increase rates of CRC 
screening among Latinos and 
Vietnamese seen in primary care 
clinics? To our knowledge, no prior 
studies have assessed the effect 
of a culturally and individually 
tailored intervention to increase 
CRC screening in diverse 
underserved populations.’ (pg. 3) 
36. Wardle 
et al (2003) 
UK 
RCT 
(2) 
GP 
surgeries in 
London 
 Medically 
underser
ved 
areas of 
London 
(e.g., 
‘The intervention materials 
addressed the multiple barriers 
shown to be associated with 
participation in earlier studies. 
Adults ages 55–64 (N _ 2,966), in 
a “harder-to-reach” group were 
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Tower 
Hamlets) 
and 
‘hard-to-
reach’ 
populatio
n 
randomized either to receive an 
intervention brochure or to a 
standard invitation group.’ (pg. 99) 
 
‘To select a “harder-to-reach” 
group, the sampling frame for the 
present study consisted of people 
who were in the screening arm of 
the main trial and had said that 
they would only probably accept 
the screening invitation.’ (pg. 100) 
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Appendix 2.4. Studiesa assessed for their reported theory use across 
items 3-11 of the Theory Coding Scheme (Michie & Prestwich, 2010) 
Study Ite
m 3 
Ite
m 4 
Item 
5 
Item 
6 
Item 
7  
Ite
m 8 
Ite
m 9 
Item 
10  
Item 
11 
Overall 
Use of 
Theory 
Score 
(0 – 8) 
Classificatio
n  
1. Braun et 
al (2005) 
0 0 1 0 0 1 1 0 1 4 Moderate 
use of 
theory 
2. Costanza 
et al 
(2007) 
1 0 1 1 0 1 0 2 0 6 High use of 
theory 
3. Fitzgibbo
n et al 
(2007) 
1 0 1 0 0 1 0 0 1 4 Moderate 
use of 
theory 
4. Gimeno-
Garcia et 
al (2009) 
1 0 1 0 2 0 0 0 1 5 Moderate 
use of 
theory 
5. Hendren 
et al 
(2011) 
1 0 1 0 0 1 0 0 1 4 Moderate 
use of 
theory 
6. Hewitson 
et al 
(2011) 
0 0 1 0 2 1 0 0 0 4 Moderate 
use of 
theory 
7. Holt et al 
(2012) 
1 0 1 0 0 1 1 2 1 6 High use of 
theory 
8. Jensen et 
al (2014) 
0 0 1 1 0 1 1 0 1 5 Moderate 
use of 
theory 
9. Katz et al 
(2015) 
1 0 1 0 0 1 0 2 0 5 Moderate 
use of 
theory 
10. Krok-
Schoen 
et al 
(2015) 
0 0 1 0 0 1 1 0 1 4 Moderate 
use of 
theory 
11. Lo et al 
(2013) 
1 0 1 0 2 0 0 2 0 6 High use of 
theory 
12. Marcus et 
al (2005) 
0 0 1 1 0 1 1 0 1 5 Moderate 
use of 
theory 
13. Menon et 
al (2011) 
0 0 1 1 2 0 1 2 0 5 Moderate 
use of 
theory 
14. Myers et 
al (2007) 
0 0 1 1 0 1 1 0 1 5 Moderate 
use of 
theory 
15. Neter et 
al (2014) 
1 0 1 0 2 0 0 2 0 6 High use of 
theory 
16. O’Carroll 
et al 
(2015) 
0 0 1 1 2 0 0 2 0 6 High use of 
theory 
17. Potter et 
al (2011) 
0 0 0 0 0 0 0 0 0 0 Low use of 
theory 
18. Price-
Haywood 
et al 
(2014) 
0 0 0 0 0 0 1 0 0 1 Low use of 
theory 
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19. Resnicow 
et al 
(2014) 
1 0 1 1 2 0 0 0 1 6 High use of 
theory 
20. Ritvo et 
al (2015) 
0 0 0 0 0 0 0 0 0 0 Low use of 
theory 
21. Ruffin et 
al (2007) 
1 0 0 0 0 0 1 0 0 2 Low use of 
theory 
22. Salimzad
eh et al 
(2014) 
0 0 1 0 2 0 0 0 1 4 Moderate 
use of 
theory 
23. Vernon et 
al (2011) 
1 0 0 0 0 0 0 0 0 1 Low use of 
theory 
24. Walsh et 
al (2010) 
1 0 1 1 2 0 0 2 0 7 High use of 
theory 
25. Wardle et 
al (2003) 
0 0 1 0 0 1 0 0 1 3 Moderate 
use of 
theory 
26. Weinberg 
et al 
(2013) 
1 0 1 1 0 1 0 0 1 5 Moderate 
use of 
theory 
27. Wilson et 
al (2015) 
0 0 1 1 2 0 0 0 1 5 Moderate 
use of 
theory 
28. Zapka et 
al (2004) 
0 0 0 0 0 0 0 0 0 0 Low use of 
theory 
Notes. aThis applied only to studies that reported using theory to develop the intervention either in the introduction or methods 
sections (k = 44). 
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Appendix 2.5. Overview and coding strategy for moderators included in 
the meta-analysis.  
 
Moderator 
Variable 
Category Description  Example studies 
Contact 
Type 
Face-to-face 
contact 
The intervention was 
delivered face-to-
face. 
 Ganz et al (2005): The study 
involved a series of face-to-face 
workshops and meetings as part of 
a quality improvement intervention. 
 Ornstein et al (2010): The study 
involved a series of practice site 
visits and meetings as part of a 
quality improvement intervention.  
 Stokamer et al (2004): Patients 
received direct, one-to-one 
educational sessions by nurses.  
 Remote 
contact 
The intervention was 
not delivered face-
to-face and used a 
variety of modes 
such as standard 
mail, internet and 
telephone. 
 Green et al (2013): Groups 1-3 
received a variation of an 
intervention using automated 
mailings linked to patients’ 
electronic health records.  
 Lewis et al (2012): Participants 
received an educational letter 
signed by their physician.  
 Wardle et al (2016): Participants in 
the four cRCTs received print 
materials each comprising of 
slightly different content.  
 Mixed 
contact 
Intervention 
incorporated some 
elements that were 
delivered face-to-
face and others that 
were delivered 
remotely.  
 Braun et al (2005): The 
intervention involved both face-to-
face educational sessions (face-to-
face component) and reminder 
telephone calls (remote 
component). 
 Roetzheim et al (2004): The study 
involved both direct-contact 
feedback sessions with clinic staff 
delivering the intervention (face-to-
face component) but also staff 
were given print training manuals 
(remote component).   
 Tu et al (2006): The intervention 
involved direct-contact educational 
sessions with a health educator 
(face-to-face component) and also 
participants viewed a video and 
received a pamphlet (remote 
components).  
Intervention 
Delivery 
Format 
Individual 
(i.e. one-to-
one) delivery 
The intervention was 
delivered on a one-
to-one basis. 
 Atlas et al (2014): Primary care 
providers provided individualised 
contact (via a letter, practice 
delegate or patient navigator) to 
patients overdue for CRC 
screening.  
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 Fortuna et al (2014): Each 
participant received either a 
reminder letter, an automated 
telephone message and/or a 
personal telephone call.  
 O’Carroll et al (2015): Each 
participant received a simple 
‘anticipated regret’ questionnaire-
based manipulation, sent with the 
standard screening invite.  
 Group or 
Mixed 
delivery 
The intervention was 
delivered to more 
than one person at a 
time or the 
intervention included 
both aspects that 
were delivered on an 
individual basis and 
aspects that were 
delivered in a group.  
 Braun et al (2005): Participants 
took part in a group educational 
session with the number of people 
per group ranging between five 
and 50. 
 Holt et al (2012): Peer community 
health advisors in each church led 
a series of two group education 
sessions on CRC and screening.  
 - Maxwell et al (2015): Community 
health advisors conducted 
educational group sessions and 
also distributed print materials and 
free gFOBT kits.  
Intervention 
provider  
Clinically-
trained health 
professionals 
Interventions were 
delivered/led by 
medically-trained 
healthcare staff 
including GPs, 
nurses, medical 
assistants, physician 
assistants, 
physicians 
 Dietrich et al (2013); Medical staff 
at the Medicaid Managed Care 
Organisation (MMCO) delivered 
the intervention.  
 Boguradzka et al (2013): the 
intervention was delivered by a 
primary care practitioner during a 
routine health visit. 
 Non-clinically 
trained health 
professionals  
Interventions were 
delivered/led by 
community/village 
health workers, 
health educators, 
patient navigators, 
cancer screening 
community 
advocates (or any 
other health worker 
carrying out 
functions related to 
health care delivery 
and was trained in 
the context of the 
intervention but had 
no formal 
professional or 
paraprofessional 
certificate or degree 
from tertiary 
education 
 Fiscella et al (2011): The 
intervention was delivered by a 
community educator. 
 Ritvo et al (2015): The intervention 
was delivered by a trained patient 
navigator. 
 Shankleman et al (2014): The 
intervention was delivered by 
bilingual, cancer screening 
community advocates. 
  Research 
staff 
Interventions were 
delivered/led by a 
 Aragones et al (2010): The 
intervention was delivered by 
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trained member of a 
research team or a 
graduate student.  
project research assistants.  
 Salimzadeh et al (2014): The 
intervention was delivered by the 
study research team.  
 Person-
independent 
(also known 
as ‘no-
contact’ 
interventions) 
The intervention was 
delivered without 
direct, real-time 
contact with an 
interventionist 
 Giorgi-Rossi et al (2011): The 
intervention involved mailing a 
standard, paper-based invite. 
 Guiriguet et al (2016): The 
intervention involved sending an 
automated reminder. 
 Schroy et al (2012): The 
intervention involved sending 
participants a DVD-formatted 
decision aid.  
Intervention 
materials 
Electronic-
based media 
and 
electronic-
based media 
plus paper-
based media 
The intervention was 
delivered through 
the use of mobile 
applications, texting, 
websites, online 
videos and/or DVDs 
etc. A proportion of 
interventions 
combined electronic 
media with print 
materials.  
 Hwang et al (2013): The 
intervention involved participants 
interacting with peers in online 
discussion forums. 
 Jensen et al (2014): participants 
were sent either a tailored or 
untailored web-message and a 
take-home pamphlet. 
 Paper-based 
media only 
The intervention was 
delivered through 
the use of printed 
materials including 
leaflets, brochures 
and standard 
screening 
invitations.  
 Neter et al (2014): Participants 
received a leaflet containing an ‘if-
then’ condition that arrived with the 
standard screening invite.  
 Van Roon et al (2011): Participants 
received an advanced notification 
letter two weeks before they were 
sent the standard screening invite.  
 Paper-based 
media plus 
phone call 
The intervention was 
delivered through 
the use of printed 
materials combined 
with a phone call(s). 
The telephone 
component usually 
involved providing 
support to the 
patient to overcome 
screening difficulties 
(e.g., telephone 
counselling) or was 
used as a reminder 
to prompt patients to 
take part in 
screening.  
 Braun et al (2005): The 
intervention involved both 
educational leaflets and a series of 
telephone calls with patients to 
address frequently encountered 
barriers. 
 Salimzadeh et al (2014): The 
intervention involved sending 
participants a print educational 
booklet and a series of reminder 
phone calls.  
 Phone call 
only 
A telephone was 
used to facilitate the 
intervention.   
 Basch et al (2006): The 
intervention involved a series of 
telephone calls tailored to 
information provided by the 
patients during a baseline survey.  
 Menon et al (2011): The 
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intervention compared the 
effectiveness of two personalised 
telephone-based interventions - 
tailored counselling and motivation 
interviewing – to usual care.  
 In person 
delivery (i.e. 
Material-
independent) 
The intervention did 
not rely on the use 
of printed materials, 
electronic media 
and/or phone calls, 
rather it relied 
predominantly on 
interpersonal 
interactions between 
the intervention 
provider(s) and the 
intervention 
recipient(s).   
 Boguradzka et al (2014): 
Participants took part in a one-to-
one discussion and received a 
personal recommendation for 
screening from a primary care 
provider.  
 Dignan et al (2014): The 
intervention involved the delivery of 
a series of academic detailing 
sessions; a method of educating 
providers, through personal 
contact, to increase CRC 
screening recommendations. 
 Paper-based 
media plus in 
person 
delivery 
The intervention was 
delivered through 
the use of printed 
materials but also 
involved one or 
more intervention 
elements that 
involved direct 
contact between the 
intervention 
provider(s) and the 
intervention 
recipient(s).    
 Ling et al (2009): The intervention 
(groups 2 and 3) involved mailing a 
standard invitation letter to 
participants, as well as providing 
them with patient navigation 
services.  
 Maxwell et al (2010): Participants 
received printed educational 
materials and participated in group 
educational sessions. 
 Potter et al (2011): Participants 
received printed educational 
materials as well as a nurse 
recommendation during a clinic 
visit. 
Setting  Community 
setting 
The intervention was 
delivered within 
community-based 
institutions such as 
churches, schools, 
voluntary 
organisations, 
neighbourhoods 
and/or local 
community health 
centres.  
 Blumenthal et al (2010): The 
intervention was delivered within 
community organisations (including 
churches and clinics) and agencies 
concerned with promoting cancer 
screening. 
 Christie et al (2008): The 
intervention took place at a non-
profit community health centre. 
 Marcus et al (2005): The 
intervention was delivered through 
14 regional call centres 
collaborating with the National 
Cancer Institute. 
 Percac-Lima et al (2008): The 
intervention took place in an urban, 
community health centre. 
 Primary or 
secondary 
care setting 
The intervention was 
delivered in a 
primary or 
secondary care 
facility; e.g., GP 
practices, hospitals, 
 Clouston et al (2014): The 
intervention took place in medical, 
primary care clinics in Manitoba, 
Canada. 
 Fortuna et al (2014): The 
intervention took place in an inner 
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primary care clinics. city, medical practice in New York, 
USA.  
 Hewitson et al (2011): The 
intervention was delivered through 
GP practices in London, UK.  
 Levy et al (2013): The intervention 
was delivered though the 
Department of Family Medicine 
and its collaboration with 16 
primary care practices in Iowa, 
USA.  
 Tinmouth et al (2014): The 
intervention was conducted in the 
context of Ontario’s CRC screening 
programme.  
Use of 
Theory 
Low or 
moderate 
use of theory 
Studies that scored 
0-2 and 3-5 on the 
TCS (specifically 
items 3-11 of the 
TCS) were 
considered to 
demonstrate low and 
moderate use of 
theory respectively.  
 Hendren et al (2011) reported 
using the Health Belief Model to 
develop the intervention. The study 
scored 4/8 on the TCS (i.e. 
moderate use of theory).  
 Potter et al (2011) reported using 
the General Model of the 
Determinants of Behavioural 
Change. The study scored 0/8 on 
the TCS (i.e. no use of theory). 
 Ruffin et al (2007) reported using 
the Elaboration Likelihood Model. 
The study scored 2/9 on the TCS 
(i.e. low use of theory).  
 High use of 
theory 
Studies that scored 
6-8 on the TCS 
(specifically items 3-
11 of the TCS) were 
considered to 
demonstrate high 
use of theory. 
 Costanza et al (2007) reported 
using the Precaution Adoption 
Process Model to develop the 
intervention and the study scored 
6/8 on the TCS. 
 Lo et al (2013) developed an 
intervention based on 
implementation intentions 
principles and the study scored 6/8 
on the TCS. 
 Resnicow et al (2014) reported 
using the Self-Determination 
Theory to develop the intervention 
and the study scored 6/8 on the 
TCS.  
Screening 
Modality 
Endoscopic 
screening 
modality 
These were studies 
that defined CRC 
screening using 
endoscopic 
procedures (i.e. 
colonoscopy, flexible 
sigmoidoscopy), 
which are diagnostic 
procedures that 
involve viewing the 
bowel internally and 
if necessary 
 Boguradzka et al (2014) defined 
screening uptake as the 
participation in colonoscopy within 
the National Colonoscopy 
Screening Programme in Poland 
during follow-up period. 
 Christie et al (2008) defined 
screening uptake as the 
completion of screening 
colonoscopy during follow-up 
period. 
 Jandorf et al (2013) defined 
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removing any 
polyps.  
screening as the completion of 
screening colonoscopy during 
follow-up period.  
 Non-
endoscopic 
screening 
modality 
These were studies 
that defined CRC 
screening uptake as 
using stool-based 
screening tests (i.e. 
gFOBT, FIT), which 
are non-endoscopic 
and require the 
collection of small 
faecal samples, 
which are then 
tested for traces of 
blood.  
 Guiriguet et al (2016) defined 
screening uptake as individuals 
returning the FIT during follow-up 
period.  
 Hagoel et al (2016) defined 
screening uptake as individuals 
returning the gFOBT during follow-
up period.  
 Raine et al (2015) defined 
screening uptake as individuals 
returning the gFOBT kit during 
follow-up period.  
 Choice to 
undergo 
either an 
endoscopic 
or non-
endoscopic 
screening 
procedure 
These were studies 
that defined 
screening uptake as 
the participation in 
either an endoscopic 
or non-endoscopic 
CRC screening 
procedure.  
 Gupta et al (2013) defined 
screening uptakes as completion of 
either colonoscopy, 
sigmoidoscopy, gFOBT or barium 
enema during follow-up period.  
 Marcus et al (2005) defined 
screening uptake as completion of 
either a colonoscopy, flexible 
sigmoidoscopy or gFOBT.  
Use of 
Reminders 
Yes These were studies 
that used reminders 
to improve CRC 
screening uptake. 
Reminders included 
automated or 
personal telephone 
calls, postcards, 
letters, text 
messages etc. 
 Fiscella et al (2011): The 
intervention involved sending 
participants two personalised 
letters, followed up by a phone call 
reminder.  
 Hagoel et al (2016): The 
intervention involved sending 
participants text-message 
reminders.  
 Percac-Lima et al (2008): The 
intervention involved sending 
patients reminders as part of a 
wider patient navigation 
intervention.  
 No These were studies 
that did not use 
reminders (of any 
form) to improve 
CRC screening 
uptake.  
 Cohen-Cline et al (2014) tested the 
effectiveness of a quality 
improvement intervention that did 
not include the use of reminders.  
 Jensen et al (2014) tested the 
effectiveness of a narrative-based 
intervention that did not incorporate 
reminders. 
Assessment 
of outcome  
Objective These were studies 
that assessed CRC 
screening uptake 
using objective 
methods (e.g., 
through claims 
and/or administrative 
data, patients’ 
electronic medical 
 Green et al (2013): Completion of 
CRC screening was based on 
evidence from patients’ electronic 
health records or claims data.  
 Jensen et al (2014): Completion of 
CRC screening was based on each 
participants’ claims data.  
 Sequist et al (2011): Completion of 
CRC screening was based on 
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records etc.) evidence from patients’ electronic 
health records. 
 Self-report These were studies 
that relied on 
patients’ self-report 
to assess CRC 
screening uptake.  
 Hwang et al (2013): CRC 
screening uptake was assessed by 
self-report.  
 Pignone et al (2011): The primary 
outcome was self-reported 
completion of any CRC screening 
during follow-up period.  
 
Risk of Bias High risk of 
bias 
These were studies 
that failed to meet 
one or more of the 
criteria set forth by 
the Cochrane Risk 
of Bias tool. 
 Dignan et al (2014): Blinding of 
outcome assessment was 
considered inadequate. The 
researchers did not perform and/or 
report the use of ITT analysis. 
 Fitzgibbon et al (2007): The 
randomisation procedure was 
inadequate (i.e. randomisation 
occurred at the clinic level and 
there were only two clinics. Also 
the researchers did not describe 
the method they used to randomise 
clinics). Attrition bias was 
considered high.  
 Unclear risk 
of bias 
These were studies 
that provided 
insufficient detail 
relating to one or 
more of the criteria 
of the Cochrane 
Risk of Bias tool. 
 Braun et al (2005): it was unclear 
whether there was adequate 
allocation concealment and 
blinding. 
 Cole et al (2002): The study did not 
provide enough detail to decipher 
whether there was adequate 
blinding of outcome assessment.  
 Goldman et al (2015): The study 
did not provide enough detail to 
determine whether there was 
adequate allocation concealment 
and blinding and whether the 
researchers conducted ITT 
analysis. 
 
 Low risk of 
bias 
These were studies 
that provided 
sufficient detail 
across all of the 
criteria of the 
Cochrane Risk of 
Bias tool.  
 Fortuna et al (2014) 
 Gupta et al (2013) 
 O’Carroll et al (2015) 
 
 
 
 
Appendix 2.6. Overview of BCT Taxonomy (v1) and its 93 hierarchically 
clustered techniques  
Pag Grouping and BCTs Pa Grouping and BCTs Pa Grouping and BCTs 
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e ge ge 
1 1. Goals and planning 8 6. Comparison of 
behaviour 
16 12. Antecedents 
 
 
 
 
 
 
 
 
 
 
 
3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5     
 
 
 
 
 
 
 
 
 
6 
 
 
 
 
 
 
 
7 
1.1. Goal setting 
(behavior) 
1.2. Problem solving 
1.3. Goal setting 
(outcome) 
1.4. Action planning 
1.5. Review behavior 
goal(s) 
1.6. Discrepancy 
between current  
behavior and goal 
1.7. Review outcome 
goal(s) 
1.8. Behavioral 
contract 
1.9. Commitment 
 
2. Feedback and 
monitoring 
2.1. Monitoring of behavior  
        by others without       
        feedback 
2.2. Feedback on 
behaviour 
2.3. Self-monitoring of   
        behaviour 
2.4. Self-monitoring of  
        outcome(s) of 
behaviour 
2.5. Monitoring of 
outcome(s)  
        of behavior without  
        feedback 
2.6. Biofeedback 
2.7. Feedback on 
outcome(s)   
        of behavior 
 
3. Social support 
3.1. Social support 
(unspecified) 
3.2. Social support 
(practical) 
3.3. Social support 
(emotional) 
 
4. Shaping knowledge 
4.1. Instruction on how to      
        perform the behavior 
4.2. Information about  
        Antecedents 
4.3. Re-attribution 
4.4. Behavioral 
experiments 
 
5. Natural consequences 
5.1. Information about 
health  
 
 
 
 
 
 
9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 
 
 
 
 
6.1. Demonstration of the     
        behavior 
6.2. Social comparison 
6.3. Information about 
others’  
        approval 
 
7. Associations 
7.1. Prompts/cues 
7.2. Cue signalling reward 
7.3. Reduce prompts/cues 
7.4. Remove access to the  
       reward 
7.5. Remove aversive 
stimulus 
7.6. Satiation 
7.7. Exposure 
7.8. Associative learning 
 
8. Repetition and 
substitution    
8.1. Behavioral  
        practice/rehearsal 
8.2. Behavior substitution 
8.3. Habit formation 
8.4. Habit reversal 
8.5. Overcorrection 
8.6. Generalisation of 
target  
        behavior 
8.7. Graded tasks 
 
9. Comparison of 
outcomes 
9.1. Credible source 
9.2. Pros and cons 
9.3. Comparative imagining 
of     
        future outcomes 
 
10. Reward and threat 
10.1. Material incentive 
(behavior) 
10.2. Material reward 
(behavior) 
10.3. Non-specific reward 
10.4. Social reward 
10.5. Social incentive 
10.6. Non-specific incentive 
10.7. Self-incentive 
10.8. Incentive (outcome) 
10.9. Self-reward 
10.10. Reward (outcome) 
10.11. Future punishment 
 
11. Regulation 
11.1. Pharmacological 
support 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19 
12.1. Restructuring the 
physical  
          environment 
12.2. Restructuring the 
social  
          environment 
12.3. Avoidance/reducing 
exposure to  
          cues for the behavior 
12.4. Distraction 
12.5. Adding objects to the  
          environment 
12.6. Body changes 
 
13. Identity 
13.1. Identification of self as 
role     
          model 
13.2. Framing/reframing 
13.3. Incompatible beliefs 
13.4. Valued self-identify 
13.5. Identity associated with 
changed  
          behavior 
 
14. Scheduled 
consequences 
14.1. Behavior cost 
14.2. Punishment 
14.3. Remove reward 
14.4. Reward approximation 
14.5. Rewarding completion 
14.6. Situation-specific 
reward 
14.7. Reward incompatible 
behavior 
14.8. Reward alternative 
behavior 
14.9. Reduce reward 
frequency 
14.10. Remove punishment 
 
15. Self-belief 
15.1. Verbal persuasion 
about  
          capability 
15.2. Mental rehearsal of 
successful  
          performance  
15.3. Focus on past success 
15.4. Self-talk 
 
16. Covert learning 
16.1. Imaginary punishment 
16.2. Imaginary reward 
16.3. Vicarious 
consequences 
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        consequences 
5.2. Salience of 
consequences 
5.3. Information about 
social and  
        environmental 
consequences 
5.4. Monitoring of 
emotional  
        consequences 
5.5. Anticipated regret 
5.6. Information about 
emotional  
        consequences 
11.2. Reduce negative 
emotions 
11.3. Conserving mental 
resources 
11.4. Paradoxical 
instructions 
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Appendix 2.7. Characteristics of studies included in the meta-analytic review 
 
Author, 
Year 
 
 
Sample 
 
Setting 
 
Study Aims  
 
Study arms 
 
Outcome 
 
Results 
Aragones 
et al, 2010 
Latino immigrant 
population in 
NYC. 
 
Age m (SD) 
years: 58.9 
(7.05) 
Primary 
care clinic 
of a large 
NYC 
teaching 
hospital 
 
(USA) 
To assess the 
effectiveness of a 
culturally and 
linguistically 
sensitive, multilevel 
intervention, 
involving patients 
and physicians, to 
improve the rate of 
CRC screening 
among Latino 
immigrants 
 
Control group: usual care  
(N physicians/patients= 31/31) 
Intervention group: 
1) Spanish language CRC educational video 
providing information about CRC screening 
modalities, prevention and risk factors 
2) A brochure in Spanish summarizing key 
information from the video 
3) One-page reminder to give to their 
physicians notifying that the patients are 
eligible for CRC screening and that they 
received CRC education  
(N physicians/patients = 34/34) 
Any 
screening 
test within 6 
months 
Overall screening rates for 
the intervention vs. control 
group was significantly 
greater: 55% vs. 18% (p = 
0.002) 
Significantly more patients 
received physician 
recommendation in the 
intervention (61%) vs. the 
control (41%) group (p = 
0.08).  
 
Atlas et al, 
2014 
Patients 
overdue for 
breast, cervical 
and/or CRC 
screening 
 
Age range: 
Breast: 42-74, 
Cervical: 21-64 
CRC: 52-75 
years  
 
N 
(practices/patien
ts): 18/103,870 
The 
Massachus
etts 
General 
Primary 
Care 
Practice-
Based 
Research 
Network 
 
(USA) 
To evaluate 
whether involving 
primary care 
providers (PCPs) in 
a visit-independent 
population 
management IT 
application led to 
more effective 
cancer screening 
 
Control practices:  
Augmented Usual care: overdue patients were 
automatically sent reminder letters via the 
automated IT application and transferred to 
practice delegate lists for follow-up  
(N practices/patients: 9/52,799) 
Intervention practices:  
Augmented usual care plus provider input:  PCPs 
determined whether contact with a patient about 
screening was needed and how best to provide it 
(i.e. visit-independent population management): 
PCPs reviewed real-time rosters of patients 
overdue for screening and provided individualised 
contact (via a letter, practice delegate or patient 
navigator) or deferred screening 
temporarily/permanently (N practices/patients: 
Mammogra
m, pap 
smear, any 
endoscopic 
CRC 
screening 
procedure 
within 12 
months 
Adjusted average screening 
rate did not differ among 
intervention and comparison 
practices for all cancers 
combined (81.6% vs 81.4%; 
p = 0.84)  
 
For CRC: No difference 
between the groups was 
observed: 77.8% vs 76.2%; p 
= 0.33) 
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9/51,071) 
Baker et 
al, 2014 
 
Members of 
community 
health centres. 
 
Age range: 51-
75 years  
 
N = 450 
Community 
health 
centres in 
Chicago, 
Illinois. 
 
(USA) 
To test the 
effectiveness of a 
multifaceted 
intervention 
designed to 
address barriers to 
CRC screening, in 
a vulnerable 
population. 
 
Control group:  
Usual care: Computerised reminders plus gFOBT 
kit and feedback on screening rates (N = 225). 
Intervention group:  
Same as G1, plus mailed reminders, gFOBt kit 
with low-literacy instructions, return envelope plus 
Telephone and text message reminders plus 
Another reminder 2 weeks later if ‘no –return’ plus 
Telephone outreach by navigator 3 months later if 
‘no-return’ (N = 225). 
gFOBT 
within 6 
months. 
Control group: 37.3% 
completed gFOBT within 6 
months. 
 
Intervention group: 82.2% 
completed gFOBT within 6 
months.  
 
The difference in screening 
uptake was statistically 
significant (p <.001). 
Barthe et 
al, 2015 
Patients eligible 
for CRC 
screening. 
 
Age range: 50-
74 years 
 
N = 3,422 
GP 
practices in 
Paris. 
 
(France) 
To assess the 
impact of a 
signature from the 
patient’s GP on a 
letter inviting 
patients to 
participate in CRC 
screening.  
Control group:  
Standard invitation letter and standard reminder 
(N = 1,527). 
Intervention group:  
Standard letter signed by GP inviting patients to 
visit the GP’s office to obtain gFOBT test (N = 
1,895). 
gFOBT 
within 6 
months. 
Screening rates were 14.8% 
in the intervention group and 
14.6% in the control group. 
There was no statistical 
difference between the 2 
groups (OR = 1.04, 95%, CI: 
0.83-1.31; p = 0.731). 
 
Basch et 
al., 2006 
Members of a 
New York health 
benefit fund that 
includes CRC 
screening 
coverage  
 
Age range: 52-
79 years 
N = 456 
New York 
City 
metropolita
n area. 
 
(USA) 
To test the 
effectiveness of a 
telephone outreach 
approach versus a 
direct mail 
approach in a 
predominantly 
African-American 
population. 
Control group:  
Mailed package that included a letter plus 
brochure about CRC screening (N = 230). 
Intervention group:  
Tailored telephone outreach by a health educator 
through repeated calls (median = 5) to educate 
patients on the need for screening and build their 
self-efficacy in obtaining screening (N = 226). 
gFOBT, 
sigmoidosc
opy, 
colonoscop
y or barium 
enema 
within 6 
months. 
Control group: 6.1% (n = 14). 
Intervention group: 27% 
received any CRC test (n = 
61). 
Rate difference = 20.9%; 
95% CI, 14.34–27.46. 
RR (Relative risk) 4.4 (2.6–
7.7).  
Blumentha
l et al., 
2010 
African 
American 
population in 
Atlanta, 
Georgia. 
 
Various 
community 
sites in 
Atlanta, 
Georgia 
including 
To assess the 
efficacy of three 
separate 
interventions for 
increasing CRC 
screening rates 
Control group: educational pamphlet outlining key 
information on CRC (N = 88). 
G1: Financial support intervention: participants 
were offered financial reimbursement for covering 
CRC out of pocket expenses including 
transportation and other nonmedical expenses (N 
Any CRC 
screening 
within 6 
months. 
Screening rates were 
significantly higher in G3 
when compared to the 
control group (33.9% vs. 
17.7%; p = 0.039). 
Rate difference: 16.2% 
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Age range: 50-
74 years 
 
N = 369 
churches, 
community 
centres or 
clinics. 
 
(USA) 
among African 
Americans.  
 
= 84). 
G2: One-on-one education: health educators 
reviewed educational materials with patients and 
engaged in one-on-one discussion about CRC 
risk and screening (N = 98). 
G3: Group education: Health educators met with 
participants in groups to review similar 
educational materials to G2 (N = 99). 
Screening rates were not 
significantly higher between 
G1 (22.2%) and G2 (25.4%) 
when compared to controls. 
Rate difference: 4.5% and 
7.7% respectively. 
Boguradzk
a et al., 
2014 
Patients eligible 
for CRC 
screening. 
 
Age range: 50-
65 years 
 
N = 600 
A group 
physician 
practice of 
four 
primary 
care 
physicians 
(PCPs) in 
the urban 
areas of 
Warsaw. 
 
(Poland) 
To compare the 
effect of PCP 
counselling vs. a 
CRC information 
leaflet, on 
participation 
screening rates in a 
primary 
colonoscopy 
screening program.  
 
Control group: PCP prompted patients to obtain a 
CRC information leaflet after a scheduled health 
visit (N = 300). 
Intervention group: PCP directly recommended 
screening at the end of health visit. Discussion 
included information about the benefits of CRC 
screening and early treatment plus 
recommendation to participate in colonoscopy 
screening plus information about the procedure 
plus help with screening arrangements (N = 300). 
Colonoscop
y within 6 
months. 
Screening colonoscopy rates 
were 47% in the intervention 
group vs. 13.7% in the 
control group (p<.05). 
PCP counselling was 
associated with higher 
adherence (AOR, 5.33, 95% 
CI: 3.55 – 8.00, p<.001). 
Braun et 
al., 2005 
Native 
Hawaiians 
eligible for CRC 
screening.  
 
Age range: >50 
years 
 
N = 121 
Hawaiian 
civic clubs 
located in 
urban and 
rural areas 
of Hawaii. 
 
(Hawaii) 
To test the 
effectiveness of an 
intervention based 
on social learning 
theory (SLT) on 
improving CRC 
screening among 
Native Hawaiians.  
 
Control group: patients received a culturally 
targeted educational presentation on CRC 
screening, a free gFOBT kit and a reminder call 
(N = 52). 
Intervention group: patients received a culturally 
targeted educational intervention based on SLT 
principles delivered by a Hawaiian CRC survivor 
plus an gFOBT demo plus multiple telephone calls 
to address barriers (N = 69). 
gFOBT 
within 21/2 
months. 
The intervention group was 
less likely to be screened 
post-intervention compared 
to the control group (OR = 
0.364, 95% CI: 0.14-0.97). 
 
Results indicated that an 
SLT-based intervention, 
contrary to expectations, was 
less effective than the 
culturally targeted 
educational session. 
Braun et 
al., 2015 
488 Medicare 
beneficiaries. 
 
General 
hospital 
Hawaii. 
To assess whether 
the use of patient 
navigators reduced 
Control group (N = 246): Received cancer 
education.  
Intervention group (N = 242): Received navigation 
Any CRC 
screening 
within 12 
Screening rates were 43% in 
the intervention group and 
27.2% in the control group 
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Age range: 60-
75 
 
N = 488 
racial disparities in 
relation to breast, 
cervical, prostate 
and CRC screening 
uptake.  
services to help them access cancer screening 
services.  
months. for flexi sig and /or 
colonoscopy screening 
uptake.  
 
Cameron 
et al., 2011 
Patients with an 
expired order of 
colonoscopy. 
 
Age range: 50-
79 years 
 
N = 628 
Urban 
academic 
adult 
primary 
care 
internal 
medicine 
practice in 
Chicago, 
Illinois. 
(USA) 
To test the efficacy 
of a 
multicomponent 
intervention to 
increase CRC 
screening among 
patients who 
received and 
accepted referral 
for colonoscopy but 
did not attend 
within 3 months. 
Control group: usual care: a reminder letter at 6 
months (N = 314). 
Intervention group: personalised reminder letter 
plus educational brochure plus DVD about CRC 
and screening based on the Extended Parallel 
Process Model of health behaviour to address 
CRC screening barriers (N = 314). 
gFOBT, FS 
or 
colonoscop
y within 6 
months. 
At 6 months 18.2% in the 
intervention group and 12.1% 
in the control group had 
completed CRC screening. 
Absolute difference of 6.1% 
(rate ratio, 1.5, 95% CI: 1.03-
2.2, p = 0.03) 
 
Christie et 
al., 2008 
Low-income 
minorities 
eligible for 
screening 
colonoscopy. 
 
Age range: >50 
years 
N = 21 
Local 
community 
health 
centre, 
NYC. 
 
(USA) 
To determine 
whether a patient 
navigator (PN) can 
increase patient 
compliance with 
CRC screening 
colonoscopy, 
among a low-
income minority 
population. 
Control group: PN- : usual care (N = 8). 
 
Intervention group: PN+: the PN assisted in 
patient education on CRC risks and prevention 
plus answered questions about colonoscopy 
preparation plus provided reminders plus bilingual 
explanations on procedures plus assisted with 
organising appointments and transportation (N = 
13).  
Colonoscop
y at 6 
months.  
53.8% of the intervention 
group completed screening 
colonoscopy vs. 13% of 
control group (p = 0.058). 
Absolute increase: 40.8% 
 
Church et 
al., 2004 
Residents, 50 
years of age or 
older. 
 
Age (m/SD): 63 
years (10.2) 
 
N = 1,255 
Wright 
County, a 
non-urban 
county in 
Minnesota. 
 
(USA) 
To test direct 
mailing of gFOBT 
kit with and without 
reminders to 
general population. 
Control group: Questionnaire only (n = 417). 
 
G1: Direct mail without reminders group:  
Questionnaire mailed plus gFOBT kit and 
instructional brochure (N = 434). 
 
G2: Direct mail with reminders group: Same 
package as G2, plus telephone reminders (N = 
404). 
gFOBT at 
12 months. 
Control group: 1.5% gFOBT 
completion rate (95% CI: −2.9–
5.9%); 7.8% for any CRC test 
(95% CI: 3.2–12.0%) 
G1: No reminders group: 16.9% 
gFOBT completion rate (95% CI: 
11.5–22.3%); 13.2% for any 
CRC test (95% CI: 8.4–18.2%). 
G2: Reminders group: 23.2% 
gFOBT completion rate (95% CI: 
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17.2–29.3%); 14.1% for any 
CRC test (95% CI: 9.1–19.1%). 
Clouston 
et al., 2014 
Family 
physicians (FPs) 
and their 
patients eligible 
for CRC 
screening. 
Age range: 50-
70 years 
N 
clinics/patients/p
hysicians = 
39/2,395/70 
Medical, 
primary 
care clinics 
in 
Winnipeg, 
Manitoba, 
Canada. 
 
(Canada) 
To evaluate 
whether a patient 
decision aid 
distributed to 
patients by their 
family physician will 
improve gFOBT 
screening rates. 
 
Control group: received usual care (N = 1,174). 
 
Intervention group: FPs gave their patients a 
patient decision aid in the form of a refrigerator 
magnet, which directed patients to accessing 
CRC information and a screening nurse managed 
support line and website (N = 1,221). 
gFOBT 
within 4 
months. 
Patients in the intervention 
group had significantly higher 
gFOBT completion rates 
(66.6%; OR 1.47, 95% CI: 
1.06-2.03, p <0.02) 
compared to controls 
(56.9%). 
Absolute difference: 9.7%. 
 
Cohen-
Cline et al., 
2014 
Patients due for 
CRC. 
 
Age range: 50-
81 years 
 
N = 13,279 
Managed 
care 
organisatio
n in 
Washington 
State. 
 
(USA) 
 
To assess whether 
an interactive voice 
response (IVR) 
system could be 
effective to engage 
people in CRC 
screening. 
 
Control group: Usual care: a personalised 
outreach letter informing patients on screening (N 
= 3,279). 
 
Intervention group: A single IVR telephone call 
including: assessment of prior CRC screening 
plus information about the benefits of screening 
and elicitation of barriers plus offer of a gFOBT kit 
mailed at home (N = 10,000). 
 
Any CRC 
screening 
at 6 and 12 
months. 
6-month follow-up: 
Adherence to CRC screening 
was 10% in the intervention 
group vs. 7.8% in the control 
group (HR, 1.32, 95% CI: 
1.14-1.52, p<0.001) (sample 
N = 13,279). 
 
12-month follow-up: CRC 
uptake was 16.6% in the 
intervention group vs 14.1% 
in the control group (HR, 
1.20, 95% CI: 1.08, 1.34, 
p<0.001) (sample N = 11, 
010). 
Cole et al., 
2002 
South Australian 
residents, 
eligible for CRC 
screening. 
 
Age range: >50 
years 
South 
Australian 
residents 
from 2 
sources: 
1) Patient 
lists of 
To assess the 
influence of GP 
endorsement on 
participation in 
screening for CRC 
by gFOBT. 
 
Control group: Usual care (N = 600). 
G1: Treatment arm 1: Invitation with no indication 
that their GP was involved (N = 600). 
G2: Treatment arm 2: received invitation 
indicating support from the practice (N = 600). 
G3: Treatment arm 3: received invitation on 
practice letterhead and signed by practice partner 
gFOBT at 3 
months. 
CRC participation rates for 
G2 (38%) and G3 (40.7%) 
were significantly higher than 
the control group/G1 (32%) 
(OR, 0.77; 95% CI: 0.60-
0.98). 
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N = 2,400 
primary 
care 
practices 
2) Electoral 
roll (ER) of 
the 
Australian 
Electoral 
Commissio
n 
plus CRC information sheet plus gFOBT kit (N = 
600). 
Absolute difference: 6% 
between G2 and control/G1 
and 8.7% for G3 and 
control/G1. 
 
Cole et al., 
2007 
Patients eligible 
for CRC 
screening.  
 
Age range: 50-
74 years 
 
(N = 2,400) 
Community 
screening 
program in 
Adelaide. 
 
(Australia) 
To determine the 
impact of three 
novel letter-based 
invitation strategies 
on population 
participation in 
CRC screening by 
FIT. 
Control group: usual care: standard invitation 
letter explaining risk of CRC and value of 
screening (N = 600). 
G1: Intervention arm 1: Risk Group: Standard 
invitation plus additional positively framed 
messages about CRC risk, generalised for CRC 
risk and relative risk for CRC (N = 600). 
G2: Intervention arm 2: Advocacy Group: 
invitation with additional messages related to 
advocacy for screening from previous screening 
program participants (N = 600). 
G3: Intervention arm 3: Advanced notification 
group: a letter introducing standard invitation 
messages followed by the standard invitation 2 
weeks later (N = 600). 
FIT kits were sent to all groups 
FIT at 3 
months. 
CRC screening uptake was 
significantly greater in G3 
(48.3%) compared to 
Controls (39.5%) (RR, 1.23, 
95% CI: 1.06-1.43, p<.05). 
 
No significant differences in 
uptake were observed 
between G1, G2 and the 
control group.  
Coronado 
et al., 2011 
Hispanic 
patients eligible 
for CRC 
screening. 
 
Age range: 50-
79 years 
 
N = 501 
Seattle 
community 
clinic. 
 
(USA) 
To evaluate 
whether a clinic-
based intervention 
would improve 
CRC screening 
rates among a 
Hispanic 
population. 
Control group: received usual care (N = 165). 
G1: Mailed gFOBT only: mailed kit plus instruction 
in English and Spanish (N = 168). 
G2: Mailed gFOBT plus outreach: mailed kits and 
instructions, telephone reminders and home visits 
(N = 168). 
gFOBT at 9 
months. 
Compared to the control 
group (2%) screening uptake 
rates were significantly 
higher (p<.001) for both G1 
(26%) and G2 (31%). 
 
Absolute difference: 24% and 
29% for G1 and G2 
respectively. 
Costanza Patients eligible Community To assess the Control group: Usual care (N = 1,261). gFOBT, FS There was no significant 
  
356 
et al., 2007 for CRC 
screening. 
 
Age range: 50-
75 years 
 
N = 2,448 
primary 
care 
practices 
(PCPs) in 
Massachus
etts. 
 
(USA) 
effectiveness of a 
computer-assisted 
tailored telephone 
counselling 
intervention on 
increasing CRC 
screening. 
 
Intervention group: patients received a mailed 
booklet on CRC screening followed by computer-
assisted telephone counselling that was based on 
the Precaution Adoption Process Model (N = 
1,187). 
or 
colonoscop
y at 2 
years. 
difference in screening rates 
between the control (19%) 
and intervention group (20%) 
on either of the screening 
methods (p = 0.68). 
 
Denberg et 
al., 2005 
Adults due for 
colonoscopy. 
 
Age range: >50 
years 
 
N = 781 
2 general 
internal 
medicine 
practices in 
Denver, 
Colorado. 
 
(USA) 
To test whether a 
brochure sent to 
patients’ homes, 
after referral for 
colonoscopy, will 
increase screening 
rates by 
colonoscopy. 
 
Control group: Received usual care (N = 395). 
 
Intervention group: an educational brochure 
encourage patients to schedule a colonoscopy, 
discussing cancer prevention and early detection, 
providing facts about CRC and polyps, description 
of colonoscopy procedure and alternative 
screening tests (N  = 386). 
 
Colonoscop
y at 4 
months.  
The intervention group had 
significantly higher rates of 
colonoscopy (70.7%) at 4 
months post intervention 
compared to the control 
group (59%) resulting in an 
11.7% higher screening rate 
(95% CI: 5.1% to 18.4%; 
p<.001). 
Dietrich et 
al., 2006 
Females 
overdue for at 
least 1 cancer 
screening (out 
of breast, 
cervical and 
bowel cancer). 
 
Age range: 50-
69 years 
 
N = 1,413 
11 
community 
and migrant 
health 
centres in 
NYC. 
 
(USA) 
To evaluate the 
effect of a 
telephone support 
intervention to 
increase rates of 
breast, cervical and 
CRC screening 
among minority and 
low-income women. 
 
Control group: received usual care (N = 694). 
 
Intervention group: received an average of 4 
tailored telephone reminder calls from prevention 
care managers who aimed at facilitating all 
aspects of the screening process and addressed 
barriers (N = 696). 
 
Any at 18 
months.  
Women in the intervention 
group had significantly higher 
CRC screening rates 
compared to those in the 
control group; 63% vs. 50%, 
p = 0.075 
 
Overall significantly more 
women in the intervention 
group were up to date for all 
3 forms of screening 
compared to controls 
(p<0.001)  
Dietrich et 
al., 2007 
Females 
overdue for at 
least 1 cancer 
screening (out 
of breast, 
cervical and 
6 
Community 
health 
centres in 
NYC. 
 
To assess the 
impact of 
prevention care 
management 
(PCM) delivered 
through a Medicaid 
Control group: women in this group received a 
modified version of the MMCO’s established 
mammography telephone outreach program and 
received up to 3 scripted phone calls plus 
educational brochures on all 3 cancers (N = 663). 
 
Any CRC 
screening 
at 10 
months.  
Women in the intervention 
group (32%) were 1.69 times 
more likely to be up to date 
for CRC screening compared 
to control women (25%) 
(95% CI: 1.03-2.77, p = 
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bowel cancer). 
 
Age range: 50-
69 years 
 
N = 1,316 
(USA) managed care 
organisation 
(MMCO) on breast, 
cervical and CRC 
screening among 
women attending 
Community Health 
Centres.  
Intervention group: women in this group received 
the PCM intervention; 3 scripted phone calls to 
identify barriers and provide support to obtain any 
needed breast, cervical and CRC screening tests 
(N = 653). 
0.04). 
Absolute difference: 7% 
For breast and cervical 
cancer rates did not differ 
significantly. 
Dietrich et 
al., 2013 
Females with 
Medicaid 
insurance in 
New York City. 
 
Age range: 50-
63 years 
 
N = 2,240 
Medicaid 
Community 
Health 
Centres in 
New York 
City. 
 
(USA) 
To test the 
effectiveness of a 
telephone outreach 
intervention versus 
usual care to 
increase CRC 
screening rates, 
among publicly 
insured women 
(Medicaid). 
Control group: usual care: standard telephone 
screening invite (N = 1,678). 
 
Intervention group: mailing of a personalised 
letter, screening recommendation from physician, 
scripted telephone outreach up to 12 times to 
address barriers, provision of reminders until 
patients were up to date with screening (N = 562). 
gFOBT, 
FS, 
colonoscop
y or barium 
enema at 
18 months.  
Control group: 30.6% CRC 
screening completion rate 
Intervention group: 36.7% 
CRC screening completion 
rate (AOR, 1.32, 95% CI: 
1.08-1.62, p< 0.01) 
Although screening rates in 
the intervention vs. control 
group were higher, the 
overall increase was driven 
by 1 clinic alone (Clinic 2; 
AOR, 1.98; 95% CI: 1.39-
2.82, p< 0.001). 
Dignan et 
al., 2014 
Primary care 
practices 
(PCPs) and their 
patients. 
 
Age range: 50-
75 years 
 
N (PCPs) = 66 
N (patients = 
3,844) 
Primary 
care 
practices in 
Appalachia
n Kentucky. 
 
(USA) 
 
To assess whether 
an academic 
detailing 
intervention that 
reaches rural 
primary care 
providers is 
effective in 
increasing CRC 
screening rates in 
rural Kentucky. 
 
Control group practices: received delayed 
intervention (N = 33 PCPs/1,842 patients). 
 
Intervention group practices: received an 
academic detailing intervention; a method of 
education where providers receive information, 
here specific to CRC, through personal contact (N 
= 33 PCPs/ 1,909 patients). 
Any CRC 
screening 
at 6 
months. 
No intervention effect was 
found for gFOBT uptake. 
 
For intervention group 
practices colonoscopy 
screening rates increased by 
15.7% at 6 months compared 
to an increase of 2.4% in 
control group practices 
(conditional on provider 
recommendation, p = 0.01).  
Absolute difference: 13.3% 
Ferreira et 
al., 2005 
Male veterans 
due for CRC 
screening.  
Two 
general 
medicine 
To assess whether 
an educational, 
quality-
Control group: received usual care (N = 963). 
 
Intervention group: health care providers  
gFOBT, FS 
and 
colonoscop
Screening tests were 
completed by 41.3% of 
patients in the intervention 
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Age range: >50 
years 
 
N = 1,978 
primary 
care 
outpatient 
firms at a 
Veteran 
Affairs (VA) 
Medical 
Centre in 
Chicago, 
Illinois. 
 
(USA) 
improvement 
workshop, directed 
to the healthcare 
provider, is 
effective in 
increasing CRC 
screening rates. 
 
attended a workshop on CRC screening plus 
every 4 to 6 months they attended quality 
improvement workshops where they received 
group screening rates, individual confidential 
feedback plus training on improving 
communication with patients with limited literacy 
skills (N = 1,015). 
y at 18 
months. 
group vs 32.4% in the control 
group (p = 0.003) (absolute 
difference: 8.9%) 
Among patients with health 
literacy skill less than 10th 
grade, screening was 
completed by 55.7% of 
patients in G2 vs. 30% in G1 
(p<0.01) (absolute difference: 
25.7%). 
Fiscella et 
al., 2011 
 
Patients 
overdue for a 
mammography 
or CRC 
screening in 
New York City.  
 
Age range: 50-
74 years 
 
N = 326 
An inner 
city, family, 
medicine 
practice in 
New York. 
 
(USA) 
 
To examine the 
effectiveness of a 
multimodal, 
screening 
promotion 
intervention on 
mammography and 
CRC screening 
rates, among a low-
income and ethnic 
minority group. 
Control group: received usual care (N = 163). 
 
Intervention group: received mailed personalised 
educational letters and phone call from patient 
navigator highlighting the importance of screening 
and that they were overdue plus mailing of gFOBT 
kit (if insured) plus prompts and medical 
assistants at point of care (N = 163). 
 
Mammogra
phy (breast 
cancer) 
 
Any CRC 
screening 
at 1 year 
(CRC 
cancer) 
Reporting CRC screening 
rates only: 
 
Control group: 10% CRC 
screening completion rate 
 
Intervention group: 28.8% 
CRC screening completion 
rates (AOR, 3.69; 95% CI, 
1.93-7.08) 
 
P value not reported. 
Fitzgibbon 
et al., 2007 
Noncompliant 
male veterans. 
 
Age range: >50 
years 
 
N = 986 
2 primary 
care clinics 
in a 
Veteran 
Affairs (VA) 
medical 
centre in 
Chicago, 
Illinois. 
 
(USA) 
To assess whether 
a combined 
provider/patient trial 
would improve: 1) 
recommendation 
rates by primary 
care providers 
(PCPs) and 2) CRC 
screening 
completion rates by 
patients. 
 
Control group: received usual care (N = 728). 
 
Intervention group: Received: 
1) A provider intervention: providers attended 
training sessions on CRC and on communicating 
health messages about CRC to patients 
effectively 
2) A patient intervention: patients received 
educational materials on CRC based on the 
Health Belief Model to address perceived barriers 
and severity of CRC and to improve self-efficacy 
plus simplified gFOBT instructions (N = 258). 
Any CRC 
screening 
at 2 years. 
Intervention patients were 
not more likely to complete 
any CRC screening 
compared to G1 (p = 0.61); 
41.6% vs. 39.5% in G1 and 
G2 respectively. 
Patients of providers who 
attended the intervention 
sessions were more likely to 
be screened (42% vs. 29%, 
p<0.05). 
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Ford et al., 
2006 
African 
American (AA) 
males eligible 
for CRC 
screening. 
 
Age range: >55 
years 
 
N = 703 
The Henry 
Ford Health 
System, 
Cancer 
Screening 
Trial site in 
Detroit, 
Michigan. 
 
(USA) 
To test the efficacy 
of a case 
management 
strategy in 
promoting cancer 
screening among 
older AA men 
(prostate, lung and 
CRC cancer). 
Control group: received usual care (N = 351). 
 
Intervention group: Case managers contacted 
participants monthly and address CRC screening 
barriers, provided information on all aspects of 
screening procedures and provided referral 
services (N = 352). 
FS, 
Prostate 
Specific 
Antigen 
Test, chest 
x-ray at 3 
years. 
There were no statistically 
significant differences 
between the intervention and 
control groups regarding 
CRC screening adherence; 
61.3% vs. 56.9% 
respectively. 
Fortuna et 
al., 2014 
Men due for 
CRC screening 
and women due 
for CRC and 
breast cancer 
(BC) screening 
 
Age range: 
males: 50-74 
years, females: 
40-74 years 
 
N = 629 
Urban, 
internal 
medicine 
practice in 
NYC 
serving a 
large black 
and 
Hispanic, 
low-income 
population. 
 
(USA) 
To assess the 
relative and 
incremental impact 
of various 
components of the 
reminder, recall and 
outreach (RRO) 
model on BC and 
CRC screening 
rates within a safety 
net practice. 
 
Active control: received reminder letter (N = 157). 
 
G1: Same as active controls plus automated 
telephone message (N = 158). 
 
G2: Same as G1 plus point of service prompt  
(N = 156). 
 
G3: Reminder letter plus personal telephone call  
(N = 153). 
Any CRC 
screening, 
mammogra
phy for BC 
at 13 
months. 
G3 had significantly higher 
CRC screening rates 
compared to active controls 
(12.2% vs. 21.5%; AOR, 2.0, 
95% CI: 1.1-3.9). 
 
G2 had significantly higher 
CRC screening rates 
compared to active controls 
(12.2% vs. 19.6%; AOR, 1.9, 
95% CI: 1.0-3.7). 
 
Active controls and G1 were 
not significantly different. 
Ganz et al., 
2005 
Provider 
Organisations 
(POs) and their 
patients 
 
Age range: >52 
years 
 
N (POs) = 36 
 
N (patients) = 
1,850 
A large 
network 
model 
health 
maintenanc
e 
organisatio
n (HMO) 
that 
contracted 
with POs 
throughout 
The aim was to 
assess whether a 
quality 
improvement (QI) 
program would 
increase CRC 
screening in a 
managed health 
care plan at the 
provider 
organisation (PO) 
level. 
Control group: received usual care. 
(N POs/patients = 17/930). 
 
Intervention group: POs received a QI program 
consisting of: educational sessions and materials 
on CRC, a medical director in each PO having the 
role of a facilitator, assistance with chart audit and 
organisational strategy, ongoing consultation aand 
organisational academic detailing focusing on the 
facilitator and the medical director. 
(N POs/patients = 19/920). 
gFOBT, FS 
and 
colonoscop
y at 2 years 
There was no difference in 
uptake between intervention 
and control POs (28% vs. 
30.6% respectively, p = 
0.22). 
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California  
(USA) 
Gimeno-
Garcia et 
al., 2009 
Patients eligible 
for CRC 
screening 
 
Age range: 50-
79 years 
 
N = 158 
Medical 
practice, 
Tenerife 
 
(Spain) 
To evaluate 
whether an 
educational video 
would improve 
patient knowledge 
and compliance 
with CRC screening 
Control group: viewed a neutral, non-medical 
video plus free gFOBT kit (N = 79). 
 
Intervention group: viewed a brief video on CRC 
risk, prognosis, main symptoms and screening 
procedures plus free gFOBT kit (N = 79). 
gFOBT at 2 
weeks. 
Rate of gFOBT return 
showed a two-fold increase 
in the intervention group 
compared to the control 
group (69.6% vs. 54.4%; p = 
0.35), OR, 2.0; 95% CI: 1.02-
3.84, p = 0.044). 
Rossi et al. 
(2011) 
Patients eligible 
for CRC 
screening. 
 
Age range: 50-
70 years 
 
N previous 
responders: 
3,196 and N 
non-responders: 
4,219 
 
N total = 7,415 
4 screening 
programs in 
Italy. 
 
(Italy) 
To assess whether 
direct mailing of 
gFOBT kits (both to 
people who had 
previously 
participated in 
screening and non-
responders) is 
effective in 
increasing 
screening 
participation. 
 
RCT 1: Responders in the previous round (not 
included in meta-analysis) 
G1: Control group: obtain gFOBT kit at the clinic 
(N = 1,600). 
G2: Intervention group: direct mailing of gFOBT kit 
(N = 1,596). 
 
RCT 2: Non-responders to previous invitation 
(included in meta-analysis)  
G1: Control group: standard recall letter to obtain 
gFOBT kit at the clinic (N = 2,112). 
G2: Intervention group: direct mailing of the 
gFOBT kit (N = 2,107. 
gFOBT at 3 
months. 
In both trials participation 
was higher with direct mailing 
of gFOBT kits: 
For previous responders: RR 
1.11 (95% CI: 1.06-1.17). 
For non-responders: RR 1.46 
(95% CI: 1.16-1.60). 
Goldberg 
et al., 2004 
A predominantly 
low-income, 
African 
American 
population 
 
Age range: 50-
80 
 
N = 139 
Urban, 
public 
hospital in 
Boston. 
 
(USA) 
To assess whether 
mailing gFOBT kits 
timed to coincide 
with patients’ 
primary care 
appointments 
would improve 
screening uptake. 
Control group: Usual care (N = 60). 
 
Intervention group: patients in this group were 
linked to a system of mailing an gFOBT kit and 
mailed reminder 2 weeks prior to a scheduled 
appointment with their physician – that is, to 
coincide with the appropriate time to begin the diet 
suggested in preparation for gFOBT) (N = 59). 
gFOBT at 
12 months. 
Screening uptake at 1-year 
follow-up was 40.7% for the 
intervention group vs. 5% for 
the control group (OR, 13.0; 
95% CI: 3.6-45.5, p<0.001). 
Goldman 
et al., 2015 
Patients with no 
CRC screening 
A health 
centre 
To determine the 
effect of a 
Control group: received usual care (N = 210). 
 
FIT at 6 
months. 
Patients who received the 
intervention were more likely 
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history. 
 
Age range: 50-
74 
 
N = 420 
network 
based in 
Chicago. 
 
(USA) 
multifaceted 
outreach 
intervention to 
increase CRC 
screening uptake 
among patients 
who had not 
completed 
screening 
previously. 
Intervention group: received screening outreach 
including FIT kits mailed to their homes, 
automated phone calls and text messages (N = 
210). 
to complete FIT that those in 
the control group (36.7% vs 
14.8%, p<0.001 at 6 months, 
40% vs 22.4% at 12 months). 
Green et 
al., 2013 
Patients 
overdue for 
CRC screening. 
 
Age range: 50-
73 years 
 
N = 4,675 
21 primary 
care 
medical 
centres of a 
non-profit 
healthcare 
delivery 
system. 
 
(USA) 
To determine 
whether an 
intervention using 
Electronic Health 
Records (EHRs), 
automated mailings 
and stepped 
increases in 
support improve 
CRC screening 
adherence. 
 
Control group: received usual care (N = 1,167). 
 
G1: Automated intervention arm: received usual 
care plus EHR-linked mailings system, which 
tracked when screening was due and sent 
automated reminder mailings (N = 1,173). 
 
G2: Assisted intervention arm: same as G2 plus 
telephone assistance from a medical assistant 
who determined patients’ intent and reviewed 
educational materials to facilitate a screening 
decision (N = 1,161). 
 
G3: Navigated intervention arm: same as G3 plus 
nurse navigation to assist patients at all stages of 
the screening process (1,174). 
Any CRC 
screening 
at 2 years. 
Screening rates were 26.3%, 
50.8%, 57.5% and 64.7% for 
controls, G1, G2 and G3 
respectively. 
 
All 3 intervention groups 
were more likely to obtain 
screening compared to 
controls, with significant 
increase by intensity. 
Absolute difference from 
control group: 24.5%, 31.2%, 
38.4% for G1, G2 and G3 
respectively (p<0.001 for all 
pair-wise comparisons)  
Green et 
al., 2016 
Patients 
overdue for 
CRC screening. 
 
Age range: 50-
73 years 
 
N = 2,208 
21 primary 
care clinics. 
 
(USA) 
To determine the 
effect of continuing 
a centralised 
gFOBT mailing 
program on 
screening 
adherence.  
 
 
Control group: the Stopped group in which 
interventions were stopped (N = 1,102). 
 
Intervention group: the Continue group which 
received mailed information regarding CRC 
screening choices, and were mailed stool kit tests 
(N = 1,106). 
Any CRC 
screening 
at 6 and 12 
months. 
CRC screening uptake was 
significantly higher in patients 
in the intervention group 
compared to the control 
group (53.3% vs. 37.3%; 
adjusted net difference, 
15.6%, p<0.001).  
Guiriguet Patients eligible Primary To evaluate the Control group: received usual care (N = 63 FIT at 12 Screening participation was 
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et al., 2016 for bowel cancer 
screening. 
 
Age range: 50-
69 years 
 
N = 130 
physicians, 
41,042 patients 
care 
centres in 
Barcelona. 
 
(Spain) 
effectiveness of an 
alert in primary care 
electronic medical 
records (EMRs) to 
increase CRC 
screening uptake. 
 
 
physicians, N = 19,423 patients). 
 
Intervention group: received usual care plus an 
alert to health professionals was incorporated in 
patients’ primary care EMRs (N = 67 physicians, 
N = 21,619 patients). 
months. 44.1% and 42.2% in the 
control and intervention 
group respectively (OR, 1.08, 
95% CI: 0.97 – 1.20, p>0.05).  
 
 
Gupta et 
al., 2013 
Uninsured 
participants, not 
up-to-date with 
CRC screening. 
 
Age range: 54-
64 years 
 
N = 5,994 
A safety net 
health 
system in 
Texas. 
 
(USA) 
1) To assess 
whether an 
organised mailed 
outreach improves 
CRC screening 
rates. 
2) Whether FIT is 
superior to 
colonoscopy in 
increasing 
screening rates. 
Control group: received usual care, which offered 
opportunistically (i.e. was visit-based) (N = 3,914). 
G1: FIT outreach group: patients received a 
mailed invitation plus free FIT kit plus a telephone 
follow-up (N = 1,600). 
 
G2: Colonoscopy outreach group: same as G2 but 
were offered the choice of a free colonoscopy 
instead of FIT (N = 480). 
Any CRC 
screening 
at 12 
months. 
Screening was significantly 
higher for both FIT (40.7%) 
and colonoscopy outreach 
(24.6%) compared to control 
group (12.1%); p<0.001 for 
both comparisons with usual 
care. 
 
Hagoel et 
al., 2016 
Patients eligible 
for bowel cancer 
screening. 
 
Age range: 50-
74 years 
 
N = 48, 091 
National 
Israeli 
bowel 
cancer 
screening 
programme
. 
 
(Israel) 
To examine the 
applicability and 
effectiveness of a 
Question-Behaviour 
Effect (QBE) 
intervention by 
comparing 4 
versions of a text 
message. 
 
Control group: received usual care (N = 9,602) 
G1: Interrogative reminders with reference to 
social context (N = 9,596). 
G2: Interrogative reminders without reference to 
social context (N = 9,631). 
G3: Non-interrogative reminders with reference to 
social context (N = 9,632). 
G4: Non-interrogative reminders without reference 
to social context (N = 9,630). 
gFOBT at 6 
months.  
Screening participation was 
significantly higher for Gs 1, 
2 and 3 when compared to 
controls. Screening rates for 
the control group and Gs 1, 
2, 3 and 4 were 8.5%, 
10.3%, 9.8%, 9.6% and 9.2% 
respectively. The highest 
gFOBT rates were achieved 
in the interrogative –reminder 
groups (i.e. Gs 1 and 2) than 
in the other 3 groups (OR 
1.11, 95% CI: 1.05 – 1.19).  
Hendren et 
al., 2014 
Patients 
overdue for 
mammography 
Inner city, 
safety-net 
primary 
To assess the 
efficacy of a 
multimodal 
Control group: received usual care (N = 181). 
 
Intervention group: patients received personalised 
Mammogra
phy for BC 
at 12 
CRC screening uptake was 
significantly higher in 
intervention vs the control 
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and CRC 
screening. 
 
Age range: 40-
74 years  
 
N = 366 
care family 
practice in 
NYC. 
 
(USA) 
intervention to 
increase 
mammography and 
CRC screening. 
invitation letters, automated phone call messages, 
a free FIT kit and a point of care prompt to 
complete screening (N = 185). 
months. 
 
Any CRC 
screening 
at 12 
months. 
group: 37.7% vs. 16.7% 
(AOR, 3.22, 95% CI: 1.65-
6.30, p =0.0002). 
Mammography: significantly 
higher screening rates in the 
intervention vs the control 
group: 29.7% vs. 16.7%, (p = 
0.034). 
Hewitson 
et al., 2011 
Patients eligible 
for CRC 
registered with a 
general 
practitioner 
(GP). 
 
Age range: 60-
75 years 
 
N = 1,288 
Letters sent 
out from 
GP 
practices in 
the 
Southern 
Programme 
Hub, in 
southern 
England. 
 
(UK) 
To investigate 
whether a GP’s 
letter encouraging 
participation and a 
more explicit leaflet 
explaining how to 
complete gFOBT 
improves uptake. 
Control group: received usual care: standard 
invitation (N = 322). 
 
G1: Personalised letter only: letters were 
personalised to patients and included key health 
messages phrase using a ‘gain-frame’ approach 
(N = 322). 
 
G2: Leaflet only: it addressed multiple barriers 
and aimed at enhancing CRC knowledge and 
improve self-efficacy (N = 322). 
 
G2: GP Letter plus Leaflet: received both the 
interventions (N = 322). 
gFOBT at 5 
months  
Compared to the control 
(49.4%), patients in G1 
(55%) had significantly 
higher screening rates (OR 
1.26; 95% CI: 1.01-1.58, p = 
0.038). 
 
Compared to Controls 
(49.4%) patients in G2 
(55.3%) had significantly 
higher screening rates (OR 
1.28; 95% CI: 1.03-1.59, p = 
0.029). 
 
Compared to Controls 
(49.4%), patients in G3 
(61.2%) were significantly 
more likely to undergo 
screening (p<.05). 
Holt et al., 
2012 
Church-going, 
African 
Americans 
(AAs). 
 
Age range: 50-
74 years 
 
N = 285 
16 African 
American 
churches in 
Alabama. 
 
(USA) 
To assess the 
effectiveness of a 
spiritually based 
intervention in 
increasing CRC 
screening among 
AAs in church 
settings. 
 
Control group: non-spiritual comparison group: 
participants received educational sessions on 
CRC and screening but no spiritually-oriented 
materials were involved (N churches = 8, N 
participants = 133). 
 
Intervention group: spiritually based intervention: 
participants received educational sessions 
regarding CRC (i.e. risk, symptoms, prevention 
Any CRC 
screening 
at 12 
months.  
Screening uptake was 42.1% 
in the control group vs. 
41.4% in the intervention 
group (p>.05) 
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and screening) and the content included scripture 
and spiritual themes relevant to the AA culture. 
Materials were based on the Health Belief Model 
(N churches = 8, N participants = 152). 
Horne et 
al., 2015 
Medicare 
patients aged 65 
or older. 
 
N = 1,220 
Clinical 
settings 
and 
community 
based 
venues. 
To investigate the 
effect of patient 
navigation in 
increasing CRC 
screening among 
older African 
Americans. 
 
 
Control group: received printed educational 
materials (PEM) only (N = 642). 
 
Intervention group: received patient navigation 
services in addition to PEM (N = 578). 
Any CRC 
screening. 
Compared with controls, the 
intervention group was more 
likely to report being up-to-
date with CRC at the exit 
interview (OR 1.55, 95% CI: 
1.07 – 2.23).  
PN was effective in 
increasing screening for 
endoscopy/colonoscopy but 
not for gFOBT. 
Hwang et 
al., 2013 
Members of an 
online weight 
loss community. 
Age range: > 50 
years 
N = 306 
Online 
weight-loss 
community 
website. 
 
(USA) 
To assess whether 
narratives and peer 
support online 
increases CRC 
screening rates. 
Control group: Basic group: participants viewed 
general educational information about CRC (N = 
153). 
 
Intervention group: Enhanced group: same as the 
control group but also had access to narratives 
and peer support pages for CRC screening in 
online forums plus were offered Amazon gift cards 
(N = 153). 
Any CRC 
screening 
at 6 
months. 
There was no difference in 
CRC uptake at 6 months 
between the intervention and 
control group (16.3% vs 
18.9% respectively, AOR 
1.33, 95% CI: 0.73, 2.42). 
Inadomi et 
al., 2012 
Participants 
eligible for CRC 
screening. 
Age range: 50-
79 years 
N = 997  
Public 
health care 
system of 
the City 
and County 
of San 
Francisco. 
(USA) 
To determine 
whether the 
approach by which 
screening is 
recommended 
influences 
adherence.  
G1: gFOBT arm: patients received a 
recommendation to screen by gFOBT from 
physician (N = 344). 
G2: Colonoscopy arm: patients received a 
recommendation to screen by colonoscopy from 
physician (N = 332). 
G3: Choice arm: patients were offered to choose 
between gFOBT or colonoscopy screening (N = 
321). 
gFOBT, 
colonoscop
y at 12 
months. 
Participants in G2 completed 
screening at a significantly 
lower rate (38%) than 
participants who were 
recommended gFOBT (67%) 
(p<0.001) or given a choice 
between gFOBT or 
colonoscopy (69%) (p<.001). 
Jandorf et 
al., 2013 
African 
American (AA) 
patients overdue 
for CRC 
Primary 
care clinic 
in NYC. 
 
To assess the 
effectiveness of 3 
patient navigation 
(PN) formats in 
Active control: Standard Navigation Group: 
received 5 phone calls intermittently before 
scheduled colonoscopy and information on CRC 
screening plus specific instructions for 
Colonoscop
y at 2 
weeks. 
No significant differences 
were shown in screening 
colonoscopy completion 
rates in the 3 arms (G1 74%, 
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screening. 
 
Age range: >50 
years 
 
N = 350 
(USA) increasing 
screening 
colonoscopy 
among an AA 
population. 
 
colonoscopy (N = 46). 
G1: Peer-patient Navigation Group: same as 
active control plus PN assistance delivered by 
community members who discussed personal 
experiences, promoted culturally targeted health 
messages, addressed concerns and assisted with 
screening arrangements (N = 181). 
G2: Pro-patient Navigation Group: same as G1 
but delivered by healthcare professionals (N = 
123). 
G2 76.4% and active control 
80.4%, p>.05). 
Jean-
Jacques et 
al., 2012 
 
Patients 
overdue for 
CRC screening. 
 
Age range: 50-
80 years 
 
N = 202 
Community 
health 
centres 
serving 
primarily a 
low-
income, 
ethnically-
diverse 
population 
in Chicago, 
Illinois. 
 
(USA) 
To assess whether 
the direct mailing of 
gFOBT kits would 
improve screening 
rates among a 
poor, racially and 
linguistically 
diverse, population. 
Control group: received usual care (N = 98). 
 
Intervention group: received mailed package 
including a letter encouraging gFOBT completion, 
CRC fact sheet, gFOBT kit with instructions plus 
reminder phone calls from bilingual lay health 
educators at 2 and 6 weeks (N = 104). 
gFOBT, FS 
or 
colonoscop
y at 4 and 
12 months. 
Control group: 5% CRC 
screening completion rate 
mainly via gFOBT 
 
Intervention group: 30% CRC 
screening completion rate 
mainly via gFOBT 
 
The difference between the 
groups was statistically 
significant at 4 and 12 
months (p< .001 and p 
= .002 respectively) 
 
Jensen et 
al., 2014 
Healthcare and 
manufacturing 
workers, eligible 
for CRC 
screening. 
 
Age range: 50-
75 years 
 
N = 288 
8 worksites 
in Indiana. 
 
(USA) 
To assess and 
compare the effect 
of 2 interventions; 
tailoring and 
narrative based 
approaches in 
increasing CRC 
screening 
adherence. 
 
Control Group: Stock: no narrative, no tailoring: a 
pamphlet involving information on CRC and 
screening options (N = 72). 
 
G1: Intervention Arm 1: Narrative: Narrative, no 
tailoring: same as G1 but CRC screening 
information was delivered through a story (N = 
72). 
 
G2: Intervention Arm 2: Tailored: Tailoring, no 
narrative: CRC and screening information was 
personalised to the patients based on baseline 
Any CRC 
screening 
at 18 
months. 
Screening uptake was 4.1%, 
11.1%, 6.9% and 18% for the 
control group, G1, G2 and 
G3 respectively. 
 
Groups receiving the 
narrative-based approach 
were 4 times more likely to 
screen than those not 
receiving narrative 
messages. 
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information (N = 72). 
 
G3: Intervention Arm 3: Tailored Narrative: 
Tailoring plus Narrative (N = 72). 
Katz et al., 
2011 
Patients eligible 
for CRC 
screening. 
 
Age range: >50 
years 
 
N = 270 
Health 
Centre 
serving a 
mostly 
minority 
and low 
SES 
population 
in Ohio. 
 
(USA) 
To determine 
whether a patient 
activation 
intervention 
improved CRC 
screening rates 
among low-income 
minority patients.  
 
Control group: viewed an educational video on 
CRC screening information (N = 132). 
 
Intervention group: same as G1 plus patient 
activation (brochure focusing on tips to prevent 
CRC) plus telephone barriers counseling (to 
address patient identified CRC screening barriers) 
Materials were based on the Protection Motivation 
Theory principles (N = 138). 
Any CRC 
screening 
at 2 
months. 
Significantly more patients in 
the intervention group 
completed CRC screening 
compared to controls (19.6% 
vs. 9.9%); OR 2.35, 95% CI: 
1.14-5.56; p = 0.020). 
 
Krok-
Schoen et 
al, 2015 
Patients eligible 
for bowel cancer 
screening. 
 
Age range: 51-
75 years 
 
N = 1,091 
The clinical 
component 
of the 
intervention 
was set 
within 
primary 
care clinics 
and the 
media 
component 
was set 
within the 
wider 
community. 
 
(USA) 
To implement and 
evaluate a county-
level intervention 
consisting of media 
and clinic-level 
components to 
increase CRC 
screening in Ohio 
Appalachian 
residents.  
 
 
Control group: received a media campaign and 
clinic intervention focused on healthy eating (N = 
525). 
 
Intervention group: received a media campaign 
and clinic intervention focused on CRC screening 
(N = 566). 
 
Any CRC 
screening  
(unclear 
follow-up). 
There was not a statistically 
significant difference in 
screening uptake between 
the control (31.4%) and 
intervention (35.2%) group. 
Lasser et 
al., 2011 
Patients 
overdue for 
CRC screening 
and spoke 
A primary 
care, 
practice-
based, 
research 
To test the 
effectiveness of a 
patient navigation-
based intervention 
G1: Control group: received usual care (N = 230). 
 
G2: Intervention group: Telephone communication 
between navigators and patients to provide CRC 
Any 
method but 
mainly 
gFOBT or 
CRC screening uptake was 
significantly higher in the 
intervention group compared 
to controls (33.2% vs. 20%; 
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English, Haitian, 
Creole, 
Portuguese or 
Spanish as their 
primary 
language. 
 
Age range = 52-
74 years 
 
N = 465 
network 
predominantl
y serving a 
low-income, 
multi-cultural 
population. 
 
(USA) 
to increase CRC 
screening rates 
among 
predominantly 
Haitian Creole or 
Portuguese-
speaking patients. 
screening education and discuss screening 
options’ pros and cons, patients’ barriers and 
concerns and stage of change. Upon choice of 
screening method, navigators explained 
instructions and arranged colonoscopy referrals. 
Navigators provided emotional support wherever 
necessary (N = 235). 
 
colonoscop
y at 12 
months. 
 
p< .001).  
Subgroup analyses indicated 
the intervention was 
particularly beneficial for 
patients whose primary 
language was not English 
(39.8% vs. 18.6%; p< .001) 
and for Black patients (39.7% 
vs. 16.7%; p = .004). 
Lee et al., 
2009 
U.S. veterans 
eligible for CRC 
screening. 
 
Age range: > 50 
years 
 
N = 775 
Veteran 
Affairs (VA) 
Medical 
Centre, 
San Diego 
California. 
 
(USA) 
Two aims: 
1) To determine 
whether a mailed 
educational 
reminder increases 
gFOBT screening 
rates. 
2) To examine 
predictors of 
gFOBT compliance. 
Control group: received usual care (N = 386). 
 
Intervention group: received a mailed educational 
reminder emphasising the importance of 
screening plus mailed gFOBT kit plus quote from 
CRC survivor plus 24/7 contact information (N = 
389). 
gFOBT at 6 
months. 
At 6 months 64.6% vs. 
48.4% of the intervention and 
control group respectively, 
had returned the gFOBT 
cards (p<0.001) 
 
Receiving a mailed reminder 
significantly increased the 
likelihood of returning the 
gFOBT kit (OR 2.02, 95% CI: 
1.29-2.70). 
Leffler et 
al., 2011 
Patients eligible 
for screening 
colonoscopy. 
 
Age (m): 60 
years 
 
N = 830 
Large 
gastroenter
ology 
referral 
centre in 
Boston. 
 
(USA) 
To test the 
effectiveness of a 
novel follow-up 
management 
system 
incorporated in 
Electronic Health 
Records (EHRs) for 
patients due for 
colonoscopy 
surveillance 
examinations. 
Control group: received usual care (N = 291). 
 
Intervention group: received a newly developed 
automated reminders system including letters sent 
to the patient and the physician prompting 
upcoming colonoscopy examinations (N = 539). 
Colonoscop
y at 6 
months. 
At 6 months 44.7% vs. 
22.6% of the intervention and 
control group respectively 
had screening procedures 
scheduled or completed 
(p<.0001). 
 
Levy et al., 
2012 
Patients due for 
CRC screening. 
16 rural 
family 
To test whether 
mailed educational 
Control group: mailed written and DVD 
educational materials with FIT (N = 186). 
FIT at 6 
months.  
No difference was observed 
for FIT return rates between 
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Age range: 52-
79 years 
 
N = 373 
medicine/p
hysician 
offices in 
the Iowa 
Research 
Network. 
 
(USA) 
 
materials and FIT, 
with or without a 
scripted telephone 
reminder, increased 
FIT testing. Also to 
compare attitudes 
toward, readiness 
for and barriers to 
screening from 
baseline to follow 
up. 
 
Intervention group: same as control group plus a 
telephone call designed to encourage screening 
and address barriers. Telephone calls were 
structured to assess knowledge of CRC 
screening, perceptions, provide basic knowledge, 
assess willingness to undergo screening, facilitate 
preferred screening test, provide supportive 
feedback (N= 187). 
 
the groups: 45.2% and 
48.7% for the control and 
intervention group 
respectively, p = .498. 
Comparing baseline with 
follow-up summary attitude 
scores improved (p<.0001), 
readiness scores improved 
(p<.0001) and there were 
fewer barriers (p = .034). 
 
Levy et al., 
2013 
 
Patients due for 
CRC screening 
 
Age range: 52-
79 years 
 
N = 743 
16 rural 
family 
medicine/p
hysician 
offices in 
the Iowa 
Research 
Network. 
 
(USA) 
 
To test the efficacy 
of three physician 
and patient 
reminder systems 
to increase CRC 
screening rates in 
rural practices. 
 
Control group: received usual care (N = 185). 
 
G1: Chart reminder group: physician reminders on 
patients’ charts (N = 185). 
 
G2: Mailed education/FIT group: same package 
as G2 plus mailed educational materials, 
brochures, a DVD, a magnet and a FIT kit (N = 
186). 
 
G3: Mailed education/FIT plus phone call group: 
same package as G3 plus a structured phone call 
from project staff, to provide education, assess 
interest in screening, explain screening tests, 
address barriers and encourage screening 
participation (N = 187). 
gFOBT, 
FIT, 
colonoscop
y, FS or 
barium 
enema at 
15 months. 
Both FIT and colonoscopy rates 
increased significantly in both 
mailed education groups (56.5% 
and 57.2% for G2 and G3 
respectively; p<.05 compared to 
usual care) but no effect for G1 
(20.5%) compared to usual care 
(17.8%l p>.05). For G3 the 
addition of a phone call did not 
further improve uptake. 
 
Lewis et 
al., 2012 
 
Patients 
overdue for 
CRC screening. 
 
Age range: 50-
75 years 
 
N = 2,282 
University 
of North 
Carolina, 
Internal 
Medicine 
practice. 
 
(USA) 
To test the efficacy 
of a physician-
linked invitation 
plus letter to 
increase CRC 
screening. 
 
  
Control group: received intervention after study 
was complete (N = 782). 
 
Intervention group: received a mailed package 
with an information and instruction brochure, 
postcard to request a decision aid, reminders, 
assistance with making screening arrangements 
(N = 716). 
Any CRC 
screening 
at 15 
months. 
For Wave A patients, rates 
significantly increased for the 
experimental group vs. control 
group (13.1% vs. 4.1%; 9% CI, 
3.1%-14.9%). 
For Wave B residents’ patients: 
no significant difference 
between experimental vs. 
control groups (1.3% vs. 1.9%, 
95% CI, -2.2%-1%) 
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Wave B attendings’ patients: no 
significant increase observed in 
the intervention vs. control group 
(6.9% vs. 2.4%, 95% CI, -1.4% - 
10.5%). 
Ling et al., 
2009 
Patients eligible 
for CRC 
screening 
 
Age range: 50-
79 years 
 
N = 599 
10 primary 
cancer 
physician 
group 
practices in 
Pittsburgh. 
 
(USA) 
To compare and 
assess the efficacy 
of 2 interventions; a 
physician 
intervention and 
patient 
management 
intervention on 
increasing 
endoscopic bowel 
screening uptake. 
 
Control group: received usual care (N = 124). 
 
G1: intervention arm 1: Tailored letter (used 
personalised salutation, acknowledged personal 
physician and contained patient-specific 
information) plus non-enhanced management (N 
= 133). 
 
G2: Intervention arm 2: non-tailored letter plus 
enhanced management (helped patients with 
office protocols implementing screening, referrals 
and administrative issues) (N = 190). 
 
G3: Intervention arm 3: tailored letter plus 
enhanced management (N = 152). 
FS, 
colonoscop
y at 12 
months. 
Enhanced management 
increased the odds of 
completing a colonoscopy or 
FS by 1.63-fold (95% CI: 
1.11-2.41; p = .01) 
The tailored letter did not 
significantly increase the 
odds of screening completion 
(OR: 1.08, 95% CI: 0.72-
1.62; p = .71). 
Screening rates were 37.9%, 
43.6%, 54.2% and 53.3% in 
the control group, G1, G2 
and G3 respectively 
(absolute difference with 
control group: 5.7%, 16.3%, 
15.4% for G1, G2 and G3 
respectively). 
Lo et al., 
2014 
Adults due for 
biennial gFOBT 
screening. 
 
Age range: 60-
69 years 
 
N = 23,182 
Greater 
London 
Hub area 
which is 
socioecono
mically 
diverse and 
has poor 
overall 
gFOBT 
uptake. 
 
(UK) 
 
Two aims: 
1) To assess the 
efficacy of an 
Implementations 
Intentions (IIs) 
intervention to 
increase CRC 
screening rates. 
 
2) To examine 
differential efficacy 
by socioeconomic 
deprivation. 
Control group: received usual care (i.e. gFOBT 
plus standard instruction leaflet) (N = 12,414). 
 
Intervention group: Same package as the control 
group plus a modified leaflet with three pre-
formulated IIs plans. (N = 10,768). 
gFOBT  
(unclear 
follow-up). 
There was no difference in 
uptake rates between the control 
(40.4%) and intervention group 
(39.7%) (OR 0.97; 95% CI: 0.91-
1.04). 
 
The intervention had a small, 
positive effect for the most 
deprived quintile (OR 1.03, 95% 
CI: 1.01-1.21) but no effect for 
the middle quintile and a 
negative effect for the least 
deprived quintile. 
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Marcus et 
al., 2005 
Adults 50 years 
or older. 
 
Age range: 50-
70plus 
 
N = 4,014 
Nine 
regional 
Cancer 
Information 
Service 
offices 
across the 
USA. 
To test the efficacy 
of targeted and 
tailored print 
materials against 
untailored print 
materials to 
increase CRC 
screening rates.  
Control group: Single Untailored (SU) group: a 
single untailored mail out of print material (N = 
699). 
 
G1: Single Tailored (ST) group: a single tailored 
mail out of print material (N = 576). 
 
G2: Multiple Tailored (MT) group: 4 mail outs of 
print materials tailored to information provided at 
baseline interviews (N = 530). 
 
G3: Multiple Retailored (MRT) group: 4 mail outs 
of print materials retailored based on updated 
information obtained at 6-month follow-up 
interviews (N = 549). 
gFOBT, FS 
or 
colonoscop
y at 14 
months. 
A significant linear trend was 
found across the SU, ST, 
MT, MRT groups at 14 
months (42%, 44%, 51% and 
48% respectively, p = 0.05). 
 
Only for MT was there a 
significant difference 
compared with SU (p = 0.03). 
No differences were found 
between MT vs. MRT at 14 
months. 
 
Maxwell et 
al., 2010 
Filipino 
American 
participants, 
non- adherent to 
CRC screening. 
 
Age range: 50-
70 years 
 
N = 548 
Filipino 
American 
community-
based 
organisatio
ns and 
churches in 
Los 
Angeles. 
 
(USA) 
 
To assess the 
efficacy of a 
multicomponent 
intervention on 
increasing CRC 
screening among 
an Asian American 
population. 
 
Control group: patients attended a small-group 
session promoting physical activity (N = 163). 
 
G1: Intervention arm 1: patients attended a small-
group educational session (guided by the Health 
Behaviour Framework) regarding CRC and 
screening plus take-home materials plus reminder 
letter to patient and physician plus free gFOBT kit 
(N = 202). 
 
G2: Intervention arm 2: same as G1 but without 
free gFOBT kit (N = 183). 
Any CRC 
screening 
at 6 
months.  
Screening rates were 9%, 
30% and 25% for the control 
group, G1 and G2 
respectively (absolute 
difference with control group: 
21% and 16% for G1 and G2 
respectively). 
 
G1 and G2 participants were 
significantly more likely to 
report screening at follow-up 
than controls (G1: OR, 4.9; 
95% CI, 2.4 – 9.9, p<.001 
and G2: OR 3.7; 95% CI: 
1.8-7.5, p<.001). 
Maxwell et 
al., 2016 
Filipino 
Americans 
previously non-
adherent to 
CRC screening. 
 
Filipino 
American 
community 
organisatio
ns that has 
previously 
To evaluate two 
strategies to 
implement an 
evidence-based 
intervention to 
promote CRC 
Active control: Basic Implementation Arm: 
involved education of Community Health Advisors 
(CHAs) on CRC and CRC screening, group 
education sessions and provided patient 
navigation services (i.e. assistance with referral, 
insurance processes, inform patient about test 
Any CRC 
screening 
at 6 
months. 
There was not a statistically 
significant difference in 
screening uptake between 
the control (49%) and 
intervention (53%) group at 
6-month follow-up.  
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Age range: 50-
75 years 
 
N = 673 
participants, 22 
community 
organisations 
participated 
in 
promoting 
CRC 
screening.  
 
(USA) 
screening in Filipino 
American 
community 
organisations.  
 
 
results etc.) (N participants/organisations = 
25/11). 
 
Intervention group: Enhanced Implementation 
Arm: same as active control group plus three 
additional components: (1) problem solving 
sessions related to CRC screening at three follow-
up time points; (2) CHAs to attend support 
sessions to continue to raise awareness about 
CRC in the Filipino American community; (3) one 
leader per organisation to join an advisory board 
to discuss activities to increase CRC screening (N 
participants/organisations = 423/11).  
 
McGregor 
et al., 2016 
Participants 
eligible for 
bowel cancer 
screening. 
 
Age range: 59-
74 
 
N = 150,417 
NHS 
English 
CRC 
screening 
programme
. 
 
(UK) 
To test the 
effectiveness of 
adding a narrative 
leaflet to the current 
information material 
delivered by the 
NHSBCSP.  
Control group: Standard invitation (SI) (N = 
76,695). 
 
Intervention group: Same as G1 plus narrative 
leaflet (SI plus N) containing quotes and stories of 
the CRC screening experience from previous 
participants (N = 73,722). 
gFOBT at 
18 weeks. 
Screening uptake did not 
differ significantly between 
the two groups (control: 
58.5%, intervention: 56.7%, 
OR 0.93, CI: 0.81-1.06; p = 
0.27). 
 
Menon et 
al, 2011 
Patients eligible 
for CRC 
screening. 
 
Age range> 50 
years 
 
N = 515 
Two large 
Mid-
western 
medical 
centres and 
one south-
eastern 
medical 
centre. 
 
(USA) 
To assess the 
efficacy of 2 
personalised 
telephone-based 
interventions: 1) 
tailored counseling 
and 2) motivational 
interviewing in 
increasing CRC 
screening in a 
predominantly 
black population. 
 
Control group: received usual care (N = 169). 
 
G1: Intervention arm 1: Tailored counselling arm: 
Participants’ beliefs, stage of readiness and 
demographics were documented in a computer 
system which then generated tailored health 
messages on CRC screening (N = 168). 
 
G2: Intervention arm 2: Motivational Interview 
arm: patients received a telephone-based 
motivational interview sessions to help them 
explore and resolve their ambivalence regarding 
CRC screening (N = 178). 
 
Any CRC 
screening 
at 12 
months.  
CRC screening rates were: 
11.8%, 23.8% and 18.5% for 
the control group, G1 and G2 
respectively; p<.05 for G1 
and G2 when compared to 
control. 
Participants in G1 were 2 
times more likely to be 
screened (0R 2.3, 95% CI: 
1.3-4.1, p<.05). 
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Both interventions were guided by Health Belief 
Model and Transtheoretical Model of Change 
theoretical principles  
Miller et 
al., 2005 
Patients eligible 
for CRC 
screening. 
 
Age range: 50-
86 years 
 
N = 93 
University-
affiliated, 
community-
based 
internal 
medicine 
outpatient 
practice.  
 
(USA) 
To determine the 
effectiveness of a 
multimedia 
computer 
programme to 
effectively teach 
patients about 
gFOBT and 
increase screening 
rates.  
 
Control group: patients received standard nurse 
counselling about gFOBT screening (N = 101). 
 
Intervention group: patients interacted with an 
educational multimedia computer program to learn 
about gFOBT screening (N = 93). 
 
gFOBT at 1 
month.  
Completion of gFOBT kits 
was similar in both groups: 
62% in the intervention group 
vs. 63% in the control group 
(p = .89). 
 
Mosen et 
al., 2010 
Patients eligible 
for CRC 
screening. 
 
Age range: 51-
80 years 
 
N = 5,905 
Non-profit, 
health 
maintenanc
e 
organisatio
n (HMO) in 
Washington 
and 
Oregon, 
consisting 
of 15 
medical 
clinics. 
 
(USA) 
To determine the 
effect of an 
automated 
telephone 
intervention on 
completion of 
gFOBT. 
Control group: received usual care (N = 2,962). 
 
Intervention group: participants received three 
automated phone calls that provided a description 
and health benefits of gFOBT (N = 2,943). 
gFOBT at 6 
months.  
At 6 months post-call, 22.5% 
vs. 16% in the intervention 
and control group 
respectively had completed 
an gFOBT (HR  1.31, 95% 
CI: 1.10-1.56, p<0.001). 
Absolute difference: 6.5%. 
 
Myers et 
al., 2007 
 
Primary practice 
patients. 
 
N = 1, 546 
Large 
urban 
practice in 
Pennsylvan
ia  
 
(USA) 
To test a targeted 
and tailored 
message delivery, 
both by mail and 
via phone outreach. 
Control group: received usual care (N = 387). 
 
G1: received the Standard Intervention (SI) 
including: mailed letter, information booklet, 
gFOBT kit and reminder letter (N = 387). 
 
G2: same as G1 plus received the Tailored 
gFOBT, 
FIT, FS, 
colonoscop
y or DCBE 
X-ray 
procedure 
at 1 and 2 
Screening uptake was 33%, 
46%, 44% and 48% for the 
control, G1, G2 and G3 
respectively. Screening rates 
were significantly higher for 
all 3 intervention groups 
compared to control (SI: p 
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Intervention (TI) including messages addressing 
barriers (N = 386). 
 
G3: same as G2 plus received the Tailored 
Intervention Phone call (TIP) which included a 
reminder phone call by an educator (N = 386). 
years.  = .001); TI: p = .002; TIP: p = 
< .001) but did not vary 
significantly across 
intervention groups. 
Neter et 
al., 2014 
Privately insured 
patients, eligible 
for repeat 
gFOBT 
screening. 
 
Age range: 50-
74 
 
N = 29,833 
Members of 
the Clalit 
Health 
Services. 
 
(Israel) 
To test the efficacy 
of an 
implementation 
intentions (IIs) 
technique to 
increase repeat 
gFOBT adherence. 
 
Control group: received usual care (N = 13,920). 
 
Intervention group: Implementation Intentions 
arm: participants received a mailed leaflet with 
detailed ‘if-then’ plans addressing frequently 
occurring CRC screening barriers (N = 13,713). 
gFOBT at 6 
months.  
gFOBT adherence was 
67.9% and 71.4% for the 
control and intervention 
groups respectively (chi 
square: 40.58, OR 1.18, 95% 
CI: 1.12 - 1.24; , p = 0.0001). 
This difference remained 
significant after controlling for 
age, gender, marital status 
and clinic SES (OR 1.17, 
95% CI: 1.11, 1.23, 
p<0.0001). 
O’Carroll 
et al., 2015 
Participants 
eligible for 
bowel cancer 
screening. 
 
Age range: 50-
74 
 
N = 60,000 
Scottish 
National 
CRC 
Screening 
programme
. 
 
(UK) 
To test the 
feasibility of an 
Anticipated Regret 
(AR) questionnaire-
based manipulation 
to increase gFOBT 
uptake in Scotland 
across all socio-
economic groups.  
Control group: Standard pre-notification leaflet (N 
= 19,604). 
 
G1: Health Locus of Control (HLOC): Same as 
control plus HLOC questionnaire (N = 19,828). 
 
G2: Anticipated Regret (AR): Same as G1 plus 
HLOC plus AR questionnaire (N = 19,934). 
gFOBT at 6 
months. 
No overall differences were 
seen between the treatment 
groups on gFOBT uptake 
(control: 57.3%, G1: 56.9%, 
G2: 57.4%). AR indirectly 
affected gFOBT uptake via 
intention, whilst ICK directly 
affected gFOBT uptake over 
and above intention.  
 
Ornstein et 
al., 2010 
Patients eligible 
for CRC 
screening.  
 
Age range: >50 
years 
 
N 
Family 
medicine 
practices in 
a research 
network 
operating 
across the 
USA. 
To assess the 
impact of a quality 
improvement (QI) 
intervention on 
increasing CRC 
screening rates. 
 
Control group: received usual care (N 
practices/patients = 16/37,258). 
 
Intervention group: practices received frequent 
EMR-based audit and feedback plus practice site 
visits for academic detailing plus ‘best-practice’ 
dissemination in annual meetings; all aimed at 
tracking CRC referral and screening performance 
gFOBT, FS 
and 
colonoscop
y at 2 
years. 
Screening uptake rates were 
significantly higher for 
patients in the intervention 
group compared to controls 
(71.2% and 62.8% 
respectively, p<.0001). This 
effect was present only for 
patients 50-75 years but not 
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(practices/patien
ts) = 32/68,150 
 
(USA) 
(N practices/patients = 16/30,892). for <75 years. 
Percac-
Lima et al., 
2009 
 
Low-income, 
non-English 
speaking 
patients overdue 
for CRC 
screening. 
 
Age range = 52-
79 years 
 
N = 1,223 
Urban 
community 
health 
centre 
Chelsea, 
Massachus
etts. 
 
(USA) 
 
To evaluate the 
efficacy of a 
culturally-tailored, 
patient navigation 
intervention to 
increase CRC 
screening among a 
low-income, 
ethnically diverse 
population. 
Control group: received usual care but received a 
delayed intervention upon study completion (N = 
409). 
 
Intervention group: Received: (1) Introductory, 
educational letter in native language; (2) Phone 
call or in-person contact with language concordant 
patient navigators to address cultural barriers; (3) 
Help with procedure scheduling, translation and 
explanation of bowel preparation, help with 
transportation and insurance coverage (N = 814). 
 
Colonoscop
y, FS, 
barium 
enema, 
gFOBT at 9 
months. 
Intervention patients had 
higher CRC screening rates 
than controls (27% vs. 12% 
for any screening method, 
p<.001; 21% vs. 10% for 
colonoscopy, p<.001). 
Phillips et 
al., 2015 
Female primary 
care patients 
eligible for 
bowel cancer 
screening. 
 
Age range: 50-
74 years. 
 
N = 600 
A family 
medicine 
practice. 
 
(USA) 
To assess the 
differential effects 
of low-cost 
automated 
telephone and 
mailed 
interventions on 
CRC screening 
rates in a primary 
care practice.  
 
 
Control group: participants received a 
personalised letter with information on CRC 
screening and screening options (N = 198). 
 
G1: Automated call intervention: participants 
received automated phone calls containing 
messages similar to those in the letter (N = 199). 
 
G2: Both: Participants received both the letter and 
automated calls (N = 203). 
Any CRC 
screening 
at 3 
months.  
Screening rates were 17%, 
14% and 24% for the control 
group, G1 and G2 
respectively. G2 had a 
statistically higher screening 
rate (p<.05) compared with 
either the control group or 
G1.  
 
Pignone et 
al., 2000 
Patients eligible 
for CRC 
screening. 
 
Age range: 50-
75 years 
 
N = 249 
3 
community 
primary 
care 
practices 
(PCPs) in 
central 
North 
Carolina. 
 
To test whether a 
decision aid 
consisting of an 
educational video, 
targeted brochure 
and chart marker 
can increase CRC 
screening rates in 
PCPs. 
Control group: participants viewed a video about 
automobile safety plus generic brochure on 
automobile safety (N = 124). 
 
Intervention group: participants viewed an 11-
minute video about CRC screening plus chose a 
colour-coded educational brochure based on their 
stage of change to indicate their degree of interest 
in screening plus a chart marker of the same 
colour was attached to their chart (N = 125). 
Any CRC 
screening 
at 6 
months. 
Screening tests were 
completed by 36.8% in the 
intervention vs. 22.6% in 
control group; absolute 
increase: 14.2%, p<.05). 
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(USA) 
Pignone et 
al., 2011 
Patients eligible 
for CRC 
screening. 
 
Age range: 52-
75 years 
 
N = 443 
Large 
health plan 
from 
selected 
areas in 
Georgia 
and Florida. 
 
(USA) 
To test whether an 
intervention 
combining a patient 
decision aid and 
academic detailing 
improves CRC 
screening uptake. 
 
Control group: received usual care (N = 232). 
 
Intervention group: Patients received a decision-
aid intervention, which outlined the pros and cons 
about screening and various screening options. 
Practices received academic detailing to facilitate 
CRC screening once patients were activated by 
the decision aid (N = 211). 
Any CRC 
screening 
at 12 
months.  
39% in intervention vs 32.2% 
in the control group reported 
receiving screening (UOR 
1.34, 95% CI: 0.99-2.05; p 
= .17). Absolute difference: 
6.8%. After adjusting for 
certain variables this effect 
was greater (OR 1.64; 95% 
CI: 0.53-2.94, p = .03). 
Potter et 
al., 2010 
Patients eligible 
for CRC 
screening during 
an annual 
influenza 
vaccination 
(FLU) 
campaign. 
 
Age range: 50-
80 years 
 
N = 114 
Community 
pharmacies 
in the San 
Francisco. 
 
(USA) 
 
To compare the 
effectiveness of 2 
pharmacy-based 
interventions, 
taking place during 
the FLU campaign, 
to increase CRC 
screening rates. 
 
Control group: On five dates patients were 
provided education and encourage to obtain 
screening from their primary care clinician (n = 
28). 
 
Intervention group: On 17 dates patients were 
sent a FIT kit directly to their home group (N = 
86). 
Any CRC 
screening 
at 6 
months. 
59.3% in FIT arm and 14.8% 
in the education arm reported 
completion of CRC screening 
(p<.001). Absolute 
difference: 44.5%. 
 
Potter et 
al., 2011 
Patients eligible 
for CRC 
screening during 
an annual 
influenza 
vaccination 
(FLU) 
campaign. 
 
Age range: 50-
75 years 
 
N = 1,372 
Six 
community 
clinics in 
San 
Francisco  
serving 
multiethnic 
patients. 
 
(USA) 
To evaluate the 
effectiveness of the 
FLU-gFOBT 
program when 
integrated with 
primary care visits 
to increase gFOBT 
screening. 
 
Active control: FLU-only group: nurses provided 
gFOBT with FLU only when ordered by the 
primary care clinician during usual care (N = 695). 
 
Intervention: FLU-gFOBT group: nurses routinely 
initiated the offering of gFOBT to eligible patients 
who were given FLU (N = 677). 
Any CRC 
screening 
at 18 
months. 
Screening uptake was 
significantly higher for the 
intervention (45.5%) 
compared to the active 
control group (35.6%) (p 
= .018). 
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Price-
Haywood 
et al., 2014 
Patients with 
limited health 
literacy (HL) 
overdue for 
CRC, breast 
and cervical 
cancer 
screening. 
 
Age range: men 
50-75 years, 
women 40-75 
years 
 
N 
physicians/patie
nts= 18/168 
Five clinics 
in New 
Orleans 
serving 
patients at 
risk for low 
HL. 
 
(USA) 
To assess whether 
training primary 
care physicians 
(PCPs), in addition 
to audit feedback 
improves their 
communication 
behaviours and 
increases breast, 
CRC and cervical 
cancer screening 
among patients 
with limited HL. 
 
Control clinics (N = 2): Audit only: Primary care 
physicians (PCPs) underwent chart audits of 
patients’ screening status semiannually up to 24 
months and received two annual feedback reports 
(N physicians/patients = 7/68). 
 
Intervention clinics (N = 3): Communication 
training plus audit: same as G1 plus PCPs 
received skills training that included standardised 
patient feedback on counseling behaviours (N 
physicians/patients =  11/93). 
Any CRC 
screening 
at 2 years. 
There were no between-
group differences in 
screening rates except for 
mammography (OR 2.9, 95% 
CI: 1.3-6.4). 
 
Raine et 
al., 2016 
People eligible 
for bowel cancer 
screening.  
 
Age range: 60-
74 years. 
 
N = 265,434 
patients, 6,480 
general 
practices 
General 
practices in 
England. 
 
(UK) 
To assess whether 
an endorsement of 
CRC screening by 
an individual’s 
general practice 
reduced the 
socioeconomic 
gradient in the 
uptake of bowel 
cancer screening in 
England.  
Control group: patients received the standard 
bowel cancer screening programme (BCSP) 
invitation (N = 134,011). 
 
Intervention group: patients received the same as 
the control group but the invitation also included a 
GP endorsement statement that appeared as a 
banner across the invitation letter saying ‘Your GP 
practice supports the Bowel Cancer Screening 
Programme’ (N = 131,423). 
gFOBT at 
18 weeks.  
Uptake was 57.5% in the 
control and 58.2% in the 
intervention group. The 
difference in uptake was 
statistically significant 
(p<.001). There was no effect 
of the intervention on the 
socioeconomic gradient.  
 
Resnicow 
et al., 2014 
 
African 
Americans 
(AAs) overdue 
for CRC 
screening 
 
Age range = 50-
74 years 
Integrated, 
health care, 
delivery 
system in 
greater 
Detroit, 
Michigan 
 
1) To examine the 
efficacy of 
minimally tailored 
vs. enhanced 
tailored CRC 
screening 
messages on CRC 
screening rates 
Active control: Minimal EHR tailoring: Participants 
received two newsletters promoting CRC 
screening, addressing barriers, increasing 
motivation etc. These health messages were 
tailored using sociodemographic variables only 
(e.g. age, gender) (N = 439). 
 
Intervention: Enhanced tailoring: same as active 
Colonoscop
y, gFOBT, 
virtual 
colonoscop
y, FS or 
barium 
enema at 
12 months.  
Screening rates between the 
active control group and the 
intervention group were not 
significantly different at 
follow-up (21% and 21.7% 
respectively, p< 0.05). 
Communication preference 
moderated the intervention 
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N = 881 
(USA) 
 
among AAs. 
2) To examine the 
moderating effect of 
communication 
preferences. 
 
control group but health messages were tailored 
on demographic, psychosocial and personality 
variables and on communication preference (N = 
442). 
 
impact but only for the 
‘autonomous preference’ 
group (i.e. control and 
intervention screening rates 
were 17.1% and 25.9%, 
p<0.05, respectively). 
Ritvo et al, 
2015 
Primary care 
patients eligible 
for colorectal 
cancer 
screening. 
 
Ag range: 50-74 
years. 
 
N = 5,240 
Primary 
care 
practices 
affiliated 
with the 
Group 
Health 
Centre 
(GHC) in 
Ontario. 
 
(USA) 
To assess whether 
a personal nurse 
patient navigation 
intervention can 
lead to an increase 
in bowel cancer 
screening rates.  
 
 
Control group: received usual care (N =2,611). 
 
Intervention group: received the tailored 
navigation intervention. A trained nurse navigator 
contacted patients by telephone to discuss CRC 
screening and helped them identify and arrange 
their  preferred screening test (N = 2,629). 
Any CRC 
screening 
at 12 
months.  
CRC screening adherence 
was higher in the intervention 
group (35%) when compared 
to control (20%) and this 
difference in screening 
uptake was statistically 
significant (OR 2.11, CI: 1.87 
– 2.39, p<.05). 
Roetzheim 
et al., 2004 
Patients eligible 
for CRC, breast 
and/or cervical 
screening. 
Age range: 50-
75 years 
 
N 
(clinics/patients) 
= 8/1,196 
8 primary 
care clinics 
in a county-
funded 
health 
insurance 
plan in 
Florida. 
 
 
(USA) 
 
To assess the 
efficacy of the 
Cancer Screening 
Office Systems 
(Cancer SOS) 
intervention 
designed to 
increase breast 
cancer, cervical 
cancer and CRC 
cancer screening in 
primary care setting 
serving mainly 
disadvantaged 
populations.  
Control clinics (N clinics/participants = 4/600): 
Patients received usual care. 
 
Intervention clinics (N clinics/participants = 4/596): 
received a non-computerised, low-cost office 
system to increase screening for the 3 cancers; it 
consisted of a cancer screening checklist to 
assess screening referrals and completed 
screening plus unannounced audits plus feedback 
sessions on performance. 
gFOBT, 
mammogra
phy, pap 
smear at 12 
months.  
At 1 year the intervention 
increased the odds of gFOBT 
screening (OR 2.5-95% CI: 
1.65-4.0, p< .0001). 
 
Ruffin et 
al., 2007 
Patients eligible 
for CRC 
screening. 
3 
communitie
s with high 
To assess the 
efficacy of a 
specially designed 
Control group: participants viewed a standard 
website with a non-interactive format (N = 87). 
 
Any CRC 
screening 
at 6 
Intervention participants were 
significantly more likely to get 
screened for CRC than 
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Age range: >50 
years 
 
N = 174 
CRC 
burden and 
large ethnic 
minority 
population. 
 
(USA) 
website to promote 
CRC screening 
(CRC Web) to a 
standard website 
on CRC screening. 
 
Intervention group: participants viewed an 
interactive website aimed at helping adults 
establish a screening option preference (i.e. 
decision aid) and facilitating screening behaviour 
(N = 87). 
months.  control participants; OR 3.23, 
95% CI: 2.73-3.50, p = 0.035. 
 
Salimzade
h et al., 
2014 
Participants 
eligible for CRC 
screening. 
 
Age range: >50 
years 
 
N = 360 
12 health 
clubs of a 
municipal 
district in 
Tehran. 
 
(Iran) 
To assess whether 
a theory-based 
intervention guided 
by the preventive 
health model is 
effective in 
increasing CRC 
screening in 
community, lay 
health 
organisations.  
Control group: received usual care (N = 180). 
 
Intervention group: participants received a 
preventive health model-based educational 
program on CRC screening plus a reminder call 
during which participants discussed facts about 
CRC, screening options and had the chance to 
express concerns relating common screening 
barriers (N = 180). 
Any CRC 
screening 
at 4 
months.  
The screening rate for CRC 
was significantly higher in the 
intervention (31%) vs. the 
control group (2.8) (OR 
15.93, 95% CI: 5.57, 45.53, 
p<.05). 
 
Schroy et 
al., 2012 
Patients eligible 
for CRC 
screening. 
 
Age range: 50-
75 years 
 
N = 825 
An urban, 
academic 
safety-net 
hospital 
and 
community 
health 
centre.  
 
To assess the 
impact of a decision 
aid-assisted shared 
decision making 
(SDM) intervention 
on CRC screening 
uptake. 
 
Control group: received usual care plus a modified 
online version of a leaflet discussing generic 
lifestyle changes (other than screening) for 
minimising risk for preventable diseases (N = 
276). 
 
G1: Intervention arm 1: decision aid plus 
personalised risk assessment (N = 280). 
 
G2: Intervention arm 2: decision aid only (N = 
269). 
Any CRC 
screening 
at 12 
months.  
Patients in G2 were 
significantly more likely to 
complete a screening test 
than controls (43.1% vs. 
34.8%, absolute difference: 
8.3%, p = 0.046) within 12 
months.  
 
The screening rates between 
the 2 intervention arms were 
similar (43.1% vs. 37.1%, p = 
0.15). 
Sequist et 
al., 2009 
Patients 
overdue for 
CRC screening. 
 
Age range: 50-
80 years 
11 
ambulatory 
health care 
centres in 
Massachus
etts. 
To compare the 
individual and joint 
impact of 
personalised 
mailings to patients 
and electronic 
Patient intervention: 2 groups: 
 
Control group: received usual care (N = 10,930). 
Intervention group: received cover letter indicating 
overdue screening status plus educational 
pamphlet plus gFOBT kit plus phone number to 
Any CRC 
screening 
at 15 
months.  
Screening rates were 
significantly higher among 
patients who received 
mailings (i.e. intervention) vs. 
those who didn’t (i.e. control) 
(44% vs. 38.1%, p<.001).  
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N 
(patients/physici
ans)= 
21,860/110 
 
(USA) 
reminders to 
primary care 
physicians (PCPs) 
to increase CRC 
screening rates.   
 
schedule endoscopic procedures (N = 10,930). 
 
Physician intervention (not included in meta-
analysis as not clear whether the participant 
sample was different from the sample in the 
patient intervention): 2 groups:  
 
G1: Control group: received usual care (N 
physicians/patients = 55/10,912). 
G2: Intervention group: physicians received 
electronic reminders during office visits with their 
patients overdue for CRC screening. Alerts were 
presented in both active and passive form within 
each patient’s EHR. The active alert required 
acknowledgement from physicians (N 
physicians/patients = 55/10,948). 
 
Screening rates were similar 
among patients of physicians 
receiving electronic 
reminders and the control 
group (41.9% vs. 40.2%, p 
= .47). 
 
 
Sequist et 
al., 2011 
Patients 
overdue for 
CRC screening. 
 
Age range: 50-
75 years 
 
N = 1,103 
A 
multispecial
ty group 
practice 
comprising 
14 
ambulatory 
health 
centres in 
Massachus
etts.  
(USA) 
To assess whether 
electronic patient 
messages and 
personalised risk 
assessments 
delivered via an 
electronic personal 
health record could 
increase screening 
rates. 
Control group: received usual care (N = 551). 
 
Intervention group: received a single electronic 
message highlighting overdue screening status 
with a link to a Web-based tool to assess their 
personal risk for CRC (N = 552). 
FS, gFOBT 
and 
colonoscop
y at 4 
months.  
Screening rates were higher 
at 1 month for the 
intervention group compared 
to the control group (8.3% vs 
0.2%, absolute difference 
8.1% p<.001) but this 
difference was no longer 
significant at 4 months 
(15.8% vs 13.1%, absolute 
difference 2.7%, p = .18). 
 
Shanklema
n et al., 
2014 
Patients eligible 
for gFOBT 
screening 
 
Age range: 59-
70 years 
 
N = 9,113 
18 
intervention 
general 
practices 
and 24 
control 
practices in 
East 
To assess the 
effectiveness of 2 
interventions; (1) 
face-to-face health 
promotion at 
general practice (2) 
health promotion 
delivered by phone 
Control GP practices: received usual care (i.e. 
NHS BCSP invitation) (N practices/patients: 
24/5,227). 
 
G1: Intervention arm 1: Health Promotion (HP) 
over the telephone: received standard invitation 
plus bilingual advocates phoned subjects a week 
after sending letters (3 attempts in total) plus 
gFOBT at 8 
months.  
Median gFOBT uptake was 
46.7% in the telephone 
intervention, 43.8% in the 
face-to-face intervention and 
39.1% in comparison 
practices (absolute 
difference: 7.6% and 4.7% 
for G1 and G2 respectively, p 
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London. among low SES 
and ethnic diversity 
populations 
 
callers offered CRC information and answered 
participants’ questions (N practices/patients: 
9/2,034). 
 
G2: intervention arm 2: face-to-face HP: received 
standard invitation letter plus an invitation to 
attend a group health information session at the 
GP practice, which were held monthly and 
attendees were offered additional pictorial and 
multi-lingual guides to the test procedure (N 
practices/patients: 9/1,852). 
= .001 when comparing 
either G1 or G2 to control). 
 
Shaw et 
al., 2013 
Patients eligible 
for CRC 
screening. 
 
Age range: 50-
70 years 
 
N 
practices/patient
s = /23673 
23 primary 
care 
practices in 
New 
Jersey. 
 
(USA) 
 
To evaluate a 
primary care 
practice-based 
quality 
improvement 
intervention (QI) 
aimed at improving 
CRC screening 
rates.  
 
Control practices: received usual care (N 
practices/patients: 11/320). 
 
Intervention practices: practices received a quality 
improvement (QI) intervention with three 
components: a multimethod assessment process 
plus a reflective adaptive process plus learning 
collaborative process (N practices/patients: 
12/353). 
Any CRC 
screening 
at 12 
months. 
There were no observed 
differences in CRC screening 
rates between control and 
intervention practices (38% 
and 53% respectively; 
p>.05). 
Simon et 
al., 2010 
Participants 
eligible for first-
time CRC 
screening.  
 
Age range: 50-
64 years 
 
N = 20,938 
Health care 
network in 
Massachus
etts. 
 
(USA) 
 
To assess whether 
an automated 
telephone outreach 
with speech 
recognition (ATO-
SR) can increase 
CRC screening 
rates. 
 
Control group: received usual care (N = 10,432). 
 
Intervention group: patients received the ATO-SR; 
a single interactive outreach call using speech 
recognition to engage participants in conversation 
about the importance of CRC screening and 
options for and barriers to screening (N = 10,506). 
 
The ATO-SR was designed to reflect the insights 
of the General Model of Determinants of 
Behaviour Change. 
Any CRC 
screening 
at 12 
months.  
The incidence of any CRC 
screening was 30.6% in the 
intervention group and 30.4% 
in the usual care group (p 
= .76). The intervention effect 
remained insignificant after 
adjusting for covariates (AOR 
1.01; 95% CI: 0.94-1.07). 
 
Stokamer 
et al., 2005 
Participants 
referred for 
gFOBT. 
 
Department 
of Veteran 
Affairs 
primary 
To determine 
whether intensive 
patient education 
increases gFOBT 
Control group: received standard patient 
education: only received the gFOBT cards and 
written instructions on how to properly collect stool 
specimens for gFOBT (N = 392). 
gFOBT at 6 
months.  
Patients in the intervention 
group were more likely than 
controls to return gFOBT 
cards (65.9% vs. 51.3%; 
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Age range: >50 
years 
 
N = 788 
care clinic 
in NYC. 
 
(USA) 
uptake. 
 
 
Intervention group: received intensive patient 
education plus a one-on-one education session by 
a primary care nurse on the importance of CRC 
screening plus received advice on how to properly 
collect stool samples for gFOBT plus received a 
2-page handout on CRC screening (N = 396). 
absolute difference: 14.6%, p 
<.001). 
 
Tu et al., 
2006 
Chinese-
Americans 
eligible for 
gFOBT 
screening.  
 
Age range: 50-
78 years 
 
N = 210 
A 
community 
clinic 
serving 
predominan
tly Asians 
in Seattle, 
Washington
. 
 
(USA) 
To evaluate a 
clinic-based, 
culturally and 
linguistically 
appropriate 
intervention to 
increase gFOBT 
screening rates 
among Chinese 
Americans.  
Control group: received usual care (N = 105). 
 
Intervention group: trilingual and bicultural health 
educators delivered bilingual materials (video, 
pamphlet plus gFOBT instructions) and a gFOBT 
kit (N = 105). 
 
gFOBT at 6 
months.  
69.5% of the intervention 
patients received gFOBT 
screening vs. 27.6% of the 
control patients (OR 5.98; 
95% CI: 3.29, 10.85, 
absolute difference: 41.9%, 
p<.05). 
 
Tinmouth 
et al., 2014 
People 
previously non-
adherent with 
CRC screening. 
 
Age range: 50-
74 years. 
 
N = 3,594 
Primary 
care cancer 
screening 
programme 
in Ontario. 
 
(Canada) 
To assess whether 
adding an gFOBT 
kit to a mailed 
invitation increases 
CRC screening 
among non-
responders.  
 
 
Control group: received usual care (N = 1,586). 
 
Intervention group: patients received a gFOBT kit 
alongside the standard screening invitation (N = 
2,008). 
Any CRC 
screening 
at 6 
months.  
Uptake was 11.5% and 
21.6% for the control and 
intervention group 
respectively (p<.001).  
 
van Roon 
et al., 2011 
 
 
Adults eligible 
for CRC 
screening. 
 
Age range: 50-
74 years 
 
N = 5,000 
Amsterdam
, 
Netherland
s 
To test whether an 
advance notification 
letter increases 
CRC-screening 
adherence. 
Control group: received usual care (N = 2,493). 
 
Intervention group: usual care plus advance 
notification letter (2 weeks in advance of 
invitation) containing information about CRC 
screening (N = 2,507). 
FIT at 8 
months.  
Sending an advance 
notification letter and 
invitation was associated 
with significantly higher 
adherence compared to 
sending an invitation letter 
alone (57.8% vs. 51.5% 
respectively, p = <.001). 
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Van 
Roosbroec
k and van 
Hal., 2012 
Patients eligible 
for CRC 
screening. 
 
Age range: 50-
74 years 
 
N = 19,542 
Three 
selected 
areas (1 
urban, 1 
residential 
and 1 rural) 
in Flanders. 
 
(Belgium) 
To compare the 
effects of 2 
invitation strategies 
on CRC screening 
uptake rates. 
 
Control group: GP group: an invitation letter 
without a FIT kit was sent by mail, with 
instructions to visit the GP for further information 
on screening and the FIT kit was provided by the 
GP (N = 8,052). 
 
Intervention group: Mail group: patients received a 
direct invitation letter with a FIT kit sent by mail (N 
= 11,490). 
 
FIT (follow-
up unclear) 
Screening uptake was 
significantly higher for the 
intervention compared to the 
control group 52.3% vs. 
27.7% respectively, 
p<.0001). 
After controlling for age 
gender and area, screening 
rates were 3 times higher in 
the intervention group vs. the 
control group (OR 2.96, 95% 
CI: 2.78-3.14, p<.001). 
Vernon et 
al., 2011 
 
Patients 
overdue for 
CRC screening. 
 
Age range: 50-
70 years 
 
N = 1,224 
A large 
medical 
group 
practice in 
the greater 
Houston, 
Texas, 
area. 
 
(USA) 
To test the 
effectiveness of a 
tailored, interactive 
intervention to 
increase CRC 
screening. 
All patients had received general check-ups in the 
last 12 months. 
 
Control group: Survey-only group: baseline survey 
(questions about their check-up) and a 6-month 
survey (questions about screening decision) (n = 
413). 
 
G1: Generic web-site group: Same as the control 
group plus viewed information about CRC 
screening on a publicly available website. (N = 
398). 
 
G2: Tailored group: received interactive, 
computer-delivered intervention about CRC 
screening. The trans-theoretical model of change 
was the primary theoretical framework (N = 413). 
Colonoscop
y, FS, 
barium 
enema, 
gFOBT 
 At 6 and 
12 months.  
No significant differences were 
found in screening rates by 12 
months (34.1%, 35.7% and 
32.9% for the control, G1 and 
G2 respectively; p>0.05).  
 
23 participants showed 
increased knowledge at 2 
weeks: (p<.004) and 6 months 
(p<.004) compared to the control 
group and G1 - and CRC 
screening efficacy at 2 weeks 
(p<.001) and 6 months (p=.009). 
 
Vinker et 
al., 2002 
 
Adults eligible 
for CRC 
screening. 
 
Age range: 50-
75 years 
 
Two 
primary 
care clinics. 
 
(Israel) 
 
To test the 
effectiveness of 
physician and 
patient reminders to 
increase gFOBT 
screening rates. 
Control group: received usual care (N = 913). 
 
G1: Physician reminder group (N = 753). 
 
G2: Patient reminder: Phone call reminder (N = 
312). 
 
gFOBT at 
12 months.  
Screening uptake was 
significantly higher in G1, G2, 
G3 compared to the control 
group (16.5%, 14.7%, 9.2% vs 
1.3% respectively, p<.001).  
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N = 2,315 G3: Patient reminder: Letter reminder (N = 329). 
Walsh et 
al., 2005 
Patients non-
adherent to 
CRC screening. 
 
Age range: 50-
79 years 
 
N 
physicians/patie
nts = 94/7,933  
Primary care 
physicians 
(PCPs) 
recruited 
from a large 
individual 
practitioner 
association 
providing 
managed 
care in San 
Francisco. 
 
(USA) 
To assess whether 
a physician and 
patient directed 
intervention 
involving academic 
detailing and direct 
mailings, increases 
the rate of CRC 
screening.  
 
Control group: received usual care (N 
physicians/patients: 44/3,717). 
 
Intervention group: Physicians underwent 
academic detailing through participating in 
educational seminars plus identified potential 
CRC screening issues for discussion plus the 
importance of recommendation was emphasised. 
Patients received a personalised letter plus 
educational brochure plus gFOBT kit (N 
physicians/patients: 50/4,276). 
Any CRC 
screening 
at 12 
months.  
No significant increase was 
observed in any CRC 
screening that occurred in 
the intervention group versus 
the control group: (12.7% vs 
12.5%, absolute difference: 
0.2%, p = .51). 
 
Walsh et 
al., 2010 
Latino and 
Vietnamese 
primary care 
patients. 
 
Age range: 50-
79 years  
 
N = 1,789 
Large 
public 
hospital in 
Santa 
Clara. 
 
(USA) 
To assess whether 
culturally tailored 
brochures with or 
without telephone 
counselling can 
increase CRC 
screening among 
Latinos and 
Vietnamese. 
Control group: received usual care (N = 256). 
 
G1: Basic intervention group: patients received a 
culturally tailored brochure plus gFOBT kit (N = 
765). 
 
G2: Enhanced intervention group: brochure as in 
G1 plus gFOBT kit plus telephone counselling (N 
= 768). 
Any CRC 
screening 
at 12 
months.  
Screening rates increased by 
7.8%, 15.1% and 25.1% in 
the control group, G1 and G2 
respectively (p<0.01 between 
each intervention and the 
control and between G1 and 
G2). 
Wardle et 
al., 2003 
A “harder-to-
reach” 
population 
eligible for CRC 
screening. 
 
Age range: 55-
64 years 
 
N = 2,966 
14 trial 
centres to 
recruit 
patients 
registered 
with GPs in 
London. 
 
 (UK) 
To assess whether 
a mailed 
intervention 
designed to 
address CRC 
screening barriers 
and modify 
negative attitudes 
towards FS would 
increase screening 
attendance. 
G1: Control group: received usual care (n = 
1,513). 
 
G2: Intervention group: received a mailed 
psychoeducational intervention (booklet) three 
weeks before receiving the usual screening 
invitation. Booklet educational materials drew on 
various frameworks; health belief model (HBM), 
Theory of Planned Behaviour and regret theories 
to address screening barriers and increase 
positive expectations (N = 1,453). 
FS at 3 
months.  
FS screening rates were 
significantly higher in G2 vs. 
G1 (53.2% vs. 49.9%). 
Absolute difference: 3.6%, 
p< .05. 
Wardle et 
al., 2016 
People eligible 
for bowel cancer 
screening. 
The English 
NHS Bowel 
Cancer 
To assess 4 
interventions aimed 
at reducing the 
4 trials: 
 
Trial 1: Gist leaflet 
gFOBT at 
18 weeks.  
Trials 1 and 2 showed no 
effects on the SE gradient of 
uptake or overall uptake. 
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Age range: 50-
74 years 
 
N = 745,011 
Screening 
Programme
. 
 
(UK) 
socioeconomic 
(SE) gradient in 
bowel cancer 
screening uptake.  
 
 
G1: Control: patients received standard 
information (N = 78,971) 
G2: Intervention: patients received standard 
information with added gist leaflet (N = 84,283). 
 
Trial 2: Narrative leaflet 
G1: Control: patients received standard 
information (N = 76,421) 
G2: Intervention: patients received standard 
information with added narrative leaflet (N = 
73,450). 
 
Trial 3: General practice endorsement 
G1: Control: patients received standard 
information (N = 133,449) 
G2: Intervention: patients received standard 
information with added GP endorsement banner 
in letter (N = 130,876). 
 
Trial 4: Enhanced reminder letter (only targeted 
individuals who had not responded within 4 weeks 
of invitation letter). 
G1: Control: patients received standard 
information (N = 90,002) 
G2: Intervention: patients received standard 
reminder letter with added banner and text (N = 
77,739). 
Trial 3 showed no effect on 
SE gradient but was 
associated with increased 
overall uptake (AOR 1.07, 
95% CI: 1.04-1.10, p<.0001). 
In Trial 4 a significant 
interaction was seen with SE 
gradient (p=.005) with a 
stronger effect in the most 
deprived quintile (p = .003) 
than in the least deprived (p 
= 0.98). For trials 1-4 overall 
uptake per trial was 57.7%, 
56.9%, 58.4% and 25.9% for 
the intervention group vs. 
57.4%, 58.7%, 57.7% and 
25.2% in the control groups, 
for each trial respectively. 
 
Weinberg 
et al., 2013 
 
Unscreened 
women. 
 
Age range: > 50 
years 
 
N = 865 
Obstetrics 
and 
gynaecolog
y practices 
in 
Pennsylvan
ia and 
Georgia.  
 
To assess the 
efficacy of two 
types of tailored, 
educational 
interventions (web- 
and print-based) on 
improving 
adherence to CRC 
screening. 
Control group: usual care (N = 171). 
G1: Intervention arm 1: Web education tailored for 
high monitoring attentional style women (N = 
171). 
 
G2: Intervention arm 2: Web education tailored for 
low monitoring attentional style women (N = 174). 
G3: Intervention arm 3: Print education tailored for 
high monitoring attentional style women (N = 
Any CRC 
screening 
at 4 
months.  
CRC screening rates were 
not significantly different in 
the web (i.e. G1 and G2; 
12.2% and 12% 
respectively), print (G3 and 
G4; 11.3% and 12.7% 
respectively) or control group 
(13.9%). Risk messages 
tailored to attentional style 
  
385 
(USA)  176). 
G4: Intervention arm 4: Print education tailored for 
low monitoring attentional style women (N = 173). 
CRC screening educational content was identical 
for both interventions. The Cognitive Social 
Information Processing model was used to tailor 
health messages to attentional style. 
had no effect on screening 
uptake for any group.  
 
White et 
al., 2015 
People eligible 
for bowel cancer 
screening in 
London. 
 
Age range: 60-
74. 
 
N = 205,541 
The English 
NHS Bowel 
Cancer 
Screening 
Programme
. 
 
(UK) 
To trial different 
combinations of 
three interventions 
aimed at increasing 
CRC screening 
uptake. 
 
 
Control Group: received usual care (N = 177, 
386). 
 
G1: received CRUK endorsement flyer only (N = 
9,702). 
 
G2: Same as G1 plus kit enhancement pack: 
included plastic gloves and ‘poo catchers’ to make 
sample collection easier (N = 8,623). 
 
G3: Same as G1 plus advertising campaign: flyer 
plus media campaign e.g.. banners highlighting 
ease of use ‘it’s easier than you think’ (N = 4,798). 
 
G4: Same as G2 plus advertising campaign: flyer 
plus enhancement pack plus media campaign (N 
= 5,032). 
  
 
gFOBT at 3 
months.  
Screening uptake rates were 
43.4%, 43%, 45.1%, 45.6% 
and 49.5% in the control 
group, G1, G2, G3 and G4 
respectively. The flyer alone 
(G1) had no impact on 
screening uptake compared 
to control. G2 resulted in a 
significant increase in uptake 
compared to control (45.1% 
vs 43.4%, OR: 1.07, p 
= .047). G3 resulted in a 
significant increase in uptake 
compared to control (45.6% 
vs 43.4%, OR = 1.09, p 
= .027). The largest increase 
in uptake was observed in 
G4 compared to control 
(49.5% vs 43.4%, OR 1.28, 
p<.001).  
Wilson et 
al., 2015 
People eligible 
for bowel cancer 
screening. 
 
Age range: 50-
74 years. 
 
N = 3,408 
National 
screening 
programme 
in Australia. 
 
(Australia) 
To compare the 
effects of a tailored 
computerised 
decision support 
tool vs a non-
tailored 
computerised 
booklet vs paper 
information on 
Control group: received usual care (N = 1,036). 
 
G1: Tailored Personalised Decision Support 
(TPDS) group: received health information tailored 
to their stage of readiness to screen (N = 1,137). 
 
G2: Non-Tailored Personalised Decision Support 
(NTPDS) group: received an online booklet with 
information about CRC screening (N = 1,136). 
gFOBT at 3 
months. 
There was no significant 
difference in uptake between 
groups; screening rates were 
34.5%, 32.5% and 33% for 
the control group, G1 and G2 
respectively.  
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gFOBT uptake. 
Zapka et 
al., 2004 
 
Patients eligible 
for CRC 
screening. 
 
Age range: 50-
75 years 
 
N = 938 
5 primary 
care 
practices in 
central 
Massachus
etts. 
 
(USA) 
To assess the 
efficacy of a mailed 
educational video 
before a physical 
examination, on 
CRC screening 
rates especially 
sigmoidoscopy. 
Control group: received usual care (N = 488). 
 
Intervention group: video about CRC: aimed at 
encouraging patients to discuss CRC screening 
with their physician at their upcoming periodical 
appointment. The videos aimed at increasing 
patient knowledge, reducing anxiety, and provide 
role modelling (based on the Precede/Proceed 
and Behavioural Model of Utilisation models) (N = 
450). 
Any but 
mainly FS 
at 6 
months. 
Screening rates were the 
same in the intervention and 
control groups (54.8% vs 
54.9% respectively; p>.05). 
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Appendix 2.8. Risk of bias assessment of all included studies. 
  
  
No of participants 
randomised 
 
          
 
Study 
 
Interven
tion  
 
Control  
 
Age 
range 
(year
s) 
 
Screeni
ng test 
 
Random 
sequence 
generation 
(selection bias) 
 
Allocation 
concealment 
(selection 
bias) 
 
Blinding of 
participants & 
personnel 
(performance 
bias) 
 
Blinding of 
outcome 
assessment 
(detection 
bias) 
 
 
Incomplete 
outcome 
data 
(attrition 
bias) 
 
Selective 
reporting 
(reporting 
bias) 
 
ITT 
analysis 
 
Overall
risk of 
bias 
 
1. Aragones 
et al (2010) 
 
 
31 
 
34 
 
50-74 
 
Any 
 
Adequate 
 
Unclear* 
 
Unclear 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
 
2. Atlas et al 
(2013) 
 
 
51,071 
 
52,799 
 
50-74 
 
Any 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Unclear 
 
Unclear 
 
3. Baker et 
al, (2014) 
 
 
225 
 
225 
 
51-75 
 
gFOBT 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
 
Adequate 
 
Adequate 
 
No 
 
Unclear 
4. Barthe et 
al 2015 
 
1,895 1,527  
55-70 
gFOBT  
Unclear 
 
Adequate 
 
Unclear 
 
Unclear 
 
Adequate 
 
 
Adequate 
 
Yes 
 
Unclear 
 
5. Basch et 
al, (2006) 
 
 
226 
 
230 
 
52-79 
 
Any test 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
 
Adequate 
 
Adequate 
 
Yes 
 
Low 
 
6. 
Blumenthal 
et al (2010) 
 
 
G1: 84 
G2: 98 
G3: 99 
 
88 
 
>50 
 
Any 
 
Inadequate**  
 
Unclear  
 
Unclear 
 
Inadequate 
 
Adequate 
 
Adequate 
 
Yes 
 
High 
 
7. 
Boguradzka 
et al (2014) 
 
300 
 
300 
 
50-65 
 
Colonos
copy 
 
Adequate  
 
Adequate 
 
Adequate 
 
Inadequate 
 
Adequate 
 
Adequate 
 
No 
 
High 
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8. Braun et 
al (2005) 
 
 
 
69 
 
 
52 
 
>50 
 
gFOBT 
 
Adequate  
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Unclear 
 
Unclear 
9. Braun et 
al (2015) 
242 246 60-75 Any  
Adequate 
 
Adequate 
 
Adequate 
 
Inadequate 
 
Inadequate 
 
Adequate 
 
Unclear 
 
High 
 
10. 
Cameron et 
al (2011) 
 
 
314 
 
314 
 
50-79 
 
Any 
 
Adequate 
 
Adequate 
 
Unclear 
 
Adequate 
 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
 
11. Christie 
et al (2008) 
 
 
13 
 
8 
 
>50 
 
colonos
copy 
 
Adequate 
 
Unclear 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Unclear 
 
High 
 
12. Church 
et al (2004) 
 
 
G1: 434 
G2: 404 
 
417 
 
>50 
 
gFOBT 
 
Adequate 
 
Adequate 
 
Unclear 
 
Inadequate 
 
Inadequate 
 
Adequate 
 
Unclear 
 
High 
 
13. 
Clouston et 
al (2014) 
 
 
1,221 
 
1,174 
 
50-70 
 
gFOBT 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Low 
 
14. Cohen-
Cline et al 
(2014) 
 
 
 
8,005 
 
 
3,005 
 
 
50-81 
 
 
Any 
 
 
Unclear 
 
 
Unclear 
 
 
Unclear 
 
 
Unclear 
 
 
Adequate 
 
 
Adequate 
 
 
Unclear 
 
 
Unclear 
 
15. Cole et 
al (2002) 
 
 
G1: 600 
G2: 600 
G3: 600 
 
600 
 
>50 
 
gFOBT 
 
Adequate 
 
Adequate 
 
 
Adequate 
 
Unclear 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
 
16. Cole et 
al (2007) 
 
 
G1: 600 
G2: 600 
G3: 600 
 
600 
 
50-74 
 
gFOBT 
 
Unclear 
 
Adequate 
 
Adequate 
 
Unclear 
 
Inadequate 
 
Adequate 
 
No 
 
High 
 
17. 
Coronado et 
al (2010) 
 
 
G1: 168 
G2: 168 
 
165 
 
50-79 
 
gFOBT 
 
Adequate 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
 
Adequate 
 
No 
 
High 
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18. 
Costanza et 
al (2007) 
 
 
1,187 
 
1,261 
 
50-75 
 
Any 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
 
19. Denberg 
et al, (2006) 
 
 
386 
 
395 
 
>50 
 
Colonos
copy 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Low 
 
20. Dietrich 
et al (2006) 
 
 
696 
 
694 
 
50-69 
 
Any 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Low 
 
21. Dietrich 
et al (2007) 
 
 
663 
 
653 
 
50-69 
 
Any 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
 
22. Dietrich 
et al (2013) 
 
 
562 
 
 
1,678 
 
50-63 
 
Any test 
 
Adequate 
 
Adequate 
 
Adequate 
 
Unclear 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
 
23. Dignan 
et al (2014) 
 
 
1,842 
 
1,909 
 
50-75 
 
Any 
 
Unclear 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Inadequate 
 
Adequate 
 
No 
 
High 
 
24. Ferreira 
et al (2005) 
 
 
1,015 
 
963 
 
>50 
 
Any 
 
Unclear 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Adequate 
 
Unclear 
 
High 
 
25. Fiscella 
et al, (2011) 
 
 
163 
 
163 
 
50-74 
 
Any test 
 
Inadequate 
 
Inadequate 
 
Unclear 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
High 
 
26. 
Fitzgibbon 
et al (2007) 
 
 
258 
 
728 
 
>50 
 
Any 
 
Inadequate 
 
Unclear 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Unclear 
 
High 
 
27. Ford et 
al (2006) 
 
 
352 
 
351 
 
>55 
 
FS 
 
Inadequate  
 
Unclear 
 
Unclear 
 
Inadequate 
 
Inadequate 
 
Adequate 
 
No 
 
High 
 
28. Fortuna 
et al (2014) 
 
 
G1: 157 
G2: 158 
 
156 
 
50-74 
 
Any 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Low 
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G3: 158 
 
29. Ganz et 
al (2005) 
 
 
920 
 
930 
 
>52 
 
Any 
 
Inadequate 
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
No 
 
High 
 
30. Gimeno-
Garcia et al 
(2009) 
 
 
79 
 
79 
 
50-79 
 
gFOBT 
 
Adequate 
 
Unclear 
 
Adequate 
 
Adequate 
 
Adequate 
 
Inadequate 
 
Unclear 
 
High 
 
31. Giorgi- 
Rossi et al 
(2011) 
 
 
2,107 
 
2,112 
 
50-70 
 
gFOBT 
 
Adequate 
 
Unclear 
 
Adequate 
 
Unclear 
 
Adequate 
 
Unclear 
 
Yes 
 
Unclear 
 
32. 
Goldberg et 
al (2004) 
 
 
59 
 
60 
 
50-80 
 
gFOBT 
 
Inadequate 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Adequate 
 
Yes 
 
High 
33. 
Goldman et 
al (2015) 
210 210 50-74 gFOBT  
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
 
Adequate 
 
Unclear 
 
Unclear 
 
34. Green et 
al (2013) 
 
 
G1: 
1,169 
G2:1.159 
G3:1,170 
 
1,166 
 
50-73 
 
Any 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
 
Adequate 
 
Yes 
 
Low 
35. Green et 
al (2015) 
1,106 1,102 50-75 Any  
Adequate 
 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Low 
36. 
Guiriguet et 
al (2016) 
21,619 8,196 50-69 FIT  
Unclear 
 
Unclear 
 
 
Adequate 
 
Unclear 
 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
 
37. Gupta et 
al (2013) 
 
 
G1: 
1,593 
G2: 479 
 
3,898 
 
54-64 
 
Any 
 
 
Adequate 
 
 
Adequate 
 
 
Adequate 
 
 
Adequate 
 
 
Adequate 
 
 
Adequate 
 
 
Yes 
 
 
Low 
38. Hagoel 
et al (2016) 
G1: 
9,596 
G2:9,631 
G3: 
9,602 50-74 gFOBT  
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Adequate 
 
Unclear 
 
Unclear 
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9,632 
G4:9,630 
 
39. Hendren 
et al (2013) 
 
185 
 
181 
 
40-74 
 
Any 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Unclear 
 
Low 
 
40. 
Hewitson et 
al (2011) 
 
 
G1: 322 
G2:322 
G3: 322 
 
322 
 
60-75 
 
gFOBT 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Low 
 
41. Holt et al 
(2012) 
 
 
152 
 
133 
 
50-74 
 
Any 
 
Adequate 
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Unclear 
 
Unclear 
42. Horne et 
al (2015) 
578 642 65-75 Any  
Unclear 
 
Unclear 
 
Adequate 
 
Inadequate 
 
Inadequate 
 
Adequate 
 
Unclear 
 
High 
 
43. Hwang 
et al (2013) 
 
 
153 
 
153 
 
>50 
 
Any 
 
Adequate 
 
Adequate 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Adequate 
 
Yes 
 
High 
 
44. Inadomi 
et al (2012) 
 
G1: 321 
G2:332 
G3: 321 
 
No 
control 
group 
 
50-79 
 
gFOBT/
colonos
copy 
 
Adequate 
 
Adequate 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Unclear 
 
Unclear 
 
45. Jandorf 
et al (2013) 
 
 
G1: 181 
G2: 123 
 
46 
 
>50 
 
Colonos
copy 
 
Adequate 
 
Unclear 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Unclear 
 
High 
 
46. Jean-
Jacques et 
al, (2012) 
 
 
104 
 
98 
 
50-80 
 
gFOBT, 
FS, 
colono-
scopy 
 
Adequate 
 
Unclear 
 
Unclear 
 
Adequate 
 
Inadequate 
 
Adequate 
 
No 
 
High 
 
47. Jensen 
et al (2014) 
 
G1: 72 
G2: 72 
G3: 72 
G4: 72 
 
72 
 
50-75 
 
Any 
 
Unclear 
 
Unclear 
 
 
Unclear 
 
Adequate 
 
Adequate 
 
Adequate 
 
No 
 
Unclear 
 
48. Katz et 
al (2012) 
 
 
138 
 
132 
 
>50 
 
Any 
 
Adequate 
 
Unclear 
 
Adequate 
 
Unclear 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
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49. Krok-
Schoen et al 
(2015) 
566 525 51-75 Any Unclear Unclear Inadequate Adequate Inadequate Adequate Unclear High 
 
50. Lasser 
et al, (2011) 
 
 
235 
 
230 
 
52-74 
 
Any test 
 
Adequate 
 
Adequate 
 
Unclear 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
 
51. Lee et al 
(2009) 
 
 
389 
 
386 
 
>50 
 
gFOBT 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Low 
 
52. Leffler et 
al (2011) 
 
 
539 
 
291 
 
>50 
 
gFOBT 
 
Adequate 
 
Adequate 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
 
53. Levy et 
al (2012) 
 
 
187 
 
186 
 
52-79 
 
FIT 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Unclear 
 
High 
 
54. Levy et 
al, (2013) 
 
 
G1: 185 
G2: 186 
G3: 187 
 
185 
 
52-79 
 
Any test 
 
Adequate 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
 
55. Lewis et 
al, (2012) 
 
 
716 
 
782 
 
50-75 
 
Any test 
 
Inadequate 
 
Inadequate 
 
Inadequate 
 
Unclear 
 
Inadequate 
 
Adequate 
 
No 
 
High 
 
56. Ling et 
al (2009) 
 
 
G1: 133 
G2: 190 
G3: 152 
 
124 
 
50-79 
 
FS, 
colonos
copy 
 
Adequate 
 
Adequate 
 
Adequate 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Unclear 
 
High 
 
57. Lo et al, 
(2013) 
 
 
12,414 
 
10,768 
 
50-74 
 
gFOBT 
 
Adequate 
 
Unclear  
 
Unclear 
 
Unclear 
 
Unclear 
 
Inadequate 
 
No  
 
High 
 
58. Marcus 
et al, (2005) 
 
G1: 576 
G2: 530 
G3: 549 
 
698 
 
50+ 
 
gFOBT, 
FS, 
colonos
copy 
 
 
Unclear 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Adequate 
 
Yes 
 
High 
 
59. Maxwell 
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et al (2010) 
 
G1: 202 
G2: 183 
163 50-70 Any Adequate Unclear Unclear Inadequate Adequate Adequate Yes High 
60. Maxwell 
et al (2015) 
423 250 50-75 Any Adequate Adequate Unclear Inadequate Adequate Adequate No High 
61. 
McGregor et 
al (2015) 
73,722 76,695 60-74 gFOBT Adequate Adequate Adequate Adequate Adequate Adequate No Low 
 
62. Menon 
et al (2011) 
 
 
G1: 168 
G2: 178 
 
169 
 
>59 
 
Any 
 
Inadequate 
 
Inadequate 
 
Inadequate 
 
Unclear 
 
Adequate 
 
Adequate 
 
No 
 
High 
 
63. Miller et 
al (2005) 
 
93 
 
101 
 
50-86 
 
gFOBT 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Unclear 
 
Low 
 
64. Mosen 
et al (2010) 
 
 
2,943 
 
2,962 
 
51-80 
 
gFOBT 
 
Adequate 
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
No 
 
Unclear 
 
65. Myers et 
al, (2007) 
 
 
G1: 387 
G2: 386 
G3: 386 
 
387 
 
50-74 
 
Any test 
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
 
Adequate 
 
Yes 
 
Unclear 
 
66. Neter et 
al (2014) 
 
 
13,677 
 
13,878 
 
50-74 
 
gFOBT 
 
Unclear 
 
Unclear 
 
Adequate 
 
Unclear 
 
Adequate 
 
Adequate 
 
Unclear 
 
Unclear 
 
67. O’Carroll 
et al (2015) 
 
G1: 
19,828 
G2:19,93
4 
 
19,604 
 
60-74 
 
gFOBT 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Low 
 
68. Ornstein 
et al (2010) 
 
 
30,892 
 
37,258 
 
>50 
 
Any 
 
Adequate 
 
Unclear 
 
Adequate 
 
Inadequate 
 
Adequate 
 
Adequate 
 
Unclear 
 
High 
 
69. Percac-
Lima et al, 
(2008) 
 
 
409 
 
814 
 
52-79 
 
Any 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Unclear 
 
Adequate 
 
Adequate 
 
Yes 
 
High 
 
70. Phillips 
et al (2015) 
 
G1: 198 
G2: 199 
G3: 203 
 
No 
control 
group 
 
50-74 
 
Any 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
 
Adequate 
 
Adequate 
 
Unclear 
 
Low 
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71. Pignone 
et al (2000) 
 
 
125 
 
124 
 
50-75 
 
Any 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Low 
 
72. Pignone 
et al (2011) 
 
 
211 
 
 
232 
 
52-75 
 
Any 
 
Inadequate 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Adequate 
 
Unclear 
 
High 
 
73. Potter et 
al (2010) 
 
 
86 
 
28 
 
50-75 
 
Any 
 
Inadequate 
 
Unclear 
 
 
Adequate 
 
Inadequate 
 
Inadequate 
 
Adequate 
 
Unclear 
 
High 
 
74. Potter et 
al (2011) 
 
 
695 
 
677 
 
50-75 
 
Any 
 
Inadequate 
 
Inadequate 
 
Inadequate 
 
Unclear 
 
Adequate 
 
Adequate 
 
Unclear 
 
High 
 
75. Price-
Haywood et 
al (2014) 
 
91 
 
67 
 
50-75 
 
Any 
 
Adequate 
 
Unclear 
 
Inadequate 
 
Inadequate 
 
Adequate 
 
Adequate 
 
No 
 
High 
76. Raine et 
al (2015) 
131,423 134,011 50-74 gFOBT Adequate Adequate Adequate Adequate Adequate Adequate Yes Low 
 
77. 
Resnicow et 
al, (2014) 
 
 
439 
 
442 
 
50-74 
 
Any 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
No 
 
High 
78. Ritvo et 
al (2015) 
2,629 2,611 50-74 Any Adequate Adequate Unclear Adequate Adequate Adequate Unclear Unclear 
 
79. 
Roetzheim 
et al (2004) 
 
 
596 
 
600 
 
50-75 
 
gFOBT 
 
Adequate 
 
Adequate 
 
Adequate 
 
Unclear 
 
Adequate 
 
Adequate 
 
Unclear 
 
Unclear 
 
80. Ruffin et 
al (2007) 
 
 
87 
 
87 
 
>50 
 
Any 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Low 
 
81. 
Salimzadeh 
et al (2014) 
 
 
170 
 
143 
 
>50 
 
Any 
 
Adequate 
 
Inadequate  
 
Inadequate 
 
Inadequate 
 
Adequate 
 
Adequate 
 
No 
 
High 
 
82. Schroy 
et al (2012) 
 
G1: 280 
 
276 
 
50-80 
 
Any 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
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 G2: 269 
 
83. Sequist 
et al (2009) 
 
 
10,930 
 
10,930 
 
50-80 
 
Any 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Yes 
 
High 
 
84. Sequist 
et al (2011) 
 
 
552 
 
551 
 
50-75 
 
Any 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Unclear 
 
Unclear 
 
85. 
Shankleman 
et al (2014) 
 
 
G1: 
2,034 
G2: 
1,852 
 
5,227 
 
59-70 
 
gFOBT 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Yes 
 
High 
 
86. Shaw et 
al (2013) 
 
 
353 
 
320 
 
50-70 
 
Any 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Yes 
 
High 
 
87. Simon et 
al (2010) 
 
 
10,506 
 
10,432 
 
50-64 
 
Any 
 
Adequate 
 
Unclear 
 
Inadequate 
 
Inadequate 
 
Adequate 
 
Adequate 
 
Yes 
 
High 
88. 
Stokamer et 
al (2004) 
 
396 
 
392 
 
>50 
 
gFOBT 
 
Adequate 
 
Adequate 
 
Adequate 
 
Unclear 
 
Adequate 
 
Adequate` 
 
Yes 
 
Unclear 
 
89. Tu et al 
(2006) 
 
 
105 
 
105 
 
50-78 
 
gFOBT 
 
Adequate 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Adequate 
 
Unclear 
 
Unclear 
90. 
Tinmouth et 
al (2014) 
2,008 1,586 50-74 Any  
Unclear 
 
Unclear 
 
Unclear 
 
Adequate  
 
Unclear 
 
Adequate 
 
Unclear 
 
Unclear  
 
91. van 
Roon et al, 
(2011) 
 
 
2,507 
 
2,493 
 
50-74 
 
FIT 
 
Adequate 
 
Adequate 
 
Adequate 
 
Unclear 
 
Adequate 
 
Adequate 
 
No 
 
Unclear 
92. Van 
Roosbroeck 
et al (2012) 
 
 
8,502 
 
11,498 
 
50-74 
 
FIT 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
 
93. Vernon 
et al, (2011) 
 
 
G1: 398 
G2: 413 
 
413 
 
50-70 
 
Any test 
 
Adequate 
 
Inadequate 
 
Inadequate 
 
Adequate 
 
Unclear 
 
Adequate 
 
Yes 
 
High 
  
396 
 
94. Vinker et 
al, (2002) 
 
 
G1: 753 
G2: 312 
G3: 337 
 
913 
 
50-75 
 
gFOBT 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Inadequate 
 
Yes 
 
High 
 
95. Walsh et 
al (2005) 
 
 
 
4,276 
 
3,717 
 
50-79 
 
Any 
 
Adequate 
 
Unclear 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Unclear 
 
High 
 
96. Walsh et 
al (2010) 
 
 
G1: 765 
G2: 768 
 
256 
 
50-79 
 
Any 
 
Adequate 
 
Unclear 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Adequate 
 
Unclear 
 
High 
 
97. Wardle 
et al (2003) 
 
 
1,453 
 
1,513 
 
55-64 
 
FlexiSig 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Yes 
 
Unclear 
98. Wardle 
et al (2016) 
G1: 
84,283 
G2: 
73,450 
G3: 
130,876 
G4: 
77,739 
C1: 
78,791 
G2: 
76,421 
G3: 
133,449 
G4: 
90,002 
60-74 gFOBT  
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
Low 
 
99. 
Weinberg et 
al (2013) 
 
 
G1: 171 
G2: 174 
G3: 176 
G4: 173 
 
171 
 
>50 
 
Any 
 
Unclear 
 
Unclear 
 
Unclear 
 
Unclear 
 
Adequate 
 
Adequate 
 
Yes 
 
Unclear 
100. White 
et al (2015) 
G1: 
9,702 
G2: 
8,623 
G3: 
4,798 
G4: 
5,032 
177,386 60-74 gFOBT  
Unclear 
 
Inadequate 
 
Adequate 
 
Adequate 
 
Inadequate 
 
Inadequate 
 
No  
 
High 
101. Wilson 
et al (2015) 
G1: 
1,137 
G2: 
1,136 
1,135 50-74 gFOBT  
Adequate 
 
Inadequate 
 
Inadequate 
 
Adequate 
 
Adequate 
 
Adequate 
 
Yes 
 
High 
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102. Zapka 
et al (2004) 
 
 
450 
 
488 
 
50-75 
 
Any 
 
Adequate 
 
Inadequate 
 
Unclear 
 
Inadequate 
 
Adequate 
 
Adequate 
 
Yes 
 
High 
Notes. ITT = Intention to Treat, gFOBt = guaiac Faecal Occult Blood test, FIT = Faecal Immunochemical Test, Gs = groups: in the event of a randomised comparative effectiveness trial or clinical trial design 
more than one groups were compared. * Could not be assessed or not reported. ** Process of allocation concealment raised the possibility of selection bias. 
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Appendix 2.9. Comparative effectiveness of health interventions to increase CRC screening uptake across samples. 
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Appendix 2.10. Effect of health interventions on CRC uptake in low SES 
populations. 
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Appendix 2.11. Effect of health interventions on CRC uptake in non-low 
SES populations 
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Appendix 2.12. Confidence intervals calculation for proportions  
a) Full sample Intervention Condition 
In order to determine the confidence interval for the proportion of 
people that were screened in the Full Sample intervention group, the 
following equation was used: 
?̂?  ± 𝑧∗√
 ?̂?(1 − ?̂?)
𝑛
 
Where ?̂?  is the sample proportion, n is the total number of 
observations (i.e. sample size), and z* is a multiplier number derived from the 
normal curve that determines the level of confidence; here z*=1.96 in order to 
obtain a 95% CIs. 
 Sample proportion calculation: 
?̂? = 469,933/919,037 = 0.5113 
 Margin error calculation: 
√
 ?̂?(1−?̂?)
𝑛
=  √0.5113 
(1−0.5113)
919,037
=  √0.5113 
0.4887
919,037
= √0.5113 ∗ 0.00000053 = √0.00000027 =
0.00052  
The margin of error is, z* multiplied by 0.00052. Therefore the margin 
of error is 1.96 * 0.00052 = 0.0010.The 95% CI for the proportion of people 
that obtained screening in the non-low SES control group is 0.5113 (or 
51.13%) plus or minus 0.0010. The lower limit of the interval is 0.5113 - 
0.0010 = 0.5103 or 51.03% and the upper limit is 0.5113 + 0.0010 = 0.5123 
or 51.23%. 
 
b) Full sample Control Condition  
In order to determine the confidence interval for the proportion of 
people that were screened in the Full Sample control group, the following 
equation was used: 
?̂?  ± 𝑧∗√
 ?̂?(1 − ?̂?)
𝑛
 
Where ?̂?  is the sample proportion, n is the total number of 
observations (i.e. sample size), and z* is a multiplier number derived from the 
normal curve that determines the level of confidence; here z*=1.96 in order to 
obtain a 95% CIs. 
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 Sample proportion calculation: 
?̂? = 509,913/1,022,128 = 0.4988 
 Margin error calculation: 
√
 ?̂?(1−?̂?)
𝑛
=  √0.4988 
(1−0.4988)
1,022,128
=  √0.4988 
0.5011
1,022,128
= √0.4988 ∗ 0.00000049 = √0.00000024 =
0.00048  
The margin of error is, z* multiplied by 0.00048. Therefore the margin 
of error is 1.96 * 0.00048 = 0.00094.The 95% CI for the proportion of people 
that obtained screening in the non-low SES control group is 0.4988 (or 
50.29%) plus or minus 0.00094. The lower limit of the interval is 0.4988 - 
0.00094 = 0.49786 or 49.78% and the upper limit is 0.4988 + 0.00094 = 
0.49974 or 49.97%. 
 
c) Non-low SES Intervention Condition 
In order to determine the confidence interval for the proportion of 
people that were screened in the Full Sample intervention group, the 
following equation was used: 
?̂?  ± 𝑧∗√
 ?̂?(1 − ?̂?)
𝑛
 
Where ?̂?  is the sample proportion, n is the total number of 
observations (i.e. sample size), and z* is a multiplier number derived from the 
normal curve that determines the level of confidence; here z*=1.96 in order to 
obtain a 95% CIs. 
 Sample proportion calculation: 
?̂? = 461,435/899,644 = 0.5129 
 Margin error calculation: 
√
 ?̂?(1−?̂?)
𝑛
=  √0.5129 
(1−0.5129)
899,644
=  √0.5129 
0.4871
899,644
= √0.5129 ∗ 0.00000054 = √0.00000028 =
0.000529  
The margin of error is, z* multiplied by 0.000529. Therefore the margin 
of error is 1.96 * 0.000529 = 0.00103.The 95% CI for the proportion of people 
that obtained screening in the non-low SES control group is 0.5129 (or 
51.29%) plus or minus 0.00103. The lower limit of the interval is 0.5129 - 
0.00103 = 0.5127 or 51.27% and the upper limit is 0.5129 + 0.00103 = 
0.5130 or 51.30%. 
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d) Non-low SES control condition 
In order to determine the confidence interval for the proportion of 
people that were screened in the non-low SES control group, the following 
equation was used: 
?̂?  ± 𝑧∗√
 ?̂?(1 − ?̂?)
𝑛
 
Where ?̂?  is the sample proportion, n is the total number of 
observations (i.e. sample size), and z* is a multiplier number derived from the 
normal curve that determines the level of confidence; here z*=1.96 in order to 
obtain a 95% CIs. 
 Sample proportion calculation: 
?̂? = 503,081/1,000,360 = 0.5029 
 Margin error calculation: 
√
 ?̂?(1−?̂?)
𝑛
=  √0.5029 
(1−0.5029)
1,000,360
=  √0.5029 
0.4971
1,000,360
= √0.5029 ∗ 0.00000050 = √0.00000025 =
0.0005  
The margin of error is, z* multiplied by 0.0005. Therefore the margin of 
error is 1.96 * 0.0005 = 0.00098.The 95% CI for the proportion of people that 
obtained screening in the non-low SES control group is 0.5029 (or 50.29%) 
plus or minus 0.00098 (rounded to 0.001 or 0.1%). The lower limit of the 
interval is 0.5029 - 0.001=0.5019 or 50.19% and the upper limit is 0.5029 + 
0.001 = 0.5039 or 50.39%. 
 
e) Low SES intervention condition 
The same equation was applied for calculating the proportion of 
people that were screened in the low SES intervention group: 
 Sample proportion calculation: 
?̂? = 8,498/19,393 = 0.4380 
 Margin error calculation: 
√
 ?̂?(1−?̂?)
𝑛
=  √0.4380 
(1−0.4380)
19,393
=  √0.4380 
0.560
19,393
= √0.4380 ∗ 0.00002888 = √0.00001265 =
0.0035  
The margin of error is, z* multiplied by 0.0035. Therefore the margin of 
error is 1.96 * 0.0035 = 0.00686. The 95% CI for the proportion of people that 
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obtained screening in the low SES intervention group is 0.4380 (or 43.80%) 
plus or minus 0.00686 (rounded to 0.0069 or 0.69%). The lower limit of the 
interval is 0.4380 - 0.0069 = 0.4311 or 43.11% and the upper limit is 0.4380 + 
0.0069 = 0.4449 or 44.49%. 
 
f) Low SES Control condition 
The same equation was applied for calculating the proportion of 
people that were screened in the low SES control group: 
 Sample proportion calculation: 
?̂? = 6,797/21,768 = 0.3122 
 Margin error calculation: 
√
 ?̂?(1−?̂?)
𝑛
=  √0.3122 
(1−0.3122)
21,768
=  √0.3122 
0.6878
21,768
= √0.3122 ∗ 0.0000316 = √0.00000986 =
0.00314  
The margin of error is, z* multiplied by 0.00314. Therefore the margin 
of error is 1.96 * 0.00314 = 0.00615. The 95% CI for the proportion of people 
that obtained screening in the low SES intervention group is 0.3122 (or 
31.22%) plus or minus 0.00615. The lower limit of the interval is 0.3122 - 
0.00615 = 0.3060 or 30.60% and the upper limit is 0.3122 + 0.00615 = 
0.3183 or 31.83%. 
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Appendix 2.13. Correlation analyses to assess potential confounds among 
categorical moderator variables. 
 
1) FULL SAMPLE CORRELATION ANALYSIS (k = 152) 
 There was a significant, negative correlation between ‘free healthcare system’ 
and ‘in person/mixed contact’, r = -.219, k = 152, p =  .007 
 There was a significant, positive correlation between ‘free healthcare system’ 
and individual delivery, r =.170, k = 152, p =  .036 
 There was a significant, negative correlation between ‘free healthcare system’ 
and ‘delivered by a person’, r = -.370, k = 152, p < 0.001 
 There was a significant, positive correlation between ‘free healthcare’ and 
‘single technique’ r = .294, k = 152, p < 0.001 
 There was a significant, positive correlation between ‘free healthcare’ and ‘non 
endoscopic screening’, r = 684, k = .152, p <0.001 
 There was a significant negative correlation between ‘in person/mixed contact’ 
and individual delivery, r =  -.501, k = 152, p < 0.001 
 There was a significant, positive correlation between ‘in person/mixed contact’ 
and ‘delivered by a person’, r = .393, k = 152, p < 0.001 
 There was a significant, positive correlation between ‘in person/mixed contact’ 
and ‘community setting’, r = .232, k = 152, p =  .004 
 There was a significant, negative correlation between ‘in person/mixed contact’ 
and ‘non endoscopic screening’, r =  -.173, k = 152, p =  .033 
 There was a significant, negative correlation between ‘in person/mixed contact’ 
and ‘objective assessment’, r = -.328, k = 140, p < 0.001 
 There was a significant, positive correlation between ‘in person/mixed contact’ 
and ‘high/unclear bias’, r =.210, k = 152, p =.009 
 There was a significant, negative correlation between ‘individual delivery’ and 
‘delivered by person’, r = -.330, k = 152, p < 0.001 
 There was a significant, positive correlation between ‘individual delivery’ and 
‘objective assessment, r =.178, k = 140, p =.036 
 There was a significant, negative correlation between ‘individual delivery’ and 
‘high/unclear bias’, r = -.167, k = 152, p =.039 
 There was a significant negative correlation between ‘ delivered by a person’ 
and ‘single technique’, r = -.245, k = 152, p =.002 
 There was a significant, positive correlation between ‘delivered by a person’ and 
‘community setting’, r =.166, k = 152, p =.041 
 There was a significant, negative correlation between ‘delivered by a person’ 
and ‘non endoscopic screening’, r =-.291, k = 152, p <.001 
 There was a significant, negative correlation between ‘delivered by a person’ 
and ‘objective assessment’, r = -.236, k = 140, p =.005 
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 There was a significant, positive correlation between ‘delivered by a person’ and 
‘high/unclear bias’, r =.162, k = 152, p =.046 
 There was a significant, negative correlation between ‘single technique’ and 
‘reminders’, r = -.191, k = 152, p =.018 
 There was a significant, positive correlation between ‘community setting’ and ‘in 
person/mixed contact’, r =.232, k = 152, p =.004 
 There was a significant, positive correlation between ‘community setting’ and 
‘delivered by person’, r =.166, k = 152, p =.041 
 There was a significant, negative correlation between ‘community setting’ and 
‘objective assessment’, r = -.336, k = 140, p < 0.001 
 There was a significant, positive correlation between ‘non endoscopic 
screening’ and ‘objective assessment, r =.219, k = 140, p =.009 
 There was a significant, negative correlation between ‘objective assessment’ 
and ‘high/unclear’ bias, r = -.219, k = 140, p =.009 
2) NON-LOW SES CORRELATION ANALYSIS (k = 105) 
 There was a significant, negative correlation between ‘free healthcare system’ 
and ‘in person/mixed contact’, r =-.245, k = 105, p =.012 
 There was a significant, positive correlation between ‘free healthcare system’ 
and ‘individual delivery, r = .223, k = 105, p =.022 
 There was a significant, negative correlation between ‘free healthcare system’ 
and ‘delivered by a person’, r = -.286, k = 105, p =.003 
 There was a significant, positive correlation between ‘free healthcare system’ 
and ‘single technique’, r =.305, k = 105, p =.002 
 There was a significant, positive correlation between ‘free healthcare system’ 
and ‘non endoscopic screening’, r =.748, k = 105, p < 0.001 
 There was a significant, negative correlation between ‘in person/mixed contact’ 
and ‘individual delivery’, r = -.524, k = 105, p < 0.001 
 There was a significant, positive correlation between ‘in person/mixed contact’ 
and ‘delivered by a person’, r =.368, k = 105, p < 0.001 
 There was a significant, negative correlation between ‘in person/mixed contact’ 
and ‘single technique’, r = -.199, k = 105, p =.042 
 There was a significant, negative correlation between ‘in person/mixed contact’ 
and ‘non endoscopic screening’, r = -.268, k = 105, p =.006 
 There was a significant, negative correlation between ‘in person/mixed contact’ 
and ‘objective assessment’, r = -.338, k = 96, p =.001 
 There was a significant, negative correlation between ‘individual delivery’ and 
‘delivered by a person’, r = -.425, k = 105, p < 0.001 
 There was a significant, negative correlation between ‘delivered by a person’ 
and ‘single technique’, r = -.227, k = 105, p =.020 
 There was a significant, negative correlation between ‘ delivered by a person’ 
and ‘non endoscopic screening’, r = -.313, k = 105, p =.001 
 There was a significant, negative correlation between ‘community setting’ and 
‘objective assessment’, r = -.349, k = 96, p < 0.001 
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 There was a significant, positive correlation between ‘community setting’ and 
‘high/unclear bias, r =.250, k = 105, p =.010 
 There was a significant, negative relationship between ‘objective assessment’ 
and ‘high/unclear bias’, r = -.206, k = 96, p =.044 
3) LOW SES CORRELATION ANALYSIS (k = 47) 
 There was a significant, positive correlation between ‘free healthcare’ and ‘non 
endoscopic screening’, r =.290, k = 47, p =.048 
 There was a significant, negative correlation between ‘in person/mixed contact’ 
and ‘individual delivery’, r = -.448, k = 47, p =.002 
 There was a significant, positive correlation between ‘in person/mixed contact’ 
and ‘delivered by a person’, r = .360, k = 47, p =.013 
 There was a significant, positive correlation between ‘in person/mixed contact’ 
and ‘community setting’, r =.415, k = 47, p =.004 
 There was a significant, negative correlation between ‘in person/mixed contact’ 
and ‘moderate/high use of theory’, r = -.671, k = 11, p =.024 
 There was a significant, positive correlation between ‘individual delivery’ and 
‘objective assessment’, r =.314, k = 44, p =.022 
 There was a significant, positive correlation between ‘delivered by a person’ and 
‘community setting’, r =.418, k = 47, p =.003 
 There was a significant, negative correlation between ‘single technique’ and 
‘reminders’, r = -.363, k = 47, p =.012 
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Appendix 3.1. Poster for Participant Recruitment 
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Appendix 3.2. Participant Information Sheet 
Participant Information Sheet (15-12-2015, version 2) 
Factors that Influence Participation in Bowel Cancer Screening 
 
Researcher: Anastasia Tsipa, School of Psychology, University of Leeds, UK 
Email: ps11ait@leeds.ac.uk, Phone number: 0113 343 9196 
Supervisors: Professor Daryl O’Connor, Professor Mark Conner & Dr Fiona 
Day 
Supervisors’ Emails: d.b.oconnor@leeds@leeds.ac.uk, 
m.t.conner@leeds.ac.uk, F.day@nhs.net   
Address: School of Psychology, University of Leeds, Leeds, LS2 9JT 
Ethics approval no: 16-0022 
Date of ethical approval: 04/02/2016  
 
Hi! My name is Anastasia and I am a doctoral research student in the School of 
Psychology at the University of Leeds.  I would like to invite you to take part in 
my research study, which is about participation in bowel cancer screening. If 
you are interested, please read the information below carefully and do not 
hesitate to contact me if you would like to ask any questions regarding the 
study. The current research is being organised and funded by the University of 
Leeds in conjunction with the Leeds City Council.  
 
What is the purpose of this study? 
 
The purpose of this research is to understand what factors may influence 
people’s decision to take part in the bowel cancer screening programme. We 
are interested in hearing your thoughts and opinions regarding the home stool 
blood test, as well as your input on how the screening programme could be 
improved in the future. We hope that the project will feed into improving 
opportunities for people of the general public to engage with bowel cancer 
screening, and also inform a range of policy and strategy suggestions relevant 
to improving the delivery of the bowel cancer screening programme as a whole.  
 
Why have I been invited to take part? 
 
You are being invited to take part in this research because you live in Leeds, 
you are registered with a GP, you are aged between 60-74 years and you don’t 
suffer from a chronic bowel illness. Regardless of whether you have completed 
the home stool blood test or not we want to hear from you! If you fit all the 
criteria mentioned above then you are suited to take part in this study.  
 
What does the study involve? 
 
We want to know more about your personal experience with the bowel cancer 
screening process and specifically the home stool blood test. There are two 
phases to this study if you wish to get involved! 
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During the first phase, I will kindly ask you to fill in a brief demographic 
questionnaire that has been given to you along with this information sheet. 
Filling in this questionnaire will confirm whether you are eligible to take part in 
this research. If you haven’t received this questionnaire, or simply can’t find it, 
you will be able to obtain one either by asking a member of staff at the reception 
of your community centre, or you can ask to receive it through the post by 
directly contacting me on 0113 343 9196. Before we start chatting on the phone 
I will state my name (Anastasia Tsipa), the name of my supervisor (Professor 
Daryl O’Connor), and the number of ethical approval. I might also ask you to tell 
me where you saw the study being advertised. When filling in the demographic 
questionnaire you will be asked to provide your contact details (an email or a 
telephone number where I can reach you) so that I can be in touch with you at a 
subsequent time and tell you about the second phase of the research.  
 
If you are eligible and happy to take part then I will contact you to arrange an 
informal one-to-one interview, which is the second phase of the study. The 
interview will take place in a quiet, public venue familiar to you (tea will be 
offered!). I will ask you a series of questions regarding your views and opinions 
about the bowel cancer screening programme, the home test screening kit and 
your participation to bowel cancer screening. There are no right or wrong 
answers. The discussion will last about 30-45 minutes and it will be audio-
recorded with your permission. This is to help me remember all the interview 
information correctly. To thank you for your participation, after the interview is 
completed you will be given £5. I will also need you to sign a receipt to confirm 
that you received the £5. 
 
Will my taking part in this project be kept confidential? 
 
The recordings of the interview will be typed up into a transcript, which will be 
anonymised. This means that all identifying details will either be changed or 
removed, e.g., names of places, people and details of very specific events. 
Transcription of the recordings will be done by the researcher, and the content 
of the interview will be kept confidential. Only the researcher will have access to 
this information. The information from the interview will then be analysed and 
used to complete the final report. Any direct quotations or comments that are 
used in the final report or any subsequent publications will be anonymised. 
Audio-recordings of the discussion will be kept on a secure university computer, 
locked with a username and password. Audio-recordings from the interviews, as 
well as the transcriptions and demographic questionnaires, will be destroyed on 
completion of the research project. 
   
Do I have to take part? 
 
No – it is entirely up to you to decide. If you are interested in participating in the 
study, I will go through this information sheet with you again before the interview 
to make sure you understand what is involved. You can ask me any questions 
before you decide: you can call or email me or ask me on that day of the 
interview. If you choose to take part you are free to stop the discussion at any 
point. If you want to stop the discussion and leave the interview you do not have 
to give a reason. There are no penalties for leaving the interview.  
 
Are there any risks in taking part? 
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I do not expect there to be any significant risks in taking part. In the unlikely 
case you do find any of the questions I ask you uncomfortable or upsetting, 
please remember that you are under no obligation to answer that question and 
you are free to leave at any point without providing a reason.  
 
Are there any benefits in taking part? 
 
Taking part might be interesting and give you the opportunity to talk with 
someone who has conducted extensive research on this topic. Furthermore, if 
you decide to take part you are contributing towards the advancement of 
scientific research, you are taking an active role in your own healthcare and you 
are having your own views expressed and included in research. Most 
importantly, this research aims to provide valuable insight into how to improve 
the delivery of the national bowel cancer, screening programme, so your 
participation is extremely important and voicing your opinion will help me reach 
this goal.  
 
What will happen to the information collected? 
 
All the collected information will be analysed in order to identify common and 
uncommon opinions and views regarding the home test screening kit. A final 
report of the research findings will be produced and presented to the Prevention 
and Early Diagnosis of Cancer group at Leeds City Council and the Health and 
Social Psychology Research group at Leeds University. The final report will 
form part of my doctoral thesis. Findings may also be used in subsequent 
publications and conference presentations. 
Ethics 
 
This research has been approved by the Faculty of Medicine and Health review 
panel, which is monitored by the University of Leeds Ethics Committee. The 
ethical guidelines for this research have been set out by the British 
Psychological Society code of ethics.  
 
More information or complaints? 
If you have any complaints about my contacting you, or anything that happens 
in the discussion, please contact my supervisor Professor Daryl O’Connor 
(project lead) by email on: d.b.oconnor@leeds@leeds.ac.uk or phone: +44 
(0)113 343 5727.   
 
I hope you have enough information about my study, but if you would like to ask 
any questions please do not hesitate to contact me: ps11ait@leeds.ac.uk or 
0113 343 9196. 
 
Thank you for considering taking part in this study. 
Anastasia Tsipa 
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Appendix 3.3. Participant Consent Form  
Consent Form 
 
Research title: Factors that Influence Participation in Bowel Cancer 
Screening: A Qualitative Analysis 
 
 
Researcher: Anastasia Tsipa, School of Psychology, University of Leeds, UK 
Email: ps11ait@leeds.ac.uk, Phone number: 0113 343 9196 
Supervisors: Professor Daryl O’Connor, Professor Mark Conner & Dr Fiona 
Day 
Supervisors’ Emails: d.b.oconnor@leeds@leeds.ac.uk, 
m.t.conner@leeds.ac.uk, F.day@nhs.net   
Address: School of Psychology, University of Leeds, Leeds, LS2 9JT 
Ethics approval no: 16-0022 
Date of ethical approval: 04/02/2016 
The purpose of this form is to make sure that you are happy to take part in the 
research and know what is involved. If you are happy to sign this sheet, please 
confirm each statement by putting your initials in the associated box.  
 
I am between 60-74 years old  
I am a permanent resident of Leeds  
To the best of my knowledge, I do not suffer from a chronic bowel 
illness (including ulcerative colitis, Crohn’s syndrome, irritable bowel 
disorder, bowel cancer) 
 
I am able to travel to my local community centre  
 
I have read the participant information sheet (dated 15-12-2015) or 
had all the information explained to me by the researcher.  
I have read and understood the information sheet (dated 15-12-
2015)  
I have had the opportunity to ask questions and to discuss the 
study.  
I have received satisfactory answers to all of my questions.  
I have received enough information about the study.   
I understand that even after completing this consent form I can 
leave from the discussion at any time without giving a reason.  
I understand that once I take part can only withdraw my responses 
within a strict time period of one month   
I understand that I am free to choose not to answer a question 
without having to give a reason.  
I understand that all my responses will be kept confidential unless I 
disclose information which poses a risk to myself or others   
I agree to the discussion being recorded (e.g., audio-recorded).  
I grant permission for my data to be shared with other researchers 
on the condition that my anonymity will be maintained.  
I grant permission for extracts from the discussion to be used in 
reports of the research (such as journal publications and 
conference presentations) on the understanding that my anonymity  
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will be maintained. 
I understand that my personal information, whether paper or 
electronic, will be stored with adequate security measures and only 
stored for as long as absolutely necessary  
I agree to take part in this study.  
  
Unique participant code: _____________ (if you have forgotten what this is, 
follow instructions below) 
Step 1: Write down the second letter of your mother’s maiden name 
________________ 
Step 2: Write down the last letter of the county in which you were born 
_______________ 
Step 3: Write down the last digit of your home telephone number 
___________________ 
Step 4: Write down the first letter of the month you were born 
_______________________ 
Step 5: Combine it all together to create your personal 4-digit 
code____________________ 
 
For example, Maggie Smith, whose mother’s maiden name is Williams, was born in 
Essex, her home telephone number is 0113 333 3333 and was born in June would 
create the code: IX3J 
 
Participant signature: ________________________ 
Date: _____________________________________ 
Name of researcher: Anastasia Tsipa 
Researcher signature: 
Date: 
Ethics Approval: ____________ 
Ethics Date: _______________ 
Supervisor: Professor Daryl O’Connor 
Contact Details: School of Psychology, University of Leeds 
Email: D.B.O’Connor@leeds.ac.uk 
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Appendix 3.4. Pre-screening Demographic Questionnaire 
Demographic Questionnaire 
 
Research Title: Factors that Influence Participation in Bowel Cancer Screening 
 
Researcher: Anastasia Tsipa, School of Psychology, University of Leeds, UK 
Email: ps11ait@leeds.ac.uk, Phone number: 0113 343 9196 
Supervisors: Professor Daryl O’Connor, Professor Mark Conner & Dr Fiona Day 
Supervisors’ Emails: d.b.oconnor@leeds@leeds.ac.uk, m.t.conner@leeds.ac.uk, 
F.day@nhs.net   
Address: School of Psychology, University of Leeds, Leeds, LS2 9JT 
Ethics approval no: 16-0022  
Date of ethical approval: 04/02/2016 
 
Thank you for agreeing to participate in this study! Before filling out the questionnaire, 
please follow the instructions below in order to create a participant code unique to you. 
This is done to make sure that any information you share with us is completely 
confidential. 
 
HOW TO CREATE YOUR UNIQUE CODE 
 
Follow the following 5 steps carefully 
 
Step 1: Write down the second letter of your mother’s maiden name 
________________ 
Step 2: Write down the last letter of the county in which you were born 
_______________ 
Step 3: Write down the last digit of your home telephone number 
___________________ 
Step 4: Write down the first letter of the month you were born 
_______________________ 
Step 5: Combine it all together to create your personal 4-digit 
code____________________ 
 
For example, Maggie Smith, whose mother’s maiden name is Williams, was born in 
Essex, her home telephone number is 0113 333 3333 and was born in June would 
create the code: IX3J 
 
Contact details (phone/email): __________________________ 
 
NOTE: Responses to any of the following questions is optional. Please feel free 
to decide which sections you wish to complete. 
 
1. Ethnicity (Please select one) 
A. White 
 Welsh/English/Scottish/Northern Irish/British 
 Irish 
 Gypsy or Irish traveller 
 Any other White background (Please specify) 
____________________________________________________ 
 
B. Asian/Asian British 
 Indian 
 Pakistani 
 Bangladeshi 
 Chinese 
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 Any other Asian background (Please specify) 
____________________________________________________ 
 
C. Black/African/Caribbean/Black British 
 African 
 Caribbean 
 Any other Black/African/Caribbean background (Please specify) 
____________________________________________________ 
 
D. Mixed/Multiple Ethnic Groups 
 White & Black Caribbean 
 White & Black African 
 White & Asian 
 Any other Mixed/Multiple ethnic background (Please specify) 
____________________________________________________ 
 
E. Other Ethnic Group  
 Arab 
 Any other ethnic group (Please specify)  
____________________________________________________ 
 
 I would rather not say  
 
2. Age (Please select one) 
 59 or under 
 60-67 
 68-74 
 75 or older 
 I would rather not say 
 
3. Gender (Please select one) 
 Female 
 Male 
 I would rather not say 
 
4. Primary language (Please select one) 
 English 
 Polish 
 Punjabi 
 Hindustani 
 Bengali 
 Gujarati 
 Arabic 
 Other (Please Specify) 
____________________________________________________ 
 
 I would rather not say  
 
5. Are you a permanent resident of Leeds? (Please select one) 
 Yes 
 No 
 I would rather not say 
 
6. If you responded Yes to Question 5, please write down your postcode in the 
space provided 
 
            My postcode: _______________________ 
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 I would rather not say  
 
7. Are you registered with a GP? (Please select one) 
 Yes 
 No 
 I would rather not say 
 
 
8. Have you ever been diagnosed with a gastrointestinal disorder?  
A. If yes, please check any that apply from the following list: 
 Ulcerative colitis 
 Crohn’s disease  
 Irritable bowel syndrome (IBD) 
 Bowel cancer 
 Other gastrointestinal disorder (Please specify) 
___________________________________________________ 
 
 I would rather not say 
 
B. ☐ No, to the best of my knowledge I haven’t been diagnosed with a 
gastrointestinal disorder  
 
9. Do you have a family history of bowel cancer? (Please select one) 
Note. This refers to you having close relative (e.g., parent, sibling) been diagnosed 
with bowel cancer, to the best of your knowledge   
 
 Yes 
 No 
 I would rather not say 
 
10. Have you received an invitation to participate in bowel cancer screening? 
(Please select one)  
 Yes 
 No 
 I’m not sure 
 
11. Have you ever used the home screening kit for bowel cancer? (Please 
select one) 
 Yes 
 No 
 I would rather not say 
 
12. When was the last time you used the home screening kit for bowel 
cancer? (Please select one) 
 Within the last 2 years 
 More than 2 years ago 
 Not applicable  
 I would rather not say 
 
Thank you! 
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Appendix 3.5. Interview Schedule 
 Introduce myself, tell them a bit about the background of my research.  
 Explain the specific study in detail and the stages involved (demographic 
questionnaire, interview).  
 Ask if they have read the information sheet. If not, give time to read 
information sheet. Allow time to respond to questions/clarify any issues. 
 Explain that interviews will be audio-recorded and respond to any 
questions/clarify an issues. Emphasise that data will be kept confidential and 
anonymous. 
 Reaffirm there are no right or wrong answers and that I am only 
interested in their views and thoughts about the bowel cancer screening test kit 
 Ask if there are any further questions 
 Obtain signed consent. 
 Record interview number at the start of the interview.  
 
Opening questions: 
 
 Are you a permanent resident of Leeds? 
 Are you registered with a GP? 
 And would you say you see your GP often? 
 Do you have any chronic health problems or any conditions you are 
dealing with at the moment? 
 Do you have a family history of cancer? 
 Have you ever received an invitation from the NHS for bowel cancer 
screening? 
 Have you ever discussed the screening kit with your GP? 
 Are you familiar with the kit you need to use for the bowel screening test? 
(if people have done the test then a series of questions are asked regarding 
their experience, their views, their feelings, their thoughts, 
suggestions/recommendations etc. If they are not aware of the screening or 
have received it and haven’t done it, discuss with them the process showing 
them the NHS leaflet and the demo kit, describe the steps they need to take to 
complete it and gauge initial reactions to the kit, whether they think it is 
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important, their views on prevention, burden of disease, maintaining good 
health etc.) 
 
Main interview questions: 
 What is your understanding/what do you know about bowel cancer?  
 What do you know about the home test kit for bowel cancer? 
 Why do you think you have been invited to complete this test kit? 
 Did you attempt to complete the test? 
 What was your feeling about completing the test? 
 Could you briefly describe the steps you took to complete the test? 
 When did you complete the test? How many times? 
 Did you understand the procedure of completing the test? 
 What did you think of the instructions?  
 How did you find the process for completing the test? (for repeat 
screeners: did you find it harder or easier the very first time you did the test 
in comparison to subsequent times when you used the test?) 
 What would have made the screening procedure easier? (if participant 
has indicated they found it complicated) 
 Were there any practical difficulties with completing the test? 
 What do you think about a one-stool sample kit compared to the three-
sample kit you have used? 
 If you did not complete the test or did it halfway or did not return it, why 
did you choose not to? 
 What was the main thing that put you off completing the test (for non-
screeners) /motivated you to do the test (for screeners)? 
 What were you feeling after you completed the kit? 
 How did you feel whilst waiting for the results? 
 Do you take part in any other screening programmes? 
 Generally would you say you keep on top of medical tests? 
 Do you think screening is important? Is so, why? If not, why not? 
 Would you say it is a priority for you to be healthy? 
 Do you believe prevention of disease is important? Why or why not? 
 Before you received the bowel screening kit had you heard about it? 
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 Have you discussed about the bowel screening kit with people close to 
you? 
 How do you feel talking about this topic with others? 
 Are you likely to talk with other people about health problems or 
concerns you might have? If so, why? If not, why not?  
 Do you think that bowel cancer is a topic discussed openly?  
 Overall how would you describe the experience of completing the kit? 
 Do you think you will participate in bowel cancer screening in the future? 
 Which aspects of the home test did you like? 
 What do you think would increase the chances of you completing the kit? 
  Do you have any suggestions of how uptake could be improved? 
 How do you think awareness about the bowel cancer screening kit could 
be raised? 
 Do you think it is important to involve communities? 
 What would you like to see happen to raise awareness on this topic in 
your community?  
 What improvements/changes would you like to see in the screening 
programme? 
  Are there any questions you would like to ask or something you would 
like me to clarify? 
Closure of interview:  
 Is there any questions/concerns you would like me to clarify?  
 Would you like to know anything further about my background?  
 Would you like to know more about the study findings once the research 
is completed?  
 Do you know of anybody else that would be interested in taking part? 
 
Thank participants for their participation in the study.  
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Appendix 3.6. Image of gFOBT screening kit 
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Appendix 3.7. Critical Appraisal Tool for Interview-Based Qualitative 
Studies in Psychotherapy/Applied Psychology. 
Evaluation Criteria 
Presence/Applicability  
(Yes, No, 
N/A)* 
Notes Score 
1. Context and purpose -   
Does the paper: -   
a. review relevant literature, 
including previous research 
studies? 
Yes pp.111-115  
Note. Relevant 
literature also 
outlined in Chapter 1 
of the thesis. 
+ 
b. present a rationale for the 
conduct of the study? 
Yes pp.114-115  
Note. Rationale for 
the need to identify 
barriers and 
facilitators to 
screening also 
outline in Chapter 1 
of the thesis.  
+ 
c. state explicitly its 
focus/aims/research 
questions? 
Yes pp.115-116 + 
2. Recruitment    
a. Are the selection criteria, 
and any deviations from 
them, described? 
Yes pp.116-117 + 
b. Is/are the method(s) of 
approaching participants 
reported? 
Yes pp. 118-119 + 
c. Is there any discussion 
about potential participants 
who did not finally take part, 
e.g., reasons for non-
participation, comparison 
with the sample or target 
population? 
No  - 
d. Did the majority of the 
potential participants 
qualified for taking part in 
the study actually take part? 
Yes  + 
e. Did the selection criteria 
and recruitment method 
enable access to a sample 
that allowed for the aims of 
the study to be investigated? 
Yes pp.115-117 + 
Consider: i. the fit between 
the target population and the 
aims of the study 
-   
ii. any bias inherited in the -   
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recruitment method e.g., 
retrospective methods may 
attract only a subgroup of 
the target population—those 
with a high interest in or 
strong feelings toward the 
research topic 
iii. how the final sample 
differs from the target 
population 
-   
f. Is the sample composition 
consistent with the 
methodology used? 
Yes pp.115-124 + 
Consider: i. the diversity and 
size of the sample in relation 
to any explicit requirements 
of the methodology used, 
e.g., requirements for a 
theoretical sample in GT and 
a homogenous sample in 
IPA 
-   
ii. implict or explicit rationale 
for any deviations from the 
above requirements 
-   
3. Situating the sample -   
Does the paper report: -   
a. participants’ age and 
gender? 
Yes pp. 126-127 + 
b. participants’ 
difficulties/presenting 
issues? 
N/A  N/A 
c. the grade or degree of 
experience that the 
therapist/ the professional 
delivering the intervention 
had? 
N/A  N/A 
d. exactly when during/after 
participants’ 
therapy/intervention the data 
was collected, e.g., a month 
after its completion? 
N/A  N/A 
e. any information about the 
recruitment setting(s)? 
   
f. the type and duration of 
the therapy/intervention, 
e.g., theoretical orientation 
of therapy, individual or 
group? 
N/A  N/A 
4. Data collection    
a. Is the interview as a 
method of data collection 
Yes  + 
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compatible with the aims of 
the study? 
Consider: i. the purpose of 
other methods of data 
collection in QR such as 
observations, transcribed 
therapy sessions 
   
ii. differences between 
quantitative and qualitative 
research 
   
b. Does the paper report the 
questions/domains that 
guided data collection? 
Yes pp.117-118 + 
c. Is the content of the 
interview questions 
consistent with the study 
aims? 
Yes p.120, pp. 414-416 + 
d. Is the degree of the 
interview structure 
appropriate to the 
methodology used? 
Yes pp.117-120, pp. 414-
416 
+ 
Consider: i. technical and 
theoretical elements and 
aims of the methodology 
used, e.g., open-ended and 
semi-structured interviews 
are recommended in GT and 
Consensual Qualitative 
Research, respectively 
-   
e. Does the paper report the 
exact form of the original 
data e.g., transcribed 
interviews, video recording? 
Yes p.120 + 
f. Does the paper report any 
procedures for refining the 
data collection method(s), 
including a pilot study? 
Yes p.118 + 
g. Was the data collection 
conducted at an optimal 
time? 
N/A  N/A 
Consider: the time of the 
interview in relation to the 
intervention e.g., one month 
to one year after therapy? 
   
h. Was the interviewer 
independent from the 
delivery of the intervention? 
N/A  N/A 
i. Was the data collection 
setting different from the 
clinic where the participants 
received therapy/the 
N/A  N/A 
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intervention ? 
5. Analysis/Findings    
a. Does the paper report the 
different stages of the data 
analysis? 
Yes pp.120-125 + 
b. Is the reported process of 
analysis consistent with the 
study methodology? 
Yes pp.120-125 + 
Consider: i. a possible 
match between the steps of 
analysis required by the 
methodology and the those 
reported in the paper 
-   
ii. appropriate use of 
language e.g. high-order 
themes are called 
categories in GT and 
superordinate themes in IPA 
-   
c. Is there sufficient data 
presented? 
Yes  + 
Consider: For most themes 
are there in each theme: 
-   
i. extracts from a few 
different participants if 
sample ≥ 8 or 
-   
ii. extracts from half of the 
participants if sample < 8? 
-   
d. Are the themes well 
grounded in the data? 
Yes  + 
Consider: i. the length and 
richness of the extracts 
-   
ii. logical connection 
between data and findings 
-   
e. Are any 
divergent/contradictory data 
presented? 
Yes e.g. views on FIT vs 
gFOBT, favourable 
views towards NHS 
vs medical mistrust 
+ 
f. Is the final structure/frame 
produced by the analysis 
sufficiently synthesised? 
Yes  + 
Consider: i. not excessive 
overlap between themes is 
displayed 
-   
ii. different levels of themes 
are presented, if appropriate 
-   
iii. the themes are grouped 
in such a way that the 
relationships between them 
are displayed 
-   
iv. the level of analysis 
required by each 
-   
  
425 
methodology, e.g., 
interrelations between 
categories is to be 
demonstrated in GT; a small 
number of dense 
superordinate themes is to 
be the final product in IPA 
g. Does the paper make 
consistent use of either 
actual numbers or phrases 
such as “the majority of the 
participants” to indicate the 
prevalence of emerging 
themes in the sampling 
corpus? 
Yes  + 
6. Auditability/Credibility -   
Does the paper: -   
a. mention the use of an 
audit trail? 
No  - 
b. use credibility checks? No  - 
c. check 
therapist’s/practitioner’s 
adherence to the therapy 
modality/intervention 
delivered? 
N/A  N/A 
d. Are the credibility 
methods used appropriate 
for the methodology of the 
study? 
N/A  N/A 
Consider: if the credibility 
methods violate any 
epistemological principles 
inherited in the methodology 
used. e.g., inter-rater 
reliability would violate the 
phenomenological principles 
of IPA 
-   
7. Impact and value    
a. Does the paper link its 
findings to its 
aims/objectives/questions? 
Yes pp.174-181 
Note. This is done in 
further depth in 
Chapter 5 (i.e., 
Discussion) . 
+ 
b. Does the paper link its 
findings to the existing 
literature? 
Yes pp.174-181 
Note. This is done in 
further depth in 
Chapter 5 (i.e., 
Discussion). 
 
+ 
c. Do clinical, practical or 
wider implications emerge 
Yes pp.174-181 (e.g., 
“Indeed the role of 
+ 
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from the findings? personal 
responsibility… 
motivate action to 
change.”).  
d. Do the findings increase 
our theoretical knowledge in 
the field? 
No  - 
e. Does the paper identify 
directions for future 
research? 
Yes pp.175-181 (e.g., p 
180: “This is 
important information 
for consideration in 
the design of 
interventions…repeat 
participation.”) 
Note. Directions for 
future research are 
further discussed in 
Chapter 5.  
+ 
f. Does the paper discuss its 
main limitations? 
Yes p.181 + 
g. Is the reported 
transferability of the findings 
justifiable by the sample? 
No  _ 
Consider: i. selection 
criteria, recruitment 
methods, sample 
composition 
-   
h. Are the analytic claims 
consistent to the aims of the 
methodology used? 
Yes  + 
Consider: the conclusions 
drawn in relation to the 
purpose of the methodology, 
e.g., a paper using thematic 
analysis cannot claim that it 
has developed a theory as 
this would require GT 
-   
8. Reflexivity:    
Have the researchers made 
disclosures regarding their: 
   
a. beliefs/assumptions about 
the under study 
phenomenon? 
No  - 
b. professional 
background/training? 
No  - 
c. relevant theoretical 
perspectives? 
No  - 
d. Have the researchers 
reflected on the impact of 
any of the above on the 
research process? 
Yes (the 
bit that 
has been 
added) 
 + 
  
427 
e. Have the researchers 
referred to a reflective 
journal? 
No  - 
f. Have the researchers 
clarified what is their 
relationship with the 
participants (even if there is 
no relationship)? 
No  - 
9. Ethics    
Has the paper:    
a. kept information that 
could lead to the 
identification of participants 
to a minimum? 
Yes p.120 + 
b. anonymised the service 
from which the data were 
collected? 
N/A  N/A 
c. reported that approval 
was granted by an 
appropriate ethical 
committee? 
Yes p.125 + 
d. avoided the use of 
discriminatory language? 
Yes  + 
Have the researchers 
clarified: 
-   
e. how they tried to ensure 
participants’ welfare?; e.g., 
option for debriefing, 
excluding vulnerable 
individuals 
No  - 
f. how they tried to ensure 
confidentiality of data? 
Yes p.120 + 
g. clarified whether informed 
consent was obtained 
Yes p.118 + 
□Score (0-1)    
*Yes Meets criterion. 
No Does not meet criterion/ Lack of sufficient information. 
N/A Criterion not applicable to the evaluated study. 
Score = .  
Score = 34/56-1034/46= 0.73 High quality
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Appendix 4.1. Participant Information Sheet  
Title of Research: Psychosocial Determinants of Bowel Cancer Screening Uptake 
  
I would like to invite you to take part in a research study. Before you decide if you want 
to participate or not, you should understand what this research will involve. Please read 
the following information carefully. If you have any questions please do not hesitate to 
contact the researchers (you will find their contact details at the end of this page). 
  
What is the purpose of the study?  
 
This study aims to investigate the psychological and social factors that might influence 
bowel cancer screening uptake. It doesn’t matter if you have done the bowel cancer 
screening or not – we want to hear from you either way!  
 
All of the survey questions refer to doing the bowel cancer screening test that is sent to 
you by the NHS every 2 years. When we refer to the bowel cancer screening test we 
mean the home test kit that requires you to collect tiny stool samples on a special card 
on 3 separate days and then send it through the post to the screening laboratory to be 
tested. The purpose of this screening test is to pick up early signs of bowel cancer. 
 
What will I have to do if I take part? 
 
After reading this information sheet, if you choose to take part in this research you will 
first be given a consent form. This consent form requires you to agree to its conditions 
if you are to take part in the study. Then you will be asked to complete a short 
demographic questionnaire that will include some lifestyle questions and also some 
questions about your past screening behaviour. Then you will be asked a few 
questions that you should answer as truthfully as possible.  
Don’t think about your responses too much, there is no right or wrong answer to any of 
the questions. It will take around 15 to 20 minutes to respond to all the questions and 
there will be instructions on each page to guide you through the questionnaire.  
 
Am I eligible to take part? 
 
To take part you must:  
 
1) Be aged between 60 and 74 years 
2) Live in the UK 
3) Have access to the internet 
 
Are there any advantages or disadvantages to taking part? 
 
You will have a chance to enter a prize draw to win 1 of 4 £50 Amazon vouchers at 
the end of the questionnaire.   
 
Some of the information asked for in this research may be considered sensitive by 
some individuals. For example, you will be asked about the bowel screening kit and 
your screening experiences which some people might find unpleasant. If at any stage 
you become distressed by the content of the questionnaire, you may stop the study. 
Responses to all questions are optional and it is completely up to you to decide 
whether you want to respond or not. If you experience any distress during the survey 
you might find it helpful to contact the following support group for any general queries 
you have about bowel cancer and the screening process. If you have any questions or 
concerns about any aspect of bowel cancer or bowel cancer screening, the following 
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organisations can help: Beating Bowel Cancer: 08450 719301 or 020 8973 0011; 
Macmillan Cancer Support: 0808 808 00 00; Cancer Research UK: 0808 800 4040.  
 
You may withdraw your data at any time, without reason or consequence, by emailing 
the researchers with your unique Participant ID code, which you will create once you 
begin the survey. You can withdraw your data until 30/07/2017. At that point data 
analysis will begin and you will no longer be able to withdraw your data. Once you have 
created your Unique Participant ID code, please keep a note of it as you will need it if 
you wish to withdraw from the study.  
 
Will my taking part in the study be kept confidential? 
 
All data collected in this study is completely anonymous and confidential. Data will be 
stored for a maximum of 5 years before being destroyed, but your confidentiality will 
remain throughout this time. Only the researchers will have access to your data but 
they will not be able to identify you. 
 
What will happen to the results of the research study? 
  
Results from this study may be published in a peer-reviewed journal (open access 
where possible) and in the academic work of the researchers. No participants will be 
identifiable in such reports. 
  
Who is organising or funding this research? 
 
The present research is funded by Leeds City Council and has been granted ethical 
approval by the School of Psychology Ethical Review Committee, University of Leeds, 
(ethical approval reference number: 17-0123, ethical approval date: 10-04-2017). 
   
Thank you in advance for your time! 
 
Further information and contact details: 
 
Researcher’s name: Anastasia Tsipa  
Researcher’s email: ps11ait@leeds.ac.uk 
 
Supervisors’ names: Professor Daryl O’Connor, Professor Mark Conner 
Supervisors’ emails: d.b.o’connor@leeds.ac.uk, m.t.conner@leeds.ac.uk 
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Appendix 4.2. Participant Consent Form  
A) Online Consent Form 
 
Title of Study: Psychosocial determinants of bowel cancer screening 
Ethical approval reference number: 17-0123 
Ethical approval date: 10-04-2017 
Researcher’s name: Anastasia Tsipa  
Researcher’s email: ps11ait@leeds.ac.uk 
Researcher’s work phone number: 07514 755392 
 
Supervisors’ names: Professor Daryl O’Connor, Professor Mark Conner 
Supervisors’ emails: d.b.o’connor@leeds.ac.uk, m.t.conner@leeds.ac.uk 
Supervisors’ phone numbers: 0113 343 5727, 0113 343 5720 
 
1. I confirm that I have read and understand the information sheet for 
the above study  
2. I understand that my participation is voluntary and that I am free 
to withdraw the data I have given until 30/07/2017 without providing a 
reason. 
3. I understand that, in the event that I wish to withdraw my data, I will need 
to provide my unique ID code created at the beginning of the survey. 
4. I understand that the data I have given will be kept confidential and only 
those who are granted permission to access it will be able to do so.  I 
give permission for my data to be used for further analysis, to be stored, 
and published. 
5. I understand that relevant sections of my data collected in the study may 
be looked at by the research group. I give permission for these 
individuals to have access to these records and to collect, store, analyse 
and publish information obtained from my participation in this study. I 
understand that my personal details will be kept confidential. 
6. I agree to take part in the above study. 
 
By clicking 'Submit and continue' you will have agreed to all of the above. 
 
B) Paper-based Participant Consent Form  
 
Title of Study: Psychosocial determinants of bowel cancer screening 
Ethical approval reference number: 17-0123 
Ethical approval date: 10-04-2017 
Researcher’s name: Anastasia Tsipa  
Researcher’s email: ps11ait@leeds.ac.uk 
Researcher’s phone number: 07514 755392 
Supervisors’ names: Professor Daryl O’Connor, Professor Mark Conner 
Supervisors’ emails: d.b.o’connor@leeds.ac.uk, m.t.conner@leeds.ac.uk 
Supervisors’ phone numbers: 0113 343 5727, 0113 343 5720 
 
The purpose of this form is to make sure that you are happy to take part in 
the research and know what is involved. If you are happy to sign this 
sheet, please confirm each statement by putting your initials next to each 
sentence.  
  
431 
  
1. I confirm that I have read and understood the information sheet for the above 
study _________________ 
 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
the data I have given until 30/07/2017 without providing a reason. 
______________ 
 
3. I understand that, in the event that I wish to withdraw my data, I will need to 
provide my unique ID code created at the beginning of the 
survey.___________ 
 
4. I understand that the data I have given will be kept confidential and only those 
who are granted permission to access it will be able to do so.  I give 
permission for my data to be used for further analysis, to be stored, and 
published. _________ 
 
5. I understand that relevant sections of my data collected in the study may be 
looked at by the immediate research group. I give permission for these 
individuals to have access to these records and to collect, store, analyse and 
publish information obtained from my participation in this study. I understand 
that my personal details will be kept anonymous and confidential. 
____________ 
6. I agree to take part in the above study._____________ 
 
Participant Signature: _______________ 
Participant Name (please print): _________________ 
Date: ________________ 
Researcher Signature: _______________ 
Researcher Name: _________________ 
Date: ________________ 
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Appendix 4.3. Survey Questionnaire 
Title of Research: Psychosocial Determinants of Bowel Cancer Screening 
Uptake 
 
Hello and thank you for taking the time out of your day to complete this survey. 
This research is subject to ethical guidelines set out by the British Psychological 
Society and has received ethical approval from the School of Psychology 
Research Ethics Committee, Faculty of Medicine and Health at the University of 
Leeds  (ref no: 17-0123); date approved: 10/04/2017). 
 
All of the survey questions refer to doing the home stool test that is sent to you 
by the NHS every 2 years. This screening test requires you to collect tiny stool 
samples on a special card and then send it through the post to the screening 
laboratory to be tested. The purpose of this screening test is to pick up early 
signs of bowel cancer. 
 
INSTRUCTIONS:  
1) Please ensure you have read the information sheet before 
completing the questionnaire 
2) Please ensure you have read and completed the consent form  
3) Please follow the instructions carefully for each question and 
respond as honestly as possible.  
Thank you. 
 
1. How old are you? Please write in years. 
  ____________________________ 
2. What is your gender?                
Male       
Female    
Other______ 
 
3. What is your primary language? (Please select one box only) 
English    
Punjabi    
Farsi    
Gujarati    
Polish    
Hindustani    
Bengali    
Arabic    
Urdu    
Other ______ 
 
4. Do you live permanently in the UK? (Please select one) 
Yes    
No    
 
5. Please write in your postcode: __________________ 
 
6. Are you registered with a GP? (Please select one) 
Yes    
No    
I would rather not say    
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7. How would you classify yourself? 
 
 
 
 
8. What is the highest level of education you have completed? (Please select 
one) 
GCSE O level or equivalent   ☐ Postgraduate degree   ☐ 
GCSE A level or equivalent   ☐ No educational qualification   ☐ 
Vocational training 
certificate/diploma ☐ 
Other ______ 
Undergraduate degree ☐ 
 
 
 
9. Occupation 
 
a) Do you supervise any other employees? Please one box only. 
Yes   ☐ 
No   ☐ 
 
b) Which one of the following occupational groups best describes what you do (or 
did before you retired)? Please  one box only 
White/Caucasian  Black or Black 
British 
Chinese or other ethnic 
group 
British   ☐ Caribbean   ☐ Chinese   ☐ 
Irish  ☐ African   ☐ Other   ☐ 
Other ______ Other ______  Other ______ 
   
Mixed Asian or Asian 
British 
 
White and Black 
Caribbean   ☐ 
Indian   ☐  
White and Black 
African   ☐ 
Pakistani   ☐  
White and Asian   ☐ Bangladeshi  ☐   
Other ______ Other ______  
 
   Unemployed 
   Homemaker   
   Retired  
   Voluntary worker 
   Modern professional occupations 
      e.g., teacher, nurse, social worker, 
welfare officer, police officer 
   Clerical & intermediate occupations  
      e.g., secretary, personal assistant, 
clerical worker, office  clerk, call  centre 
agent, nursery nurse, nursing auxiliary 
   Senior managers or administrators  
      Usually responsible for planning, 
organizing and coordinating work  and for 
finance, e.g. finance manager, chief 
executive 
   Semi-routine manual and service 
occupations 
      e.g., postal worker, machine operative, 
security guard, caretaker,  farm worker, 
catering assistant, receptionist, sales 
assistant 
   Routine manual and service 
occupations  
      e.g., HGV driver, van driver, cleaner, 
porter, packer, sewing machinist, 
messenger, labourer, waiter / waitress, bar 
staff 
   Middle or junior managers  
       e.g., office manager, retail manager, 
bank manager,  restaurant manager, 
warehouse manager, publican 
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10. W
h
at is your marital status? (please  one box only) 
Married/civil partnership    
Living with your partner but not married    
Widowed    
In a relationship but not married or living with partner    
Single    
Separated/Divorced  
 
11. To the best of your knowledge do you have a family history* of bowel 
cancer? 
   *Note: This refers to you having a close relative (e.g., parent, sibling) with 
bowel cancer 
   Yes    
   No    
 
12. Have you received an invitation to participate in bowel cancer screening? 
(Please select one)  
Yes    
No  
I’m not sure    
 
13. Have you ever used the home screening kit for bowel cancer? (Please 
select one) 
Yes    
No   
I would rather not say    
 
a) If you responded ‘yes’ to Question 12, have you ever had a result that was 
unclear or positive? 
Yes, I have had an unclear result    
Yes, I have had a positive result    
I have had both an unclear and a positive result    
Other ______ 
 
14. When was the last time you used the home screening kit for bowel 
cancer? (Please select one) 
Within the last 2 years    
More than 2 years ago    
Not applicable (please provide reason if not applicable: ________) 
I would rather not say   
Other_____ 
 
15. How would you say your health is at the moment? 
Very poor    
Poor    
Fair    
Good    
Very good    
 
16. How easy do you find it to understand leaflets and letters about your 
health? 
Very easy    
    Technical and craft occupations 
        e.g., motor mechanic, fitter, inspector, 
plumber, printer, tool maker, electrician, 
gardener, train driver 
 
   Traditional professional occupations  
       e.g., accountant, solicitor, medical 
practitioner, scientist, civil / mechanical 
engineer. 
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Fairly easy    
Fairly difficult    
Very difficult    
 
17. As far as you are aware, which of the following are symptoms of bowel 
cancer? Please select all that apply. 
 
1. Blood in the stool    
2. Change of bowel habit    
3. Diarrhea or constipation     
4. Pain in abdomen    
5. Pain in back passage    
6. Bleeding in back passage   
7. Bowel does not empty    
8. Unexplained weight loss    
9. Tiredness    
10. Lump in abdomen    
 
18. As far as you are aware, which of the following are risk factors for bowel 
cancer? Please select all that apply. 
 
1. Older age    
2. Close relative with bowel cancer     
3. Drinking alcohol    
4. Low physical activity    
5. Low intake of fruits or vegetables    
6. High intake of fatty food    
7. Red and processed meat    
8. Overweight    
9. Diabetes    
10. Bowel disease    
 
19. How many chronic illnesses, if any, do you have at the moment? Examples 
of chronic illnesses include arthritis, asthma, cancer, diabetes, heart disease, 
multiple sclerosis etc. 
 
0    
1   
2   
3    
4+    
 
20. Please tick the box that best suits your answer. Doing the bowel cancer 
screening test is… 
 
Useful ☐  ☐  ☐  ☐  ☐  ☐  ☐ Useless 
Beneficial  ☐  ☐  ☐  ☐  ☐  ☐  ☐ Harmful 
Pleasant ☐  ☐  ☐  ☐  ☐  ☐  ☐ Unpleasant 
Disgusting ☐  ☐  ☐  ☐  ☐  ☐  ☐ Not disgusting 
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21. Below is a list of statements relating to bowel cancer and the bowel 
cancer screening test. Please circle the number describing the extent to 
which you agree or disagree with each statement. 
 
 Statement 
Disagree 
strongly 
Disagree 
moderately 
Disagree 
a little 
Neither 
agree 
nor 
disagree 
Agree 
a little 
Agree 
moderately 
Agree 
strongly 
1 
My chances of 
getting bowel cancer 
are great 
1 2 3 4 5 6 7 
2 
I worry a lot about 
getting bowel cancer 
1 2 3 4 5 6 7 
3 
If I had bowel cancer 
my whole life would 
change  
1 2 3 4 5 6 7 
4 
Problems I would 
experience from 
bowel cancer would 
last a long time  
1 2 3 4 5 6 7 
5 
Doing the bowel 
cancer screening test 
prevents future 
problems for me 
1 2 3 4 5 6 7 
6 
Doing the bowel 
cancer screening test 
will give me peace of 
mind about it  
1 2 3 4 5 6 7 
7 
I find it embarrassing 
to do the bowel 
cancer screening test  
1 2 3 4 5 6 7 
8 
I find it disgusting to 
do the bowel cancer 
screening test  
1 2 3 4 5 6 7 
9 
Doing the bowel 
cancer screening test 
is too time-
consuming 
1 2 3 4 5 6 7 
10 
I find it hard to 
remember to do the 
bowel cancer 
screening test 
1 2 3 4 5 6 7 
11 
I find the instructions 
of the bowel cancer 
screening test 
confusing 
1 2 3 4 5 6 7 
12 
I find it difficult to 
collect the stool 
samples for the 
bowel cancer 
screening test 
1 2 3 4 5 6 7 
13 
Not having privacy at 
home makes it 
difficult for me to do 
the bowel cancer 
screening test 
1 2 3 4 5 6 7 
14 
If I found out I had 
bowel cancer, the 
idea of treatment for 
it scares me 
1 2 3 4 5 6 7 
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15 
I think it is pointless 
to do the bowel 
cancer screening test 
if I haven’t 
experienced any 
symptoms 
1 2 3 4 5 6 7 
16 
It is pointless to do 
the bowel cancer 
screening test 
because if I had it, it 
would already be too 
late for treatment 
1 2 3 4 5 6 7 
17 
I don’t know much 
about bowel cancer 
as a disease 
1 2 3 4 5 6 7 
18 
I am confident that I 
can do the bowel 
cancer screening test 
even if I find it difficult 
1 2 3 4 5 6 7 
19 
I am confident that I 
can do the bowel 
cancer screening test 
even if I don’t like 
doing it 
1 2 3 4 5 6 7 
20 
Doing the bowel 
cancer screening test 
is up to me  
1 2 3 4 5 6 7 
21 
Doing the bowel 
cancer screening test 
is in my control 
1 2 3 4 5 6 7 
22 
Doing the bowel 
cancer screening test 
would help keep me 
healthy for my loved 
ones 
1 2 3 4 5 6 7 
23 
Doing the bowel 
cancer screening test 
would help prevent 
me from needing 
painful treatment 
1 2 3 4 5 6 7 
24 
Doing the bowel 
cancer screening 
tests does not 
guarantee I won’t get 
bowel cancer in the 
future 
1 2 3 4 5 6 7 
25 
People who are 
important to me want 
me to do the bowel 
cancer screening test 
1 2 3 4 5 6 7 
26 
People who are 
important to me have 
done the bowel 
cancer screening test 
1 2 3 4 5 6 7 
27 
I intend to do the 
bowel cancer 
screening test 
1 2 3 4 5 6 7 
28 
I expect to do the 
bowel cancer 
screening test 
1 2 3 4 5 6 7 
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29 
Using the bowel 
cancer screening kit 
will help detect 
problems so they can 
be treated earlier 
1 2 3 4 5 6 7 
30 
I would be more 
likely to do the bowel 
cancer screening  
test if I had practical 
support from others 
1 2 3 4 5 6 7 
31 
I would be more 
likely to do the bowel 
cancer screening test 
if I had emotional 
support from others 
1 2 3 4 5 6 7 
32 
I feel confident in 
understanding written 
health information  
1 2 3 4 5 6 7 
33 
If you don’t have your 
health you don’t have 
anything 
1 2 3 4 5 6 7 
34 
There are many 
things I care more 
about than my health  
1 2 3 4 5 6 7 
35 
Good health is only 
of minor importance 
in a happy life  
1 2 3 4 5 6 7 
36 
There is nothing 
more important than 
good health  
1 2 3 4 5 6 7 
37 
I would do the bowel 
cancer screening 
test, if I only had to 
collect one stool 
sample instead of 
three samples on 
three different days 
1 2 3 4 5 6 7 
38 
I would not find it 
embarrassing to 
collect one stool 
sample instead of 
three samples on 
three different days  
1 2 3 4 5 6 7 
39 
I see myself as 
dependable and self-
disciplined 
1 2 3 4 5 6 7 
40 
I see myself as 
anxious and easily 
upset 
1 2 3 4 5 6 7 
41 
I see myself as 
disorganised and 
careless 
1 2 3 4 5 6 7 
42 
I see myself as calm 
and emotionally 
stable 
1 2 3 4 5 6 7 
